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Abstract 
The high demand for biopharmaceuticals has been met thanks to improved 
upstream productivity. Downstream, which has not advanced at the same pace, 
calls for new clarification strategies to cope with the increased process-related 
impurities associated with upstream improvements.   
This thesis has focused on the implementation of polyelectrolyte flocculation 
between centrifugation and depth filtration during the primary recovery of a 
monoclonal antibody Chinese hamster ovary (CHO) cell process. A 
high-throughput, automated ultra scale-down (USD) flocculation methodology 
was developed with industrial relevance in mind for process development 
activities. The impact flocculation had on depth filtration and protein A 
chromatography performance was subsequently investigated and supported by 
analytical assays and techniques to assess impurity removal. 
Cell densities at time of harvest > 20x106 cells.mL-1 were critical for flocculation 
to occur on centrifuged CHO cell cultures. Flocculant addition time limited the 
flocculation scale-up success between two vessels with different geometrical 
ratios and working volumes (1.5 L and 800 µL). The influence of mixing time 
scales (macromixing, mesomixing and micromixing) on this variable defined the 
USD flocculation scale-up basis, which was: predominance of micromixing in the 
vessels (flocculant addition time scale-up) and constant power input per unit 
volume (impeller speed scale-up).  
The implementation of constant pressure, single-layer USD filtration methods 
with flocculated feeds was precluded due to the low filter capacity values 
obtained (< 35 L.m-2). In contrast, constant flux filtration with multi-layer depth 
filters at laboratory scale reached manufacturing-scale filter capacity values 
(> 490 L.m-2). Flocculation achieved larger depth filtration capacities and lower 
process-related impurities before protein A chromatography when compared to 
the current manufacturing processing option. Post-protein A chromatography, 
the clear eluate obtained with flocculation contrasted with the turbid eluate of 
the current processing option. Mass spectrometry data confirmed the turbid 
eluate was mainly constituted of negatively charged CHO cell protein 
precipitates.   
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Nomenclature 
A Effective filtration area (m2) 
Absλ  Absorbance at λ nm wavelength (A.U.) 
a Constant for the minimum asymptote in a four parameter logistic 
non-linear regression model 
b Constant for the steepness of the curve in a four parameter logistic 
non-linear regression model 
C  Clearance from the vessel bottom to the impeller (m) 
CHx  Constant domain on the heavy chain of an immunoglobulin G where 
x = 1, 2 or 3 
CL  Constant domain on the light chain of an immunoglobulin G 
c Correction factor to account for non-ideal flow inside the centrifuge 
Db  Baffle diameter (m) 
Di  Impeller diameter (m) 
Dm  Diameter of the magnetic disc (m) 
DT  Tank or vessel diameter (m) 
Dt  Turbulent diffusivity (m2.s-1) 
d Constant for the inflection point of the curve in a four parameter 
logistic non-linear regression model 
di Internal diameter of the pipe/tip used for reagent addition (m) 
dx Particle size characteristic descriptor where x = 10, 50 or 90 (µm) 
dV/dt Instantaneous volumetric flow rate (m3.s-1) 
E Correction factor to account for the deceleration time in a 
bench-top centrifuge 
Nomenclature 
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e Constant for the maximum asymptote in a four parameter logistic 
non-linear regression model 
F Correction factor to account for the acceleration time in a 
bench-top centrifuge 
Fc  Effector part of an immunoglobulin G 
FV Variable region of an immunoglobulin G responsible for selectivity 
in antigen binding 
Fv,i Percentage volume frequency particle size distribution in the i 
particle size interval  
Ḡ  Average shear rate (s-1) 
g  Gravitational acceleration (m.s-2) 
Hb  Distance between the baffle and the vessel’s wall (m) 
Hib  Height of the impeller blade (m) 
HL  Height of the liquid level in a vessel (m) 
I  Intensity of the emerging radiation (cd) 
I0  Intensity of the incident radiation (cd) 
J  Filter flux rate (L.m-2.h-1) 
K Constant for the theoretical calculation of the characteristic large 
eddy disintegration mesomixing time 
KB Equilibrium constant of the reaction between iodine and iodide 
ions to form triiodide (m3.mol-1) 
l Path length of the beam of light through the sample or path length 
of the cuvette (m) 
N  Impeller speed (s-1) 
n Number of separation discs in the stack of a disc-stack centrifuge 
Nomenclature 
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nf  Number of feed points in a vessel 
nx  Number of moles of species x (mol) 
OD600  Optical density at 600 nm wavelength (A.U.) 
ODf Optical density of the feed material prior to centrifugation (A.U.) 
ODs  Optical density of the centrifuge supernatant (A.U.) 
ODws Optical density of the best possibly clarified centrifuge supernatant 
or well-spun (A.U.) 
P  Power input (W) 
P0  Impeller power number 
Pi  Inlet pressure during constant flux filtration (bar) 
pH*  Iodine dismutation pH 
Q  Volumetric filtrate flow rate (m3.s-1) 
Q0  Initial volumetric filtrate flow rate (m3.s-1) 
Q0
∗  Initial volumetric filtrate flow rate per unit filter area (L.m-2.s-1) 
Qb Feed rate at which an external fluid is added into a mixing vessel in 
semibatch operation mode (m3.s-1) 
Qx Centrifuge volumetric flow rate (m.s-1) where x = lab (bench-top 
centrifuge), ds (disc-stack centrifuge), tub (tubular bowl 
centrifuge) 
Re  Reynolds number 
Rf  Filter resistance (m-1) 
r* Ratio between the distance from the vessel’s central vertical axis to 
the feed point and the vessel radius 
r1 Bench-top centrifuge inner radius (m) 
Nomenclature 
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r2 Bench-top centrifuge outer radius (m) 
ri Disc-stack centrifuge separation disc inner radius (m) 
ro Disc-stack centrifuge separation disc outer radius (m) 
S Correction factor for the area occupied by the caulks in a disc-stack 
centrifuge 
T Temperature (K or °C) 
t Filtration time (s) 
t0 Filtration time when the star-up phase is completed during ultra 
scale-down constant pressure filtration (s) 
tc Circulation time (s) 
tcrit Critical addition time (s) 
td Characteristic turbulent dispersion mesomixing time (s) 
te Characteristic micromixing time (s)  
tf Feed or reagent addition time (s) 
tm Characteristic macromixing time (s) 
ts Characteristic large eddy disintegration mesomixing time (s) 
u̅ External fluid velocity in the vicinity of the feed pipe through which 
the reagent is added into the mixing vessel (m.s-1) 
u̅r Mean radial velocity component of u̅ (m.s-1) 
u̅t Mean tangential velocity component of u̅ (m.s-1) 
ur Radial component of the fluid velocity relative to the tip speed 
ut Tangential component of the fluid velocity relative to the tip speed 
V Filtrate volume (m3) 
V* Cumulative filtrate volume per unit filter area (L.m-2) 
Nomenclature 
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V0
∗ Cumulative filtrate volume per unit filter area when the start-up 
phase is completed during ultra scale-down constant pressure 
filtration (L.m-2) 
V%,i Percentage volume particle size distribution in the i particle size 
interval  
VB Volume of reagent added into the flocculation mixing vessel (m3) 
VH Variable domain on the heavy chain of an immunoglobulin G 
VL  Variable domain on the light chain of an immunoglobulin G 
Vl  Vessel’s liquid working volume (m3) 
Vlab Volume of material in a centrifuge tube when using a bench-top 
centrifuge (m3) 
Vmax
∗  Maximum predicted filtration throughput before complete filter 
plugging (L.m-2) 
vg Speed of a small spherical particle suspended in a viscous fluid and 
under a gravitational field (m.s-1) 
vtip  Impeller tip speed (m.s-1) 
Wi  Width of the i particle size interval  
Wib  Width of the impeller blade (m) 
X1 Extent of the reaction between borate ions and acid to form boric 
acid 
X2  Extent of the Dushman reaction 
XS  Fluid segregation index 
[x]  Molar concentration of species x (mol.m-3) 
[x]0  Initial molar concentration of species x (mol.m-3) 
Nomenclature 
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YS Yield of the Dushman reaction under imperfect micromixing 
conditions 
YST Yield of the Dushman reaction under perfect micromixing 
conditions 
Greek letters 
Γ  Torque force (N) 
ΔP Pressure drop across the filter (Pa) 
Λc Macroscale concentration (m) 
Σ Equivalent settling area of a centrifuge (m2) 
Φ Relative local energy dissipation rate 
α Constant in the linearised filtration models for constant pressure 
and constant flux filtration 
β Constant in the linearised filtration models for constant pressure 
and constant flux filtration 
δ Constant in the linearised filtration models for constant pressure 
and constant flux filtration 
ε Local turbulent energy dissipation rate per unit mass of 
fluid (W.kg-1) 
ελ Molar extinction coefficient at λ nm wavelength of the species being 
quantified in the sample (m2.mol-1) 
εavg  Average turbulent energy dissipation rate per unit mass of 
fluid (W.kg-1) 
εmax  Maximum turbulent energy dissipation rate per unit mass of 
fluid (W.kg-1) 
θ Separation disc half angle in a disc-stack centrifuge (radians) 
μ Fluid dynamic viscosity (Pa.s) 
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ν Fluid kinematic viscosity (m2.s-1) 
ρ Liquid density (kg.m-3) 
ω Radial velocity in a centrifuge (s-1) 
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Abbreviations 
ACN   Acetonitrile 
ADC   Antibody Drug Conjugate 
ATPS   Aqueous Two-Phase System 
BCA   Bicinchoninic Acid 
CFD   Computational Fluid Dynamics 
CGMPs  Current Good Manufacuring Practices 
CHO   Chinese Hamster Ovary 
CMO   Contract Manufacturing Organisation 
CV   Column Volume 
dAb   domain Antibody 
DNA   Deoxyribonucleic Acid 
DSP   Downstream Processing 
EBA   Expanded Bed Adsorption chromatography 
EDD Engulfment-Deformation-Diffusion mechanistic model for 
micromixing time 
EMA   European Medicines Agency 
Fab   Fragment of antibody 
FDA   Food and Drug Administration 
G3PDH  Glyceraldehyde-3-Phosphate Dehydrogenase 
GRP78   78 kDa Glucose-Regulated Protein or Chaperone BiP 
GS   Glutamine Synthetase 
HCD   High Cell Density 
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HCP   Host Cell Protein 
HPLC   High Performance Liquid Chromatography 
HTP   High-Throughput 
IEM Interaction by Exchange with the Mean mechanistic model 
for micromixing time 
IgG   Immunoglobulin G 
LCD   Low Cell Density 
LC-MS/MS Liquid Chromatography – Mass Spectrometry/Mass 
Spectrometry 
mAb   monoclonal Antibody 
MALDI-TOF/TOF Matrix-Assisted Laser Desorption/Ionisation - Time Of 
Flight - Time Of Flight 
MES   2-(N-morpholino)ethanesulfonic acid 
MW   Molecular Weight 
MWCO  Molecular Weight Cut-Off 
NFF   Normal Flow Filtration 
NTU   Nephelometric Turbidity Units 
PBS   Phosphate Buffered Saline 
pDADMAC  poly-(Diallyldimethylammonium) Chloride 
PEG   Polyethylene Glycol 
PEI   Polyethylenimine 
ppm   parts per million 
PSD   Particle Size Distribution 
PTFE   Polytetrafluoroethylene 
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QbD   Quality by Design 
sdAb   single domain Antibody 
SDS-PAGE Sodium Dodecyl Sulphate - Polyacrylamide Gel 
Electrophoresis 
STR   Stirred Tank Reactor 
TFA   Trifluoroacetic Acid 
TFF   Tangential Flow Filtration 
TMP   Transmembrane Pressure 
UF/DF   Ultrafiltration/Diafiltration 
USD   Ultra Scale-Down 
USP30   Ubiquitin carboxyl-terminal hydrolase 30 
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1. Introduction 
1.1. Antibodies for Therapeutic Use 
Therapeutic monoclonal antibodies (mAbs) have demonstrated a considerable 
level of success in the pharmaceutical market (see Section 1.1.3). Their success 
as drugs relies upon the robust and flexible nature of immunoglobulins (IgGs) 
(Chames et al., 2009; Elvin et al., 2013). Therapeutic mAbs were made possible 
when in 1975 Georges Köhler and César Milstein immortalised hybridoma cells 
that were secreting antibody of a predefined specificity (Chames et al., 2009; 
Salemi et al., 2015). The early therapeutic mAbs faced immunogenicity and 
efficacy problems due to their murine nature (Chames et al., 2009). However, 
advancements in molecular biology in the early 90s resulted in optimised mAbs 
of improved immunogenicity, efficacy and potency; cloning the IgG genes in 
eukaryotic expression vectors, molecular evolution procedures and in vitro 
selection methods were key to mAb evolution (Chames et al., 2009; Hoogenboom 
and Chames, 2000). Further improvements in molecular and genetic engineering 
allowed mAbs to evolve from murine molecules to chimeric (i.e. 70 % human with 
a fully human Fc portion), humanised (i.e. 85-90 % human) and fully human 
antibodies (Chames et al., 2009).  
1.1.1. Monoclonal Antibody (mAb) Structure 
Therapeutic mAbs are IgG molecules with a molecular weight (MW) around 150 
kDa composed of two identical heavy and light chains linked by disulphide bonds 
and carrying post-translational modifications such as glycosylations (see Figure 
1.1) (Chames et al., 2009; Chan and Carter, 2010). There are four subclasses or 
isotypes of IgG (IgG1 to IgG4), which differ in the number and position of the 
disulphide bonds (Seiler et al., 1985). Each heavy chain (MW ~ 50 kDa) contains 
a variable domain (VH) and three constant domains (CH1, CH2 and CH3). Each light 
chain (MW ~ 25 kDa) is constituted of a variable domain (VL) and a single 
constant domain (CL) (Chan and Carter, 2010; Sommerfeld and Strube, 2005). 
According to their functions, the mAb can be further divided into the Fc and Fv 
regions (see Figure 1.1). The Fv region is in charge of selectively binding to the 
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antigen by the variable domains. The Fc region is the effector part of the antibody 
and interacts either with the Fc receptors for IgG on effector cells or with the 
complement component C1q triggering different immunological responses inside 
the patient’s body (Brekke and Sandlie, 2003; Chan and Carter, 2010; Elvin et al., 
2013). For in-depth descriptions of the mechanisms of action used by therapeutic 
mAbs the reader is referred to Chames et al. (2009) and Chan and Carter (2010).  
 
Figure 1.1. Structure and key features of an IgG molecule.   
All IgG molecules consist of two identical light chains and two identical heavy 
chains. The heavy chains, which are constituted of one variable domain (VH) and 
three constant domains (CH1, CH2 and CH3) each, are covalently linked in the hinge 
(i.e. flexible) region. The light chains, which contain one variable domain (VL) and a 
single constant domain (CL), are covalently linked to the heavy chain via their 
constant domain. Antigen recognition and binding is effectuated by the 
complementarity determining regions (CDR) of the light and heavy chain variable 
domains. The Fc region, which carries the post-translational glycosylation, is in 
charge of effectuating the cellular immunological responses. Figure adapted from 
Brekke and Sandie (2003) and Chan and Carter (2010).  
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1.1.2. Therapeutic mAbs and Antibody-Related Molecules 
1.1.2.1. Therapeutic mAbs 
The molecular structure of mAbs has been described in Section 1.1.1. Therapeutic 
mAbs are large proteins derived either from immunisation of unmodified or 
transgenic animals, or from display technologies that use libraries of IgG nucleic 
acid sequences from a variety of sources (Chan and Carter, 2010; Elvin et al., 
2013).  
Most clinical studies have shown that large amounts of therapeutic mAb need to 
be injected into the patients to achieve clinical efficacy (Chames et al., 2009). To 
improve their therapeutic action, the Fc region or the carbohydrate composition 
of the glycosylation post-translational modification (see Figure 1.1) is engineered 
resulting in the  ‘next generation mAbs’ (Chames et al., 2009; Chan and Carter, 
2010).  
1.1.2.2. IgG-Based Bispecific Antibodies 
Another strategy to further increase the clinical potential of mAbs is the 
generation of bispecific antibodies, where monospecific mAbs are engineered to 
bind a second antigen while maintaining high affinity for the first antigen (Chan 
and Carter, 2010). To obtain these IgGs the VL and VH domains (see Figure 1.1) 
are modified with variable domains of a second antigen-binding specificity, or by 
linking a single variable domain with a second specificity to the IgG (Chan and 
Carter, 2010).   
1.1.2.3. Antibody Fragments (Fabs) 
Fragments of antibody are mAb fragments that lack the effector function (i.e. Fc 
region) but retain the binding activity of a full-size IgG (Chames et al., 2009; Chan 
and Carter, 2010). They are constituted by the entire IgG light chain (VL and CL) 
and the variable (VH) and CH1 constant domains of the IgG heavy chain (see   
Figure 1.1). Antibody fragments do not carry any post-translational modification 
and can be functionally expressed in Escherichia coli (Brekke and Sandlie, 2003). 
Because of their reduced size, these therapeutic molecules overcome the 
limitations of full-size mAbs to penetrate the target tumors (Chames et al., 2009). 
1. Introduction 
 33 
 
However, their serum half-life is shorter than that of full-size mAbs and they are 
rapidly eliminated by renal clearance (Chames et al., 2009; Chan and Carter, 
2010). Nonetheless, their small size makes Fabs suitable for 
radioimmunotherapy and imaging applications (Chames et al., 2009).  
1.1.2.4. Domain Antibodies (dAbs) 
Single domain antibodies (sdAb), also referred to as scFv (single chain Fv region), 
are monovalent molecules comprising the variable domains of the IgG heavy and 
light chains (i.e. the Fv region; see Figure 1.1) linked by a short peptide linker 
(Chan and Carter, 2010). These molecules can be efficiently expressed in bacteria, 
and due to their small size and single-domain nature they can access epitopes on 
the target surface that larger antibody fragments cannot reach (Saerens et al., 
2008). However, their very short half-life in serum (~2 hours) stops them from 
being used as therapeutic antibodies (Chames et al., 2009). Instead, they are used 
in serotherapy to neturalise toxins and as binding moieties when integrated into 
more complex molecules (Chames et al., 2009; Saerens et al., 2008).  
Multimerisation of dAbs has resulted in the creation of diabodies, triabodies and 
tetrabodies. These multivalent molecules have increased serum half-life (Chames 
et al., 2009), they can have different antigen specificities (Brekke and Sandlie, 
2003; Chames et al., 2009; Elvin et al., 2013; Saerens et al., 2008), and they can be 
combined with other antibody domains to allow specific Fc-mediated effector 
functions in the immunological response (Chan and Carter, 2010; Saerens et al., 
2008).  
1.1.2.5. Fc-Fusion Proteins 
Fc-fusion proteins are molecules in which the IgG Fc region has been genetically 
linked to a protein of interest (e.g. enzyme, extracellular domain of a receptor or 
protein ligand). The Fc region confers (i) increased serum life-time of the 
molecule; (ii) easier heterelogous expression and purification; and (iii) the ability 
to interact with the Fc-receptors found on immune cells to trigger an 
immunological response (Carter, 2011; Huang, 2009).  
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1.1.2.6. Antibody-Drug Conjugates (ADCs) 
Antibody-drug conjugates are mAbs that have been covalently linked to small 
drug molecules of particularly high cytotoxicity. Each antibody will typically 
carry more than one drug molecule. Antibody-drug conjugates specifically bind 
to the target cancer cells where the drug is delivered. Therefore, ADCs offer lower 
systemic toxicity when compared to cancer chemotherapy treatments. Also, 
different linker chemistries can be used to attach the drug molecules to the 
antibody to allow control over the pharmacokinetics and delivery of the cytotoxic 
drug (Hamilton, 2015).  
1.1.3. Market Analysis for Therapeutical mAbs 
Since the approval of the first therapeutic mAb in 1986 (immunosuppressant 
Orthoclone OKT3), mAbs and antibody-related molecules have grown to become 
the dominant product class within the biopharmaceutical market (Ecker et al., 
2015). Forty-seven antibody products (i.e. mAbs and antibody-related 
molecules) have been approved in the USA and/or Europe for the treatment of 
diverse diseases, though they mainly target cancer, inflammatory and 
immunological disorders (Chan and Carter, 2010; Ecker et al., 2015; Elvin et al., 
2013; Reichert, 2012). The majority of the commercialised antibody products are 
full-length mAbs expressed in mammalian cell lines. Only three antibody 
products are expressed in Escherichia coli i.e. two Fabs and one Fc-fusion protein 
(Ecker et al., 2015; Reichert, 2012). A comprehensive list of the therapeutic 
antibody products currently marketed in the USA and Europe can be found in the 
review by Ecker and co-workers (2015).  
The sales from all antibody products grew by 90 % from 2008 to 2013, with 
global sales revenue of almost $75 billion (Ecker et al., 2015). However, the 
majority of sales are generated by five therapeutic mAbs with blockbuster status, 
i.e. bevacizumab/Avastin®; rituximab/Rituxan®; adalimumab/Humira®; 
infliximab/Remicade®; and trastuzumab/Herceptin® (Elvin et al., 2013). It is 
expected that the global sales of therapeutic antibody products will continue 
growing to reach world-wide sales of more than $94 billion by 2017 and nearly 
$125 billion by 2020 (Ecker et al., 2015). Sales will be driven by the predicted 
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increase in demand for the antibody products commercialised at the present time 
and also by new approved products given that over 300 antibody product 
candidates are currently in different phases of clinical trials (Ecker et al., 2015; 
Elvin et al., 2013; Reichert, 2012). The introduction of biosimilars, and new 
markets thereof, are expected to be other factors driving sales growth for 
antibody products in the future (Ecker et al., 2015) 
The increase in global demand for therapeutic antibody products will require an 
even further increase in the manufacturing capability of these products, which 
has justified the implementation of mAb manufacturing platforms (see 
Section 1.2).  
1.2. Current Manufacturing Process for mAbs 
The biochemical similarities between different therapeutic mAbs has resulted in 
the emergence of templated recovery and purification schemes (Low et al., 2007; 
Shukla et al., 2007). A ‘platform’ unit operation is described as “one that can be 
used without much optimisation in a wide range of feed conditions” (Low et al., 
2007). Established production platforms offer advantages over individualised 
production processes because they increase speed to market (reduce time and 
investment during process development), and harmonise practises and 
information across different manufacturing sites (Low et al., 2007). Nonetheless, 
significant biochemical differences between therapeutic mAbs may exist, thus 
causing downstream purification challenges that require the departure from 
established mAb production platforms (Shukla et al., 2007).  
This subsection gives an overview of the unit operations that have become part 
of a typical therapeutic mAb production platform. Figure 1.2 sums up the 
manufacturing process flow.   
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Figure 1.2. Manufacturing platform process for therapeutic monoclonal 
antibodies.  
Figure adapted from Low et al. (2007) and Shukla et al. (2007).  
 
1.2.1. Cell Hosts 
The choice of cell host will be dictated by the antibody structure, the importance 
of glycosylation as a post-translational modification, the required productivity, 
ease of purification and production costs (Chadd and Chamow, 2001; Li et al., 
2010). Bacterial and mammalian producing cell lines constitute the cell hosts for 
commercialised mAb products, although the expression of mAb products in yeast 
cells, transgenic animals, insect cells and plants has also been reported (Chadd 
and Chamow, 2001; Li et al., 2010; Reichert, 2012). Bacterial systems 
(i.e. Escherichia coli), which lack the cellular machinery to glycosylate proteins, 
are suitable for the expression of Fabs and dAbs (Chadd and Chamow, 2001). 
Therapeutic mAbs and antibody-related molecules that require glycosylation 
(e.g. Fc-fusion proteins) are expressed in mammalian cell systems (Chadd and 
Chamow, 2001; Shukla et al., 2007). These cell hosts include Chinese Hamster 
Ovary (CHO) cells, NS0 or SP2/0 murine myeloma cells and PER.C6® human cells 
(Chadd and Chamow, 2001; Elvin et al., 2013; Li et al., 2010; Reichert, 2012). 
Nonetheless, the preferred expression system for commercialised therapeutic 
mAbs are CHO cells (Low et al., 2007; Reichert, 2012).  
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1.2.2. Cell Culture 
Different types of bioreactor have been employed at industrial scale for 
mammalian cell culture. These include stirred tank bioreactors, hollow filter 
bioreactors, airlift bioreactors and rotary cell culture systems. Nonetheless, 
suspension cell culture in stainless steel stirred tank bioreactors has become the 
cell culture platform of choice for large scale production of commercially 
available therapeutic mAbs. Stirred tank bioreactors provide: a homogeneous 
environment for cell growth; convenient control of process parameters; and 
facile scale up. Fed-batch is the most successfully used feeding strategy at large 
production scale, although repeated batch and perfusion are other feeding 
strategies also favoured at industrial scale. Different cell lines have shown to 
more easily adapt to fed-batch cell cultures, and provide higher cell density, 
viability and antibody titres (Jain and Kumar, 2008).  
1.2.3. Primary Recovery 
The aim of primary recovery is to remove the solids (i.e. cells and cell debris) 
present in the cell culture broth from the liquid phase where the mAb is in soluble 
form as they are secreted by the cells. Continuous disc-stack centrifugation 
coupled with depth filtration has become the industry standard for primary 
recovery (Low et al., 2007; Shukla et al., 2007). This combination has shown to 
be robust enough to provide satisfactory clarification performance despite 
existing variations in cell density and viability between different mAb production 
processes (Shukla et al., 2007). High cell densities and low shear centrifuges have 
relegated cross-flow microfiltration to small scale or low capital cost mAb 
production, given that it cannot offer the scalability and process performance 
robustness that centrifugation can (Low et al., 2007). Depth filtration is used as a 
secondary clarification step to remove cells and cell debris still present in the 
centrifuge supernatant, which must be removed prior to chromatography (Low 
et al., 2007; Shukla et al., 2007). However, direct depth filtration can also be used 
for whole cell broth removal, although it is only common for bench, pilot or 
smaller commercial-scale applications (Liu et al., 2010). Charged depth filters are 
preferred over uncharged depth filters due to the combined action of mechanical 
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sieving and zeta potential to remove impurities (Low et al., 2007). An absolute 
filter with pore size rating of 0.45 µm or 0.20 µm follows depth filtration to ensure 
the removal of solid particulates and bacteria before chromatography; bacteria 
are only removed when using 0.20 µm filters (Shukla et al., 2007).  
1.2.4. Purification 
The main consideration when designing the purification strategy is purity, 
although other key considerations include overall yield, process throughput, 
robustness, reliability and scalability (Shukla et al., 2007). The following are 
classified as impurities: host cell proteins (HCPs), deoxyribonucleic acid (DNA), 
endotoxins and some cell culture media additives (process-related impurities), 
and high MW mAb aggregates (product-related impurities). Viruses are also 
regarded as impurities, and must be cleared during mAb purification (Liu et al., 
2010; Shukla and Thömmes, 2010; Shukla et al., 2007).  
Chromatographic steps have become the backbone of current biopharmaceutical 
purification processes due to their high selectivity and resolution (Liu et al., 2010; 
Shukla and Thömmes, 2010). Protein A chromatography is the capture step of 
choice in mAb platform processes (Low et al., 2007; Shukla and Hinckley, 2008; 
Shukla et al., 2007). Protein A chromatography offers a high degree of clearance 
for HCPs due to the specific affinity of the protein A ligand for the Fc region of 
mAbs. Protein A chromatography has been shown to reduce >90 % the HCP 
content in clarified CHO cell broths (Shukla and Hinckley, 2008; Shukla et al., 
2007). Protein A chromatography consists of the following steps: (i) loading of 
clarified cell culture broth at neutral pH (pH 6-8); (ii) one or more washes at 
intermediate pH (pH 4-6) to remove HCPs and other impurities; (iii) mAb elution 
at low pH (pH 2.5-4); (iv) stripping the column at pH ~ 2 to remove any remaining 
impurities; (v) cleaning the column at alkaline pHs; and (vi) regenerating the 
column with equilibration buffer (if subsequently used) or storing the column in 
storage buffer, typically containing ethanol (Liu et al., 2010; Shukla and Hinckley, 
2008; Shukla et al., 2007).   
As detailed in Figure 1.2, a viral inactivation step typically follows capture protein 
A chromatography. The Food and Drug Administration (FDA) regulatory 
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guidelines for the production of biopharmaceutical products derived from human 
or animal cell lines require the use of two dedicated orthogonal steps for viral 
reduction (U.S. Department of Health and Human Services, Food and Drug 
Administration, 1998). A low pH incubation step (pH ≤ 3.8) is typically included 
post-protein A chromatography as elution is performed at low pH. Following acid 
inactivation, the solution is then neutralised to ensure mAb stability (Shukla et 
al., 2007).  
At least two chromatography steps, referred to as polishing steps, follow 
protein A chromatography to achieve the required purity levels to ensure patient 
safety (see Figure 1.2). Orthogonal chromatographic modes of interaction are 
selected to effectively separate the impurities still present in the protein A 
chromatography eluate (i.e. HCPs, mAb aggregates, DNA and leached protein A 
ligands). Cation exchange chromatography and anion exchange chromatography 
operated in flow-through mode has been the post-protein A purification 
sequence adopted by a number of commercialised therapeutic mAbs. While 
cation exchange chromatography removes HCPs, aggregates and leached protein 
A ligands, anion exchange chromatography clears DNA and further HCPs. Other 
chromatographic modes such as hydrophobic interaction chromatography, size 
exclusion chromatography, hydroxyapatite and immobilised metal affinity 
chromatography have also been successfully implemented. However, the 
chromatographic mode chosen will depend upon the nature of the impurities 
present and its ability to reduce the viral load (Shukla et al., 2007).  
Viral filtration is typically performed after one of the polishing chromatographic 
steps as the second viral inactivation step (see Figure 1.2). The placement of the 
viral filters in the process will depend upon the volume to be filtered. Therefore, 
the type of viral filter employed can be standardised, but the placement and size 
of the filters will be specific to the mAb process (Shukla et al., 2007).   
1.2.5. Ultrafiltration/Diafiltration (UF/DF) 
Upon completing downstream purification, the mAb is concentrated while the 
product buffer is exchanged for the formulation buffer (see Figure 1.2) employing 
an UF/DF unit (van Reis and Zydney, 2007; Shukla et al., 2007). Standardised 
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specifications for the type of membrane, transmembrane pressure (TMP) and 
cross-flow rate employed, as well as the concentration factor at which 
diafiltration is performed can be used for all mAbs. Nonetheless, fluid viscosity 
and mAb aggregation concerns need to be solved on a case-by-case basis (Shukla 
et al., 2007).  
1.3. Current Manufacturing Challenges in mAb 
Production and Proposed Solutions 
1.3.1. Challenges 
1.3.1.1. Increasing Cell Densities  
In the past two decades the intensive optimisation work in cell line selection, 
growth media, feeding strategies and bioreactor conditions has led to increased 
product titre and cell density values; some biopharmaceutical companies have 
reported 5-10 g.L-1 of mAb and cell densities of >20x106 cells.mL-1 for a 14-day 
fed-batch mammalian cell process (Huang et al., 2010; Kelley, 2009; Li et al., 
2010; Shukla and Thömmes, 2010). The high cell densities achieved have 
introduced elevated levels of process-related impurities that have placed 
increased demands upon traditional primary recovery and purification 
operations (Low et al., 2007; Singh et al., 2013; Westoby et al., 2011). As a 
consequence, process bottlenecks have shifted from upstream to downstream, 
which accounts for ~80 % of the total mAb production costs (Hogwood et al., 
2013a; Kelley, 2009; Shukla and Thömmes, 2010).  
1.3.1.2. Precipitation and Non-Specific Binding during Protein A 
Chromatography 
Low pH elution during protein A chromatography has been shown to induce 
product aggregation for some mAbs or precipitate HCPs that are non-specifically 
interacting with either the product or the resin (Liu et al., 2010; Shukla and 
Thömmes, 2010; Shukla et al., 2007; Tarrant et al., 2012). Low pH elution can 
therefore result in: (i) reduced product yield; (ii) reduced column lifetime if 
precipitation occurs during elution; (iii) increased process costs and complexity 
if an additional solid-liquid separation step post-protein A chromatography is 
1. Introduction 
 41 
 
needed; and (iv) a more challenging fluid for the chromatographic polishing steps 
(Kandula et al., 2009; Shukla and Thömmes, 2010; Shukla et al., 2007).  
1.3.1.3. Ultra-High Protein Concentrations during UF/DF 
The high mAb doses (>100 mg.mL-1) of some blockbuster mAb therapies have 
turned UF/DF into a challenging unit operation considering the large volumes 
and ultra-high protein concentrations processed during buffer exchange. Protein 
aggregation can occur during pumping or during exposure to stainless steel 
surfaces for long periods of time. Aggregation this late into the process can have 
a detrimental effect and poses serious patient safety risks (Shukla and Thömmes, 
2010).  
1.3.2. Potential Solutions during Primary Recovery 
The development of novel bioprocess technologies for both upstream and 
downstream unit operations has been pursued in response to: (i) the burden on 
the primary recovery and purification steps arising from increased cell densities 
and productivities (see Section 1.3.1); (ii) the need to increase production 
capacity; and (iii) the pressure to further reduce cost of goods (Kelley, 2009; 
Singh et al., 2016). Primary recovery is gaining importance in production since 
reduced levels of impurities and adventitious agents such as endotoxins and 
viruses can be achieved with thoughtful primary recovery designs (Shukla and 
Thömmes, 2010; Singh et al., 2016; Yigzaw et al., 2006). Reduced burden on 
primary recovery and purification unit operations has resulted into: (i) reduced 
depth filter area requirements; (ii) increased protein A resin lifetime; and 
(iii) less precipitates during the pH adjustment of the protein A chromatography 
pool (Hogwood et al., 2013b; Liu et al., 2010; Yigzaw et al., 2006). The following 
primary recovery technologies are being revisited as viable solutions to address 
the current downstream bottleneck in mAb processes.  
1.3.2.1. Expanded Bed Adsorption (EBA) Chromatography  
Expanded bed adsorption chromatography integrates solid-liquid separation, 
volume reduction and partial purification in one unit operation by capturing the 
product with resins of high specificity and capacity while processing crude 
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feedstock (Anspach et al., 1999; Shukla and Thömmes, 2010; Xu et al., 2014). For 
a review on the principles of EBA chromatography and its theoretical 
considerations the reader is referred to Anspach and co-workers (1999).  
Expanded bed chromatography has been applied for the product capture and 
clarification of mammalian, Escherichia coli and yeast systems as well as cell 
homogenates (Anspach et al., 1999; Xu et al., 2014). However, the 
implementation of EBA is not without limitations (Anspach et al., 1999), i.e. the 
(i) requirement of a minimal bed height for efficient protein adsorption; (ii) low 
flow rates and long processing times can affect the feedstock quality and product 
stability; (iii) presence of cells and impurities adsorbing to the resin can hinder 
the diffusion of proteins into the beads thereby lowering protein binding 
capacity; (iv) dependence on the feedstock’s viscosity and density values 
compromises chromatographic bed stability; and (v) cells or cell aggregates can 
foul and block the fluid distribution system. Nonetheless, improved resins and 
flow distribution systems have been recently introduced to allow large-scale 
processing and to increase process robustness (Shukla and Thömmes, 2010).  
1.3.2.2. Aqueous Two-Phase Systems (ATPS) 
Aqueous two-phase systems are regarded as downstream purification strategies, 
although they have also been used for the extraction of cells, viruses and plasmid 
DNA (Albertsson et al., 1970; Benavides et al., 2006; Bradley and Scott, 2004; 
Frerix et al., 2005; Kumar et al., 2001; Singh et al., 2016). This technology consists 
of two immiscible aqueous phases normally created by two polymers (e.g. 
polyethylene glycol (PEG) and dextran) or one polymer (e.g. PEG) and one salt 
(e.g. phosphates, sulfates and citrates) mixed in water (Shukla and Thömmes, 
2010; Singh et al., 2016). The target product and the impurities will dissolve in 
one or the other liquid phase depending on the composition of the two-phase 
system and their own properties (Singh et al., 2016). This technology does not 
degrade or denature the product, and has shown to achieve 90 % product 
recovery as well as significantly reduce process impurities in mAb processes 
(Singh et al., 2016). Nonetheless, the high salt concentrations required to achieve 
high product yields hinder the implementation of ATPS at manufacturing scale; 
the high salt concentrations required at large scale can potentially shorten the life 
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of the equipment and precipitate the target product (Singh et al., 2016). 
Multi-staging the ATPS extraction process has been proposed as a solution (Singh 
et al., 2016). 
1.3.2.3. Crystallisation 
Crystallisation is the process by which a specific solute comes out of solution 
when approaching its supersaturation point, which can be achieved by solution 
cooling, solvent addition, chemical reaction, pH change or solvent evaporation 
(Hekmat, 2015). Crystallisation processes have been reported to be highly 
variable thus they need to be designed and developed on a case-by-case basis 
(Hekmat, 2015). They have also been described as time consuming, result in low 
process yields and be of particular difficulty in the context of crystallisation of 
full-length mAbs (Hebel et al., 2013). Although crystallisation has been proposed 
as an alternative primary recovery strategy, preparative crystallisation from 
impure protein solutions requires feed pre-conditioning methods such as 
precipitation or extraction to be successful (Hekmat, 2015).  
1.3.2.4. Precipitation  
Precipitation is an established technology in other industries (e.g. plasma protein 
industry). Precipitation consists in lowering the solubility of target soluble 
molecules (either the product or process impurities) to create solid particles that 
can be removed or recovered employing a solid-liquid separation step (Roush 
and Lu, 2008; Singh et al., 2016). Precipitation is achieved by (i) pH or 
conductivity changes; or (ii) adding precipitants like ethanol, PEG, 
polyethersulfone or capryilic acid (Lydersen et al., 1994; Shpritzer et al., 2006; 
Shukla and Thömmes, 2010; Singh et al., 2016; Westoby et al., 2011). 
Precipitation can also be achieved by polymers carrying affinity tags that respond 
to changes in temperature, ionic strength or pH. This technology is referred to as 
affinity precipitation, and the targets in this case are recombinant proteins linked 
to small peptides or domains (Singh et al., 2016).  
Precipitation in mammalian cell mAb processes has achieved lower levels of DNA, 
HCPs and cellular debris, inactivated viruses and improved the filtration 
throughput and filter capacity of subsequent filtration steps (Brodsky et al., 2012; 
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Lydersen et al., 1994; Westoby et al., 2011). Nonetheless, process selectivity, 
scalability, robustness, costs as well as precipitant clearance need to be evaluated 
and guaranteed before implementing precipitation at manufacturing scale 
(Shukla and Thömmes, 2010; Singh et al., 2016).  
1.3.2.5. Flocculation  
Flocculation is extensively implemented in the waste water treatment, food, 
beverage and cosmetic industries (Roush and Lu, 2008; Singh et al., 2016). 
Flocculation has also been used in the biopharmaceutical industry for bacterial, 
yeast and mammalian cell processes to improve primary recovery clarification 
efficiency, yield and robustness as well as to reduce the impurity levels (Barany 
and Szepesszentgyörgyi, 2004; Cordes et al., 1990; Kim et al., 2001; Liu et al., 
2010; McDonald et al., 2009; Milburn et al., 1990; Peram et al., 2010; Riske et al., 
2007; Salt et al., 1995, 1996; Singh et al., 2013). When used as a primary recovery 
strategy in mammalian cell processes, flocculation has been shown to minimise 
the post-centrifugation depth filter requirements in high cell density processes 
(Liu et al., 2010; Low et al., 2007) and enhance the clarification throughput of 
subsequent filtration operations (Riske et al., 2007). A detailed description of the 
fundamentals of flocculation follows in Section 1.3.3.  
1.3.3. The Fundamentals of Polyelectrolyte Flocculation 
For the purpose of this thesis, this section only discusses the fundamentals of 
flocculation when charged polymers (i.e. polyelectrolytes) are used as 
flocculating agents or flocculants.  
1.3.3.1. Flocculation Mechanisms of Action 
Flocculation consists in the destabilisation of colloidal suspensions upon the 
addition of a flocculant; the flocculant adheres to dispersed particulates present 
in the suspension and generates larger-sized particles as a result (Singh et al., 
2016). The flocculation process can be broken down in the following steps (see 
Figure 1.3) (Bratby, 1980; Gregory, 1986):  
(i) Dispersion of the flocculant in the solution. Mixing is required to avoid local 
flocculant overdosage and re-stabilisation of the particles.  
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(ii) Adsorption of the flocculant onto the particles. This is a transport-limited 
step which relies on Brownian motion for the polymer to become 
progressively attached to the surface of the particles. Adsorption will 
occur via hydrogen bonds, electrostatic or hydrophobic interactions.  
(iii) Re-conformation of the adsorbed flocculant to give a configuration in 
equilibrium. Little is known about the rate at which re-configuration is 
achieved, and it is questioned whether a temporary configuration is 
reached before the next destabilisation step. 
(iv) Collision between destabilised particles to form aggregates. Aggregates will 
be formed via the ‘electrostatic patch’ and/or the ‘bridging’ mechanisms 
(see Figure 1.3.B and Figure 1.3.C).  
(v) Floc break-up. The nature of the break-up process depends on the size of 
the flocs relative to the microscale of turbulence (see Section 1.5.2). 
Rupture due to fluctuating dynamic pressure will occur on flocs with a 
diameter larger than 100 µm.  
Providing further insight into the flocculation mechanisms of action, flocculation 
by the ‘electrostatic patch’ mechanism describes the agglomeration of small 
particles, whose charges have been neutralised by the polyelectrolyte molecules, 
due to electrostatic attraction (see Figure 1.3.B) (Bratby, 1980; Roush and Lu, 
2008). Flocculation by ‘bridging’ refers to the collision of adjacent 
polyelectrolyte-coated particles that result in the formation of bridges and 
increasingly larger flocs thereof (see Figure 1.3.C) (Bratby, 1980; Roush and Lu, 
2008). Each flocculation mechanism will be favoured under certain flocculation 
conditions, although they are not exclusive and can happen at the same time. 
Electrostatic patch neutralisation will occur when strong ionic attraction 
between the flocculant and the particle surface exists; this situation will be given 
when using high charge density flocculants, and at low particle concentration and 
low ionic strength conditions (Bratby, 1980). The bridging mechanism will occur 
when using low charge density or high MW flocculants, and/or at high particle 
concentration and high ionic strength conditions (Bratby, 1980). The flocculation 
mechanism of action will determine floc strength. The bridging mechanism 
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generates strong flocs, yet floc disruption is irreversible when exposed to shear 
stress (Bratby, 1980; Singh et al., 2016). On the contrary, flocs obtained by the 
electrostatic patch mechanism are weaker, but re-flocculation can occur after floc 
breakage (Bratby, 1980; Singh et al., 2016).  
 
Figure 1.3. Steps during polyelectrolyte flocculation (A) and flocculation 
mechanisms of action (B and C).  
A. Steps describing the destabilisation of a colloidal suspension upon the addition of 
a flocculant. These are: (i) dispersion of the flocculant in the solution; (ii) adsorption 
of the flocculant onto the particles; (iii) re-conformation of the adsorbed flocculant 
to give a configuration in equilibrium; (iv) collision between destabilised particles 
to form aggregates; and (v) floc break-up. B. Flocculation by the ‘electrostatic 
patch’ mechanism. C. Flocculation by the ‘bridging’ mechanism. Refer to the text for 
a detailed description of the steps involving the destabilisation of colloidal 
suspensions and the flocculation mechanisms involved. Diagram adapted from 
Bolto and Gregory (2007). 
 
1.3.3.2. Flocculation Kinetics 
The collision between destabilised particles leading to the formation of flocs is a 
two-stage process. Perikinetic and orthokinetic flocculation (first and second 
stage, respectively) are governed by the forces whereby the particles come 
together and agglomerate, which in turn are determined by the size of the flocs 
(Bratby, 1980). Table 1.1 summarises the key aspects of perikinetic and 
orthokinetic flocculation.  
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Mathematical models describing both perikinetic and orthokinetic flocculation 
can be found in Bratby (1980). An in-depth review of these mathematical models 
is out of the scope of this thesis thus an overview of these follows. Von 
Smoluchoswski proposed a mathematical model describing perikinetic 
flocculation for spherical particles diffusing in a radial direction that has not been 
further developed. Contrary, many different models have been proposed for 
orthokinetic flocculation. From the first orthokinetic models, which assumed 
laminar flow conditions, others have been developed to account for turbulent 
regimes, floc break-up and the random motion of the flocculated particles 
(Bratby, 1980).  
Table 1.1. Key aspects of perikinetic and orthokinetic flocculation.  
Summary from Bratby (1980).  
 
 
Driving force Step 
Performance 
variables 
Perikinetic 
flocculation 
Brownian motion/ 
Thermal agitation 
Immediately after 
destabilisation of 
the colloidal 
suspension 
Particle diameter 
(diameter < 1 µm) 
Orthokinetic 
flocculation 
Induced velocity 
gradients in the 
liquid (i.e. liquid 
mixing) 
After perikinetic 
flocculation is 
completed 
Fluid velocity 
gradients 
Flocculation time 
 
1.3.3.3. Types of Flocculant 
Flocculants can be classified as cationic, anionic or multimodal (see Table 1.2). 
The choice of flocculant will be dictated by the charge of the target molecules, 
which will in turn depend upon the pH of the solution and the pI of the target 
molecules (Singh et al., 2016).  
1.3.3.3.1. Cationic Flocculants 
Poly-diallyldimethylammonium chloride (pDADMAC) is a water-soluble 
quaternary ammonium polymer that has been used to flocculate cell culture 
fluids in order to provide a clarification alternative to centrifugation in high cell 
density cell culture harvests (McNerney et al., 2015; Singh et al., 2016; Tomic et 
al., 2015).  
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The group of polyamines consists of polymers with multiple amine functional 
groups that are protonated (i.e. positively charged) over a wide pH range due to 
the basic nature of the amine groups (Singh et al., 2016). This group of cationic 
polymers includes polyethylenimine (PEI), polyvinylamine, 
poly-N-methylvinylamine and polyallylamine (Singh et al., 2016). Polyamines 
have been used in the flocculation of yeast (Cordes et al., 1990; Milburn et al., 
1990; Salt et al., 1995, 1996), bacterial (Barany and Szepesszentgyörgyi, 2004; 
Salt et al., 1995) and mammalian cell processes (Ma et al., 2010; Peram et al., 
2010).  
Polyaminoacids have been employed in mammalian cell culture processes to 
flocculate clarified and non-clarified cell culture broths. Flocculation with 
polyaminoacids (e.g. polyarginine and polylysine) has been assessed as a 
replacement for one or more chromatographic steps (Peram et al., 2010).  
Chitosan is a linear polymer of beta-(1-4) linked D-glucosamine monomers 
generated by the chemical deacetylation of chitin, which is typically obtained 
from arthropod shells (Liu et al., 2010). Chitosan is a promising flocculant since 
it is inexpensively produced from non-mammalian sources and can be currently 
obtained with high purity and low monomer levels (Liu et al., 2010). Nonetheless, 
potential allergies from patients to arthropods (i.e. shellfish) is a concern. 
Chitosan has been used to flocculate yeast (Liu et al., 2010), bacterial (Barany and 
Szepesszentgyörgyi, 2004; Strand et al., 2003) and mammalian cell feed streams 
(Riske et al., 2007).  
1.3.3.3.2. Anionic Flocculants 
Anionic polyelectrolytes were used by McDonald et al. (2009) to selectively 
flocculate mAbs from CHO cell harvests with the aim to replace the capture and 
intermediate chromatographic steps during downstream purification. This study 
showed the limited application of anionic flocculants with high titre and high 
conductivity CHO cell broths; feed dilution was required to selectively flocculate 
the mAb.  
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Table 1.2. Characteristics of polyelectrolyte flocculants used in 
biopharmaceutical processes.  
Summary from Felo et al. (2015), Liu et al. (2010), Roush and Lu (2008), and Singh 
et al. (2016).   
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1.3.3.3.3. Multimodal Ionic Flocculants 
Multimodal ionic flocculants respond to the limitations of cationic and ionic 
flocculants with regards to: feed dilution before flocculant addition, difficulty 
re-dissolving the flocs after anionic flocculation, excess residual polymer and 
operating at very specific flocculation conditions. Multimodal ionic flocculants 
can successfully flocculate over wide pH and conductivity ranges. They also easily 
re-dissolve after floc formation as they come out of solution upon changing the 
environmental conditions (e.g. presence of multivalent ions) (Kang et al., 2013; 
Singh et al., 2016).  
1.3.3.4. Flocculation Process Variables 
Flocculation performance has been reported to depend upon a large number of 
physico-chemical variables that relate to the characteristics of both the flocculant 
and the fluid being flocculated. Therefore, careful consideration should be given 
to optimise the flocculation step in order to yield a process with high product 
recovery and maximum impurity removal. The flocculation variables described 
to significantly impact process performance and robustness are the following 
(Bratby, 1980; Kim et al., 2001; Salt et al., 1995; Singh et al., 2016): 
(i) Flocculant physico-chemical characteristics: MW, charge in reference to 
the particle’s surface charge, charge density, rigidity, linear or branched.  
(ii) Flocculant concentration.  
(iii) Mode of flocculant addition.  
(iv) Hydrophobic-hydrophilic balance within the floc. 
(vi) Fluid characteristics: nature and amount of insoluble particulates, pH, 
ionic strength, properties of the target molecules.  
(vii) Mixing regime or shear stress encountered in the flocculation vessel.   
(viii) Duration of flocculation. 
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1.3.3.5. Evaluation of Flocculation Performance  
The first approach towards evaluating flocculation performance is analysing 
product yield and impurity removal (Cordes et al., 1990; Milburn et al., 1990; 
Peram et al., 2010). Floc diameter is also a key parameter, as particle size will 
significantly impact upon the performance of the subsequent centrifugation 
and/or filtration steps (Kim et al., 2001; Riske et al., 2007; Shpritzer et al., 2006). 
Floc strength is another important factor, particularly when the flocs are 
processed via centrifugation, due to the shear forces encountered in the 
centrifuge feed zone (Riske et al., 2007; Shpritzer et al., 2006). Finally, the amount 
of residual flocculant must be quantified to ensure the flocculating agents are 
removed to acceptable levels in the final drug product (Liu et al., 2010).  
Different methods exist to evaluate product yield and impurity removal. These 
range from commercially available kits to analytical techniques developed 
in-house; the preference will vary from manufacturer to manufacturer. Floc 
diameter can be determined via light scattering measurements (Kim et al., 2001; 
Salt et al., 1996; Strand et al., 2003) or using the Coulter counter device (Cordes 
et al., 1990). Nonetheless, optical density and turbidity measurements 
(Bonnerjea et al., 1988; Kim et al., 2001; Milburn et al., 1990; Peram et al., 2010; 
Riske et al., 2007; Salt et al., 1995, 1996; Strand et al., 2003), zeta potential 
measurements (Cordes et al., 1990; Salt et al., 1996; Strand et al., 2003; Treweek 
et al., 1979), sedimentation velocity measurements under gravitational or 
centrifugal forces (Bratby, 1980) and filtration rate measurements (Kim et al., 
2001) are other widespread techniques used to empirically evaluate flocculation 
performance. With regards to floc strength, macroscopic and microscopic 
methodologies can be applied (Jarvis et al., 2005). Bell and Dunnill (1982a, 
1982b) exemplify the use of macroscopic methodologies to study floc strength: 
evaluating the average velocity gradient to which particles are exposed inside the 
flocculation vessel. Finally, residual flocculant concentration in the process feed 
can be measured with the following techniques: spectrophotometry (Treweek et 
al., 1979), zeta potential measurements (Barany and Szepesszentgyörgyi, 2004), 
surface plasmon resonance spectroscopy, quantitative polymerase chain 
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reaction, high performance liquid chromatography, enzyme-linked 
immunosorbent assay and fluorescent tags (Singh et al., 2016).  
1.3.3.6. Dosage Curves in Polyelectrolyte Flocculation 
Flocculant dosage curves are generated by plotting increasing flocculant 
concentrations against the residual turbidity (or spectrophotometric absorbance 
at λ nm) in the supernatant liquid after a given settling period (Hughes et al., 
1990; Roussy et al., 2005; Tenney et al., 1969). Flocculation performance in 
flocculant dosage curves can also be expressed by filtration rate of the flocs (Adin 
and Rebhun, 1974; Slater and Kitchener, 1966), chemical oxygen demand 
reduction and colour removal in wastewater treatment experiments (Guibal and 
Roussy, 2007; Lee et al., 2011; Tenney and Stumm, 1965) or number of cells left 
in the supernatant (Busch and Stumm, 1968; Strand et al., 2001). However, 
supernatant turbidity and absorbance measurements are regarded as simpler 
and quicker approaches that result in equivalent information (Busch and Stumm, 
1968; Slater and Kitchener, 1966).  
Figure 1.4 shows an example of a flocculant dosage curve. When flocculant 
concentration is less than optimum, insufficient bridging to withstand the 
shearing forces imposed by the mixing conditions will occur and no flocs will be 
formed (‘No flocculation’ region in Figure 1.4). Flocculation will commence when 
enough flocculant is added to bring neighbouring solid particles together and 
form aggregates (‘Gradual flocculation’ region in Figure 1.4). Furthermore, no 
significant amounts of flocculant will be detected in the supernatant in this region 
since all flocculant added is adsorbed to the solid particles. Optimal flocculant 
dose corresponds to that where supernatant turbidity is at its minimum 
(‘Optimal’ in Figure 1.4). A complete reduction in medium turbidity will never be 
achieved, and the optimum flocculant dose will be that at wich an increase in dose 
results in an insignificant improvement of supernatant turbidity. Finally, at 
flocculant concentrations larger than the optimum flocculant dose, 
re-stabilisation of the solid particles takes place (‘Re-stabilisation’ in Figure 1.4). 
When the surface of the solid particles become covered with flocculant, they start 
to repel each other because of electrostatic or static hinderance, or both. At this 
point, excess flocculant will be detected in the supernatant (Busch and Stumm, 
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1968; Hughes et al., 1990; Qian et al., 2004; Strand et al., 2003; Tenney and 
Stumm, 1965; Tenney et al., 1969).  
 
 
 
 
 
 
 
 
 
Figure 1.4. Example of flocculant dosage curve in polyelectrolyte 
flocculation.  
 
 
Flocculant dosage curves are employed to investigate the optimal flocculant 
concentration for a given test condition (Gasner and Wang, 1970; Guibal and 
Roussy, 2007; Lee et al., 2011). However, they can also be plotted for various test 
conditions to evaluate the effect of the following parameters on flocculation 
performance: pH, ionic strength, viscosity and composition of the medium, solids 
concentration, concentration and age of the flocculant stock solution, mode of 
flocculant addition, type of flocculant and its molecular weight (Barany and 
Szepesszentgyörgyi, 2004; Hughes et al., 1990; Owen et al., 2002; Qian et al., 
2004; Roussy et al., 2005; Strand et al., 2003; Sukenik et al., 1988; Tenney et al., 
1969). The information obtained not only helps select the right flocculant dosage 
for a given set of conditions but also sheds some light into the governing 
flocculation mechanisms (Gasner and Wang, 1970; Narkis and Rebhun, 1983; 
Roussy et al., 2005; Strand et al., 2003). For instance, very sharp optimum 
flocculant dosage curves when using strong cationic or anionic polyelectrolytes 
indicate flocculation via the bridging mechanism (see Section 1.3.3.1) (Gasner 
and Wang, 1970). In contrast, the electrostatic patch flocculation mechanism (see 
No 
flocculation 
Gradual 
flocculation 
Optimal  Re-
stabilisation 
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Section 1.3.3.1) generates curves where the slope of the re-stabilisation region 
(see Figure 1.4) is much steeper than that of the charge neutralisation segment 
(‘Gradual flocculation’ in Figure 1.4) (Guibal and Roussy, 2007).  
1.3.4. Considerations for Implementing Flocculation at 
Manufacturing Scale  
The cytoxicity of residual monomers and additives present in commercially 
available flocculants converts them into critical process variables during the 
selection of flocculating agents. Biopharmaceutical grade flocculants, which 
guarantee limited polymer variability to comply with the requirements of current 
good manufacturing practices (CGMPs), exist but are few in number. Therefore, a 
judicious risk analysis with regards to the cytotoxicity of the flocculants used 
must be conducted considering most approved mAbs are administered via the 
parenteral route. In addition to this, effective flocculant clearance to an 
acceptable residual level in the final drug product must be demonstrated (Aunins 
and Wang, 1989; Singh et al., 2016; Thömmes and Etzel, 2007). The 
methodologies used for the detection of residual quantities of polymer in the 
process feed are listed in Section 1.3.3.  
Finally, other important factors to be considered before the implementation of 
flocculation at manufacturing scale are: (i) the effect that the flocculant chosen 
has upon the product quality attributes and the lifetime of the chromatographic 
resins; and (ii) the scalability of this unit operation from laboratory to pilot and 
manufacturing scale (Singh et al., 2016).  
1.4. Scale-Down Technologies for the Study of 
Primary Recovery  
The initial scale-down studies aimed at modelling process performance using 
traditional engineering principles. The first scale-down studies were pilot-scale 
models that reduced the amount of material required down to the litre scale. 
Smaller scale-down models were further developed, ultimately leading to the 
creation of ultra scale-down (USD) devices. Ultra scale-down models work within 
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the millilitre scale and they are used to determine the key dominating effects 
during scale-up of bioprocesses (Tait et al., 2009; Titchener-Hooker et al., 2008).  
1.4.1. Centrifugation  
1.4.1.1. Small Scale Centrifugation Mimics 
The first attempts to scale down centrifugation were pursued by Mannweiler and 
Hoare (1992). In their initial approach they reduced the centrifuge separation 
area by removing some of the separation discs of a small disc stack centrifuge. 
Nonetheless, the amount of material required to operate the centrifuge was not 
significantly reduced since the centrifuge solids holding space remained 
unchanged. Subsequently, the next attempt by Maybury et al. (1998) consisted in 
decreasing both the centrifuge separation area and volume process material 
requirements by placing different solid inserts inside the centrifuge bowl. 
The development towards the USD centrifugation approach started with protein 
precipitation scale-down studies (Boychyn et al., 2000). Based upon the use of 
Sigma theory (see Section 1.4.1.2), the authors mimicked the clarification 
performance of a multichamber bowl industrial-scale centrifuge with a bench-top 
centrifuge. However, the extent of solids removal was over-predicted by 50 % 
because the shear stress encountered in the feed zone of the continuous flow 
centrifuge used was not accounted for. The USD centrifugation model was further 
optimised including the Sigma value (seeSection 1.4.1.2) and the contributory 
effect that the acceleration and deceleration stages have upon centrifugation 
performance (Maybury et al., 2000).  
Following these USD centrifugation studies, Boychyn et al. (2001) used the 
high-speed shearing device first described by Levy et al. (1999) to reproduce the 
energy dissipation rates encountered in the feed zone of a multichamber 
centrifuge. The performance of a large-scale multichamber centrifuge was 
mimicked by first pre-shearing the feed with the high-speed shearing device 
described and then using a bench-top centrifuge. The shear forces encountered 
in the feed zones of other large-scale continuous centrifuges were subsequently 
investigated (Boychyn et al., 2003). The USD centrifugation model has been 
verified with Saccharomyces cerevisiae (Boychyn et al., 2003; Tustian et al., 2007), 
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Escherichia coli (Berrill et al., 2008; Chatel et al., 2014; Tustian et al., 2007) and 
mammalian (Hutchinson et al., 2006; Lau et al., 2013) cell suspensions.  
Centrifugation was further scaled down to 96-well plates, thus allowing the study 
of centrifugation in a high-throughput mode (Tait et al., 2009). The methodology 
consisted in using a 96-well plate filled with different volumes of pre-sheared 
bioprocessing material to obtain varying equivalent flow rates on a single 
microplate. Centrifugation performance was predicted within a ±10 % error 
margin when compared to the previous bench-top USD centrifugation 
methodology.  
1.4.1.2. Sigma Theory 
Sigma theory was first described by Ambler (1959). This theory allows describing 
centrifugation performance in terms of separation area independently of the 
process parameters. It is out of the scope of this thesis to include the derivation 
of Sigma theory, for which the reader is referred to Ambler (1959).  
The Sigma theory is based on Stokes’ law, which describes the drag force exerted 
on a small spherical particle suspended in a viscous fluid. Considering that (i) the 
speed of a small spherical particle suspended in a viscous fluid and under a 
gravitational field (vg, m.s-1) will be constant under identical process conditions 
independently of the size and geometry of the centrifuge; and that (ii) two times 
vg is equal to the ratio of volumetric flow rate (Q, m3.s-1) to equivalent settling 
area (∑, m2), it is possible to compare different centrifuges with gravity settling 
systems on the basis that (Ambler, 1959; Maybury et al., 2000):  
  (Equation 1.1) 
where Vlab is the volume of material in a centrifugal tube for a bench-top 
centrifuge (m3), tlab is the centrifugation time of a batch centrifuge (s), ∑ is the 
equivalent settling area of the centrifuge (m2), c is the correction factor to account 
for the deviation from the ideal flow patterns used to define particle dynamics in 
the centrifuge (Maybury et al., 2000), Q is the volumetric flow rate to the 
centrifuge (m3.s-1), and the suffixes refer to different centrifuge geometries (lab 
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is bench-top centrifuge, ds is disc stack centrifuge and tub is tubular bowl 
centrifuge). The value of ∑ is specific to the centrifuge geometry used and to the 
centrifugation conditions at which it is operated. The equations for the 
calculation of the ∑ value of widely used centrifuge designs can be found in 
Ambler (1959) and Maybury et al. (2000). The values of c are also specific to each 
centrifuge design, and while it is generally accepted that the correction factor for 
a bench-top centrifuge is equal to 1, different c values have been reported for the 
same large-scale centrifuge design (Boychyn et al., 2003; Maybury et al., 2000).  
1.4.2. Normal Flow Filtration (NFF) 
Normal flow filtration, also referred to as dead-end filtration, is the filtration 
mode where the direction of fluid flow is perpendicular to the filter; NFF differs 
from tangential flow filtration (TFF) in that fluid flows parallel to the filter in the 
latter. In addition to the direction of the fluid flow, filtration can also be classified 
in constant pressure or constant flux rate depending upon the driving force used. 
Constant pressure filtration can be further divided into positive and negative 
pressure filtration (van Reis and Zydney, 2007).  
1.4.2.1. Membrane Filtration vs. Depth Filtration 
In bioprocesses membrane filtration is used for pressure-driven separations such 
as microfiltration, virus filtration and ultrafiltration (van Reis and Zydney, 2007). 
Membrane pore size varies depending upon its application; microfiltration (pore 
size 0.05 – 10 µm) uses membrane filtration to retain cells and cell debris thus 
allowing proteins and smaller solutes into the filtrate, virus filtration (pore size 
20 – 70 nm) uses membrane filtration to retain viruses, and ultrafiltration (pore 
size 1 - 20 nm) uses membrane filtration to retain proteins and other 
macromolecules (van Reis and Zydney, 2007). Microfiltration is the only 
membrane filtration step applied during primary recovery, and it is usually 
operated in TFF mode to minimise membrane fouling and increase product yield 
and throughput (Liu et al., 2010). Membrane filters can generate a particle-free 
harvest solution that requires no secondary clarification before capture 
chromatography if a 0.2 µm-rated membrane is used (van Reis and Zydney, 
2001). However, the trend towards high cell density cell cultures limits the 
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implementation of membrane filtration processes during primary recovery (van 
Reis and Zydney, 2001).  
Depth filtration operates in NFF mode and uses porous filter material to retain 
particles inside the tortous filter matrix (see Figure 1.5) rather than just on the 
filter surface (van Reis and Zydney, 2007; Shukla and Kandula, 2009). This 
mechanism allows for the retention of more particles than surface retention can 
achieve (Shukla and Kandula, 2009). Consequently, depth filtration is used when 
the feedstream contains high particle loads (i.e. during primary recovery 
operations, though not exclusively) (Liu et al., 2010; Shukla and Kandula, 2009). 
The depth filters used in the biopharmaceutical industry cover pore size ranges 
from <0.1 to 15 µm. However, the rise of commercially available multi-layer 
depth filters has extended particle size retention up to 100 µm by layering 
multiple depth filter sheets of different pore size ranges (Singh et al., 2016). 
Multi-layer depth filters retain large particles inside the filter matrix as opposed 
to on the filter surface, which normally results in fast fouling rates as the result of 
cake layer formation (Singh et al., 2016). Furthermore, more compacted depth 
filtration processes are obtained with multi-layer depth filters. Depth filters are 
typically composed of cellulose or polypropylene fibers, a porous filter aid such 
as diatomaceous earth to increase the surface area, and a binder (Liu et al., 2010; 
Shukla and Kandula, 2009; Shukla et al., 2007; Singh et al., 2016). The binder can 
be charged to confer the depth filter media a positive charge; otherwise, an 
additional charged polymer may be added (Liu et al., 2010; Shukla and Kandula, 
2009). Therefore, the structure and composition of depth filters allow solids 
removal to be accomplished via both adsorptive (i.e. hydrophobic, electrostatic 
and multi-modal interactions) and size exclusion-sieving mechanisms (Liu et al., 
2010; van Reis and Zydney, 2007; Singh et al., 2016; Yigzaw et al., 2006). Finally, 
depth filters can incorporate a filter membrane with an absolute pore size at the 
bottom-most layer to protect the subsequent guard filter (Shukla and Kandula, 
2009).  
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Figure 1.5. Schematic representation of the cross-section area and particle 
retention in a depth filter.  
A single depth filter layer is approximately 2-4 mm thick and is defined by its 
nominal pore rating and charge (Liu et al., 2010). The figure shown describes the 
different modes by which particles are removed via depth filtration. While small 
particles are retained within the filter matrix via size-based retention mechanisms 
and/or adsorptive mechanisms, particles larger than the porous opening are 
retained on the filter surface. Figure adapted from Shukla and Kandula (2009).  
 
 
1.4.2.2. Small Scale Filtration Mimics 
Early scale-down filtration studies investigated ultrafiltration of protein 
solutions to assess the effect of membrane polarisation (Porter, 1972), pH and 
ionic strength (Fane et al., 1983) on filtration performance. Commercially 
available laboratory-scale filters have since been developed; these enable the 
study of different types of membranes, depth filters and operational variables. 
Despite all this progress, the feed volume requirements of laboratory-scale filters 
limit the number of studies that can be performed during early process 
development. To counteract these limitations, scale-down and ultra scale-down 
NFF systems have been developed in the past two decades (see Table 1.3). 
Reynolds (2003) described a modified Nutsche filter (i.e. a laboratory batch 
filtration vessel) with an active filtration area of 10 cm2 that was used to mimic 
the continuous filtration performance of a production-scale rotary vertical leaf 
filter of 24 m2. Different commercially available small-scale and high-throughput 
membrane filtration devices were investigated by Chandler and Zydney (2004) 
(see Table 1.3). The authors concluded that while 96-well filtration plates could 
be used for scalability purposes, care must be taken: (i) when scaling filtration 
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results from small systems employing flat sheet membranes to larger-scale 
systems with more complex patterns, such as pleated membranes; and (ii) to 
ensure the membrane resistance values of the small-scale systems are consistent 
with these of the larger filtration systems. Vandezande et al. (2005) published 
another attempt to scale down NFF filtration. In this case the authors successfully 
scaled down a nanofiltration step (i.e. membrane filtration) from 12.6 to 4.52 cm2 
using a custom-made NFF device (see Table 1.3). A significant improvement was 
achieved by Jackson et al. (2006) with the automation of 96-well filter plate 
experiments. The authors also presented two custom-made filtration systems of 
8 and 24 wells that could be automated. The custom-made filtration systems 
showed: (i) good scalability results with a conventional laboratory-scale 
membrane cell (3.8 cm2); (ii) reduced errors associated with 96-well filter plates; 
and (iii) that simultaneous evaluation of different filter types was possible. 
Furthermore, automation enabled time-point measurements of the permeate. 
The active filtration area of Jackson’s et al. (2006) custom-made 8-well filtration 
module was further reduced to 0.28 cm2 by Kong et al. (2010) (see Table 1.3), 
which was used along with the automated platform for the study of plasmid DNA 
sterile filtration. The scalability of this 0.28 cm2 filter module has been confirmed 
in membrane filtration experiments (Kong et al., 2010), and in depth filtration 
studies using mammalian cell culture broths (Hogwood et al., 2013b; Lau et al., 
2013).  
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Table 1.3. Normal flow filtration scale-down methods.  
 
Scale-down system 
Filtration 
mode 
Feed volume 
Active 
filtration area 
Modified laboratory 
Nutsche filter 
(Reynolds et al., 
2003) 
Continuous, 
constant flux 
or constant 
pressure 
Not specified 10 cm2 
96-well filter plate 
and 
Syringe filters 
(Chandler and 
Zydney, 2004) 
Batch, 
constant 
positive 
pressure 
Not specified 
0.28 cm2  
(96-well plate) 
 
2.7, 3.6, 4.3 cm2 
(syringe filters) 
Custom-made 
filtration module 
with 16 separate 
stirred cells 
(Vandezande et al., 
2005) 
Batch, 
constant 
positive 
pressure 
25 mL 4.5 cm2 
Automated 
96-well filter plate 
and 
Custom-made 8 & 
24-well filter module 
(Jackson et al., 2006) 
Batch, 
constant 
negative 
pressure 
0.30 mL (96-well) 
0.83 mL (8-well) 
2.5 mL (24-well) 
0.28 cm2  
(96-well) 
 
0.79 cm2  
(8 & 24-well) 
Automated 
custom-made 8-well 
filter module  
(Hogwood et al., 
2013b; Kong et al., 
2010; Lau et al., 
2013) 
Batch, 
constant 
negative 
pressure 
5 mL 0.28 cm2 
 
 
1.4.2.3. Normal Flow Filtration Performance Analysis 
During filtration process development, NFF performance is judged on two 
mechanical performance criteria (capacity and retention) and the quality of the 
filter effluent. Capacity is defined as the volume of fluid that can be processed per 
filter unit area before a maximum differential pressure is reached; capacity is 
generally expressed in litres per square meter (L.m-2). Capacity measurements 
can be acquired in constant flux rate or constant pressure filtration mode; in the 
former filter capacity will correspond to a maximum pressure limit, and in the 
latter filter capacity will correspond to a maximum flux limit. However, filtration 
end-point can occur before the established pressure or flux limits in the event of 
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solids breakthrough (i.e. abrupt increase in filtrate turbidity). Filter retention is 
traditionally determined by the trailing sterilising-grade filter (typically 0.22 µm 
pore size), and corresponds to this last filter’s filtration capacity when operated 
in constant flux rate mode. Finally, filtrate quality is assessed by measuring 
(i) filtrate turbidity or optical density to evaluate solids content; and 
(ii) impurities (i.e. DNA, HCPs, etc.) and product yield (van Reis and Zydney, 2007; 
Yavorsky et al., 2003).  
Capacity measurements acquired in constant pressure filtration mode allow for 
a variable flux rate over time. As a consequence, filter capacity predictions might 
be underestimated; the high initial flux rates that can occur under contant 
pressure filtration can inefficiently load the filter and cause premature filter 
clogging as a result. Therefore, constant flux filtration capacity measurements are 
recommended for a more accurate filtration performance profile (Yavorsky et al., 
2003).  
Filter capacity values, obtained either in contant pressure or contant flux rate 
mode, are used for filter sizing purposes and to evaluate the filter fouling 
mechanism. Filter sizing methods include the flow decay method, Vmax analysis 
and Pmax analysis. The flow decay method, which consists in measuring the 
cumulative filtrate volume until flux rate drops to 10-20 % its initial value, 
requires large volumes of process fluid. In contrast, in the Vmax and Pmax analyses 
data is obtained over a short period of time; filtration is performed at constant 
pressure and constant flux mode, respectively. The Vmax and Pmax data is later 
extrapolated to longer filtration times to calculate the maximum fluid volume the 
filter can process; the linearised form of the corresponding filtration fouling 
model is used for this purpose (van Reis et al., 1991; Yavorsky et al., 2003).  
Filter fouling can occur on the filter surface by pore blockage or cake layer 
formation, as well as within the filter porous structure (see Figure 1.5 and     
Figure 1.6). Filter fouling causes a decay in flux rate during constant pressure 
operation and increases pressure drop during constant flux operation. Four 
classical filtration fouling models exist for Newtonian solid-liquid suspensions. 
These models are standard pore blockage, intermediate pore blockage, pore 
constriction, and cake filtration (see Figure 1.6). Each filter fouling model is 
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described by a mathematical equation specific to each filtration mode 
(i.e. constant flux and constant pressure). These models assume that: (i) there is 
no back-transport or detachment; and (ii) all filter pores are of equal diameter 
and length and are parallel one another. Each filtration fouling model has a 
linearised form of the equation, which is used during data analysis and model 
indentification (van Reis and Zydney, 2007).  
 
 
Figure 1.6. Schematic representation of the four classic filter fouling 
mechanisms.  
Standard pore blockage assumes the fouling particles completely obstruct the filter 
pores without the superimposition of other particles; this model is typically 
observed when the fouling particles are larger than the filter pore size. Intermediate 
pore blockage occurs when the filter pores are obstructed by the foulant, although 
this model allows for particle superimposition on the filter surface. Pore 
constriction occurs when the foulant leads to a reduction in the effective filter pore 
size due to the deposition of fouling particles along the walls of the filter pores; the 
pore column volume will decrease as filtration progresses until complete pore 
blockage. Cake filtration is the result of fouling particles depositing on the filter 
surface; the cake layer provides additional resistance to fluid flow, which increases 
as filtration progresses (Iritani, 2013; van Reis and Zydney, 2007).  
 
 
1.4.3. Flocculation 
Few small-scale flocculation studies have been carried out to date. Some of the 
flocculation studies published in the literature have used laboratory-scale 
working volumes, e.g. 8 mL (Strand et al., 2003) and 15 mL (Bonnerjea et al., 
1988; Milburn et al., 1990). However, none of the flocculation work published has 
aimed at developing a small-scale mimic of larger scale flocculation processes. 
The closest study to this approach was that of Berrill and co-workers (2008), in 
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which the authors investigated, at laboratory-scale (~100 mL), the interactions 
between flocculation and centrifugation in order to develop a flocculation step 
that enhanced subsequent centrifugation performance.  
1.5. Mixing for Microscale Process Development 
1.5.1. Mixing in Microplates 
The use of microplates in process development studies requires a detailed 
understanding of the hydrodynamic phenomena taking place inside the wells 
(Micheletti and Lye, 2006). Several publications on fluid dynamics (Weiss et al., 
2002; Zhang et al., 2008) and gas-liquid mass transfer (Barrett et al., 2010; Doig 
et al., 2005; Hermann et al., 2003) in microtitre plates can be found in the 
literature. This subsection describes the effect that the mixing method and well 
geometry have upon the fluid dynamics inside microplate wells.   
1.5.1.1. Mixing Methods in Microplates 
1.5.1.1.1. Orbital Shaking 
Orbital shaking is described as “the simplest and most efficient way of promoting 
liquid mixing when considering multiple wells or plates” (Micheletti and Lye, 
2006). Orbital mixing has been the mixing method of choice for several 
microscale process development (Barrett et al., 2010; Hermann et al., 2003; Lye 
et al., 2003) and gas-liquid mass transfer (Doig et al., 2005; Lye et al., 2003) 
investigations. Many authors (Barrett et al., 2010; Duetz and Witholt, 2001; Weiss 
et al., 2002; Zhang et al., 2008) have used the mixing model developed by Büchs 
et al. (2001) to describe fluid motion in orbitally shaken microwells. Büchs’ 
mixing model describes orbitally shaken systems as a fluid being ‘in-phase’ (fluid 
follows the rotating movement of the shaker) or ‘out-of-phase’ (fluid does not 
follow the rotating movement of the shaker). Reynolds number is also commonly 
used to describe fluid motion in microwells (Micheletti and Lye, 2006).  
Fluid motion in orbitally shaken microplates has been shown to be influenced by: 
(i) the shaking frequency and amplitude of the orbit; (ii) the diameter and 
geometry of the microwell; (iii) the liquid fill volume; and (iv) the properties of 
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the fluid, such as density and viscosity (Barrett et al., 2010; Doig et al., 2005). 
Orbital frequency and amplitude have been shown to greatly impact upon the 
gas-liquid mass transfer rates in microplates (Duetz and Witholt, 2001; Hermann 
et al., 2003). However, fluid motion in microwells has been shown to be more 
strongly dependent on the orbital amplitude than on frequency (Zhang et al., 
2008). 
1.5.1.1.2. Jet Mixing 
In this case fluid motion is created by the liquid flow originated when liquid is 
added into a well. If liquid addition into a well is performed in a single jet, mixing 
solely occurs during the lifespan of the jet. Thereby, it is common to repeat this 
operation more than once to achieve a homogeneous solution inside the well. Jet 
mixing performance has been shown to depend upon the following variables: 
(i) jet nozzle position; (ii) relative size of the well/vessel to the jet flow; 
(iii) volumetric flow rate at which the liquid is added; (iv) liquid volume added; 
and (v) the shape of the well (Nealon et al., 2006).  
1.5.1.1.3. Magnetic Mixers 
Magnetic stirrers have been long used at laboratory-scale to mix solutions. 
Different magnetic stirrer designs fit for mixing in microwells are currently 
commercially available (e.g. V&P Scientific Inc., CA, USA), although no studies 
have been performed to date on characterising fluid motion in magnetically 
mixed microwells.  
1.5.1.1.4. Other Methods 
Surface acoustic waves (Beckman Coulter Life Sciences, IN, USA) and adaptative 
focused acoustics (Covaris Inc., MA, USA) are two commercially-available mixing 
technologies that can be applied during high-throughput screening in microwells. 
Both technologies resort to the use of acoustic energy to develop a non-contact 
mixing methodology that accelerates mass transport-limited diffusion processes 
at the micro- and nanolitre scale. Other commercially-available mixing systems 
rely on sonication (e.g. SonicMan™, Brooks Automation Inc., MA, USA), although 
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the generation of heat and the typically-large dimensions of these mixing systems 
have hindered their widespread implementation.  
1.5.1.2. Impact of Microwell Geometry on Mixing 
Zhang and co-authors (2008) studied orbital mixing in microwells with two 
different commercially-available microplate configurations (96- and 24-well 
microplates). Their studies using computational fluid dynamics (CFD) showed 
that the fluid velocity profiles in each microplate geometry was different. This 
difference stemmed from an axial component to the fluid velocity (in addition to 
the radial fluid motion) present in the 96-well but not in the 24-well  microplates 
that resulted in a greater mixing performance. The authors’ CFD results were 
confirmed by measurements of power consumption and energy dissipation rate 
values indicating considerably greater energy dissipation rates in the 96-well 
microplate. However, these findings cannot be extrapolated to all microplate 
systems given that power consumption and energy dissipation rate estimations 
strongly depend upon the size of the microwell, the fill volume and the frequency 
and amplitude in orbitally shaken systems (Zhang et al., 2008).  
The shape of the microwell itself has also been found to impact upon the fluid 
dynamics. Nealon et al. (2006) studied the effect that different well dimensions 
had on macromixing time (see Section 1.5.3) when employing the jet mixing 
method (see Section 1.5.1.1.2). Macromixing time differed up to one order of 
magnitude. Furthermore, the liquid volume required to ensure complete 
macromixing was also subject to the dimensions of the microwell. Nealon et al. 
(2006) also suggested that using microwells with a V-shaped bottom could result 
in decreased macromixing times and increased mixing efficiency. Finally, 
Hermann et al. (2003) showed that square-shaped microwells acted as baffles 
inside the well, which resulted in increased turbulence and gas-liquid transfer 
rates.  
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1.5.2. Turbulent Mixing and Scale-Up Correlations in Stirred 
Tank Reactors (STRs) 
Turbulence is a flow regime characterised by fluid moving erratically in the form 
of cross-currents. Turbulent flow then contrasts with laminar flow, where fluid 
flow is characteristically streamlined (Doran, 1995).  
1.5.2.1. Kolmogorov’s Theory of Isotropic Turbulence 
Kolmogorov’s theory of isotropic turbulence has been extensively and 
successfully used to describe turbulent flows in stirred tanks, which are 
described by the values of energy dissipation rate per unit mass of fluid 
(ε, W.kg-1). This theory is only valid at high turbulent conditions, i.e. high 
Reynolds numbers (Kawase and Moo-Young, 1990).  
The kinetic energy contained in a turbulent fluid is directed into rotational flows 
called eddies. Eddies of different sizes co-exist inside the reactor for as long as 
turbulence lasts. The largest eddies (i.e. primary eddies) have a length scale of 
similar magnitude to that of the main flow stream, and in a stirred vessel they are 
produced by mechanical and/or pneumatic agitation. Primary eddies are 
anisotropic as well as unstable, and disintegrate into smaller eddies of 
intermediate size. Eventually, the intermediate eddies break up into smaller 
eddies that will in turn break up into smaller ones until the smallest size of 
isotropic eddies, also called microeddies, is reached  (Doran, 1995; Kawase and 
Moo-Young, 1990; Kresta, 1998).  
Mixing is achieved by dispersion during the turbulent disintegration of eddies 
into smaller ones. However, below the size of the microeddies mixing relies on 
molecular diffusion. During fluid flow dispersion, the kinetic energy contained in 
the primary eddies is transmitted to eddies of decreasing size. But when the 
eddies become microeddies, their kinetic energy is dissipated as heat (see    
Figure 1.7). Therefore, fluid flow dispersion is limited by the size of the 
microeddies formed in a particular system, which is given by the Kolmogorov 
scale of mixing. According to Kolmogorov’s theory of isotropic turbulence, the 
size of the microeddies depends upon the power supplied by the stirrer providing 
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liquid motion, and the kinematic viscosity of the fluid (Bałdyga and Bourne, 1999; 
Doran, 1995; Kawase and Moo-Young, 1990; Kresta, 1998).  
At infinitely large Reynolds numbers energy dissipation by viscous effects is 
unimportant, and the energy spectrum is only determined by ε (i.e. by the power 
supplied by the stirrer). Kolmogorov referred to this energy spectrum as ‘inertial 
subrange’ (see Figure 1.7). However, as the size of the eddies decrease, energy 
dissipation is affected by fluid viscosity (Bałdyga and Bourne, 1999; Kawase and 
Moo-Young, 1990; Kresta, 1998).  
 
Figure 1.7. Schematic representation of the energy spectrum of turbulence 
according to Kolmogorov’s theory of isotropic turbulence.  
Primary eddies are produced by mechanical and/or pneumatic agitation and are 
the highest energy-containing eddies. The primary eddies eventually break up into 
smaller ones until the smallest-size eddies (i.e. microeddies) are reached. At large 
Reynolds numbers (i.e. within the inertial subrange), energy dissipation during eddy 
break-up is independent of fluid viscosity. However, as the size of the eddies 
decreases, the viscous forces increasingly affect energy dissipation (i.e. viscous 
dissipation). Figure adapted from Kawase and Moo-Young (1990). 
 
Local isotropic turbulence in stirred turbulent vessels is an idealised situation 
since the local rate of energy dissipation has been shown to vary by several 
orders of magnitude throughout a stirred vessel. Compared to other models, 
Kolmogorov’s theory of isotropic turbulence simplifies the complex 
hydrodynamics encountered in mixing vessels, which include gas-liquid 
interfaces that are difficult to rigorously characterise with a simple model.  
Nonetheless, turbulent fluid flow inside a mixing vessel can be reasonably 
represented by energy dissipation rate values. Finally, different authors have 
shown that Kolmogorov’s theory of isotropic turbulence can be also used with 
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non-Newtonian fluids, such as non-Newtonian fermentation broths (Kawase and 
Moo-Young, 1990; Kresta, 1998).  
1.5.2.2. Turbulent Fluid Flow in STRs  
Turbulent energy dissipation is not homogeneously distributed inside a STR, 
where the highest turbulent regimes are found in the impeller region. The fluid 
currents converge in the impeller region and it is here where exchange of 
material occurs. Fluid flow is slower and mainly streamlined away from the 
impeller blade tips and the impeller discharge stream. Consequently, mixing in 
these regions is much less intense than in the impeller region. In addition to this, 
fluid in STRs is recirculated due to the periodic pumping action of the impeller. 
Besides turbulent dispersion (see Section 1.5.2.1), fluid flow recirculation is the 
main reason for mixing in STRs. Fluid flow follows a specific pattern inside STRs, 
which is determined by the: (i) impeller design; (ii) properties of the fluid; and 
(iii) size and geometric proportions of the vessel, baffles and impeller. 
Nonetheless, fluid flow patterns inside STRs can be broadly classified into axial 
and radial flows depending on the direction of the liquid leaving the impeller (the 
impeller design used will determine the direction of the flow). Radial-flow 
impellers (see Figure 1.8, left), such as the six-blade disc turbine, drive liquid flow 
radially from the impeller against the walls of the tank, where the flow divides 
into two streams: one flows up to the top of the tank, and the other to the bottom; 
the flow recirculates and eventually returns back to the impeller region. 
Axial-flow impellers (see Figure 1.8, right), such as pitched-blade turbines, drive 
liquid flow downwards from the impeller against the floor of the tank, where it 
then spreads out over the floor and flows up along the tank wall before being 
drawn back to the impeller (Bourne and Yu, 1994; Doran, 1995; Ng and 
Yianneskis, 2000).  
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Figure 1.8. Fluid flow patterns produced by radial-flow and axial-flow 
impellers in a tank equipped with baffles.  
The figure schematically describes the fluid flow patterns generated by radial-flow 
and axial-flow impellers in a tank equipped with baffles as observed from the side 
of the stirred tank. The following impellers have been represented in the figure: 
six-blade disc turbine (radial flow) and three-pitched blade turbine (axial flow). 
Figure adapted from Doran (1995).  
 
1.5.2.3. Scale-Up Correlations in STRs for Turbulent Conditions 
Local turbulent energy dissipation rate per unit mass of fluid (ε) is used to 
describe the hydrodynamic stresses encountered in STRs (Henzler, 2000; 
Hortsch and Weuster-Botz, 2010; Zhou and Kresta, 1996). However, established 
“rules of thumb” such as constant power input per unit volume (P/Vl) and 
constant torque per unit volume (Γ/Vl) are traditionally used to size mixing 
vessels during the scale-up process.  
1.5.2.3.1. Constant Power Input Per Unit Volume 
Constant power input per unit volume has been used as a scale-up basis with 
considerable success in some areas (Ho et al., 1987; Kresta, 1998; Uhl and Von 
Essen, 1986). The P/Vl ratio is also expressed as the average energy dissipation 
rate per unit mass of fluid (εavg) in a vessel (Hortsch and Weuster-Botz, 2010; 
McCabe et al., 2001):  
 (Equation 1.2) 
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where εavg is the average turbulent energy dissipation rate per unit mass of fluid 
(W.kg-1), P is the power input (W), ρ is the liquid density (kg.m-3), Vl is the vessel’s 
liquid working volume (m3), Po is the impeller power number, N is the impeller 
speed (s-1) and Di is the impeller diameter (m). Scaling up based on constant P/Vl 
has been reported to require exact geometric similarity since P/Vl averages the 
largely different values of ε encountered in a STR; values of ε near the impeller 
are at least 10 times larger than in the bulk of the tank (Kresta, 1998; Zhou and 
Kresta, 1996). Constant N3Di2 (W.kg-1) (Kresta, 1998; Zhou and Kresta, 1996) and 
constant average shear rate (G̅, s-1) (Camp and Stein, 1943; Koh et al., 1984) have 
been described as alternative scale-up correlations to more closely match the 
maximum ε values encountered in the vessel. Nonetheless, N3Di2 and G̅ are both 
proportional to εavg.  
1.5.2.3.2. Constant Torque Per Unit Volume 
Constant torque per unit volume is described by constant impeller tip speed (Ho 
et al., 1987; Uhl and Von Essen, 1986). This is calculated as follows (Doran, 1995):  
 (Equation 1.3) 
where vtip is the impeller tip speed (m.s-1), N is the impeller speed (s-1) and Di is 
the impeller diameter (m).  
Both these two scale-up “rules of thumb” require geometric similarity between 
the stirred tanks used for the scale-down or scale-up process. However, process 
performance can be replicated at a different scale if the key process variables that 
determine the scale-up success are reproduced (Titchener-Hooker et al., 2008; 
Zlokarnik, 2002).  
1.5.3. Mixing Time Scales and their Effect on Kinetic Processes 
When putting two miscible and reactive fluids in contact, mixing directly 
influences the chemical reaction if the reaction kinetics are faster or are of the 
same order as the characteristic time for the mixing steps leading to 
homogenisation (Bałdyga and Bourne, 1990, 1999; Fournier et al., 1996a; 
Marcant and David, 1991; Schaer et al., 1999; Villermaux and Falk, 1994). Mixing 
has been shown to determine product quality in industrially relevant processes 
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such as precipitation, polymerisation and crystallisation. The following product 
quality attributes were affected by mixing: MW distribution (polymerisation), 
size distribution and average particle size (crystallisation and precipitation) 
(Bałdyga and Bourne, 1999; Bałdyga and Pohorecki, 1995; Fournier et al., 1996b; 
Marcant and David, 1991; Pohorecki and Bałdyga, 1988; Villermaux and Falk, 
1994).  
To investigate if a chemical process is affected by mixing, the characteristic time 
of the three main mixing mechanisms needs to be calculated. These mixing 
mechanisms are classified according to the scale of the vessel (i.e. characteristic 
length scale) at which they are relevant, and occur in both turbulent and laminar 
conditions. These mixing time scales are classified as macromixing, mesomixing 
and micromixing (see Figure 1.9) (Bałdyga and Bourne, 1992, 1999; Bałdyga and 
Pohorecki, 1995; Vicum et al., 2004).  
 
Figure 1.9. Schematic diagram of the characteristic length scales of mixing 
in a standard stirred tank reactor equipped with a six-bladed disc turbine.  
Figure adapted from Espuny Garcia del Real et al. (2014). 
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Macromixing refers to the mixing on the scale of the whole vessel (Bałdyga and 
Bourne, 1999; Bałdyga and Pohorecki, 1995; Bourne et al., 1989), i.e.  
macromixing refers to the large-scale flow processes that cause the realisation of 
large-scale distributions (Bałdyga and Pohorecki, 1995). Macromixing, which is 
independent of fluid viscosity under turbulent conditions (Bourne et al., 1989), 
controls the mean reactant concentration for the other two smaller mixing time 
scales (meso- and micromixing), and moves fluids that are undergoing meso- and 
micromixing through environments where the turbulent properties vary 
(Bałdyga and Bourne, 1992, 1999; Bałdyga and Pohorecki, 1995). Macromixing 
can be well characterised by the macroscopic flow patterns; in STRs macromixing 
is characterised by the circulation time (Bałdyga and Pohorecki, 1995). 
Macromixing models are only physically meaningful for slow reactions only, as 
they employ the average concentration of reactants in the whole mixing tank. 
Mixing and kinetic models for fast or instantaneous reactions need to consider 
smaller mixing time scales (Bałdyga and Bourne, 1999).  
Mesomixing considers the inhomogeneity appearing around the feeding point 
when fresh material is added into a vessel at high feed rates, whether in batch 
(i.e. single addition), semibatch (i.e. continued but limited addition) or 
continuous modes (Bałdyga and Pohorecki, 1995). Fast chemical reactions will 
occur near the feeding point, where a plume of fresh feed is formed after the 
addition of fresh material. This plume will be of coarse scale relative to the 
micromixing time scale, but of fine scale relative to the scale of the vessel (see 
Figure 1.9). The turbulent exchange between the fresh material and its 
surroundings occurs via two mesomixing mechanisms: (i) turbulent dispersion; 
and (ii) large eddy disintegration. First, the fresh plume will diffuse into the 
turbulent environment (i.e. turbulent dispersion), where the large eddies 
carrying the fresh material will subsequently disintegrate into small spots 
containing the fresh material (i.e. large eddy disintegration). While mixing by 
inertial disintegration of large eddies (see Section 1.5.2) proceeds without any 
direct effect on molecular mixing, the structure of the large eddies and the small 
spots of fresh material will determine the environment for micromixing (Bałdyga 
and Bourne, 1999; Bałdyga and Pohorecki, 1995).  
1. Introduction 
 74 
 
Micromixing, the smallest of the mixing time scales, refers to the viscous 
deformation of fluid elements (see Section 1.5.2) followed by molecular diffusion 
(see Figure 1.9) (Bałdyga and Bourne, 1999; Bałdyga and Pohorecki, 1995). 
Micromixing has been described to be the mixing time scale responsible for 
influencing the selectivity, yield and product quality of several industrial 
processes such as polymerisation, crystallisation and precipitation (Assirelli et 
al., 2002; Bałdyga and Pohorecki, 1995; Fournier et al., 1996b; Guichardon and 
Falk, 2000; Marcant and David, 1991; Pohorecki and Bałdyga, 1988). 
Micromixing is also responsible for product distribution in fast parallel and 
competitive-consecutive chemical reactions, where reagents are initially present 
in separate feed streams (Bałdyga and Bourne, 1990; Bałdyga and Pohorecki, 
1995; Bourne and Yu, 1994; Bourne et al., 1989; Rousseaux et al., 1999). Many 
publications have demonstrated the dependence of micromixing time on impeller 
speed, location of the feeding point, feeding time, diameter of the feeding pipe 
and viscosity of the fluid (Bałdyga et al., 1993; Bourne et al., 1989, 1995; Fournier 
et al., 1996b; Gholap et al., 1994; Marcant and David, 1991). Therefore, process 
performance, including that of subsequent solid-liquid separation steps for 
particle-inducing processes such as precipitation, can be improved by 
characterising micromixing efficiency (Guichardon and Falk, 2000; Pohorecki 
and Bałdyga, 1988; Rousseaux et al., 1999).  
Unlike macromixing,  micromixing is measured through indirect methods (Rice 
and Baud, 1990). Physical (e.g. conductometric and optical) and chemical 
methods can be used to experimentally characterise micromixing; the reader is 
referred to to Fournier et al. (1996b) for a detailed description of these methods. 
Different micromixing models can also be employed to predict micromixing time; 
these models are classified as mechanistic and analytical (Bałdyga and Bourne, 
1999; Villermaux and Falk, 1994). Mechanistic models are based on simple and 
idealised mechanisms that simulate the mixing process (Bałdyga and Bourne, 
1999). Although mechanistic models do not properly describe the physics of 
mixing, it is possible to fit the model parameters to theories of turbulence. The 
mechanistic models for micromixing time are (Bałdyga and Bourne, 1999): (i) the 
three-environment or interdiffusion model; (ii) the coalescence and redispersion 
model; (iii) the interaction by exchange with the mean (IEM) model; (iv) diffusion 
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models; and (v) both the discrete and continuous engulfment-deformation-
diffusion (EDD) models. Both discrete and continuous EDD models are based on 
the same theory, which relate to the relevant aspects of turbulence; for this 
reason, EDD models give reasonable results when compared to experimental 
data (Bałdyga and Bourne, 1999). With regards to the analytical models for 
micromixing time, these are based on a comprehensive description of the fluid 
dynamics in the mixing region, and are possible thanks to the development of CFD 
(Villermaux and Falk, 1994). Refer to Bałdyga and Bourne (1999) for a detailed 
description of the micromixing models covered in this subsection.  
Micromixing models are of interest to successfully predict the course of fast 
complex reactions such as competitive-consecutive and parallel reactions. For 
instance, in polymerisation processes micromixing models can be employed to 
predict the consumption of the initiator compound or the effects of mixing upon 
the degree of polymerisation; in precipitation and crystallisation processes, 
micromixing models have been used to predict particle size distribution and 
explain the effect of mixing on particle morphology as well as on protein solubility 
(Bałdyga and Pohorecki, 1995).  
1.6. Aims of the Research 
The primary focus of this project was to evaluate the use of flocculation as a feed 
conditioning strategy to assist in the clarification and impurity reduction 
performed by primary recovery unit operations during mAb production, using an 
industrially relevant mammalian glutamine synthetase (GS) CHO cell line. The 
objectives listed in Section 1.7 are used to define the different goals of the project 
and lay out the content of the subsequent thesis results chapters.   
1.7. Objectives of the Research 
The objective throughout the project was to obtain process-relevant data useful 
for the biopharmaceutical industry. Consequently, industrially relevant process 
materials, operational settings and equipment that mimicked the conditions 
encountered at manufacturing scale during mAb production with GS-CHO cell 
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lines were used in this thesis. The research objectives of the project, which relate 
to the thesis results chapters, are summarised below:  
Objective 1: Assess the possibility to use flocculation as a 
post-centrifugation feed conditioning strategy, identify a successful 
flocculant and establish the analytical methods and protocols to 
characterise flocculation performance.  
The absence of literature describing flocculation processes on post-centrifuged 
mammalian cell broths suggested the importance of an evaluation into whether 
such process materials could indeed be successfully flocculated. Reference in the 
literature to flocculating agents interfering with analytical methods commonly 
used to analyse flocculation performance required an investigation into such 
incidences with the flocculant used in this thesis. Chapter 3 describes the 
evaluation of different GS-CHO cell lines to validate the flocculation of 
post-centrifuged mammalian cell broths. This chapter also characterises the 
implementation, development and optimisation, when necessary, of analytical 
methods and protocols to evaluate flocculation performance, which are later used 
in subsequent thesis chapters.  
Objective 2: Develop and validate an ultra scale-down flocculation 
methodology for the rapid evaluation of flocculation conditions during 
early process development.  
The extended flocculation literature demonstrates flocculation performance is 
determined by numerous process variables. This required the development of a 
scaled-down, high-throughput, automated methodology to evaluate multiple 
flocculation conditions. Such a platform was particularly required to enhance the 
understanding of how cell culture and centrifugation conditions would impact 
upon flocculation performance. Chapter 4 describes the development of this 
methodology which was validated with clarified Baker’s yeast homogenate, used 
as an example of high-solid content biological material. This methodology was 
subsequently validated with centrifuged mammalian cell process material in 
Chapter 5, which also includes an overview of high-throughput and automated 
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approaches for the rapid evaluation of flocculation performance in mammalian 
cell processes.  
Objective 3: Evaluate the capacity of post-centrifuge flocculation to assist 
depth filtration in the removal of solids and process-related impurities 
during mAb production with GS-CHO cell lines.  
The introduction of flocculation requires a subsequent solid-liquid separation 
step to remove the flocs formed upon the addition of the flocculating agent. Depth 
filtration post-centrifugation was the solid-liquid separation step chosen to make 
use of the primary recovery process currently implemented by Lonza Biologics 
during mAb production. Chapter 6 describes the integrated study of flocculation 
and depth filtration with ultra scale-down methodologies. This chapter includes 
an overview on how flocculation and depth filtration affected filtration 
performance and discusses options to minimise their negative effect. The 
evaluation of flocculation’s capacity to assist in the removal of solids and 
process-related impurities is described in Chapter 7. The studies were carried out 
at laboratory scale by comparing the clarification and purification performances 
achieved by current and proposed flocculated primary recovery strategies. This 
comparative evaluation is extended in Chapter 8 to protein A chromatography, 
which constituted the first chromatographic step of the mAb production process, 
by identifying the process-related impurities co-eluting with the product. This 
chapter concludes the investigation of the impact that post-centrifuge 
flocculation had upon subsequent primary recovery and purification unit 
operations.   
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2. Materials and Methods 
This chapter describes the materials and methods for the experimental work 
presented in this thesis. Each results chapter will then summarise the 
experimental set-up and the experimental conditions of the studies included in 
the chapter. All chemicals used were of AnalaR (or equivalent) grade and, unless 
otherwise stated, purchased from Sigma-Aldrich (Gillingham, UK). All buffers and 
reagents were prepared using laboratory deionised water (Milli-Q, 
Merck-Millipore, MA, USA). Data analysis was performed, unless otherwise 
stated, in Microsoft Excel and graphical presentation in Sigma Plot (version 11.0, 
Systat Software Inc., Chicago, IL, USA).  
2.1. Preparation of Mammalian Cell Centrate 
Two different glutamine synthetase Chinese hamster ovary (GS-CHO) cell lines 
stably expressing an IgG4 monoclonal antibody (mAb) were used. These were the 
CY01 and the Xceed™ cell lines. Each cell line expressed a different IgG4 
monoclonal antibody, but the pI of both ranged between 6.8 and 7.2 as 
determined by isoelectric focusing (Lonza Biologics, personal communication). 
The CY01 GS-CHO cell line, which was generously provided by Lonza Biologics 
(Slough, UK), reached maximum cell densities during cell culture of 
9.7x106 cells.mL-1 and product titres of 0.8 g.L-1; this cell line will be referred to 
as low cell density (LCD) cell line in this thesis. Higher maximum cell densities 
during cell culture (47x106 cells.mL-1) and product titres (6.5 g.L-1) were achieved 
with the Xceed™ GS-CHO cell line; this cell line will be referred to as high cell 
density (HCD) cell line in this thesis. High cell density cell culture broths were 
employed in all mammalian cell experiments unless otherwise stated.  
2.1.1. Low Cell Density Mammalian Cell Line 
2.1.1.1. Cell Storage and Recovery 
A working cell bank, made up by 1 mL vials (1x108 cells.mL-1), had been created 
from the master cell bank vials provided by Lonza Biologics (Slough, UK). The 
cells were stored in liquid nitrogen in chemically defined medium (CD-CHO 
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medium, Life Technologies, Paisley, UK) containing 10 % v/v dimethyl sulfoxide. 
During cell recovery one working cell bank vial was placed in a 37°C unstirred 
water bath (SUB14, Grant Instruments, Royston, UK) for 2 minutes before 
decanting its contents into a 15 mL, sterile conical bottom centrifuge tube 
(ThermoFisher Scientific, Waltham, USA) containing 9 mL of CD-CHO medium at 
37°C. The tube was centrifuged at 450g for 5 minutes (Eppendorf 5180R, 
Hamburg, Germany), after which the supernatant was discarded. The cell pellet 
was re-suspended in 5 mL of CD-CHO medium at 37°C and then transferred into 
a 125 mL un-baffled shake flask with vent caps (Corning Incorporated Life 
Sciences, MA, USA) containing 20 mL of CD-CHO medium at 37°C. Flasks were 
incubated overnight (SANYO CO2 Incubator MC0-181C, Watford, UK) at 37°C and 
5 % CO2 on an orbital shaker set at 2.5 rps (IKA® 260, Wolf Laboratories, York, 
UK). Cell viability was checked the following day as described in the 
Section 2.1.1.5.  
2.1.1.2. Cell Maintenance  
Cells were cultured in 250 mL disposable, un-baffled shake flasks with vent caps 
(Corning Incorporated Life Sciences, MA, USA) containing 100 mL of CD-CHO 
medium (Life Technologies, Paisley, UK). Incubation conditions were those used 
during cell line recovery. Cells were sub-cultured every 3 or 4 days (i.e. during 
the exponential growth phase) for up to 25 passages. Post-inoculation viable cell 
density was kept at 0.2x106 cells.mL-1. The cell culture medium contained 25 μM 
L-methionine sulphoximine at a final concentration of 0.1 % v/v to maintain the 
selective pressure on the cells containing the glutamine synthetase plasmid. 
When larger cell culture volumes were required (e.g. for the 5 L STR cell culture 
seeding train), 1 L disposable, un-baffled shake flasks with vent caps (Corning 
Incorporated Life Sciences, MA, USA) containing 300 mL of CD-CHO medium at 
37°C were used.  
2.1.1.3. Cell Culture – Shake Flask 
Cells were cultured in CD-CHO medium (Life Technologies, Paisley, UK) for 9 days 
at the same cell culture conditions and post-inoculation viable cell density used 
during cell line maintenance. Samples with a volume of 1.5 mL were taken in 
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aseptic conditions for cell viability, product titre and total protein concentration 
measurements as described in the Section 2.1.1.5, 2.10.2 and 2.10.1, respectively.  
2.1.1.4. Cell Culture – Stirred Tank Reactor 
Cell culture broth was obtained from a third party, but using the CY01 (i.e. LCD) 
cell line. Cells were cultured for 12 days in two 5 L stirred tank reactors (STRs) of 
3.5 L working volume run in parallel with an in-built control system (BIOSTAT® 
B-DCU control unit, Sartorius Stedim, Göttingen, Germany) and operated at the 
following set-points: 37.0 ± 0.1°C, pH 7.10 ± 1.0 and dissolved oxygen tension of 
30.0 ± 1.0 % air saturation. The set pH was maintained using CO2 sparging and 
sodium carbonate buffer (100 mM NaHCO3 and 100 mM Na2CO3). The set 
dissolved oxygen tension was kept constant using air and oxygen pumped at 
100 cm3.min-1 via a horse-shoe sparger. Mixing was achieved with a single 
three-pitched blade impeller (45° angle) operated at 4.3 rps and aligned to 
generate a down-pumping flow. Cell culture was carried out in fed-batch mode 
using CD-CHO medium (Life Technologies, Paisley, UK). Glucose concentration 
was measured daily with the BioProfile 400 Automated Analyser (Nova 
Biomedical, Deeside, UK) and maintained at 2 g.L-1 by bolus addition of a 10-times 
concentrated CD-CHO medium feed (Life Technologies, Paisley, UK), 
supplemented with glucose up to 150 g.L-1; bolus addition was performed using 
a tube welder (Terumo SCD IIB Sterile tubing Welder, Terumo Medical 
Corporation, Elkton, USA) or a septum. Cell culture sample volumes of 500 μL 
were centrifuged (Microcentrifuge 5424 R, Eppendorf, Hamburg, Germany) for 
1 minute at 216.7 rps and 20°C to recover the supernatant prior to glucose 
analysis. Harvesting occurred during the cell culture decline phase.  
2.1.1.5. Cell Viability and Cell Count 
Cell viability and cell count were measured using an automated cell viability 
analyser (Vi-Cell™ XR Cell Viability Analyser, Beckman Coulter, High Wycombe, 
UK) based on trypan blue exclusion (Strober, 2001). Samples were either 
non-diluted or diluted 1 in 2 using phosphate buffered saline (PBS). Each cell 
count and viability value was the average of 50 separate measurements taken 
using the instrument’s pre-defined CHO cell settings.  
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2.1.1.6. Cell Clarification  
Limited volumes of LCD cell culture were available, thus the implementation of 
ultra scale-down techniques to clarify the cell culture broth was required. The 
LCD cell culture broth was clarified via USD centrifugation, for which a 
high-speed rotating shear device was used in combination with a bench-top 
centrifuge to mimic the process-scale centrifugation conditions, including the 
shear forces encountered in the feed zone of an industrial centrifuge. The shear 
device, which was developed and constructed by the Mechanical workshop at 
UCL (Levy et al., 1999), consists of a 40 mm diameter and 1 mm thick stainless 
steel rotating disc contained in a chamber of 50 mm diameter and 10 mm height 
(Hutchinson et al., 2006). A custom-built power unit controls the rotational speed 
of the disc, which ranges from 0 to 333.3 rps (Chatel et al., 2014). The chamber 
has a total volume of 20 mL, although 50 mL disposable syringes were used to 
dispense the liquid into the chamber ensuring any air within it was displaced.  
Low cell density cell culture broth was sheared for 20 seconds at 100 rps with the 
shearing device to mimic the conditions encountered in the Westfalia CSA-1 
disc-stack centrifuge (Westfalia Separator GmbH, Oelde, Germany), which was 
the hydro-hermetically sealed (i.e. low shear stress) centrifuge used to clarify 
HCD cell culture broth (see Section 2.1.2). These shearing conditions, which are 
equivalent to exposing the material to a maximum energy dissipation rate per 
unit mass of fluid, εmax, of 0.045x106 W.Kg-1 (Chatel et al., 2014), have been shown 
to be sufficient for all material to be subjected to the energy dissipation present 
in the chamber (Hutchinson et al., 2006). The target disc speed was set with 
20 mL of deionised water before shearing the cell culture broth. The sheared 
samples were transferred to 50 mL sterile conical bottom centrifuge tubes, and 
then centrifuged (Eppendorf 5810R, Eppendorf, Hamburg, Germany) for 
18 minutes at 66.7 rps to mimic the centrifugation conditions (i.e. Q/∑ = V/(t∑)) 
used to clarify HCD mammalian cell culture broth (Westfalia CSA-1 disc stack 
centrifuge, 163.3 rps, 70 L.h-1; see Section 2.1.2). The ∑ value for the bench-top 
centrifuge used was equal to 1.60 m2 and was calculated as follows: 
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  (Equation 2.1) 
where ∑lab is the equivalent settling area of a batch bench-top centrifuge (m2), 
clab is the calibration factor for a batch centrifuge (clab = 1; Hutchinson et al., 
2006), Vlab is the volume of material in the centrifuge tube (Vlab = 5x10-5 m3), ω is 
the radial velocity (s-1), E is the correction factor (E = 0.018) to account for 
deceleration and is equal to the fraction of overall centrifugation time for 
deceleration assuming a linear deceleration rate (Maybury et al., 2000), F is the 
correction factor (F = 0.027) to account for acceleration and is equal to the 
fraction of overall centrifugation time for acceleration assuming a linear 
acceleration rate (Maybury et al., 2000), g is the gravitational acceleration (m.s-2), 
r1 is the centrifuge inner radius (r1 = 0.100 m) and r2 is the outer radius of the 
suspension in the centrifuge tube (r2 = 0.191 m).  
Only the upper 50 % volume of centrifuged supernatant inside the centrifuge 
tubes was recovered in order to avoid disturbing the pellet. The recovered 
supernatant was pooled before measuring its particle size distribution (PSD) by 
laser light diffraction (see Section 2.11.4) as well as its optical density at 600 nm 
wavelength (OD600) to calculate the percentage solids remaining (see 
Section 2.11.3). The clarified LCD cell culture was then flocculated within a period 
of one hour. A 2 mL supernatant sample was always set apart and stored at -80°C 
for future analysis.  
2.1.2. High Cell Density Mammalian Cell Line 
High cell density mammalian cell broth was provided by Lonza Biologics (Slough, 
UK) and either clarified at UCL or in Lonza Biologics’ premises via pilot-scale 
centrifugation. Different batches of HCD cell culture broth were used in this 
thesis.  
2.1.2.1. Cell Culture 
Cells were cultured at Lonza Biologics’ premises in a 15 L STR (10 L working 
volume) with an in-built control system and fed-batch mode for 14 days.          
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Table 2.1 summarises the cell culture data of the different batches of HCD cell 
culture broth used in this thesis.  
2.1.2.2. Cell Clarification 
High cell density cell culture was clarified via disc-stack centrifugation within 
minutes of harvesting the bioreactor when clarification was performed at Lonza 
Biologics (Slough, UK). Centrifugation was performed within 3 hours of 
harvesting the bioreactor when performed at the Advanced Centre for 
Biochemical Engineering (UCL, London, UK). Table 2.2 summarises the 
centrifugation conditions and the clarification performance achieved for each batch 
of HCD cell culture used.  
Centrifugation at Lonza Biologics (Slough, UK) was performed with an Alfa Laval 
MBPX-404 disc-stack centrifuge (Alfa Laval Corporate AB, Lund, Sweden) 
equipped with a hydro-hermetically sealed feed zone. Solid-liquid separation was 
performed inside 89 conical stacked discs (at 45° angle) with 0.5 mm gap 
between each disc. The total separating bowl volume was 2.2 L with a solids 
holding capacity of 1.1 L. The centrifuge operated at a bowl speed of 158.3 rps 
and unknown flow rate (60 – 400 L.h-1). The calculated Sigma value, ∑,  for this 
centrifuge at the operating conditions used was 5276 m2. 
At UCL cell culture clarification was performed with a Westfalia CSA-1 disc-stack 
centrifuge (Westfalia Separator GmbH, Oelde, Germany) equipped with a 
hydro-hermetically sealed feed zone. In this centrifuge solid-liquid separation 
was performed inside 45 conical stacked discs (at 38.5° angle) with 0.5 mm gap 
between each disc. The centrifuge bowl volume was equal to 0.6 L and the solids 
holing capacity to 0.25 L. The Westfalia CSA-1 disc-stack centrifuge was operated 
to mimic the clarification performance achieved by the centrifugation step of one 
of Lonza Biologics’ mAb cell culture processes. Ten litres of well-mixed HCD cell 
culture broth were pumped (605 Di peristaltic pump, Watson-Marlow Pumps 
Group, Wilmington, US) at a constant flow rate of 70 L.h-1 into the centrifuge, 
which was operated at a bowl speed of 163.3 rps and temperature of 23°C. The 
resultant Q/Σ value was 2.85x10-8 m.s-1; the calculated ∑ value at the operating 
conditions used was 681.2 m2. The ∑ value was calculated as follows:  
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 (Equation 2.2) 
where ∑ds is the equivalent settling area of a disc-stack centrifuge (m2), cds is the 
calibration factor to account for non-ideal flow in a disc-stack centrifuge 
(cds = 0.4 - 0.5; Hutchinson et al., 2006), n is the number of centrifuge separation 
discs in the stack, S is the correction factor for the area occupied by the caulks 
(S = 0.9), ω is the radial velocity (s-1), r0 is the centrifuge separation disc outer 
radius (r0 = 0.055 m), ri is the centrifuge separation disc inner radius 
(ri = 0.026 m), g is the gravitational acceleration (m.s-2) and θ is the centrifuge 
separation disc half angle (radians). Centrifugal separation was performed at a 
backpressure of ∼ 1.5 bar to ensure the centrifuge feed zone stayed fully flooded 
(i.e. hydro-hermetically sealed). The supernatant was recovered in fractions of 
0.6 L, which were then analysed via OD600 measurements. The supernatant 
fractions that did not correspond to the centrifugation steady state were 
discarded while the rest were pooled. The OD600 of the final pooled centrate was 
then measured to calculate the percentage solids remaining (see Section 2.11.3). 
The PSD of the HCD mammalian cell centrate was studied by laser light diffraction 
(see Section 2.11.4) before being stored. Storage conditions differed depending 
on the batch number (see Table 2.2). The HCD mammalian cell centrate from 
batch number 1 (see Table 2.2) was stored in 0.5 L fractions at 5°C for a period of 
up to 94 days and at -80°C in one 200 mL fraction. Sodium azide to a final 
concentration of 0.05 % w/v was added to the centrate kept at 5°C to prevent 
bacterial growth (Lichstein and Soule, 1944). The HCD mammalian cell centrate 
batch number 2 (see Table 2.2) was stored in Lonza Biologics’ premises at -20°C 
and in 1.6 L fractions; the centrate was later shipped to UCL stored on dry ice. The 
HCD centrate from batch number 3 and 4 (see Table 2.2) were stored at -80°C in 
0.5 L and 50 mL fractions. 
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Table 2.1. Cell culture data of the high cell density cell culture material. 
Cells (Xceed™ cell line) were cultured in a 15 L STR and in fed-batch mode for 
14 days at Lonza Biologics’ premises (Slough, UK). Peak cell density refers to the 
maximum cell density value achieved during cell culture. Product titre was 
measured on day 14 of cell culture before harvesting. Cell culture and product titre 
data were supplied by Lonza Biologics (Slough, UK). 
 
  Cell culture 
Batch  
Thesis 
chapter 
Peak total 
cell density 
(cells.mL-1) 
Total cell density 
at harvest 
(cells.mL-1) 
Viability 
at harvest 
(%) 
Product 
titre 
(g.L-1) 
1 3 29.0x106 19.5x106 65 3.8 
2 5 28.0x106 20.0x106 78 4.7 
3 6 29.0x106 23.0x106 72 0.8 
4 7 & 8 46.6x106 30.0x106 80 6.5 
 
 
 
 
 
Table 2.2. Centrifugation conditions and clarification performance data of 
the high cell density cell culture material.  
Cells (Xceed™ cell line) were cultured in a 15 L STR and in fed-batch mode for 
14 days at Lonza Biologics’ premises (Slough, UK). Cell culture clarification at pilot 
scale using a low-shear disc-stack centrifuge. Centrifugation performance was 
assessed by the percentage solids remaining in the clarified supernatant calculated 
as described in Section 2.11.3. 
 
 Clarification 
Batch  Location Centrifuge 
Q/∑ 
(m.s-1) 
Solids 
remaining (%) 
1 UCL Westfalia CSA-1 2.85x10-8 2.2 
2 Lonza Biologics Alfa Laval MBPX-404 Unknown Unknown 
3 UCL Westfalia CSA-1 2.85x10-8 3.5 
4 UCL Westfalia CSA-1 2.85x10-8 1.6 
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2.2. Preparation of Clarified Yeast Homogenate 
High activity Baker’s yeast (Saccharomyces cerevisiae) provided by DCL London 
(London, UK) was suspended to 28 % w/v in phosphate buffer (0.1 M NaH2PO4, 
adjusted to pH 6.5 using 3 M NaOH). The yeast suspension was next homogenised 
with a Lab60 continuous flow high-pressure homogeniser (APV UK Ltd., Crawley, 
UK); homogenisation conditions were: five discrete passes, 500 bar pressure and 
constant temperature of 4°C. The homogenate was then centrifuged (Beckam 
Avanti J-E centrifuge fitted with a JA-10 rotor; Beckam Coulter Ltd., High 
Wycombe, UK) for 45 minutes at 105 rps and 4°C. The supernatant was recovered 
and stored at -20°C in aliquots of 45 mL for future use while the cell debris 
sediment was discarded. The PSD of the clarified yeast homogenate was 
measured prior to freezing by laser light diffraction as described in Section 2.11.4. 
The fresh Baker’s yeast supplied was processed within one to two days from the 
delivery date. The supernatant was stored for a maximum of three weeks.  
2.3. Configuration and Operational 
Characterisation of the Flocculation Systems  
The flocculation mixing systems used were classified in three different scales 
depending on their volumetric dimensions as follows: pilot scale (above 1 L 
working volume), laboratory scale (1 mL to 1 L working volume), and USD scale 
(below 1 mL working volume).  
2.3.1. Pilot Scale  
2.3.1.1. Configuration 
An LH fermentation reactor and corresponding stirrer driving unit (Model 500 
Series II, L.H. Engineering Co Ltd, Stoke Poges, Buckinghamshire, UK) was used. 
The reactor consisted of a 2 L vessel of 124.5 mm diameter (DT) and 1.5 L working 
volume, equipped with a 41.5 mm diameter (Di) six-bladed disc turbine 
positioned at 1/3 the vessel diameter from the bottom, also referred to as 
clearance (C) (see Figure 2.1  and Figure 2.2). To achieve a turbulent regime the 
reactor had four baffles of 12.5 mm diameter (Db) located 1.3 mm (Hb) away from 
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the vessel’s wall. Reagent additions were via a 3.0 mm internal diameter pipe (di) 
positioned 13 mm away from the centre of the impeller blade and controlled with 
a calibrated syringe pump (Ultra programmable PHD Ultra, Harvard Apparatus 
Ltd., Kent, UK) equipped with two disposable 100 mL syringes filled with reagent. 
The pipe was only submerged in the liquid vessel during reagent addition. See 
Figure 2.1 for a schematic diagram of the reactor and Figure 2.2 for impeller 
dimensions.  
2.3.1.2. Operational Characterisation 
A calibrated stroboscope (RS Components Ltd, Birchington Road, Corby, 
Northants, UK) was used to confirm the coupling between the reactor’s shaft 
rotational speed and the driving unit rotational speed display, which indicated 
speeds ranging from 1.7 to 18.3 rps in 0.83 rps intervals. The coupling was 
studied across a total range of 21 rotational speeds. A reflective paper stuck on 
the impeller shaft was used as the reference point. Triplicate readings were made 
at different speeds and at a fixed distance of 3 cm from the reference point.  
Controlled reagent additions by the syringe pump were calibrated at nine 
different flow rates (184, 150, 120, 90.0, 60.0, 30.0, 15.0, 6.00 and 3.00 mL.min-1) 
using a 0.5 M sulphuric acid solution (98 % v/v concentrate, Merck KGaA, 
Darmstadt, Germany) and a 4 % w/v PEI stock solution (linear, molecular weight 
(MW) = 50,000 - 100,000 Da; MP Biomedicals LLC, Illkirch-Graffenstaden, 
France). The weight of the reagent displaced by the syringe pump (6 mL when 
using sulphuric acid and 37.5 mL when using PEI) was measured with an 
analytical balance (Ohaus Pioneer™ PA413, Ohaus Corporation, USA). Volume 
was calculated with their corresponding density values, which were 1050 kg.m-3 
(0.5 M sulphuric acid) and 1030 kg.m-3 (4 % w/v PEI). Measurements were 
performed in triplicate. 
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Figure 2.1. Diagram to scale of the pilot-scale flocculation system.  
A 2 L stirred tank reactor of standard geometrical configuration equipped with a 
six-bladed disc turbine (as detailed in Figure 2.2) was used during the flocculation 
experiments at pilot scale. The vessel’s dimensional specifications are detailed in the 
diagram. Key geometrical ratios were as follows: HL:DT = 1:1; Di:DT = 1:3; Di:C = 1:1; 
DT:Db = 1:10; DT:Hb = 1:100, where HL is the height of the liquid level, DT is the 
diameter of the tank, Di is the impeller diameter, C is the clearance between the tank 
bottom and the impeller, Db is the diameter of the baffle, Hb is the distance between 
the baffle and the tank’s wall and di is the internal diameter of the pipe used for 
reagent addition.  
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Figure 2.2. Diagram to scale of the six-bladed disc turbine used in the pilot-
scale flocculation system.  
The impeller’s dimensional specifications are detailed in the diagram. Key 
geometrical ratios were as follows: Hib:Di = 1:4; Wib:Di = 1:5, where Hib is the height 
of the impeller blade, Di is the impeller diameter and Wib is the width of the impeller 
blade.  
 
 
2.3.2. Laboratory Scale  
A custom made (UCL Mechanical workshop) glass vessel with a total volume of 
100 mL and 70 mL working volume was used. The vessel, of 44.4 mm diameter 
(DT), was equipped with four 5 mm stainless steel baffles (Db) and either a 20 mm 
diameter (Di) stainless steel six-bladed disc impeller (UCL Mechanical workshop) 
or a 20 mm diameter (Di) plastic three-pitched blade impeller (Cornwall Model 
Boats Ltd., Cornwall, UK). Mixing motion was provided by an overhead motor 
with rotational speeds ranging from 0 to 33.3 rps to which the impellers were 
attached. Impeller clearance (C) was equal to 1/3Di (six-bladed disc impeller) or 
1/2Di (three-pitched blade impeller). Reagent additions were performed 
manually by accurately pipetting the required volume of reagent near the 
impeller blade without disturbing its rotational motion.   
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2.3.3. Ultra Scale-Down Scale 
2.3.3.1. Configuration 
A microwell-based mixing system of 800 μL working volume was used. This 
system consisted of a 1.2 mL 96-well microplate (square round-bottom 
microplate, ABGene, Epsom, UK) and a custom-made perforated Perspex lid with 
96 magnetic impellers fixed to it (see Figure 2.3.A). Each impeller consisted of 
two neodymium magnetic discs of 3.4 mm diameter (Dm) coated in a 
0.05 mm thick layer of parylene and encapsulated in a 5.5 mm diameter (Di) 
polytetrafluoroethylene (PTFE) seal (V&P Scientific, San Diego, USA). The PTFE 
seal had been perforated through its horizontal axis to fix the impeller to the lid 
by a 0.5 mm metallic wire. The impeller freely rotated through its horizontal axis 
at a clearance, C, of 5 mm from the liquid level as well as from the bottom of the 
plate when located on a magnetic stirrer (Model 75CI, V&P Scientific). The 
magnetic motor rotational speed could be adjusted by a unit controller within a 
scale of 0 to 100 % relative speed with an accuracy of 5 %. The magnetic stirrer 
was mounted on the deck of a liquid handling robot (Freedom EVO® 150, Tecan, 
Männedorf, Switzerland) via a custom-made Perspex platform (Figure 2.3.B). 
Controlled reagent additions were via PTFE-coated stainless steel tips of 1 mm 
internal diameter (di) located in the centre of the microwell with the outlet 1 mm 
above the tip of the impeller disc. These tips were located above the microwell 
mixing system and were only submerged in the liquid vessel during reagent 
addition (see Figure 2.3.B). Refer to Figure 2.4 for the schematic diagram of the 
mixing device.  
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Figure 2.3. Picture of the ultra scale-down flocculation system (A) and its 
operating set-up (B).  
A. The ultra scale-down flocculation system consisted of a 1.2 mL 96-well 
microplate and a custom-made perforated Perspex lid with 96 magnetic impellers 
attached to it. The lid is inverted in the picture to reveal the impellers that would 
remain inside the wells during normal operating conditions. B. The ultra 
scale-down flocculation system was located on a magnetic stirrer mounted on the 
deck of a Tecan liquid handling robot thanks to a custom-made Perspex platform. 
The picture shows the controlled addition of reagent into one of the microplate 
wells.  
 
A 
B 
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Figure 2.4. Diagram to scale of the ultra scale-down flocculation system.   
The diagram describes the dimensional specifications of one of the 96 wells the 
microplate-based ultra scale-down flocculation system consisted of. In each well 
there was one magnetic impeller that rotated through its horizontal axis; each 
magnetic impeller was constituted of two magnetic discs coated in a PTFE seal.  
Reagent additions were performed at 1 mm from the impeller via a stainless-steel, 
PTFE-coated tip of 1 mm internal diameter. The tip for reagent additions accessed 
the centre of the well vertically through the perforated Perspex lid to which the 
impellers were fixed to. The system’s working volume was 800 µL per well.  
 
2.3.3.2. Operational Characterisation 
A calibrated stroboscope (RS Components Ltd, Birchington Road, Corby, 
Northants, UK) was used to determine the equivalence of the unit controller 
percentage speed scale in revolutions per second, and confirm the coupling 
between the magnetic discs and the magnetic drive. A reflective paper stuck on 
the magnetic spinning drive as well as on the impellers selected was used as a 
reference point. To ensure impeller speed was constant across the microplate, 
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19 different impellers were assessed. These were located in the following wells: 
A1, A6, A12, B3, B9, D3, D4, D5, D6, D7, D8, E1, E12, F4, F7, F10, H1, H7 and H12. 
Twenty one different speeds were studied; these ranged from the 0 % to the 
100 % speed of the unit controller, and were separated in 5 % speed intervals. 
Measurements were done in triplicate and at a fixed distance of 3 cm from the 
reference point.  
In order to ensure accurate liquid handling by the Freedom EVO® 150 robotic 
platform, new liquid classes were created using the Freedom EVOware® software 
(Tecan, Männedorf, Switzerland). New liquid classes were created for the 
following solutions: 12, 6, 4, 3 and 1 % w/v PEI (linear, MW from 50,000 to 
100,000 Da; MP Biomedicals LLC, Illkirch-Graffenstaden, France), and 
0.5 M sulphuric acid (98 % v/v concentrate, Merck KGaA, Darmstadt, Germany). 
The liquid handling of water-based solutions was performed with the default 
‘Water’ liquid class provided by the software. The new liquid classes were 
calibrated at four different volumes (100, 50, 20 and 10 µL) and for all eight tips 
of the liquid handling arm. The liquid dispensed by each tip was weighed using 
an analytical balance (Ohaus Pioneer™ PA413, Ohaus Corporation, USA) and 
converted into volume with the solution’s density value, which was determined 
as described in Section 2.11.6. The dispensed volume data was plotted against the 
diluent volume; diluent volume refers to the volume specified in the software to 
be dispensed by the liquid handling robot (see Figure 2.5 for an example). The 
linear regression between the dispensed and the diluent volumes was calculated 
to determine the offset and the slope values of the linear regression equation. The 
calibration of the new liquid classes was completed by introducing the average of 
the offset and slope (i.e. factor) values of the linear regression equations 
calculated in the Freedom EVOware® software.  
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Figure 2.5. Example of calibration of a new liquid class in the liquid handling 
robot.  
This example of calibration shows the four-point calibration curve of tip number 1 
with a 4 % w/v PEI solution between 10 and 100 µL. The volume dispensed by the 
tip was weighted and the equivalent volume calculated with the solution’s density 
value (4 % w/v PEI density = 1030 kg.m-3). Measurements were done in triplicate. 
To obtain the calibration curve, the experimental dispensed volume data was 
plotted against the diluter volume (i.e. desired volume) data. The linear regression 
equation between these two variables was then calculated to obtain the offset and 
the slope values, which were then introduced into the software’s liquid handling 
robot for accurate liquid handling.  
 
 
2.4. Mixing Time Scale Studies 
2.4.1. Theoretical Calculation of Mixing Time Constants 
The theoretical values of the different characteristic mixing times were calculated 
for the pilot scale flocculation system only since they apply to baffled tanks with 
fully developed turbulence (Bałdyga and Bourne, 1992, 1999; Vicum et al., 2004). 
For the calculation of mesomixing time (both mesomixing turbulent dispersion 
and mesomixing turbulent disintegration) a stationary, homogeneous and 
isotropic turbulent environment was assumed to exist inside the pilot scale 
mixing system.  
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2.4.1.1. Macromixing  
Macromixing characteristic time was calculated as described by Bałdyga and 
Bourne (1999): 
  (Equation 2.3)   
where tm is the macromixing time (s) and tc is the circulation time (s). For a 
six-bladed disc impeller tc was calculated as below (Bałdyga and Bourne, 1999):  
 (Equation 2.4)   
where N is the impeller speed (s-1), DT is the vessel diameter (m) and Di is the 
impeller diameter (m). This equation was assumed to be valid for impeller 
clearances (C) equal to 1/2 and 1/3 the liquid height (HL). Refer to Section 2.3.1 
for the geometrical specifications of the flocculation vessel and impeller used at 
pilot scale.  
2.4.1.2. Mesomixing  
The characteristic time for mesomixing turbulent dispersion was calculated as 
described by Bałdyga and Bourne (1999): 
 (Equation 2.5)  
where td is the dispersive mesomixing time (s), Qb is the feed rate at which an 
external fluid is added into the mixing vessel (m3.s-1), ū is the external fluid 
velocity in the vicinity of the feed pipe through which the liquid is added into the 
mixing system (m.s-1) and Dt is the turbulent diffusivity (m2.s-1). The value of Qb 
was calculated as the ratio of flocculant volume added to addition time. The value 
of ū was approximated by the fluid’s mean radial and mean tangential velocities 
as follows (Bałdyga and Bourne, 1999):  
 (Equation 2.6)  
where ū is the external fluid velocity in the vicinity of the feed pipe (m.s-1), ūr is 
the mean radial velocity (m.s-1), ūt is the mean tangential velocity (m.s-1), ur is the 
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radial component of the fluid velocity relative to the tip speed, ut is the tangential 
component of the fluid velocity relative to the tip speed, N is the impeller 
speed (s-1) and Di is the impeller diameter (m). The radial and tangential 
components of the fluid velocity relative to the tip speed (ur and ut, respectively) 
were determined from the turbulent flow studies of Wu and Patterson (1989). 
While the configuration of the vessel used by these authors was the same as the 
pilot-scale flocculation system used (see Figure 2.1), the dimensions were 
different. Ratios instead of distances were considered to account for this 
variation; in particular, the ratio between the radial component (i.e. distance 
from the vessel central vertical axis to the feed point) and the vessel radius was 
considered for the calculations of ur and ut. The feed point located 
perpendicularly to the impeller blade at 7.7 cm from the vessel central vertical 
axis in Wu and Patterson’s (1989) work was used to calculate ū. At these 
conditions ur and ut were 0.42 and 0.27, respectively. Turbulent diffusivity was 
calculated according to Bałdyga and Bourne (1999) as follows:  
 (Equation 2.7) 
where Dt is the turbulent diffusivity (m2.s-1), ε is the local turbulent energy 
dissipation rate per unit mass of fluid (W.kg-1) and Di is the impeller diameter (m). 
Local turbulent energy dissipation was calculated applying the experimental flow 
model described by Bourne and Yu (1994). This model divides the flow generated 
in a STR by a six-bladed disc turbine in six characteristic flow regions, and offers 
an estimate of the value of ε in each one of them. The feed point in the pilot-scale 
flocculation system was located in region 2 of Bourne and Yu’s (1994) 
experimental flow model, and at a relative distance to the tank radius between 
0.46 and 0.8 (refer Section 2.3.1 for the detailed configuration of the pilot scale 
system). At these conditions the experimental flow model stated that:  
 (Equation 2.8)      
where Φ is the relative local energy dissipation rate, ε is the local turbulent 
energy dissipation rate per unit mass of fluid (W.kg-1), εavg is the average 
turbulent energy dissipation rate per unit mass of fluid (W.kg-1), r* is the ratio 
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between the distance from the vessel’s central vertical axis to the feed point and 
the vessel radius. Equation 2.8 was used in all the local turbulent energy 
dissipation calculations.  
The characteristic time for mesomixing turbulent disintegration was calculated 
as described by Bałdyga and Bourne (1999): 
 (Equation 2.9) 
where ts is the characteristic time for turbulent disintegration mesomixing (s), 
K is a constant equal to 2, Λc is the macroscale concentration (m) and ε is the local 
turbulent energy dissipation rate per unit mass of fluid (W.kg-1). The value of Λc 
was calculated according to Bałdyga and Bourne (1999) as follows:  
 (Equation 2.10) 
where Λc is the macroscale concentration (m), VB is the volume of reagent added 
into the mixing vessel (m3), ū is the external fluid velocity in the vicinity of the 
feed pipe (m.s-1), nf is the number of feed points in the mixing vessel and tf is the 
feed addition time (s). The value of ū was calculated according to Equation 2.6. 
Only one feed point was used at pilot scale during the flocculation studies (see 
Figure 2.1).  
2.4.1.3. Micromixing  
Micromixing characteristic time was calculated as follows (Bałdyga and Bourne, 
1999):  
 (Equation 2.11) 
where te is the micromixing time (s), v is the kinematic viscosity of the fluid inside 
the vessel (m2.s-1) and ε is the local turbulent energy dissipation rate per unit 
mass of fluid (W.kg-1).  
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2.4.2. Experimental Characterisation of Micromixing Time 
Micromixing time inside the USD and pilot-scale flocculation vessels was 
experimentally characterised by a system of fast parallel competing reactions 
developed by Fournier et al. (1996b) whose yield is sensitive to micromixing.  
2.4.2.1. Theoretical Considerations 
The experimental method used to calculate micromixing time consists in 
determining the segregation state of the fluid, which is quantified by the 
segregation index (XS). The segregation index is a function of the characteristic 
reaction time and micromixing time. The reaction time is given by the 
experimental conditions. The micromixing time is a function of the hydrodynamic 
conditions encountered inside the reactor; that is, micromixing time depends 
upon the feed addition time, the feed addition point and the mixing intensity 
(Fournier et al., 1996a, 1996b). This allows the study of the effect of feed addition 
time upon the value of XS to characterise the conditions where micromixing are 
free from the influence of macromixing and mesomixing time in a semibatch 
reactor. For a particular vessel and fixed hydrodynamic conditions, the value of 
XS gradually decreases as feed addition time increases until its value equals that 
of the critical addition time (tcrit), beyond which the value of XS remains constant. 
The value of tcrit is not a precise quantity. Instead, tcrit designates the transition 
from a situation where product distribution is inhomogeneous and both 
meso- and micromixing controlled (tf < tcrit), to a situation where reaction rate 
and product distribution are micromixing controlled (tf > tcrit) (Bałdyga and 
Bourne, 1992; Guichardon and Falk, 2000). At tf values smaller than tcrit, product 
distribution can also be controlled by macromixing time; macromixing time will 
be the controlling mechanism when the product concentration gradients develop 
at the scale of the entire vessel instead of in the vicinity of the feed point, which 
can occur at very high feed addition rates (Bałdyga et al., 1993).  
The segregation state of the fluid is measured by the formation of iodine (I2) 
under the influence of an acid (H+) in an alkaline medium. The formation of 
iodine is subjected to two fast, parallel competing chemical reactions. These are: 
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an acid-base neutralisation (Reaction 1) and an oxidation reaction called the 
Dushman reaction (Reaction 2).  
 (Reaction 1)    
 (Reaction 2) 
Reaction 1 is instantaneous, whereas Reaction 2 is fast but of the same order of 
magnitude as the micromixing process. Under perfect micromixing conditions 
the acid is instantaneously dispersed in the reactive medium and totally 
consumed by Reaction 1 as it is in stoichiometric defect with respect to the borate 
ions (H2BO3
−). In these conditions iodine is not produced since Reaction 2 is 
comparatively slower. In contrast, if mixing of the acid is not achieved down to 
molecular scale iodine is produced. That is, when micromixing time is in the same 
range or larger than the reaction time of Reaction 2, the acid remains inside 
segregated acid clouds. Following complete consumption of borate ions, the acid 
can react with iodide (I−) and iodate (IO3
−) to produce iodine. Therefore, the 
formation of iodine is a measure of the segregration state of the fluid.  Iodine may 
further react with the excess iodide to form triiodide (I3
−) according to Reaction 3.  
  (Reaction 3) 
Triiodide has absorption maxima at wavelengths of 288 and 353 nm, although 
the latter offers less interference with iodide and solvent adsorption. The 
concentration of triiodide in the fluid can therefore be quantified by the 
Beer-Lambert law, which states that (Hollas, 2004):  
 (Equation 2.12) 
where Absλ is the absorbance value obtained at λ nm wavelength (A.U.), I0 is the 
intensity of the incident radiation (cd), I is the intensity of the emerging 
radiation (cd), ελ is the molar extinction coefficient at λ nm wavelength of the 
species being quantified in the sample (m2.mol-1), [x] is the concentration of the 
species being quantified in the sample (mol.m-3) and l is the path length of the 
beam of light through the sample (m). Substituting the variables for the 
concentration of triiodide ions at λ equal to 353 nm:  
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 (Equation 2.13)   
where [I3
−] is the concentration of triiodide ions (mol.m-3), Abs353 is the 
absorbance of the bulk measured at the end of the acid injection at 353 nm 
wavelength (A.U.), l is the path length of the cuvette (m) and ε353 is the molar 
extinction coefficient of triiodide at 353 nm, which for a double-beam 
spectrophotometer is 2606 m2.mol-1 (Guichardon and Falk, 2000).  
The values of the segregation index (XS) range between 0 and 1. When the value 
of XS is equal to 0, the system is perfectly micromixed. And when XS is equal to 1, 
the system is completely segregated. Any value between 0 and 1 describes partial 
segregation, which is calculated as the ratio of the yields for the Dushman 
reaction (i.e. Reaction 2 or formation of iodine) obtained under imperfect and 
perfect micromixing (Fournier et al., 1996b; Guichardon and Falk, 2000): 
 (Equation 2.14) 
where XS is the segregation index, YS is the yield of the Dushman reaction under 
imperfect micromixing conditions, or actual iodine yield, and YST is the value of 
YS when micromixing is infinitely slow, or maximum iodine yield.  
Under imperfect micromixing conditions, the actual yield of iodine will be the 
ratio between the moles of acid consumed by the reaction to produce iodine and 
the total moles of acid injected. At iodide concentrations lower than 
1.4x10-1 mol.L-1, which is the case in the experimental mixing time studies 
performed in this thesis (see Table 2.3), the number of acid moles consumed is 
stoichiometrically proportional to the sum of the final iodine and triiodide 
concentrations (Fournier et al., 1996b). Thus, the yield of the Dushman reaction 
under imperfect micromixing conditions (YS) is calculated as follows (Guichardon 
and Falk, 2000):  
 (Equation 2.15) 
where nI2 is the number of moles of iodine produced (mol), nI3−  is the number of 
moles of triiodide produced (mol), nH0+ is the number of moles of acid 
2. Materials and Methods 
 
 101 
 
injected (mol), Vl is the working volume of the flocculation vessel (m3), [I2] is the 
final molar concentration of iodine (mol.m-3), [I3
−] is the final molar concentration 
of triiodide (mol.m-3), VB is the volume of acid injected into the flocculation 
vessel (m3) and [H+]0 is the initial molar concentration of acid or molar 
concentration of acid in the solution injected (mol.m-3). The molar concentration 
of triiodide achieved after the completion of the fast parallel competing reactions 
was calculated applying Equation 2.13. The final molar concentration of iodine 
was determined by combining the mass balance equation for iodide and the 
equilibrium constant for Reaction 3. The mass balance equation for iodide states 
that (Guichardon and Falk, 2000): 
 (Equation 2.16)    
where [I−] is the final molar concentration of iodide (mol.m-3), [I−]0 is the initial 
molar concentration of iodide (mol.m-3), [I2] is the final molar concentration of 
iodine (mol.m-3) and [I3
−] is the final molar concentration of triiodide (mol.m-3). 
The equilibrium constant of Reaction 3 is calculated as follows (Guichardon and 
Falk, 2000): 
 (Equation 2.17) 
where the equilibrium constant KB (m3.mol-1) is a function of the temperature, or 
T (K). The equilibrium constant of Reaction 3 is calculated as follows (Palmer et 
al., 1984):  
 (Equation 2.18) 
where KB is the equilibrium constant of the reaction (m3.mol-1) and T is the 
temperature at which the reaction takes place (K). When Equation 2.16 and 
Equation 2.17 are combined, a second-order algebraic equation where iodine 
concentration is the unknown variable is obtained:  
 (Equation 2.19) 
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where [I2] is the final molar concentration of iodine (mol.m-3), [I−]0 is the initial 
molar concentration of iodide (mol.m-3), [I3
−] is the final molar concentration of 
triiodide (mol.m-3) and KB is the equilibrium constant of Reaction 3 (m3.mol-1).  
When micromixing is infinitely slow, Reaction 1 and Reaction 2 are considered 
quasi-instantaneous compared to the mixing process. Under these conditions, the 
acid ions are consumed in proportion to the local concentration of borate and 
iodate ions, and the formation of iodine only relates to the stoichiometric ratio of 
the reactants (Fournier et al., 1996b; Guichardon and Falk, 2000). The selectivity 
between Reaction 1 and Reaction 2 in these conditions is written as (Fournier et 
al., 1996b):  
 (Equation 2.20) 
where X1 and X2 are the respective extents of Reaction 1 and Reaction 2. 
Therefore, the maximum iodine yield, or YST, is calculated as below (Fournier et 
al., 1996b; Guichardon and Falk, 2000):  
 (Equation 2.21)  
where X2 is the extent of Reaction 2, X1 is the extent of Reaction 1, [IO3
−]0 is the 
initial molar concentration of iodate ions (mol.m-3) and [H2BO3
−]0 is the initial 
molar concentration of borate ions (mol.m-3). The initial concentration of borate 
ions is known because when boric acid (H3BO3) reacts with a strong base such as 
sodium hydroxide (NaOH), both used in the experimental method employed in 
this thesis to calculate micromixing time (see Table 2.3), the following three 
reaction products are generated (Fournier et al., 1996b):  
 (Reaction 4.a) 
 (Reaction 4.b) 
 (Reaction 4.c) 
The concentration of borate ions at equilibrium is pH dependent. The molar 
concentrations of sodium hydroxide and boric acid employed in the experimental 
method used in this thesis to calculated micromixing time (see Table 2.3) led to a 
2. Materials and Methods 
 
 103 
 
buffer pH of 9.14. Since the pKa value of Reaction 4.a is also 9.14 (Guichardon and 
Falk, 2000), sodium hydroxide and boric acid are assumed to have totally reacted 
to form an equimolecular mixture of boric acid and borate ions (Fournier et al., 
1996b; Guichardon and Falk, 2000). Therefore, the initial concentration of boric 
acid was equal to the initial concentration of borate ions.  
Finally, borate ions have a twofold role. They are the reactants in Reaction 1, and 
they act as buffering species to keep the pH of the solution constant. The control 
of the pH is of utmost importance because iodine formation is thermodynamically 
possible in the absence of acid aggregates when the mean pH value is lower than 
pH*, where pH* is iodine dismutation pH. When pH < pH*, the iodide and iodate 
ions, which are present in excess at the experimental conditions employed to 
calculate micromixing time (see Table 2.3), can react with the acid released by 
Reaction 4.a to form iodine and shift the equilibrium of Reaction 4.a to the left. To 
ensure that the formation of iodine is only due to bad micromixing, the buffer 
composition used in the experiments has to guarantee pH working values 
between 8.5 and 9.5 since the value of pH* is close to 7. The dissociation of iodine 
at extreme alkaline pHs also needs to be avoided by not working at high pH values 
(Fournier et al., 1996b; Guichardon and Falk, 2000).  
2.4.2.2. Experimental Conditions 
The experiments to calculate micromixing time were performed at room 
temperature (i.e. 22°C) with the following reactant concentrations, which were 
adopted from the work of Guichardon and Falk (2000). First, stock solutions of 
boric acid, sodium hydroxide (VWR International, BDH Prolabo, Leuven, 
Belgium), potassium iodide (KI) and potassium iodate (KIO3) were prepared as 
described in Table 2.3. All stock solutions were prepared with laboratory 
deionised water as a diluent and just before use to avoid the oxidation of the 
reagents. The volumes of stock solution described in Table 2.3 were carefully 
pipetted into the flocculation systems in the following sequence to guarantee that 
the iodide and iodate ions coexisted in a basic solution with the aim to prevent 
the thermodynamic formation of iodine. Boric acid and sodium hydroxide were 
first mixed to obtain an alkaline buffer solution. Potassium iodide was then 
added, followed by potassium iodate and deionised water to the final working 
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volume of the flocculation system. The molar composition of the bulk solution 
before acid addition is detailed in Table 2.3. At this point, the pH of the bulk 
solution was 9.14. After setting the impeller to the required speed, a volume equal 
to 8x10-3 times the vessel’s working volume of 0.5 M sulphuric acid (98 % v/v 
concentrate, Merck KGaA, Darmstadt, Germany) was added to the bulk solution. 
Two minutes after the end of the acid injection, the absorbance of the resultant 
solution was measured at 353 nm wavelength (BioMate™ 3S Spectrophotometer, 
Eppendorf, Hamburg, Germany) using disposable UVette® cuvettes (Eppendorf, 
Hamburg, Germany).  
Published literature (Bałdyga and Bourne, 1999; Bourne et al., 1989, 1995; 
Gholap et al., 1994) shows that fourfold to sevenfold increases in the viscosity of 
the bulk solution cause significant changes in the micromixing time. However, the 
differences in viscosity between the flocculant stock solutions, the clarified cell 
culture material used during the flocculation experiments (see Section 4.3.2 and 
Section 5.3.1) and the water-based solutions used to characterise micromixing 
time (see Table 2.3) were found to be modest in comparison. Thus, no 
viscosity-raising additives were added to the buffering solution during the 
micromixing time experiments.  
Table 2.3. Composition and stock solution volumes used in the 
experimental characterisation of micromixing.  
Laboratory deionised water was used as the diluent. Reactants were weighted on 
an analytical scale (Ohaus Pioneer™ PA413, Ohaus Corporation, USA) and 
volumetric quantities were measured by calibrated pipettes. The table details the 
composition of the stock solutions prepared for the micromixing time studies 
performed (Stock solution), the volume of each stock solution used to prepare the 
final buffering solution in each flocculation system before acid addition 
(Micromixing time studies), and the final composition of the bulk fluid before acid 
addition (Final molar concentration). 
 H3BO3 NaOH KI KIO3 H2O 
Stock 
solution 
Weight (g) 22.5 7.27 3.87 0.99 - 
Water volume (mL) 600 200 20.0 200 - 
Micromixing 
time studies 
Pilot scale (mL) 450 150 15.0 150 735 
Microwell (μL) 240 77.0 8.00 80.0 395 
Final molar concentration  
(x10-3 mol.L-1) 
182 90.9 11.7 2.31 - 
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2.5. Scale-Up Correlations for Flocculation 
Studies 
Average turbulent energy dissipation rate per unit mass of fluid (εavg) and 
impeller tip speed (vtip) are the scale-up “rules of thumb” employed during 
flocculation scale-up. Refer to Section 1.5.2 for the equations used to calculate εavg 
and vtip. 
At pilot scale Po was determined from the literature. When Reynolds number (Re) 
is larger than 3x103, the Po of a six-bladed disc turbine is 5.8 (McCabe et al., 2005); 
the change from a turbulent to a transitional flow regime was considered to take 
place at Re < 103 (Norwood and Metzner, 1960). A reduction of 5.6 % in the value 
of Po at pilot scale was considered when Re < 3x103 (Bates et al., 1963). The 
Reynolds number of the pilot-scale flocculation system was calculated as 
described in Section 2.6. The P0 of the magnetic impeller from the USD 
flocculation system was empirically estimated as described in Section 4.3.1.   
2.6. Reynolds Number for Stirred Tank Reactors 
The Reynolds number for the pilot-scale flocculation vessel (see Section 2.3.1) 
was calculated as follows (Doran, 1995):   
 (Equation 2.22) 
where Re is the impeller Reynolds number, N is the impeller speed (s-1), Di is the 
impeller diameter (m), ρ is the fluid density (kg.m-3) and µ is the fluid dynamic 
viscosity (Pa.s). In a baffled stirred tank reactor of standard geometrical 
configuration (i.e. HL:DT = 1:1; Di:DT = 1:3; DT:Db = 1:10) equipped with a 
six-bladed disc turbine of standard geometrical ratios (i.e. Hib:Di = 1:4; 
Wib:Di = 1:5) and positioned at 1/3 the tank diameter from the bottom of the 
vessel, the change from a turbulent to a transitional flow regime was considered 
to take place at Re < 103 (Norwood and Metzner, 1960). 
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2.7. Flocculation Studies 
Flocculation experiments were always performed at room temperature 
(i.e. 22°C) and using PEI (linear, MW = 50,000 - 100,000 Da; MP Biomedicals LLC, 
Illkirch-Graffenstaden, France) as the flocculating reagent. The volume of 
flocculant stock solution added into the flocculation vessel was always 5 % of the 
vessel’s liquid working volume. Different PEI stock solutions were used 
depending on the final PEI concentration. Flocculant stock solutions were 
prepared by mixing the required amount of PEI with a buffer of the same pH and 
ionic strength conditions as these of the flocculation experiment. The effect that 
PEI, a weak base (Shepherd and Kitchener, 1956), had on the final pH was 
assumed to be negligible due to the stronger buffering capacity of the buffers 
used. Flocculant stock solutions were prepared the day before the experiment 
and allowed to mix overnight to ensure the flocculant was well mixed.  
2.7.1. Mammalian Cell Centrate  
2.7.1.1. Pilot Scale 
Flocculation was performed in a 1.5 L STR of standard geometrical configuration 
at pH 7 with controlled flocculant additions at 13 mm from the impeller blade 
using a calibrated syringe pump. The volume of PEI stock solution added into the 
vessel was always equal to 75 mL. Refer to Section 2.3.1 for a description of the 
pilot-scale flocculation system and its experimental set-up. Flocculant 
concentration, impeller speed and flocculant addition rate varied depending on 
the flocculation study. After the addition of PEI into the vessel, the flocs were 
allowed to mature for 10 minutes. Phosphate buffered saline (obtained from PBS 
tablets) was the diluent used to prepare the PEI stock solutions employed at this 
scale.  
2.7.1.2. Laboratory Scale 
Flocculation was performed in a 70 mL working volume glass vessel (see 
Section 2.3.2) by manually pipetting 3.5 mL of PEI stock solution as close to the 
impeller blade as possible but without disturbing its rotation. The flocculant was 
added into the vessel in a single addition. Flocculation was performed at different 
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pHs, PEI concentrations and with different impeller designs. At this scale, flocs 
were allowed to mature for 15 minutes. The flocculant stock solutions and the 
buffers used for their preparation varied depending on the pH and the PEI 
concentration conditions of the experiment.  
2.7.1.3. Ultra Scale-Down Scale 
Flocculation was performed at pH 7 in the 96-well mixing system described in 
Section 2.3.3 with controlled flocculant additions at 1 mm from the magnetic 
impeller using a Freedom EVO® 150 Tecan (Männedorf, Switzerland) liquid 
handling platform. The volume of PEI stock solution added into each well was 
always equal to 40 µL. Flocculant concentration, impeller speed and flocculant 
addition rate varied depending on the flocculation study. To accurately aspirate 
and dispense the PEI stock solutions, new liquid classes were created for the 
liquid handling robot (see Section 2.3.3). Flocculation was performed in four 
microwells (D4, D5, D6, D7) or in the entire 96-well microplate depending on the 
flocculation study. After flocculant injection, the flocs were allowed to mature for 
10 minutes. Phosphate buffered saline (obtained from PBS tablets) was the 
diluent used to prepare the PEI stock solutions employed at this scale.  
2.7.2. Clarified Yeast Homogenate  
Flocculation was performed at pH 6.5 by adding a 4 % w/v PEI stock solution to 
a final flocculant concentration of 0.2 % v/v. Impeller speed and flocculant 
addition rate varied depending on the flocculation study. An aging time of 
10 minutes was allowed for the flocs to mature; shorter ageing times have 
successfully flocculated centrifuged yeast homogenates when using PEI (Milburn 
et al., 1990). At USD scale, flocculation was performed in four different wells (D4, 
D5, D6, D7). Refer to Section 2.3.1 and Section 2.3.3 for a detailed description of 
the set-up and the configuration of the flocculation systems used at pilot and USD 
scale, respectively.  
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2.8. Depth Filtration Studies 
2.8.1. Ultra Scale-Down Constant Pressure Filtration 
Ultra scale-down filtration was performed using a robotic liquid handling 
platform (Freedom EVO® 100, Tecan, Männedorf, Switzerland) equipped with a 
two-position high-throughput vacuum separation module (TeVacS, Tecan, 
Männedorf, Switzerland). This module allowed operating at constant vacuum 
pressures between 100 and 700 mbar. Filter discs (6.4 mm diameter, 0.32 cm2 
surface area) were cut in-house from 60 x 60 cm filter sheets (DE45 grade 
Millistak+® DE media series, EMD Millipore, MA, USA) or 50 mm filter discs 
(05SP grade Zeta Plus™ SP series, 3M Purification Inc., St Paul, USA) using a drill 
and a hardened carbon steel hollow punch of ¼” diameter (Cromwell Group Ltd, 
Leicester, UK). Refer to Table 2.4 for the filter specifications. The cut-out discs 
were then placed in the correct orientation into the lower part of the 
custom-made filter housings (Mechanical workshop, UCL) (Figure 2.6.A). The 
upper part of the filter housing, which works as a reservoir of up to 5 mL for the 
process material, was screwed onto the bottom part. The effective filtration area 
was reduced to 0.28 cm2 as a consequence. The assembled filter housings were 
then placed within the filtration block (Mechanical workshop, UCL), which was 
fitted onto the vacuum separation module (Figure 2.6.B) with filtrate collection 
containers located underneath each housing. Filtration was performed at room 
temperature, normal flow filtration mode (i.e. flow perpendicular to the filter 
surface) and constant pressure. Filtration was monitored in real-time 
(3 - 9 seconds interval) in an associated Microsoft Excel spreadsheet thanks to 
the robot’s liquid level detection system. The output data obtained was 
cumulative filtrate volume versus filtration time. Prior to filtration with process 
material, 15 mL of deionised water were passed through the filter (536 L.m-2) at 
the same operating pressure the filtration experiment was performed in order to 
wet the filter and calculate the filter water flux. Filter water flux rates were 
calculated to ensure correct filter orientation within the filter housing and 
satisfactory filter performance, as well as to calculate filter resistance according 
to the following equations (Doran, 1995):   
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  (Equation 2.23) 
 (Equation 2.24) 
where J is the filter flux rate (L.m-2.h-1), A is the effective filtration area (m2), dV/dt 
is the instantaneous volumetric flow rate (m3.s-1), ΔP is the pressure drop across 
the filter (Pa), μ is the dynamic viscosity of the fluid (Pa.s) and Rf is the filter 
resistance (m-1). While the dV/dt values were calculated from the first derivative 
of the linear regression obtained for the water flux versus the pressure drop data, 
μ was constant and equal to the dynamic viscosity of water at 22°C, which is 
9.7x10-4 Pa.s (Perry and Green, 2008). After the water flux measurements, the 
process material was filtered until the initial flux value had dropped by 90 %. 
Filter loading was kept constant in all filtration experiments.  
Table 2.4. Specifications and operating conditions of the depth filters used 
in the ultra scale-down, constant pressure filtration experiments.  
 
Thesis 
chapter 
Filter Specifications  
ΔP 
(mbar) 
6 
Millistak+® 
DE45  
1-0.50 μm; 1 layer; Positively charged; 
Max ΔP 2.1 bar; Flushing 50 L.m-2 
EMD Millipore 
100 
400 
700 
6 
ZetaPlus™ 
05SP grade  
10-1.50 μm; 1 layer; Positively charged; 
Max ΔP 2.4 bar; Flushing 54 L.m-2 
3M Purification Inc. 
100 
400 
700 
 
The data from the constant pressure, normal flow filtration experiments (i.e. flux 
decline data) was analysed using the four classical filtration models: pore 
blockage, intermediate pore blockage, pore constriction, and cake filtration (van 
Reis and Zydney, 2007). The governing equations describing these four filtration 
models when operating at constant pressure are summarised in   Table 2.5. These 
equations assume that the filter fouling rate is proportional to the rate at which 
the fouling material is brought onto the filter by the filtration flow, thus 
neglecting any back-transport or detachment mechanisms (van Reis and Zydney, 
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2007). The linearised forms of the four constant pressure filtration models were 
used to analyse the filtration data and for filtration model identification purposes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6. Detailed experimental set-up of the ultra scale-down, constant 
pressure normal flow filtration methodology.  
A. Custom-made (Mechanical Workshop, UCL) ultra scale-down normal flow 
filtration set-up. B. Ultra scale-down filtration set-up fitted onto the 
high-throughput vacuum separation module (TeVacS, Tecan) located on the deck 
of the robotic liquid handling platform (Freedom EVO® 100, Tecan).  
 
Table 2.5. Governing equations for the four classic filter fouling models 
during constant pressure filtration.  
The equations were adapted from van Reis and Zydney (2007). The variables are as 
follows: Q is the filtrate flow rate (m3.s-1), Q0 is the initial filtrate flow rate (m3.s-1), 
V is the filtrate volume (m3), t is the filtration time (t), β, α, and δ are constants.  
 
Constant pressure Flow rate (Q) Linearised form 
Pore blockage 
 
 
Intermediate 
blockage   
Pore constriction 
  
Cake filtration 
 
 
 
 
Filter housing: 
Upper part 
Filter housing: 
Bottom part 
Filter  
Filtrate collection containers 
Filtration 
blocks 
Vacuum module 
Filtration block 
Filter housing 
Liquid handling 
arm 
 
A B 
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2.8.1.1. Modified Pore Constriction Model 
Lau and co-workers (2013) re-wrote the linearised equation for the pore 
constriction constant pressure filtration model to account for the significant 
filtration changes occurring in timescales of the order of 1 to 60 seconds when 
employing the USD constant pressure filtration methodology. The modified pore 
constriction model can identify the filtration start-up phase, that is, the moment 
when the depth filter discs placed in the USD filtration housings are operating as 
designed (i.e. when the filters are compressed and filled with process fluid). The 
linearised modified pore constriction model is written as (Lau et al., 2013):  
 (Equation 2.25) 
where t is the filtration time (s), t0 is the filtration time value when the start-up 
phase is completed (s), V* is the cumulative filtrate volume per filter area (L.m-2), 
V0
∗ is the value of cumulative filtrate volume per filter area when the start-up 
phase is completed (L.m-2), Vmax
∗  is the maximum predicted filtration throughput 
before complete filter plugging (L.m-2) and Q0
∗  is the initial filtrate flow rate per 
filter area (L.m-2.s-1).  
Equation 2.25 was applied when the pore constriction model was the filtration 
model that best fitted the USD constant pressure depth filtration data. The values 
of t0 and V0
∗ were identified for each filtration run. The calculated t0 values ranged 
from 4.5 to 8.3 seconds. The methodology used to identify t0 and V0
∗ is described 
in Figure 2.7 to Figure 2.9 with an example of calculation. First, the normalised 
cumulative filtrate volume (V*) was plotted against filtration time (t) (Figure 2.7). 
The line of best fit was determined, making sure there was a good fit for the early 
filtration period (i.e. t < 20 seconds). A fourth order polynomial fit was obtained for 
all the filtration runs. The modified pore constriction model (Equation 2.25) was then 
plotted for different theoretical values of t0 (i.e. t0 = 1, t0 = 2, etc.) (Figure 2.8). The 
intercepts of the linear best fit equations obtained for each value of t0, that is, the 
values of Q0
∗ , were recorded. The line of best fit obtained from plotting V* over t 
(fourth order polynomial) (Figure 2.7) was used to provide the first derivative 
dV*/dt values for filtration times (t) ranging from 0 to 11 seconds. The resultant 
values are plotted in Figure 2.9. In this plot the Q0
∗  values recorded from Figure 2.8 
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were also graphically represented to determine the start-up filtration time (t0). The 
value of t0 for the filtration run was that of the filtration time (t) in Figure 2.9 where 
dV*/dt was equal to Q0
∗ . Finally, the value of V0
∗ was calculated substituting t for t0 in 
the experimental line of best fit (fourth order polynomial) obtained in Figure 2.7.  
Ultra scale-down depth filtration performance was assessed based upon (i) the 
maximum predicted filtration throughput before complete filter plugging (𝑉𝑚𝑎𝑥
∗ ) 
and (ii) filtrate clarification as described by the filtrate OD600 measurements 
performed as described in Section 2.11.1.  
 
 
Figure 2.7. Example of calculation of the filtration start-up phase during 
ultra scale-down constant pressure filtration – Step 1.  
The figure represents the normalised cumulative filtrate volume data against 
filtration time. This example data set was obtained when using the ultra scale-down 
constant pressure filtration system to depth filter HCD mammalian cell centrate 
flocculated using the ultra scale-down flocculation device described in Section 2.3.3. 
Flocculation conditions were: 0.30 % w/v PEI and 1 μL.s-1 flocculant addition rate. 
Filtration conditions were: 700 mbar constant vacuum pressure, DE45 depth filter 
media (EMD Millipore). The R2 value of the line of best fit was 0.99.  
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Figure 2.8. Example of calculation of the filtration start-up phase during 
ultra scale-down constant pressure filtration – Step 2. 
The data plotted in Figure 2.7 was transformed using the modified pore constriction 
model (Equation 2.25) with t0 values ranging from 0 to 10 seconds. Linear lines of 
best fit (R2 > 0.99) were calculated for each data set and are plotted in the figure. 
The y-axis intercept of the lines of best fit corresponded to 1 𝑄0
∗⁄ , and the slope to 
1 𝑉𝑚𝑎𝑥
∗⁄ .  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9. Example of calculation of the filtration start-up phase during 
ultra scale-down constant pressure filtration – Step 3.  
The dV*/dt values at different filtration times (t) were obtained from the first 
derivative of the line of best fit for the experimental filtration data plotted in    
Figure 2.7. The 𝑄0
∗ values were the y-axis intercept of the lines of best fit obtained 
for the transformed data at different t0 (Figure 2.8). The intercept between the 
dV*/dt and 𝑄0
∗ curves plotted in the figure corresponds to the value of t0, that is, the 
value of filtration time when the start-up phase is completed. In this example t0 = 6 
s and 𝑄0
∗ = 1.34 L.m-2.s-1 or 4824 L.m-2.h-1.  
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2.8.2. Laboratory-Scale Constant Flux Filtration 
Constant flux filtration was performed at laboratory scale with an ÄKTAcrossflow 
filtration system controlled by Unicorn version 4.0 software (GE Healthcare, 
Uppsala, Sweden) that monitored the cumulative filtrate volume, filtrate 
absorbance at 280 nm wavelength (Abs280), filtrate pH, inlet pressure (Pi), 
pressure drop (ΔP) and flux. The system was primed with 0.2 litres of process 
material before every filtration run. Constant flux filtration was performed at 
room temperature and normal flow filtration mode. Filtration was stopped when 
the maximum Pi specified by the manufacturer of the filter was reached, or when 
all the process material was filtered. Filtrate was manually collected in 10 mL 
fractions allowing the off-line measurement of filtrate OD600 and filtrate Abs280 
with a spectrophotometer according to Section 2.11.1. The first five 10 mL 
fractions were always discarded to avoid filtrate dilution due to the presence in 
the system of buffer used to flush the filters. The remaining filtrate fractions were 
pooled and either (i) aliquoted in 50 mL tubes and stored at -80°C for future 
analysis and/or processing; (ii) stored at 4°C for next-day processing; or 
(iii) immediately processed through another filter.  
Different depth filter capsules from different manufacturers were employed 
depending upon the aim of the study. Sterile filtration was always performed with 
the same filter type. Table 2.6 describes the filters used and their specifications, 
as well as the operating conditions employed. Phosphate buffered saline 
(obtained from PBS tablets) filtered through an absolute 0.22 μm 
polyethersulfone filter (Stericup® filter units, Millipore, MA, USA) was used to 
flush the filters. Connection adapters were purchased from Cole-Parmer 
International (Court Vernon Hills, IL, USA).  
The data from the constant flux, normal flow filtration experiments was analysed 
using the four classical models: pore blockage, intermediate pore blockage, pore 
constriction, and cake filtration (van Reis and Zydney, 2007). The governing 
equations describing these four filtration models when operating at constant flux 
are summarised in Table 2.7. These equations assume that the filter fouling rate 
is proportional to the rate at which the fouling material is brought onto the filter 
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by the filtration flow, thus neglecting any back-transport or detachment 
mechanisms (van Reis and Zydney, 2007). The linearised forms of the four 
constant flux filtration models were used to analyse the filtration data and for 
filtration model identification purposes.  
Table 2.6. Specifications and operating conditions of the filter capsules used 
in the laboratory scale, constant flux filtration experiments.  
 
Thesis 
chapter 
Filter Specifications  
Flux 
(LMH) 
6 - 7 
Clarisolve® 
40MS μPod® 
(CS40MS01L3) 
40 μm particles; 23 cm2; 8 layers; 
Positively charged; Max Pi 2.1 bar; 
Flushing 36 min at 3.8 mL.min-1 
EMD Millipore 
100 
7 
ZetaPlus™ BC25 
capsule EXT 
grade 60ZA05A 
(BC0025S60ZA05A) 
3-0.30 μm; 25 cm2; 2 layers; 
Positively charged; Max Pi 2.75 bar; 
Flushing 2.7 min at 50 mL.min-1 
3M Purification Inc. 
130 
7 
ZetaPlus™ BC25 
capsule EXT 
grade 90ZA05A 
(BC0025S90ZA05A) 
3-0.20 μm; 25 cm2; 2 layers; 
Positively charged; Max Pi 2.75 bar; 
Flushing 2.7 min at 50 mL.min-1 
3M Purification Inc. 
130 
7 
SartoScale 
Disposable 
Sartopore® 2 
0.45/0.2 μm 
(5445307HS--FF) 
0.45/0.2 μm; 17.3 cm2; 1 layer;  
No charge; Max Pi 4 bar;  
Flushing 2.7 min at 50 mL.min-1 
Sartorius (Epsom, Surrey, UK) 
100 
130 
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Table 2.7. Governing equations for the four classic filter fouling models 
during constant flux filtration.  
The equations were adapted from van Reis and Zydney (2007). The variables are as 
follows: P is the pressure across the filter (Pa), P0 is the pressure across the filter at 
the start of the filtration process (Pa), V is the filtrate volume (m3), t is the filtration 
time (t), β, α, and δ are constants.  
 
Constant flux Pressure (P) Linearised form 
Pore blockage 
  
Intermediate 
blockage   
Pore constriction 
  
Cake filtration 
 
 
 
2.9. Affinity Chromatography  
Affinity chromatography was performed with a 4.7 mL MabSelect SuRe 
pre-packed chromatography column (HiScreen MabSelect SuRe, GE Heathcare, 
Uppsala, Sweden) with 30 mg.mL-1 theoretical dynamic binding capacity.  The 
protocol consisted of a pre-rinse step followed by equilibration, loading, three 
post-load washing steps, elution, strip, regeneration and neutralisation. Table 2.8 
describes the buffer column volumes (CVs), buffer composition and the 
volumetric and linear velocities used in each chromatographic step. The column 
was stored at 4°C in 20 % ethanol. All buffers used were filtered through an 
absolute 0.22 μm polyethersulfone filter (Stericup® filter units, Millipore, MA, 
USA).  
An ÄKTA avant chromatographic system (GE Healthcare, Uppsala, Sweden) that 
allowed in-line Abs280, pH and conductivity measurements was used. The built-in 
cooling fraction collector enabled the collection of 2 mL fractions during the run 
as well as the storage of samples at 5°C. Unicorn 6.1 software (GE Healthcare, 
Uppsala, Sweden) was used for system control, data collection and data analysis. 
Sample injection was automatic.  
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2.10. Analytical Methods 
2.10.1. Quantification of Total Protein Concentration 
Samples were centrifuged (Eppendorf 5415R, Eppendorf, Hamburg, Germany) at 
216.7 rps and 4°C for 30 minutes in 1 mL tubes to remove the solid particulates 
before protein quantification analysis. Total protein concentration was 
determined using a bicinchoninic acid (BCA) kit (Pierce™ BCA protein assay, 
Thermo Scientific, Rockford, USA) and following the manufacturer’s protocol for 
the microplate procedure. Absorbance measurements at 562 nm wavelength 
were performed with a microplate reader (Safire2™, Tecan Group Ltd., 
Maännedorf, Switzerland) as described in Section 2.11.1. Measurements were 
performed in triplicate in flat bottom transparent 96-well microplates (Sarstedt 
AG & Co, Nümbrecht, Germany).  
Table 2.8. Affinity chromatography protocol.  
 
Step Buffer composition CVs 
Volumetric & 
linear velocity 
(mL.min-1 & 
cm.h-1) 
Pre-rinse 0.1 M sodium hydroxide 3 3.13 / 400 
Equilibration 
50 mM sodium phosphate, 
250 mM sodium chloride pH 7.0 
6 3.13 / 400 
Load Sample N/A 1.57 / 200 
Wash 1 
50 mM sodium phosphate, 
250 mM sodium chloride pH 7.0 
2 1.57 / 200 
Wash 2 
50 mM sodium phosphate,  
2.0 M sodium chloride pH 7.0 
4 3.13 / 400 
Wash 3 
50 mM sodium phosphate, 
250 mM sodium chloride pH 7.0 
2 3.13 / 400 
Elution 10 mM sodium formate pH 3.5 5 3.13 / 400 
Strip 100 mM citric acid pH 2.1 2 - 6 3.13 / 400 
Regeneration 0.1 M sodium hydroxide 3 3.13 / 400 
Neutralisation 
50 mM sodium phosphate, 
250 mM sodium chloride pH 7.0 
6 3.13 / 400 
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2.10.2. Quantification of Monoclonal Antibody 
Concentration 
Quantification of the mAb expressed by the GS-CHO mammalian cell lines used 
was performed via high performance liquid chromatography (HPLC) using an 
Agilent 1200 Series HPLC system (Agilent Technologies LDA UK Ltd, Stockport, 
UK) and a 1 mL HiTrap Protein G HP pre-packed chromatography column 
(GE Healthcare Life Sciences, Little Chalfont, UK). All samples were centrifuged 
(Eppendorf 5415R, Eppendorf, Hamburg, Germany) at 216.7 rps and 4°C for 
30 minutes to remove any particulates present in them. To determine the 
unknown mAb concentration in the tested samples, a standard curve was 
prepared from serial dilutions of a reference standard which was cell-line 
specific. All dilutions were performed using the equilibration buffer. Samples and 
reference standard dilutions were loaded into a 0.5 mL HPLC round bottom 
microplate (CrossLab 96-well plate, Agilent Technologies LDA UK Ltd, Stockport, 
UK) by pipetting 300 µL per well. The microplate was then covered with a silicone 
plate seal (Pre-Slit Well Cap, ThermoFisher Scientific Inc., Rockford, USA) to 
minimise liquid losses through evaporation. Reference standards were measured 
in duplicate and samples in triplicate. Protein was detected by UV absorbance at 
280 nm wavelength. The elution peak areas of both the reference standards and 
the samples were recorded, and the unknown mAb concentration was 
determined by interpolation from the reference standard curves generated.   
Different HPLC methods were employed depending on the cell line used. For the 
LCD mammalian cell culture (i.e. CY01 cell line), the column was equilibrated for 
4.0 minutes at 1 mL.min-1 with 20 mM sodium phosphate, pH 7.0, and then loaded 
with 100 μL of sample at 2 mL.min-1. The column was then washed for 8 minutes 
with equilibration buffer pumped at 2 mL.min-1. Elution was performed with 
20 mM glycine, pH 2.8 pumped at 2 mL.min-1 for 3 minutes. A post-elution wash 
with equilibration buffer pumped at 2 mL.min-1 for 4 minutes followed. Finally, 
the column was stripped for 1 minute with elution buffer pumped at 2 mL.min-1 
before regenerating the column by gradually reducing the elution buffer to 
0 % v/v and increasing the equilibration buffer to 100 % v/v. The reference 
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standard for the LCD mammalian cell culture samples was purified IgG4 
expressed in the CY01 cell line present at a concentration of 2.8 g.L-1.  
In the HPLC method used with HCD mammalian cell samples (i.e. Xceed™ cell 
line), the column was first equilibrated for 2.0 minutes at 2.0 mL.min-1 with 
20 mM sodium phosphate, 110 mM sodium chloride, pH 7.0, and then loaded with 
100 μL of sample at 2 mL.min-1. The column was then washed with equilibration 
buffer for 2.5 minutes at 2 mL.min-1. A second wash with 20 mM sodium 
phosphate, 500 mM sodium chloride, pH 7.0 pumped at 2 mL.min-1 for 
4.0 minutes was introduced to elute the interfering flocculant. The column was 
next re-equilibrated for 4.0 minutes with equilibration buffer at 2 mL.min-1 
before eluting with 20 mM glycine, pH 2.8 pumped at 2 mL.min-1 for 5.0 minutes. 
A post-elution wash with equilibration buffer pumped at 2 mL.min-1 for 
2.0 minutes followed before stripping the column with elution buffer at 
2 mL.min-1 for 1.5 minutes. Finally, the column was regenerated for 2 minutes by 
gradually increasing at 2 mL.min-1 the equilibration buffer from 0 to 100 % v/v. 
The reference standard used with the HCD mammalian cell samples was donated 
by Lonza Biologics (Slough, UK) and consisted of a purified IgG4 expressed in the 
Xceed™ cell line present at a concentration of 8.2 g.L-1.  
2.10.3. Quantification of DNA Concentration 
The content of DNA in the samples was quantified using a commercially available 
fluorometric assay (Quant-iT™ PicoGreen® dsDNA assay kit, Invitrogen, Paisley, 
UK). The method was carried out according to the manufacturer’s protocol using 
a 96-well, flat bottom black microplate (Nunc™ Microplate, 96 well plate 
non-treated non-sterile without lid black, ThermoFisher Scientific, MA, USA). 
Samples were diluted in 1 x Tris-EDTA buffer prepared with UltraPure 
DNase/RNase-Free distilled water (ThermoFisher Scientific, MA, USA) and the 
20-times concentrated Tris-EDTA buffer supplied in the kit. Fluorescence 
measurements were performed at standard fluorescein wavelengths (excitation 
at 480 nm and emission at 520 nm) with a microplate reader as described in 
Section 2.11.1. To ensure that the sample readings remained within the 
instrument’s detection range, the microplate reader gain was optimised so that 
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the sample containing the highest DNA concentration yielded a fluorescence 
intensity near to the fluorometer’s maximum. Sample DNA measurements were 
performed in triplicate.   
2.10.4. Quantification of Chinese Hamster Ovary Host Cell 
Proteins 
A commercially available immunoassay kit consisting of a chemiluminescent 
homogeneous bead-based technology was used for the detection of CHO host cell 
proteins (HCPs) (AlphaLISA® CHO HCP broad reactivity kit, PerkinElmer, MA, 
USA). The quick, two-incubation step protocol described in the manufacturer’s 
protocol was chosen for the quantification of HCPs in HCD mammalian cell 
samples. All the HCD mammalian cell samples and the reference standards were 
tested in triplicate at a range of dilution factors using the dilution buffer provided 
in the kit. The assay was performed in 96-well microplates (White ½ 
AreaPlate-96, PerkinElmer, MA, USA) sealed with TopSeal™-A Adhesive Sealing 
Film (PerkinElmer, MA, USA) to minimise liquid losses through evaporation. 
Measurements were performed using the EnVision® Multilabel reader 
(PerkinElmer, MA, USA) by selecting the AlphaScreen for AlphaLISA assays. The 
standard curve readings were analysed with an online tool (www.myassays.com) 
using a four parameter logistic curve fit (Equation 2.26) with 1/Y2 data weighting 
to account for the change in variance occurring with an increase in signal. An 
example of standard curve is plotted in Figure 2.10. The CHO HCP concentration 
in the HCD mammalian cell samples was determined from the fit. The values 
falling outside of the 80 - 120 % liner range were not considered for the final 
analysis. The equation of a four parameter logistic non-linear regression model 
describes:   
 (Equation 2.26) 
where x is the independent value (i.e. concentration of the reference standard), y 
is the dependent value (i.e. response value) and a, b, d and e are constants. These 
constants refer to the following: a is the minimum asymptote or response value 
at 0 reference standard concentration, b is the steepness of the curve, d is the 
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inflection point or point on the curve where the curvature changes direction and 
e is the maximum asymptote or the response value for infinite reference standard 
concentration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10. Example of standard curve for CHO host cell protein 
measurements.   
Chinese hamster ovary host cell proteins were quantified using a chemiluminescent 
homogeneous bead-based technology (AlphaLISA® CHO HCP broad reactivity kit). 
Samples were tested at a range of dilution factors to ensure they were within the 
assay range. An EnVision® Multilabel reader (PerkinElmer) with AlphaScreen was 
used for the fluorescence measurements. Unknown concentrations of CHO host cell 
proteins were interpolated from the standard curve, with all standards and 
unknown concentration samples measured in triplicate.  
 
 
2.10.5. Sodium Dodecyl Sulphate-Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) 
Samples were mixed with 4-times concentrated lithium dodecyl sulphate sample 
buffer (NuPAGE®, Invitrogen, Paisley, UK), then incubated for 10 minutes at 
100°C (Thermomixer®, Eppendorf, Hamburg, Germany) and finally centrifuged 
(Eppendorf 5415R, Eppendorf, Hamburg, Germany) for 1 minute at 216.7 rps 
before loading them according to manufacturer’s protocol into a 4 - 12 % pre-cast 
Bis-Tris gel (NuPAGE®, 10 or 12 wells format, Invitrogen, Paisley, UK). For 
SDS-PAGE analysis under reducing conditions, a ten-times concentrated reducing 
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agent (NuPAGE® Reducing Agent (10x), Invitrogen, Paisley, UK) was added to the 
lithium dodecyl sulphate sample buffer prior to heat treatment. A MW standard 
was used for band identification; MarK12™ Unstained Standard (Invitrogen, 
Paisley, UK) was used in Chapter 3 and PageRuler™ Unstained protein ladder 
(ThermoFisher Scientific, MA, USA) was used in Chapter 8. Electrophoresis was 
performed in a gel tank (XCell SureLock® Mini-Cell, Invitrogen, Paisley, UK) at a 
constant voltage of 200 volts for 45 minutes in the presence of 
2-(N-morpholino)ethanesulfonic acid (MES) buffer prepared from a 20-times 
concentrated NuPAGE® MES SDS running buffer (Invitrogen, Paisley, UK) diluted 
with deionised water. For gel electrophoresis under reducing conditions 
NuPAGE® Antioxidant (Invitrogen, Paisley, UK) was added to the running buffer 
in the upper buffer chamber to maintain reducing conditions and to prevent 
protein re-oxidation. The post-electrophoresis gels were removed from the 
cassettes and rinsed three times with deionised water. The rinsed gels were then 
stained with either a Coomassie based staining solution (InstantBlue™, Expedeon 
Ltd, Swavesey, UK) or with Silver staining (SilverQuest™ Silver Staining Kit, 
Invitrogen, Paisley, UK) according to the manufacturer’s protocol. After staining, 
gels were scanned (Gel Doc™ EQ Gel Documentation System, Bio-Rad 
Laboratories, CA, USA) to acquire images for further analysis.  
2.10.6. Liquid Chromatography-Mass Spectrometry/Mass 
Spectrometry (LC-MS/MS) 
Samples were first precipitated with acetone (Fisher Scientific UK, 
Loughborough, UK) by adding four times the sample volume of cold (-20°C) 
acetone to the samples before vortexing and incubating for 60 minutes at -20°C. 
Acetone-compatible 20 mL plastic tubes were used. The samples were then 
centrifuged (Heraeus™ Megafuge™ 16R, ThermoFisher Scientific Inc., Waltham, 
USA) for 10 minutes at 253.3 rps and -10°C. The supernatant was discarded, and 
the remaining acetone in the samples was left to evaporate from the uncapped 
tubes at room temperature for 30 minutes.  
Per every 10 mg of precipitated sample, 2.5 mL of a freshly prepared solution 
made of 8 M urea (ESA Inc., Chelmsford, MA, USA) and 100 mM ammonium 
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bicarbonate (Fluka Chemie AG, Buchs, Switzerland) were added. The mixture was 
then vortexed to resuspend the precipitated proteins in the protein 
denature-inducing environment. Following this, 0.1 mL of freshly prepared 
450 mM DL-dithiothreitol were added after which the mixture was incubated at 
room temperature for one hour to reduce the disulphide bonds of the proteins. 
Carboxymethylation was performed by adding 1 mL of a freshly prepared 
100 mM iodoacetamide solution and incubating the mixture for 15 minutes at 
room temperature. The protein mixture was then diluted with 6.4 mL of 
deionised water. Finally, protein digestion was performed by adding 1 mL of a 
0.5 mg.mL-1 trypsin solution into the protein mixture and incubating at 37°C for 
one hour; the trypsin solution was prepared with sequencing-grade modified 
porcine trypsin (Promega Corporation, Madison, WI, USA) diluted with trypsin 
resuspension buffer (Promega Corporation, Madison, WI, USA). 
A small volume (10 µL) of digested sample was loaded into a Jupiter® 5 µm 
(particle size) C18 300 Å column (Phenomenex Inc., Cheshire, UK) for reversed 
phase HPLC separation using an UHPLC+ Focused UltiMate 3000 system 
(ThermoFisher Scientific Inc., Waltham, USA). Peptides were eluted in an 
acetonitrile (ACN) multi-step gradient where the two mobile phases were a 
0.05 % v/v trifluoroacetic acid (TFA) (ThermoFisher Scientific Inc., Waltham, 
USA) solution and a 90 % v/v ACN, 0.05 % v/v TFA solution. The peptide fractions 
separated by reversed phase HPLC were collected with an automatic liquid 
handling system (PROTEINEER fc II, Bruker Daltoniok GmbH, Leipzig, Germany) 
on an AnchorChip™ target plate with transporter technology (Bruker Daltoniok 
GmbH, Leipzig, Germany) as they eluted from the column; every chromatographic 
peak constituted a spot on the target plate. A peptide calibration mixture was 
then manually loaded onto the target plate by pipetting 0.5 µL of calibration 
mixture on every calibration spot. The calibration mixture was prepared by first 
dissolving the contents of the Peptide Calibration Standard II (Bruker Daltoniok 
GmbH, Leipzig, Germany) with 125 µL of a solution made of 30 % v/v ACN and 
0.1 % v/v TFA; following this, 1.5 µL of the peptide calibration standard solution 
were mixed with 300 µL of matrix solution, which was made of 280.5 µL of a 
85 % v/v ACN, 0.1 % v/v TFA solution, 13.5 µL of Bruker Matrix HCCA (Bruker 
Daltoniok GmbH, Leipzig, Germany), 3 µL of a 10 % v/v TFA solution and 3 µL of 
2. Materials and Methods 
 
 124 
 
a 100 mM ammonium phosphate monobasic solution. The target plate was finally 
loaded into a matrix-assisted laser desorption/ionisation – time of flight/time of 
flight (MALDI-TOF/TOF) mass spectrometer (ultrafleXtreme, Bruker Daltoniok 
GmbH, Leipzig, Germany) for mass spectrometry analysis.  
The raw data obtained from each of the LC-MS/MS runs was exported as an mgf 
file and searched against all taxonomy entries of the SwissProt/UniProt protein 
sequence database using the ‘MASCOT MS/MS Ions Search’ online tool available 
on the Matrix Science website (www.matrixscience.com). The search parameters 
used to filter the protein hits during protein identification were: no missed 
cleavages, carboxymethyl set as fixed modification, oxidation and amidated 
(C-term) set as variable modifications, 50 ppm peptide mass tolerance, 0.5 Da 
MS/MS fragment mass tolerance, peptide charge of +1 and monoisotopic mass 
values.  
2.11. Physical Methods 
2.11.1. Absorbance and Fluorescence Measurements  
Absorbance measurements that did not require a high-throughput approach 
were performed with 1 cm path length disposable cuvettes (UVette®, Eppendorf, 
Hamburg, Germany) and a double-beam spectrophotometer (BioMate™ 3S 
Spectrophotometer, Eppendorf, Hamburg, Germany). Mammalian cell culture 
samples with absorbance measurements above 1.0 absorbance units (A.U.) were 
diluted with PBS to ensure the measurements were within the linear range. 
Absorbance and fluorescence measurements for samples in 96-well microplates 
were performed using a microplate reader (Safire2™, Tecan Group Ltd., 
Maännedorf, Switzerland). Measurement specifications varied depending on the 
microplate used and the measurement wavelength. Measurements were always 
performed in triplicate.  
2.11.2. Turbidity Measurements 
Turbidity was measured with a tungsten filament lamp turbidimeter (2100Q 
Portable Turbidimeter, Hach, Loveland, CO, USA). Measurements required a 
sample volume of 15 mL and were expressed in nephleometric turbidity 
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units (NTU). A 10 NTU reference standard was used to verify the turbidimeter 
calibration curve before each measurement. When required, re-calibration was 
performed with three reference standards (20, 100 and 800 NTU). The 
instrument’s rapidly settling turbidity measuring mode was used with rapidly 
settling samples. Measurements were performed in triplicate.  
2.11.3. Calculation of Percentage Solids Remaining 
Centrifugation performance was assessed in terms of percentage solids 
remaining in the supernatant, which was calculated as follows: 
   (Equation 2.27) 
where ODs is the optical density of the centrifuge supernatant (A.U.), ODws is the 
optical density of the best possibly clarified centrifuge supernatant, also referred 
to as well-spun (A.U.), and ODf is the optical density of the feed material prior to 
centrifugation (A.U.). To obtain the well-spun supernatant, 2 mL of feed material 
were centrifuged (Eppendorf 5415R, Eppendorf, Hamburg, Germany) for 
30 minutes at 220 rps and 4°C leading to a V/tΣ equal to 1.4x10-9 m.s-1. Optical 
density, which refers to absorbance, was measured at 600 nm wavelength 
according to Section 2.11.1.    
2.11.4. Particle Size Measurements by Laser Light 
Diffraction 
Particle size distribution was measured by blue and red laser light diffraction 
through a sample flow cell using the Mastersizer 2000 instrument (Malvern 
Instruments Ltd., Malvern, UK) connected to a Hydro 2000SM wet dispersion unit 
(Malvern Instruments Ltd., Malvern, UK) set at 16.7 rps. The instrument’s particle 
size detection range was from 0.02 to 2000 μm. The background signal of 60 mL 
of diluent was subtracted before gradually adding the sample into the dispersion 
unit until red laser obscuration readings between 13 and 19 % were reached; the 
instrument’s red laser obscuration range was between 10 and 20 %. Different 
diluents were used depending on the pH of the sample. For mammalian cell 
samples, PBS was used with pH 7 or untreated samples; 20 mM sodium succinate, 
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156 mM sodium chloride pH 4.0 was used for pH 4 mammalian cell samples; 
20 mM acetic acid, 140 mM sodium chloride pH 5.0 was used for pH 5 mammalian 
cell samples; and 20 mM N-[Tris(hydroxymethyl)methyl]-
3-aminopropanesulfonic acid, 149 mM sodium chloride pH 8.5 was used for 
pH 8.5 mammalian cell samples. The diluent for clarified yeast homogenate 
samples was always 100 mM sodium phosphate pH 6.5 buffer. Three 
measurements per sample were consecutively taken to ensure no particle 
breakage occurred in the dispersion unit. The wet dispersion unit was emptied at 
the end of each measurement and flushed with 120 mL of deionised water three 
consecutive times before the next measurement. To verify the performance of the 
instrument, polydisperse glass microsphere standards (Malvern Instruments 
Ltd., Malvern, UK) were used periodically; the performance criteria was set at a 
relative standard deviation between the glass microsphere d50 measurements 
of ≤ 5 %.  
The samples measured were complex and variable biological mixtures of 
unknown refractive indices, so the sample refractive index was assumed to be 
that of a 10 g.L-1 globulin solution, which is 1.336 (Adair and Robinson, 1930); 
the total protein concentration values of the samples measured were always 
above 10 g.L-1 (see Section 4.3.1 and Section 5.3.1). Therefore, all the reported 
PSD results are the equivalent of globulin particle diameters. The same approach 
in the PSD measurement of complex biological mixtures when using the 
Mastersizer 2000 instrument has been reported in the literature (Chatel et al., 
2014); the authors used the refractive index of latex particles, and they also 
stated that changes in the values of the refractive index resulted only in small 
variations in the size distributions.  
Particle size distribution was plotted as described by Chatel et al. (2014). The 
output particle size data obtained by the instrument was percentage volume 
against the mean size of the particle size interval. The particle size interval was 
not constant throughout the instrument’s particle size detection range 
(0.02 - 2000 µm) but increased with particle size instead. In order to rationalise 
the data sets, percentage volume distributions were converted to volume 
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frequency distributions. For a particle size interval i, the volume frequency 
distribution is calculated as:  
 (Equation 2.28) 
where Fv,i is the volume frequency distribution, V%,i is the percentage volume in 
the size interval and Wi is the width of the particle size interval; the subscripts i 
refer to the particle size interval number.  
During PSD analysis the focus was on volume rather than on number distribution. 
The key performance factor was assessing which process conditions reduced the 
volume fraction of submicron particles that would negatively impact upon the 
subsequent solid-liquid separation step.  
2.11.5. Viscosity Measurements 
A Brookfield cone and plate DV-II+ viscometer (Brookfield Engineering 
Laboratories Inc., MA, USA) fitted with a spindle (Spindle 40) was used to study 
the rheological behaviour and measure the viscosity of biological and 
non-biological materials. A sample volume of 500 μL was exposed to increasing 
and decreasing shear sweeps performed in six increases and six reductions with 
30 seconds hold at each one of them. Shear rates ranged from 37.5 to 1200 s-1. 
Measurements were taken at 22°C; temperature control was performed via a 
cooling water circuit. Measurements were done in quadruplicate.  
2.11.6. Density Measurements 
For every density measurement, three different sample volumes (25, 50 and 
200 mL), measured with 25 mL, 50 mL and 200 mL volumetric flasks, were 
weighted on an analytical balance (Ohaus Pioneer™ PA413, Ohaus Corporation, 
USA). Triplicate independent measurements were performed for each sample 
volume. The density value of the sample was the average of the nine independent 
measurements.  
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2.12. Optical Microscopy 
Phase contrast microscopic images were taken with a Nikon TE2000-PFS 
inverted microscope (Nikon Instruments Europe B.V, Badhoevedorp, The 
Netherlands) equipped with a charge-couple device camera. Process image 
analysis was carried out with ‘ImageJ v. 1.47’ (http://rsb.info.nih.gov/ij/). 
Samples were prepared by carefully pipetting 20 µL of sample onto a glass slide 
and then placing a coverslip on top.  
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3. Evaluating Flocculation with Centrifuged 
Mammalian Cell Culture Fluids 
3.1. Introduction and Aims 
In this thesis flocculation is understood as a particle conditioning step in which 
insoluble particulates are agglomerated and removed from the liquid phase by 
the addition of a flocculating agent; the new insoluble particulates formed, called 
flocs, are then processed via a solid-liquid separation step to recover the clarified 
fluid. In contrast, precipitation is understood as the formation of insoluble solids 
from soluble species caused by changes in the physico-chemical conditions of the 
fluid or by the addition of a precipitating agent.  
Flocculation was performed on centrifuged Chinese hamster ovary (CHO) cell 
culture fluid to remove the cell debris and other process-related impurities 
present in centrifuge supernatants and that result in the premature clogging of 
the subsequent depth filter (Iammarino et al., 2007). All the examples of 
flocculation in mammalian cell processes found in the literature describe the 
flocculation of cell culture fluids to improve the clearance of cells and cell debris 
(Aunins and Wang, 1989; Coffman et al., 2006; Kang et al., 2013; Riske et al., 2007; 
Shpritzer et al., 2006; Singh et al., 2013). Since no evidence is given in the 
literature of successful flocculation processes using centrifuged mammalian cell 
culture fluids, the work detailed in this chapter explored the flocculation of 
centrifuged cell culture fluids from different CHO cell lines using 
polyethylenimine (PEI) as the flocculating agent. A small set of flocculation 
variables was also investigated to analyse how they affected flocculation 
performance, which was described by the size distribution of the flocs, the 
product yield and impurity removal achieved.  
Flocculation with cationic polyelectrolytes, such as that of PEI, has been found to 
interfere with some analytical assays used to quantify impurity removal (Peram 
et al., 2010). In order to ensure the results obtained when assessing flocculation 
performance were accurate, the interference between PEI and the analytical 
assays employed was studied under different flocculation conditions.  
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Summary of the chapter’s aims and objectives:  
1. Evaluate the use of different CHO cell lines and cell culture scales to obtain 
centrifuged mammalian cell culture fluid for the flocculation experiments.  
2. Assess different storage methods for the centrifuged CHO cell culture fluid 
used in the flocculation experiments.  
3. Estimate the interference of PEI with the analytical assays used to quantify 
flocculation performance and optimise the protocols, if necessary, to reduce 
or avoid flocculant interference.  
4. Study the flocculation of centrifuged CHO cell fluids and the effect that 
different flocculation variables have on flocculation performance.  
3.2. Experimental Set-Up 
3.2.1. Mammalian Cell Culture and Centrifugation 
Low cell density (LCD) and high cell density (HCD) mammalian cell culture was 
prepared as described in Section 2.1.1 and Section 2.1.2, respectively. While LCD 
product titre was measured as described in Section 2.10.2, HCD product titre data 
was provided by Lonza Biologics (Slough, UK). Total protein concentration was 
measured according to Section 2.10.1.  
3.2.2. Flocculation Experiments 
All experiments were performed at laboratory scale using the methodology 
described in Section 2.7.1. A linear PEI with molecular weigth (MW) between 
50,000 and 100,000 Da was used as the flocculating agent. Both the LCD and HCD 
mammalian cell centrate were used in the flocculation studies. The HCD 
mammalian cell centrate used had been stored at 5°C during a maximum period 
of 15 days in the presence of 0.05 % w/v sodium azide. The range of PEI 
concentrations and pH values chosen for the flocculation experiments were 
selected based on Lonza Biologics’ in-house knowledge of flocculation processes 
when using their commercial CHO cell lines. Different PEI concentrations, pHs 
and impeller designs were used to evaluate how these process variables affected 
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flocculation performance (see Table 3.1). Different PEI stock solutions were used 
depending on the final PEI concentration and pH. The PEI stock solutions were: 
0.20 % w/v (final 0.01 % w/v), 2.0 % w/v (final 0.10 % w/v), 4.0 % w/v (final 
0.20 % w/v), 6.0 % w/v (final 0.30 % w/v) and 12 % w/v (final 0.60 % w/v). The 
flocculant was diluted in the following buffers depending on the pH of the 
experiment: PBS (pH 7.0); 20 mM sodium succinate, 156 mM NaCl, pH 4.0 
(pH 4.0); 20 mM acetic acid, 140 mM sodium chloride, pH 5.0 (pH 5.0); and 
20 mM TAPS, 143 mM sodium chloride, pH 8.5 (pH 8.5). These flocculant 
solutions were prepared the day before the experiment and mixed overnight to 
ensure PEI was homogeneously distributed. The pH of the mammalian cell 
centrate was adjusted before flocculant addition with 1 M sodium hydroxide or 
1 M citric acid.  
Table 3.1. Experimental conditions of the flocculation studies performed 
with low and high cell density mammalian cell centrate.  
 
Sample 
PEI concentration 
(% w/v) 
pH Impeller design 
LCD mammalian 
cell centrate 
0.20 7.0 
six-bladed disc 
turbine 
HCD 
mammalian cell 
centrate 
0.01; 0.10; 0.20; 
0.30; 0.60 
7.0 
six-bladed disc 
turbine 
0.30 
4.0; 5.0; 7.0; 
8.5 
six-bladed disc 
turbine 
0.10; 0.60 7.0 
three-pitched blade 
impeller 
 
Flocculation performance was assessed (i) studying the size distribution of the 
flocs using laser light diffraction measurements (see Section 2.11.4), and 
(ii) quantifying total protein concentration (see Section 2.10.1), mAb 
concentration (see Section 2.10.2) and DNA concentration (see Section 2.10.3). 
The same parameters were also measured on the non-treated HCD mammalian 
cell centrate used for comparison purposes. Particle size distribution 
measurements were performed nine times.  
3. Evaluating Flocculation with Centrifuged Mammalian Cell Culture Fluids 
 
 132 
 
3.2.3. Assay-Flocculant Interference Studies  
The values of PEI concentration and pH chosen for the assay-PEI interference 
studies were selected to represent the range of flocculation conditions studied in 
this thesis.  
3.2.3.1. Polyethylenimine Absorbance Spectrum  
Polyethylenimine absorbance was measured at 14 different wavelengths ranging 
from 260 to 750 nm. These wavelengths were: 260, 280, 320, 360, 400, 430, 460, 
500, 550, 562, 595, 600, 660 and 750 nm. The effect of PEI concentration and 
buffer pH on PEI absorbance was studied at 0.10, 0.30 and 0.60 % w/v PEI diluted 
in pH 7.0 buffer (phosphate buffered saline (PBS)) or in pH 4.0 buffer (20 mM 
sodium succinate, 156 mM sodium chloride, pH 4.0). The PEI solutions were 
prepared the day before the experiment and allowed to mix overnight to ensure 
the flocculant was homogeneously distributed. Absorbance measurements were 
performed using 1-cm path length disposable cuvettes as described in 
Section 2.11.1.  
3.2.3.2. Quantification of Total Protein Concentration 
Total protein concentration was measured as described in Section 2.10.1. The 
equivalent total protein concentration values obtained with 0.10, 0.30 and 
0.60 % w/v PEI diluted in pH 5.0 buffer (20 mM acetic acid, 140 mM sodium 
chloride, pH 5.0), pH 7.0 buffer (PBS) and pH 8.5 buffer (20 mM TAPS, 143 mM 
sodium chloride, pH 8.5) were compared to the results obtained with non-treated 
(i.e. non-flocculated) HCD mammalian cell centrate. The PEI solutions were 
prepared the day before the experiment and allowed to mix overnight to ensure 
the flocculant was homogeneously distributed.  
3.2.3.3. Quantification of Monoclonal Antibody (mAb) Concentration 
Monoclonal antibody concentration in flocculated and non-treated mammalian 
cell centrate was quantified as described in Section 2.10.2. The chromatograms 
obtained with 0.10, 0.30 and 0.60 % w/v PEI diluted in PBS buffer were compared 
to those of non-treated HCD mammalian cell centrate to evaluate flocculant 
interference. The HPLC protocol referred to as ‘LCD mammalian cell centrate 
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protocol’ (see Section 2.10.2) was used to measure the mAb concentration in 
samples from the CY01 cell line, as well as to evaluate flocculant interference 
during HPLC analysis. A new HPLC protocol was developed to minimise PEI 
interference during mAb quantification; this new protocol is referred to as ‘HCD 
mammalian cell centrate protocol’ (see Section 2.10.2). The new HPLC protocol 
was tested with purified IgG4 (expressed in the Xceed™ cell line) and purified IgG4 
spiked with PEI to a concentration of 0.60 % w/v. The spiked mAb solution was 
prepared by adding the required amount of pure PEI (i.e. not in solution) into the 
purified IgG4 to minimise mAb dilution.  
3.2.3.4. Quantification of DNA Concentration 
Quantification of DNA was performed as described in Section 2.10.3. The 
equivalent DNA concentrations of 0.10, 0.20, 0.30 and 0.60 % w/v PEI diluted in 
PBS were compared to that of non-treated HCD mammalian cell centrate to 
evaluate PEI interference.  
3.3. Results and Discussion 
3.3.1. Characterisation of Different Mammalian Cell Lines 
Two different mammalian cell lines expressing a human IgG4 (CY01 and Xceed™) 
were used; while the CY01 cell line was cultured in a 250 mL orbitally-shake flask 
and in 5 L STRs, the Xceed™ cell line was cultured in a 15 L STR. Figure 3.1.A 
shows that very different cell densities were achieved between the two cell lines. 
The CY01 cell line reached a total cell density at time of harvest of 
8.47x106 cells.mL-1 with viabilities between 62 and 68 % depending on the cell 
culture scale (see Figure 3.1.A). The CY01 cell growth curves were similar despite 
the different scales and systems (250 mL shaked flask versus 5 L STR) as well as 
feeding strategies (batch versus fed-batch, respectively) used (see Figure 3.1.A). 
Maximum total cell density, also referred to as peak cell density, with the CY01 
cell line was achieved after 8 days at both scales. The batch mode feeding strategy 
accounted for the shorter cell culture duration (9 days) at the 250 mL scale, 
where cell viability rapidly dropped to 62 % after reaching a peak cell density of 
9.1x106 cells.mL-1 (see Figure 3.1.A). The fed-batch mode used in the 5 L STRs 
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achieved a lower cell death rate after cell density peaked to 9.7x106 cells.mL-1; 
harvest occurred on day 12 with a cell viability of 68 % (see Figure 3.1.A). The 
Xceed™ cell line was cultured in a 15 L STR, which was harvested on day 15 with 
a total cell density of 19.5x106 cells.mL-1 and viability of 65 %. Cell density peaked 
on day 10 with a value of 29.0x106 cells.mL-1 (see Figure 3.1.A). Therefore, with 
the Xceed™ cell line total cell density at time of harvest was 33 % smaller than 
peak cell density; with the CY01 cell line the difference was of 6.9 % at the 250 mL 
scale and of 13 % at the 5 L scale. When comparing the values of peak cell density 
achieved by each CHO cell line, Xceed™ achieved cell densities 3 times higher than 
these obtained by the CY01 cell line. With regards to the viable cell density at time 
of harvest, the increment was between 2.2 and 2.4 fold in favour of the Xceed™ 
cell line. Feeding strategy (batch versus fed-batch) or cell culture scale did not 
impact upon the cell densities achieved, as observed with the CY01 250 mL shake 
flask and 5 L STR scales. Instead, the difference in cell density originated in the 
CHO cell line used. For this reason, in this thesis the CY01 cell line will be referred 
to as low cell density (LCD) cell line, and the Xceed™ cell line as high cell density 
(HCD) cell line.  
When comparing the product titres achieved by the two CHO cell lines            
(Figure 3.1.B), final product concentration depended upon both the CHO cell line 
and the feeding strategy used. Monoclonal antibody concentration in the 5 L STRs 
was 2.5 fold larger than that in the 250 mL shake flask despite the CY01 cell line 
was used at both scales (see Figure 3.1.B). The different feeding strategies used 
at each scale (fed-batch and batch, respectively) could explain the higher cell 
productivity encountered in the 5 L STR. When compared to the product 
concentration reached by the Xceed™ cell line in the 15 L STR, the difference was 
of 5.0 fold (5 L STR) and 12 fold (250 mL shake flask) (see  Figure 3.1.B). Total 
protein concentration also differed depending on the CHO cell line and feeding 
strategy used (see Figure 3.1.B). Total protein concentration in the LCD centrate 
was 1.5 fold higher in the 5 L STRs than in the 250 mL shake flask. The difference 
increased to 7.1 fold (250 mL shake flask) and 4.6 fold (5 L STR) when compared 
to the HCD mammalian cell centrate (i.e. 15 L STR) (see Figure 3.1.B).  
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Figure 3.1. Characterisation of CY01 and Xceed™ mammalian cell lines.  
Cell culture in the 250 mL shake flask and two 5 L STRs were performed at UCL with 
the CY01 cell line. Cell culture in the 15 L STR was performed with the Xceed™ cell 
line at Lonza Biologics’ premises (Slough, UK). Cell count and viability (A) and 
product titre (B) for the CY01 cell cultures were measured according to Section 2.1.1 
and Section 2.10.2, respectively. Cell culture (A) and product titre (B) data from the 
Xceed™ cell line were provided by Lonza Biologics. Total protein concentration (B) 
was measured after cell culture clarification via centrifugation as described in 
Section 2.10.1. In (A) error bars indicate one standard deviation where n = 2. In (B) 
error bars indicate one standard deviation from three repeated measurements 
where n = 1.  
  
A 
B 
3. Evaluating Flocculation with Centrifuged Mammalian Cell Culture Fluids 
 
 136 
 
Finally, the ratio of mAb to total protein content varied with both the cell culture 
scale and the CHO cell line. Antibody represented 18 % of the total protein 
content in the 250 mL shake flask, 27 % in the 5 L STRs, and 30 % in the 15 L STR. 
Therefore, the mAb to total protein ratio increased with the cell culture scale. 
However, it was possibly determined by the feeding strategy used, since the 
difference between the 5 L and 15 L STRs was only of 3 % despite employing 
different CHO cell lines.  
3.3.2. Effect of Cell Density on Flocculation Performance 
Flocculation was performed on cell culture centrate after disc-stack 
centrifugation. While HCD cell culture was clarified via pilot-scale centrifugation, 
LCD cell culture was clarified employing the USD centrifugation methodology 
(see Section 1.4.1) to mimic the HCD cell culture clarification conditions. The 
PSDs of the centrate obtained from each cell culture system were measured by 
laser light diffraction and are plotted in Figure 3.2. The centrate was constituted 
of submicron particles regardless of the CHO cell line and the feeding strategy 
used (see Figure 3.2). Typically, particles much smaller than 1 µm are difficult to 
remove using a disc-stack centrifuge at practical operating conditions 
(Iammarino et al., 2007). The values of percentage volume frequency for the 
submicron particles ranged between 81 and 214 %, depending upon the feeding 
strategy used during cell culture (see Figure 3.2). Fed-batch cell cultures      
(Figure 3.2, middle and Figure 3.2, bottom) resulted in maximum percentage 
volume frequencies between 191 % (5 L STR) and 214 % (15 L STR), which were 
2.5 fold larger than that of the batch cell culture (250 mL shake flask) (Figure 3.2, 
top).  
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Figure 3.2. Particle size distribution of non-flocculated and flocculated 
mammalian cell centrate obtained from different CHO cell lines.  
Cell culture fluid from the 250 mL shake flask and 5 L STR (both using the CY01 cell 
line) were clarified via USD centrifugation as described in Section 2.1.1. Cell culture 
fluid from the 15 L STR (Xceed™ cell line) was provided by Lonza Biologics (Slough, 
UK) and clarified at UCL via pilot scale disc-stack centrifugation (see Section 2.1.2). 
Centrate was flocculated at laboratory scale with 0.20 % w/v PEI, pH 7.0 and 
six-bladed disc turbine as described in Section 2.7.1. Error bars indicate one 
standard deviation from nine repeated measurements where n = 1. 
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The difference in the maximum percentage frequency values observed for the 
submicron particles between the 15 L STR, 5 L STR and 250 mL shake flask (see 
Figure 3.2) could be due to the longer duration of the fed-batch cell cultures (see 
Figure 3.1.A); particularly, the difference in the maximum percentage frequency 
values could have been due to the significant drop in cell viability observed in the 
fed-batch cell cultures after reaching peak cell density (40 % - 5 L STR and 
55 % - 15 L STR) (see Figure 3.1). Literature shows an increase in solids carry 
over in the centrate of clarified mammalian cell cultures with cell culture age and, 
in particular, with non-viable cell density (Iammarino et al., 2007; Tait et al., 
2009). Higher cell densities and lower cell viabilities result in larger amounts of 
cell debris and other solid impurities released into the cell culture (Iammarino et 
al., 2007). In addition to this, Figure 3.1.A also shows that total cell density at time 
of harvest had dropped by 13 % (5 L STR) and by 33 % (15 L STR) from their 
corresponding peak cell density values. These data suggest cell death by necrosis 
where cells break down and release their cellular contents into the media (Arden 
and Betenbaugh, 2004; Krampe and Al-Rubeai, 2010).  
Polyethylenimine, a cationic polyelectrolyte, was the flocculating agent chosen 
for the flocculation experiments performed in this thesis. This polymer has been 
extensively characterised with respect to its physico-chemical properties (Horn, 
1980; Lindquist and Stratton, 1976; Shepherd and Kitchener, 1956). In addition 
to this, it has been commonly used to flocculate biological fluids (Barany and 
Szepesszentgyörgyi, 2004; Cordes et al., 1990; Milburn et al., 1990; Peram et al., 
2010; Salt et al., 1995, 1996). Low and high cell density centrate were flocculated 
with 0.20 % w/v PEI and pH 7 at laboratory scale. Figure 3.2 shows the size 
distribution of the flocs obtained depended on the CHO cell line used. While 
flocculation with the LCD centrate (i.e. from the CY01 cell line) resulted in 
submicron flocs (Figure 3.2, top and Figure 3.2, middle), flocculation with the 
HCD centrate (i.e. from the Xceed™ cell line) led to flocs ranging between 20 and 
185 µm in diameter (Figure 3.2, bottom). Since the aim of the process was to 
flocculate the submicron particles present in centrifuged mammalian cell 
cultures to generate feeds easier to process (Riske et al., 2007; Singh et al., 2013; 
Thömmes and Etzel, 2007), the CY01 cell line proved to be inappropriate for the 
flocculation studies performed in this thesis.  
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Flocculation of the submicron particles present in the mammalian cell centrate 
seemed to be linked to the cell density values achieved during cell culture and not 
to the cell culture scale or the feeding strategy used (i.e. fed-batch or batch). It is 
possible that the minimum flocculant dose required with LCD centrate was 
higher than 0.20 % w/v PEI. However, increasing the flocculant content would 
have been counter-productive for the subsequent depth filtration stage (see 
Chapter 6 and Chapter 7) due to electrostatic repulsive forces between the 
flocculant and the depth filter media, both positively charged. Furthermore, 
higher PEI concentrations could have resulted in higher amounts of residual 
flocculant in the feed, thus posing further complications in the capture and 
polishing chromatography steps (Peram et al., 2010). A flocculant with different 
physico-chemical characteristics to these of the PEI used could have successfully 
flocculated the submicron particles of the LCD centrate. Nonetheless, the aim was 
to mimic the conditions encountered at production scale, where CHO cell lines 
with cell densities similar to that of the HCD cell line (i.e. > 20x106 cells.mL-1) are 
employed (Westoby et al., 2011). Therefore, the flocculation studies performed 
in this thesis were limited to the HCD centrate, that is, to the Xceed™ cell line.   
3.3.3. Flocculant Assay Interference 
Some polyelectrolytes used as flocculating agents have been reported to interfere 
with certain analytical assays employed to assess flocculation performance 
(Peram et al., 2010). The effect of residual PEI on the assays chosen to evaluate 
flocculation performance was unknown. The interference of PEI on the total 
protein, mAb and DNA quantification methods chosen was studied at different 
pHs and PEI concentrations as these were the only two physico-chemical 
variables adjusted during the flocculation experiments.  
3.3.3.1. PEI Absorbance Spectrum 
The absorbance of PEI at different wavelengths was measured to study whether 
the presence of this polyelectrolyte would interfere with the spectrophotometric 
measurements used for protein and DNA quantification, as well as solids content 
assessment. The wavelengths studied ranged from 260 to 750 nm, and included 
DNA and protein quantification measurements at 260 nm and 280 nm, 
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respectively (Mathews et al., 2000), solids content assessment at 600 nm (Berrill 
et al., 2008; Chatel et al., 2014; Hogwood et al., 2013b; Kim et al., 2001; Lau et al., 
2013; Tait et al., 2009; Tustian et al., 2007) and wavelengths at which protein 
concentration is measured with commercially available kits (562 nm - BCA 
protein assay kit from ThermoFisher Scientific; 595 nm - Coomassie-Bradford 
protein assay kit from ThermoFisher Scientific; 660 nm - protein quantification 
kit from ThermoFisher Scientific; 750 nm - Lowry protein assay kit from 
ThermoFisher Scientific).  
Figure 3.3 shows that PEI absorbance gradually decreased with increasing 
wavelengths. The highest absorbance values were obtained at 260 nm, but from 
500 nm onwards absorbance did not exceed the 0.009 A.U. (see Figure 3.3). 
Increasing concentrations of PEI led to higher absorbance readings, but the 
difference in absorbance values between the different PEI concentrations tested 
decreased with higher wavelengths (see Figure 3.3). Therefore, the larger the 
absorbance wavelength, the less sensitive the measurement was to the presence 
and concentration of PEI. Lower pHs (i.e. pH 4) led to higher absorbance readings 
than neutral pHs (i.e. pH 7) (see Figure 3.3). Considering that PEI is a weak base 
where the secondary amines have a pKa of 10.0 (Shepherd and Kitchener, 1956), 
the lower the pH was, the more secondary amino groups were protonated. Due 
to the electrostatic repulsive forces between the positively charged groups, it is 
possible that the molecules of PEI were stretched at low pHs thus exposing more 
polymer surface and increasing the absorbance values.  
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Figure 3.3. Polyethylenimine absorbance spectrum between 260 and 
750 nm wavelength.   
Absorbance measurements were performed with 1-cm path length disposable 
cuvettes as described in Section 2.11.1. Samples were prepared by diluting the 
necessary amount of PEI in PBS buffer (pH 7) or 20 mM sodium succinate, 
156 mM sodium chloride, pH 4.0 buffer (pH 4). Absorbance measurements were 
performed at the following wavelengths: 260 (DNA quantification), 280 (protein 
quantification), 320, 360, 400, 430, 460, 500, 550, 562 (BCA protein assay kit, 
ThermoFisher Scientific), 595 (Coomassie-Bradford protein assay kit, 
ThermoFisher Scientific), 600 (solids content), 660 (protein quantification kit, 
ThermoFisher Scientific) and 750 nm (Lowry protein assay kit, ThermoFisher 
Scientific). Error bars indicate one standard deviation where n = 3.  
 
 
3.3.3.2. Total Protein Quantification  
Total protein concentration was quantified with a commercial BCA assay kit (see 
Section 3.3.3.2). Flocculant interference was studied by comparing the equivalent 
total protein concentration values obtained with different PEI concentrations and 
pHs to that of HCD mammalian cell centrate. The results are plotted in Figure 3.4. 
Higher PEI concentrations led to higher equivalent total protein concentration 
values; these values ranged from 0.17 g.L-1 (0.10 % w/v PEI) to 0.57 g.L-1 
(0.60 % w/v PEI) (see Figure 3.4). Buffer pH did not impact upon the results (see 
Figure 3.4). Polyethylenimine interference represented 0.3 % (0.10 % w/v PEI), 
3.4 % (0.30 % w/v PEI) and 4.5 % (0.60 % w/v PEI) of the total protein 
concentration in the HCD mammalian cell centrate used. Nonetheless, PEI 
interference was expected to be lower than 4.5 % during the flocculation 
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experiments considering the residual concentration of PEI was going to be lower 
than 0.6 % w/v after flocculation.  
High cell density mammalian cell centrate was considered to be free from any 
agents interfering with the total protein assay used. The manufacturer of the 
protein assay kit ensures the assay is compatible with sodium azide at 
concentrations < 0.2 % w/v; the concentration of sodium azide used to preserve 
the HCD mammalian cell centrate stored at 5°C was 0.05 % w/v.   
 
 
Figure 3.4. Polyethylenimine  interference with total protein quantification.  
Total protein concentration measurements were performed as described in 
Section 2.10.1. Samples were prepared by diluting the necessary amount of PEI in 
20 mM acetic acid, 140 mM sodium chloride, pH 5.0 buffer (pH 5), PBS buffer (pH 7) 
or 20 mM TAPS, 143 mM sodium chloride, pH 8.5 buffer (pH 4). Mammalian cell 
centrate was obtained after the clarification of HCD mammalian cell culture fluid 
(Xceed™ cell line; peak cell count = 29.0x106 cells.mL-1) with a pilot-scale disc-stack 
centrifuge (Q/Σ = 2.85x10-8 m.s-1) (see Section 2.1.2). Error bars indicate one 
standard deviation where n = 3.  
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3.3.3.3. Monoclonal Antibody Quantification 
Monoclonal antibody concentration was quantified via HPLC using a pre-packed 
protein G chromatography column. Polyethylenimine interference was studied 
comparing the chromatograms obtained with different concentrations of PEI to 
that of HCD mammalian cell centrate. The HPLC protocol used consisted of 
(i) sample loading; (ii) column wash with equilibration buffer (20 mM sodium 
phosphate, pH 7.0); (iii) elution (20 mM glycine, pH 2.8); (iv) post-elution wash 
with equilibration buffer; (v) column strip with elution buffer; and (vi) column 
re-equilibration with equilibration buffer. Figure 3.5 shows the HPLC 
chromatograms obtained with 0.10, 0.30 and 0.60 % w/v PEI, as well as with HCD 
mammalian cell centrate. A strong elution peak was obtained in all PEI samples 
despite the absence of mAb (see Figure 3.5). Furthermore, the signal of the 
elution peak was proportional to the concentration of PEI in the sample (see 
Figure 3.5). Other small peaks in the PEI samples were obtained during the 
post-elution wash and column re-equilibration steps (see Figure 3.5). These data 
suggested PEI eluted under low pH conditions; the post-elution peaks observed 
were obtained after a low pH step (elution and column strip). Polyethylenimine 
could have bound either to the protein G ligand or to the matrix, which has 
occurred during protein A chromatography when using other polyamines (Peram 
et al., 2010). The interaction between PEI and the chromatographic resin could 
displace the bound antibody. In addition to this, the chromatograms showed PEI 
and mAb eluted at the same time (9.8 and 9.7 minutes, respectively) (Figure 3.5). 
Due to the high absorbance of PEI at 280 nm wavelength (see Figure 3.3), the 
co-elution of PEI with the product would have resulted in a higher equivalent 
mAb concentration.  
The HPLC mAb quantification protocol was modified introducing an additional 
washing step before mAb elution to avoid the co-elution of PEI with the product. 
A low pH wash was not considered to prevent mAb eluting before the elution step. 
Instead, a high ionic strength wash was chosen; high amounts of sodium chloride 
would compete with the PEI molecules for electrostatic interactions with the 
resin. The addition of a high salt washing step before mAb elution required a new 
equilibration step in-between. Therefore, the optimised HPLC method consisted 
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of (i) sample loading; (ii) wash with an equilibration buffer of higher ionic 
strength (20 mM sodium phosphate, 110 mM sodium chloride, pH 7.0); (iii) high 
salt wash (20 mM sodium phosphate, 500 mM sodium chloride, pH 7.0); 
(iv) column re-equilibration wash with equilibration buffer; (v) elution (20 mM 
glycine, pH 2.8); (vi) post-elution wash with equilibration buffer; (vii) column 
strip with elution buffer; and (viii) column re-equilibration with equilibration 
buffer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Chromatograms displaying polyethylenimine interference 
during monoclonal antibody quantification.  
Monoclonal antibody was quantified via HPLC with a pre-packed protein G column 
applying the LCD mammalian cell line protocol described in Section 2.10.2. 
Polyethylenimine samples were prepared by mixing overnight the required amount 
of flocculant in PBS buffer. Mammalian cell centrate was obtained after the 
clarification of HCD mammalian cell culture fluid (Xceed™ cell line; peak cell 
count = 29.0x106 cells.mL-1) with a pilot-scale disc-stack centrifuge 
(Q/Σ = 2.85x10-8 m.s-1) (see Section 2.1.2). 
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The optimised HPLC method was tested with purified mAb and purified mAb 
spiked with PEI to a final 0.60 % w/v concentration, which was the maximum PEI 
concentration used in the flocculation experiments performed in this thesis. The 
chromatograms obtained are shown in Figure 3.6. Two small chromatographic 
peaks (20 and 5 mAU) were observed before the elution step when testing the 
purified mAb (Figure 3.6, top). The 20 mAU peak was obtained during the first 
wash with equilibration buffer (see Figure 3.6, top); this peak could have been 
due to process-related impurities still present in the purified sample, or to mAb 
fragments resulting from the freeze-thawing process (the purified mAb samples 
were kept at -20°C). The 5 mAU peak was observed during the high salt wash (see 
Figure 3.6, top); while product elution could not be discarded, the elution of mAb 
fragments or other impurities should be considered as well. A 185 mAU peak was 
obtained with purified mAb during the low pH elution step (see Figure 3.6, top), 
which was attributed to mAb elution; the elution peak area was equal to 4777.6 
units. Other smaller peaks (< 5 mAU) were also observed during the post-elution 
washes (see Figure 3.6, top). The great difference in peak area between the 
elution step and the high salt wash and post-elution washes suggested that mAb 
only eluted during the low pH elution step. In the presence of PEI (see Figure 3.6, 
bottom), the flocculant was observed to elute during both the first equilibration 
buffer wash (85 mAU) and the high salt wash (170 mAU). In comparison to the 
non-optimised HPLC mAb quantification protocol (see Figure 3.5), PEI eluted 
during the first wash due to the higher ionic strength of the equilibration buffer 
used in the improved HPLC protocol. The intensity of the mAb elution peak 
(185 mAU) in the presence of PEI (Figure 3.6, bottom) was the same as that of the 
purified mAb sample (Figure 3.6, top). The elution peak area also remained 
unchanged in the presence of PEI (4754.4 units), thus indicating the same amount 
of mAb eluted during the low pH elution step in the presence and absence of PEI. 
The improved HPLC mAb quantification method was tested independently three 
times leading to the same results as the ones discussed here. However, only one 
chromatogram for the purified mAb sample (Figure 3.6, top) and another one for 
the mAb sample spiked with PEI (Figure 3.6, bottom) have been shown for 
exemplification purposes.  
3. Evaluating Flocculation with Centrifuged Mammalian Cell Culture Fluids 
 
 146 
 
 
Figure 3.6. Chromatograms of the improved HPLC monoclonal antibody 
quantification protocol for samples with and without polyethylenimine.  
Monoclonal antibody was quantified via HPLC with a pre-packed protein G column 
applying the HCD mammalian cell line protocol described in Section 2.10.2. The 
required amount of pure PEI (i.e. not in solution) was spiked into a solution of 
purified mAb to prepare the ‘mAb + 0.60 % w/v PEI’ samples. The flocculant was 
mixed in with a vortex mixer. No flocs were observed upon PEI addition and 
subsequent mixing. Purified mAb was supplied by Lonza Biologics (Slough, UK).  
 
3.3.3.4. DNA Quantification 
Quantification of DNA in flocculated and non-flocculated samples was performed 
with a commercially available kit (see Section 3.2.3.4). Polyethylenimine 
interference was studied comparing the DNA concentration values obtained with 
different concentrations of PEI to these of HCD mammalian cell centrate.        
Figure 3.7 shows the PEI samples obtained equivalent DNA concentrations 
between 1.3 and 1.4 µg.mL-1. Increasing PEI concentration from 0.10 to 
0.60 % w/v resulted in lower equivalent DNA concentration values; the reduction 
obtained from 0.10 to 0.60 % w/v PEI was of 12 % or the equivalent 0.17 µg.mL-1. 
The DNA concentration in HCD mammalian cell centrate was 35 µg.mL-1, thus it 
was one order of magnitude larger than these of the PEI samples. The maximum 
value of equivalent DNA concentration for the PEI samples tested 
(0.10 % w/v PEI with 1.4 µg.mL-1) represented 4.1 % that of the HCD mammalian 
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cell centrate. With an interference below 5 %, optimising this DNA quantification 
assay was not considered necessary.  
 
 
 
 
 
 
 
 
 
Figure 3.7. Polyethylenimine interference with DNA quantification. 
The DNA content in the samples was quantified with a commercially available kit 
as described in Section 2.10.3. Polyethylenimine samples were prepared adding the 
required amount of PEI to PBS buffer and mixing overnight. Mammalian cell 
centrate was obtained after the clarification of HCD mammalian cell culture fluid 
(Xceed™ cell line; peak cell count = 29.0x106 cells.mL-1) with a pilot-scale disc-stack 
centrifuge (Q/Σ = 2.85x10-8 m.s-1) (see Section 2.1.2). Error bars indicate one 
standard deviation where n = 3.  
 
 
3.3.4. Effect of Flocculation Conditions on Flocculation 
Performance 
Three different flocculation variables (flocculant concentration, pH and impeller 
design) were studied to assess how they affected flocculation performance, which 
was evaluated via PSD measurements and total protein, mAb and DNA 
quantification analysis.  
3.3.4.1. Particle Size Distribution 
The PSDs of the flocs obtained with different PEI concentrations, pHs and 
impeller designs are plotted in Figure 3.8. Polyethylenimine was manually added 
into the flocculation vessel, thus no tight control upon flocculant addition rate 
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was guaranteed. As described in Section 4.3.3 and Section 5.3.2, flocculant 
addition rate is a critical flocculation variable affecting the size distribution of the 
flocs. Consequently, the results plotted in Figure 3.8 cannot be taken as a 
thorough description of the PSDs obtained under the conditions tested, but as an 
approximation of the impact that these variables have upon flocculation 
performance.   
Figure 3.8, top shows the different PSDs obtained with 0.01, 0.10, 0.30 and 
0.60 % w/v PEI. The submicron particles present in the HCD mammalian cell 
centrate (see Figure 3.2) were not flocculated with 0.01 % w/v PEI (see           
Figure 3.8, top). However, PEI concentrations larger than or equal to 
0.10 % w/v PEI resulted in flocs always larger than 2 µm (see Figure 3.8, top). A 
narrow monomodal distribution of flocs sized between 2.0 and 33 µm was 
obtained with 0.10 % w/v PEI (see Figure 3.8, top). Wide bimodal PSDs ranging 
from 2.30 to 240 µm were achieved with 0.30 and 0.60 % w/v PEI (see Figure 3.8, 
top). These results showed there was a minimum PEI concentration required to 
flocculate the submicron particles present in the HCD mammalian cell centrate, 
and another optimal PEI concentration to obtain a monomodal and narrow 
distribution of flocs. Pre-treated feeds with narrow and monomodal size 
distributions are of interest for the subsequent solid-liquid separation steps such 
as centrifugation (Berrill et al., 2008) or depth filtration (Singh et al., 2013).  
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Figure 3.8. Effect of flocculation variables on floc size distribution.  
Laboratory-scale (see Section 2.3.2 for vessel details) flocculation with HCD 
mammalian cell (Xceed™ cell line; peak cell count = 29.0x106 cells.mL-1) centrate 
(Q/Σ = 2.85x10-8 m.s-1) was performed as described in Section 2.7.1. Different PEI 
concentrations (0.01, 0.10, 0.30, 0.60 % w/v PEI; 6-bladed disc turbine; pH 7.0), pHs 
(4.0, 5.0, 7.0, 8.5; 6-bladed disc turbine; 0.30 % w/v PEI) and impeller designs 
(6-bladed disc or 3-pitched blade; 0.10 and 0.60 % w/v PEI; pH 7.0) were studied. 
Particle size distribution was measured via laser light diffraction as detailed in 
Section 2.11.4. Error bars represent one standard deviation where n = 9. 
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The effect of pH on the size and distribution of flocs was studied at four different 
pH values. Figure 3.8, middle shows pH values ≤ 5 resulted in narrow monomodal 
distributions with flocs sized between 2.5 and 30 µm. Higher pH values (pH ≥ 7) 
led to bimodal PSDs with flocs between 2.3 and 90 µm (see Figure 3.8, middle). 
The difference in the PSDs obtained at pHs 4 - 5 and pHs 7 - 8.5 could have been 
caused by protein precipitation occurring at the low pHs tested. A sudden change 
in the turbidity of the centrate was visually observed upon acid addition; the pH 
of the HCD mammalian cell centrate used was adjusted with a concentrated acid 
to avoid feed dilution. Acid-induced protein precipitation in mammalian cell 
culture fluids has been well documented (Chollangi et al., 2015; Lydersen et al., 
1994; Senczuk et al., 2016; Singh et al., 2016; Westoby et al., 2011). Protein 
precipitation would have increased the particulate content in the HCD 
mammalian cell centrate. Therefore, the narrow PSDs characterised by the high 
percentage volume frequency values observed at pH 4 and pH 5 (see Figure 3.8, 
middle) could be explained by the presence of flocs or by the combination of flocs 
and protein precipitates.  
Impeller design was expected to affect the size distribution of the flocs, 
considering that a six-bladed disc turbine and a three-pitched blade impeller 
generate different mixing patterns inside a mixing vessel (radial-flow versus 
axial-flow, respectively) (Doran, 1995). However, Figure 3.8, bottom shows the 
PSDs obtained with the two impeller designs were very similar. The same 
monomodal size distribution was obtained at 0.10 % w/v PEI with the six-bladed 
disc and the three-pitched blade impellers used; floc size ranged in both cases 
between 2.30 and 29.7 µm (see Figure 3.8, bottom). At 0.30 % w/v PEI, the size 
of the flocs was the same with both impellers (2.30 to 237 µm), but the bimodal 
PSD curves differed slightly (see Figure 3.8, bottom). The similar PSDs observed 
with the six-bladed disc and the three-pitched blade impellers used could have 
resulted from the presence of the same predominant mixing time scale in both 
vessels (see Section 4.3.8). 
3.3.4.2. Total Protein, mAb and DNA Concentration  
Flocculation performance with regards to product yield, protein and DNA 
impurity removal was studied at three different flocculant concentrations (0.10, 
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0.30 and 0.60 % w/v PEI); lower PEI concentrations were not studied since the 
results in Figure 3.8, top showed that 0.01 % w/v PEI was unable to successfully 
flocculate the submicron particles present in the HCD mammalian cell centrate 
used. In addition to this, the effect of pH on product yield and impurity removal 
was not studied because of the combined effect of protein precipitation and 
flocculation at low pH values (see Figure 3.8, middle and Section 3.3.4.1). The 
results for product yield, protein and DNA impurity removal obtained with the 
flocculated samples were compared to these of HCD mammalian cell centrate, 
which was used as a control.  
Figure 3.9 shows the total protein, mAb and DNA concentration results obtained 
for the HCD mammalian cell centrate and for the same HCD centrate flocculated 
at 0.10, 0.30 and 0.60 % w/v PEI. Protein removal in the flocculated samples 
could not be concluded due to the large error bars obtained during total protein 
concentration analysis (see Figure 3.9, top). The mAb quantification results    
(Figure 3.9, middle) showed no product loss occurred during flocculation with 
0.10, 0.30 and 0.60 % w/v PEI. An increase in mAb concentration of 0.02 g.L-1 was 
obtained with the HCD centrate samples flocculated with 0.30 % w/v PEI (see 
Figure 3.9, middle), although this increment was attributed to experimental 
error. The error bars in the mAb quantification results increased with flocculant 
concentration (see Figure 3.9, middle). However, a direct correlation between 
experimental error and PEI interference could not be established since the error 
bar for 0.10 % w/v PEI was smaller than that of the HCD mammalian cell centrate 
(see Figure 3.9, middle). Flocculation with PEI reduced up to 575 times the DNA 
content in the HCD mammalian cell centrate (see Figure 3.9, bottom). DNA 
removal depended on the PEI concentration used, with larger flocculant 
concentrations being less efficient at reducing the DNA content (see Figure 3.9, 
bottom); a 575 fold reduction was achieved with 0.10 % w/v PEI, 341 fold with 
0.30 % w/v PEI and 130 fold with 0.60 % w/v PEI. The DNA quantification results 
showed that (i) an optimal PEI concentration for DNA removal existed, and 
(ii) PEI, a positively charged polylectrolyte, was very effective at flocculating DNA 
at any of the concentrations studied.  
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Figure 3.9. Product yield and impurity removal during flocculation with 
polyethylenimine.  
Centrifuged (Q/Σ = 2.85x10-8 m.s-1) HCD mammalian cell culture fluid (Xceed™ cell 
line; peak cell count = 29.0x106 cells.mL-1) was flocculated at laboratory scale as 
described in Section 2.7.1. Total protein and DNA concentration were measured as 
described in Section 2.10.1 and Section 2.10.3, respectively. Product content was 
measured via protein G HPLC and using the HCD mammalian cell protocol (see 
Section 2.10.2). Error bars represent one standard deviation where n = 3. MMC 
refers to mammalian cell centrate.  
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3.4. Conclusions 
This chapter has described the evaluation of different mAb-producing CHO cell 
lines used to generate mammalian cell culture centrate for the flocculation 
experiments. The analytical techniques and assays chosen to assess flocculation 
performance were also investigated. A summary of the chapter conclusions, with 
reference to their aims and objectives, are below.  
1. Evaluate the use of different CHO cell lines and cell culture scales to obtain 
centrifuged mammalian cell culture fluid for the flocculation experiments.  
Maximum cell densities larger than 20x106 cells.mL-1 achieved during cell culture 
were necessary for polyethylenimine to successfully flocculate the submicron 
particles present in the centrifuged mammalian cell fluids evaluated. Such high 
cell densities were only reached by the Xceed™ CHO cell line studied. A change in 
the cell culture scale and/or the feeding strategy (i.e. fed-batch or batch) did not 
improve the flocculation success. Therefore, only centrifuged cell culture fluid 
obtained from the Xceed™ CHO cell line could be used in the flocculation 
experiments. 
2. Assess different storage methods for the centrifuged CHO cell culture fluid 
used in the flocculation experiments.  
The limited availability of Xceed™ cell centrate (supplied by Lonza Biologics, 
Slough, UK), and the rapid change in its particulate content when stored at 5°C, 
made freezing temperatures the best storage option. Freezing also guaranteed 
the same starting experimental conditions to all the Xceed™ cell centrate samples 
as long as they were obtained from the same cell culture batch.  
3. Estimate the interference of PEI with the analytical assays used to quantify 
flocculation performance and optimise the protocols, if necessary, to reduce 
or avoid flocculant interference.  
The high absorbance values obtained with polyethylenimine at a wide spectrum 
of wavelengths limited the use of total protein and DNA quantification methods 
to colorimetric assays with absorbance readings above 500 nm. The interference 
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of polyethylenimine with the total protein, DNA and product quantification 
methods then chosen showed it was necessary to assess flocculant interference 
based on the sample results and on a case-by-case basis. That is, it is necessary to 
consider the different flocculation parameters changed during the flocculation 
studies.  
4. Study the flocculation of centrifuged CHO cell fluids and the effect that 
different flocculation variables have on flocculation performance.  
Flocculant concentration and pH, unlike impeller design, determined the size 
distribution of the particles when flocculating Xceed™ cell centrate with 
polyethylenimine. Nonetheless, these were preliminary results since flocculant 
addition time, a critical parameter affecting the size distribution of the flocs (see 
Section 4.3.3 and Section 5.3.2), was not tightly controlled. The ability to 
flocculate the submicron particles present in the Xceed™ cell centrate at 
concentrations as low as 0.10 % w/v, the high affinity for DNA, and the high 
product yield obtained, suggested polyethylenimine was a good flocculant 
candidate for the flocculation experiments that follow in this thesis.  
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4. Development of an Automated Ultra Scale-
Down Flocculation Technique 
4.1. Introduction and Aims 
The results obtained in Chapter 3 show that the success of flocculation processes 
is determined by a large number of variables and factors, which has also been 
reported in the literature (Bratby, 1980; Kim et al., 2001; Salt et al., 1995). A large 
experimental space requires the use of high-throughput, automation and 
multifactorial design approaches during early process development. However, no 
attempts have been made to develop a flocculation platform that (i) produces 
process-relevant material at the microliter scale; and (ii) generates data 
equivalent to that of production-scale. A platform with these characteristics is 
also needed to acquire in-depth process understanding during early process 
development so that time to market, risk of failure and associated costs are 
reduced (Titchener-Hooker et al., 2008). This chapter describes the development 
of an ultra scale-down (USD) flocculation technology that will allow the 
exploration of the large experimental space and the understanding of the key 
process interactions between this and other subsequent unit operations 
(e.g. centrifugation, microfiltration and/or depth filtration).  
Summary of the chapter’s aims and objectives:  
1. Investigate the critical parameters controlling the scale-up/scale-down of 
flocculation unit operations between two geometrically different vessels. 
2. Develop an USD flocculation platform based upon the process understanding 
acquired.  
3. Successfully scale-up the flocculation process of pre-clarified cell broths 
between two non-geometrically similar vessels.  
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4.2. Experimental Set-Up 
4.2.1. Operational Characterisation of the Flocculation Systems 
Refer to Section 2.3.1 (pilot scale) and Section 2.3.3 (USD scale) for the detailed 
methodologies used to achieve a tight control over impeller speed and volume of 
reagent added.   
4.2.2. Preparation and Characterisation of the Clarified Baker’s 
Yeast Homogenate and Polyethylenimine 
Clarified Baker’s yeast homogenate was prepared as described in Section 2.2 and 
stored at -20°C. The centrate percentage solid content was calculated as 
described in Section 2.11.3 as a quality control measure for the different batches 
of material prepared. The centrate was defrosted at room temperature prior to 
use. The fresh and thawed centrate were also characterised by their particle size 
distribution (PSD) measured by laser light diffraction according to Section 2.11.4. 
The dynamic viscosity and density of the thawed centrate were measured as 
described in Section 2.11.5 and Section 2.11.6, respectively. 
A 4 % w/v polyethylenimine (PEI) stock solution was used to flocculate the 
clarified yeast homogenate. The PEI stock solution was prepared fresh the day 
before each flocculation experiment by mixing overnight the required amount of 
PEI in phosphate buffer (0.1 M NaH2PO4, adjusted to pH 6.5 using 3 M NaOH). The 
dynamic viscosity and density of the PEI stock solution were measured at 22°C as 
described in Section 2.11.5 and Section 2.11.6, respectively. 
4.2.3. Mixing Time Scale Studies 
4.2.3.1. Theoretical Calculation 
Macromixing, mesomixing and micromixing time constants were theoretically 
calculated for the pilot-scale flocculation system only. Equation 2.3 to Equation 
2.11 were used to calculate the characteristic mixing times. Calculations were 
performed for an impeller speed of 4.8 rps and for nine different feed addition 
times (tf) (12, 18, 24, 45, 71, 102, 143, 200 and 254 s). The value of impeller speed 
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used was the same as that of the flocculation studies with changing flocculant 
addition times (see Section 4.2.4). Nine tf values were chosen to represent a wider 
range of flocculant addition times than these used in the experimental 
characterisation of micromixing. The values of flocculant addition volume and 
kinematic viscosity used in the calculations were 75 mL and 1.92x10-6 m2.s-1, 
respectively. These were the actual experimental values; kinematic viscosity was 
that of the clarified yeast at 22°C.  
4.2.3.2. Experimental Calculation 
At pilot scale, critical addition time (tcrit) was estimated at three different impeller 
speeds (1.8, 4.8, and 7.9 rps) and eight acid addition times (340, 250, 170, 120, 
70.0, 40.0, 20.0 and 3.80 s). At USD scale, tcrit was estimated at two different 
impeller speeds (17 and 27 rps) and eight acid addition times (6.4, 5.5, 4.3, 3.2, 
2.0, 9.1x10-1, 3.2x10-1 and 7.0x10-3 s). Refer to Section 2.4.2 for the detailed 
experimental methodology.  
4.2.4. Flocculation Studies 
Flocculation conditions were those detailed in Section 2.7.2. Impeller speed and 
flocculant addition time varied depending upon the flocculation study as follows.  
4.2.4.1. Effect of Flocculant Addition Time 
The value of impeller speed was kept constant while flocculant addition time 
changed. Since the volume of flocculant added was constant and equal to 75 mL, 
addition time was also expressed as addition rate. At pilot scale, impeller speed 
was set to 4.8 rps and flocculant addition rate to 8.57, 10.7, 15.0, 21.4, 30.0, 47.6, 
90.0, 120 and 184 mL.min-1. At USD scale, impeller speed was set to 17 rps, or 
20 rps during the validation studies, and flocculant addition rate was 1.00, 5.00, 
20.0, 100, 250, 400, 550, 700 and 900 μL.s-1. The impeller speeds chosen were 
intermediate values within the range of impeller speeds of the motors used at 
each scale. During the validation studies, impeller speed at USD scale was 
calculated based on the following scale-up “rule of thumb”: constant average 
turbulent energy dissipation rate per unit mass of fluid (εavg); that is, impeller 
speed at USD scale was that translating into an equal εavg value as that one of pilot 
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scale. The ranges of flocculant addition rate used were limited by the liquid 
handling robot (USD scale) and the syringe pump (pilot scale) employed. The PSD 
of the resultant flocs was measured according to the Section 2.11.4 to evaluate 
the effect of flocculant addition rate upon flocculation performance.  
4.2.4.2. Effect of Impeller Speed 
The value of flocculant addition rate was kept constant whilst impeller speed 
changed. At pilot scale, flocculant addition rate was set to 15 mL.min-1 and 
impeller speed to 1.8, 3.4, 4.8, 6.0, 6.8, 7.5 and 7.9 rps. At USD scale, flocculant 
addition rate was set to 1 μL.s-1 and impeller speed to 5.3, 8.4, 12, 15, 17, 20, 23 
and 27 rps. The flocculant addition rate values were chosen to guarantee the 
predominance of a micromixing regime in the flocculation vessel. The ranges of 
impeller speed studied were determined by the speed limits of the motors used 
at each scale. Average turbulent energy dissipation rate per unit mass of fluid 
(εavg) and impeller tip speed (vtip) were calculated for the same ranges of impeller 
speed. Calculations were performed as detailed in Section 2.5.  
4.3. Results and Discussion 
4.3.1. Operational Characterisation of the Flocculation Systems 
Impeller speed and reagent addition rate were the two variables changed during 
the mixing time scale and flocculation studies. The volume of reagent added was 
kept constant at each scale during the mixing time and flocculation studies. 
However, this variable also affected flocculation performance. An accurate 
control over these variables was necessary to successfully scale-up flocculation 
between the two mixing systems. Consequently, the flocculation systems used at 
each scale were operationally characterised before performing the mixing time 
and flocculation experiments. The impeller power number (Po) of the microwell 
mixing device used at USD scale was also empirically determined.  
4.3.1.1. Pilot Scale 
The coupling between the rotational speed displayed on the system’s driving unit 
and the speed of the vessel’s impeller shaft was studied to precisely control 
impeller speed at pilot scale. The results are plotted in Figure 4.1. The correlation, 
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which showed a strong linear regression (R2 = 0.999), was used to calculate the 
rotational speed of the vessel’s driving unit during the mixing time and 
flocculation studies. There was a constant negative offset of 0.18 rps between the 
displayed and actual rotational speeds. Smaller actual speeds were also described 
by a slope below the value of 1, although the difference became narrower with 
faster rotational speeds.  
 
 
 
 
 
 
 
 
Figure 4.1.  Operational characterisation of the impeller speed in the stirred 
tank reactor used at pilot scale.  
A calibrated stroboscope was used to determine the coupling between the 
rotational speed of the STR driving unit or motor and the vessel’s impeller shaft. The 
linear regression plotted was y = -0.175 + 0.977x with R2 = 0.999. The error bars 
represent one standard deviation where n = 4. Refer to Section 2.3.1 for the detailed 
methodology.  
 
The volume of acid and polyethylenimine (PEI) added into the stirred tank 
reactor (STR) used at pilot scale was critical for the outcome of the mixing time 
and flocculation studies. Consequently, the calibration of the syringe pump used 
at pilot scale for controlled reagent additions was tested. Table 4.1 shows the 
0.5 M sulphuric acid solution used in the mixing time studies was delivered with 
an accuracy of 98.9 %. Table 4.2 shows the accuracy for the PEI stock solution 
was 99.4 %.  
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Table 4.1. Calibration of the syringe pump used at pilot-scale flocculation 
for controlled 0.5 M sulphuric acid addition.  
A programmable syringe pump was used. The solution used was 0.5 M sulphuric 
acid. The total volume of acid added was equal to 6 mL. Calibration was tested by 
measuring with an analytical balance the weight of the reagent displaced by the 
syringe pump. Volume was calculated with the 0.5 M sulphuric acid density of 
1050 kg.m-3. Refer to Section 2.3.1 for the detailed methodology. 
 
Flow rate (mL.min-1) Weight (g) Volume (mL) 
184 8.23 8.06 8.25 7.84 7.68 7.86 
150 8.29 8.64 8.22 7.90 8.23 7.83 
120 8.27 8.47 8.86 7.88 8.07 8.44 
90.0 8.16 8.32 8.69 7.77 7.92 8.28 
60.0 8.26 8.19 9.15 7.87 7.80 8.71 
30.0 8.69 8.22 8.16 8.28 7.83 7.77 
15.0 8.43 8.37 8.10 8.03 7.97 7.71 
6.00 8.71 8.14 8.28 8.30 7.75 7.89 
3.00 8.55 8.34 8.09 8.14 7.94 7.70 
 
 
Table 4.2. Calibration of the syringe pump used at pilot-scale flocculation 
for controlled PEI addition.  
Calibration methodology was as described in Table 4.1. A 4 % w/v PEI solution was 
measured. Total volume of PEI added was equal to 75 mL. The density of the PEI 
stock solution used was 1030 kg.m-3.  
 
Flow rate (mL.min-1) Weight (g) Volume (mL) 
184 76.37 75.70 77.26 74.15 73.50 75.01 
150 77.04 76.36 76.14 74.80 74.14 73.92 
120 77.15 77.07 76.89 74.90 74.83 74.65 
90.0 75.29 76.13 75.79 73.10 73.91 73.58 
60.0 76.41 77.12 76.54 74.18 74.87 74.31 
30.0 77.09 76.27 76.29 74.84 74.05 74.07 
15.0 76.07 76.09 77.01 73.85 73.87 74.77 
6.00 75.18 77.25 76.30 72.99 75.00 74.08 
3.00 76.26 75.89 76.89 74.04 73.68 74.65 
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4.3.1.2. USD Scale 
The rotational speed of the magnetic motor used at USD scale was expressed as 
% speed by the manufacturer. Speed ranged from 0 to 100 %, but its equivalence 
in revolutions per second needed to be determined before the mixing time scale 
and flocculation studies. Figure 4.2.A shows that the percentage speed scale 
followed a strong linear correlation (R2 = 0.999) with the rotational speed of the 
motor spindle. The lowest and maximum speeds were 5.2 and 28 rps, 
respectively. An offset of 4.7 rps in the linear regression equation confirmed that 
the motor rotated at even 0 % speed.   
The coupling between the spindle and the impellers was studied to confirm the 
magnets were rotating at the same speed as the motor. Nineteen different 
impellers across the microwell mixing system were evaluated to also ensure 
there were no differences in rotational speed across the microplate. Figure 4.2.B 
shows the coupling between the impeller located in well D3 and the magnetic 
motor. The results described a strong linear correlation (R2 = 0.999) between the 
motor and the impeller rotational speed. The speeds were equivalent 
(i.e. slope = 1), but there was a constant offset of -0.13 rps for the impeller speed. 
The other eighteen impellers studied showed that the slope equalled to 1 in all 
cases but the offset ranged from -0.17 to 0.05 rps. The differences in the impeller 
speed offset could not be correlated to a specific zone on the microplate but were 
arbitrary instead. The average offset value, which was equal to -0.05 rps, was 
taken into account in all studies. 
Because the viscosity values of the PEI stock solution and 0.5 M sulphuric acid 
used in the experiments were higher than that of water, a specific liquid class for 
each solution was created in the software of the liquid handling robot. Specific 
liquid classes are created to accurately aspirate and dispense fluid. Each liquid 
class was calibrated with four different liquid volumes. The offsets between the 
dispensed volume and set volume (i.e. diluter volume) calculated ranged 
between -1.229 and 0.113 µL. No trend between the solution’s density and/or 
viscosity and the calculated offset was observed.  
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The magnetically-driven disc impeller power number was empirically estimated 
from the global best fit of the USD and pilot scale εavg values. Three power 
regression equations (y = axb) were obtained from plotting the pilot scale εavg 
values against the particle size characteristic descriptors d10, d50 and d90 of the 
flocs generated (see Section 4.3.7); these values correspond, respectively, to the 
particle diameter below which 10 %, 50 % and 90 % of the sample volume exists. 
The power regression constants a and b were used to calculate the Po of the 
USD-scale impellers as follows: 
 (Equation 4.1.a) 
 (Equation 4.1.b) 
 (Equation 4.1.c) 
where εavg is the average turbulent energy dissipation per unit mass (W.kg-1), dx is 
the particle size characteristic descriptor (μm) where x is 10, 50 or 90, ay and 
by are the power regression curve constants where y refers to the d10, d50 or d90 
data sets, Po is the power number, N is the impeller speed (s-1), Di is the impeller 
diameter (m) and Vl is the liquid working volume (m3). STR and USD subscripts 
refer to the stirred tank reactor and microwell mixing systems, respectively. The 
impeller power number was calculated for 24 different conditions. The average 
value, which was equal to 0.85, was used in all the εavg calculations at USD scale.  
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Figure 4.2. Operational characterisation of the impeller speed in the 
microwell mixing device used at USD scale.  
A. A calibrated stroboscope was used to determine the equivalence of the magnetic 
motor % speed scale in revolutions per second of the magnetic drive. The linear 
regression plotted was y = 4.722 + 0.229x with R2 = 0.999. Error bars indicate one 
standard deviation where n = 6. Refer to Section 2.3.3 for the detailed methodology. 
B. A calibrated stroboscope was used to confirm the coupling between the magnetic 
discs and the magnetic drive. For the impeller speed measurements the stroboscope 
was located at a fixed 3 cm from the reference point. The linear regression plotted 
was y = -0.130 + 1.001x with R2 = 0.999. Horizontal error bars indicate one standard 
deviation where n = 6. Vertical error bars indicate one standard deviation where 
n = 3. Refer to Section 2.3.3 for the detailed methodology.  
A 
B 
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4.3.2. Characterisation of the Flocculation Feed Streams 
The percentage solid content of the clarified yeast homogenate used in the 
flocculation studies was 5.6 %. Percentage solids remaining was calculated as 
detailed in Section 2.11.3. Variability in the solids content up to 32 % was 
observed possibly due to the inherent batch to batch inconsistency of the fresh 
Baker’s yeast supplied. Table 4.3 shows the OD600 values obtained at each step of 
the preparation of the clarified yeast homogenate. The decrease in OD600 between 
homogenisation and centrifugation described the reduction in particulates 
present in the feed. Despite the variability in the % solids content, the PSD of the 
clarified yeast homogenate followed the same bimodal distribution as shown in 
Figure 4.3. The fresh supernatant was primarily constituted of submicron 
particles, as represented by the peak between 0 and 0.75 μm with an equivalent 
420 % volume frequency. A second peak existed between 1 and 250 μm with a 
maximum volume frequency of 2.8 % at 2 μm. Particles larger than 250 μm were 
not detected. Since the clarified yeast supernatant was stored at -20°C, the 
freeze-thaw effect on the PSD of the clarified yeast homogenate was studied. The 
PSD continued to be bimodal after freeze-thawing (see Figure 4.3). The 
population of particles between 0 and 0.75 μm decreased after freeze-thawing, 
while that between 1 and 250 μm increased on average; however, the large error 
bars obtained for the particles between 1 and 250 μm, which overlapped the PSD 
obtained with fresh material, made it impossible to conclude the 1-250 μm 
population changed after freeze-thawing (see Figure 4.3). The supernatant total 
protein concentration was equal to 30 ± 3 g.L-1 upon freeze-thawing; this result 
was in accordance with the total protein concentration values reported in the 
literature for clarified Baker’s yeast homogenate (Milburn et al., 1990). The 
density and dynamic viscosity values measured at 22°C were 1020 kg.m-3 and 
1.66 mPa.s, respectively. Finally, with regards to the flocculant, the 4 % w/v PEI 
stock solution used had a density of 1030 kg.m-3 and a dynamic viscosity of 1.98 
mPa.s at 22°C. Both the clarified Baker’s yeast homogenate and the 4 % w/v PEI 
stock solution used were Newtonian fluids.  
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Table 4.3. Change in OD600 during the different steps of the clarified yeast 
homogenate preparation.  
OD measurements were taken immediately after the preparation of each solution 
with a double-beam spectrophotometer according to Section 2.11.1. Well-spun 
samples, which represent the samples with the highest clarification achievable, 
were the supernatants recovered after centrifuging (Eppendorf 5424R; Eppendorf, 
Hamburg, Germany) the clarified homogenate for 30 minutes at 220 rps and 4°C. 
The third column describes one standard deviation where n = 9.   
Sample Average OD600 Standard deviation 
Whole yeast cells 109.4 15.2 
Homogenate 34.2 2.69 
Clarified homogenate 2.54 0.410 
Well-spun 0.681 0.151 
 
4.3.3. Effect of Flocculant Addition Time on Particle Size 
Distribution 
The aim was to investigate how flocculant addition time, or addition rate, 
modulated flocculation performance in the pilot and USD mixing systems. The 
studies were performed by varying the flocculant addition time (tf). Flocculation 
performance was described by the particle size characteristic descriptors d10, d50, 
and d90.  
As observed in Figure 4.4, narrower and smaller PSDs were gradually obtained 
with longer tf values at USD and pilot scale. The decrease in particle size was 
similar in both flocculation systems, with a 60 % reduction in the d90 data set. The 
values of d50 decreased by 57 % and these of d10 by 30 %. In addition to this, the 
smallest and largest particles generated at both scales were similarly sized, with 
size differences only ranging from 0.2 to 13 %. Higher variations in particle size 
were observed at USD scale when using fast flocculant addition rates. This might 
have been due to a non-homogeneous, thus non-reproducible, distribution of the 
flocculant inside the microwell.  
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Figure 4.3. Freeze-thawing effect upon the particle size distribution of 
clarified yeast homogenate.  
The PSD curves were divided in 3 graphs with the x and y-axis scales adjusted 
accordingly. PSD was measured by laser light diffraction as described in 
Section 2.11.4. Error bars indicate one standard deviation where n = 9 (fresh) and 
n = 44 (frozen). Frozen material was allowed to reach room temperature before the 
PSD measurements were taken.  
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Figure 4.4. Effect of flocculant addition time on PSD in the USD and pilot 
scale flocculation systems.  
The closed data points ( ,   ,   ) represent the pilot-scale data sets. The open data 
points (  ,   ,   ) describe the USD-scale data sets. Freeze-thawed clarified yeast 
homogenate was flocculated at room temperature with a final PEI concentration of 
0.2 % w/v and a impeller speed equal to 17 rps (USD scale) and 4.8 rps (pilot scale). 
Flocculant was added at different rates with addition time varying from 0.04 to 40 s 
(USD scale) and from 11.7 to 255 s (pilot scale). After PEI addition the flocs were 
allowed to mature for 10 minutes (refer to Section 2.7.2 for the detailed flocculation 
methodology). PSD was measured by laser light diffraction immediately after floc 
maturation according to Section 2.11.4. Error bars indicate one standard deviation 
where n = 8 (USD scale) and n = 3 (pilot scale).  
 
The important effect of flocculant addition rate upon PSD was already 
demonstrated by Berrill and co-authors (2008), who obtained wider and more 
complex flocculated populations with shorter flocculant addition times. However, 
this is not an exclusive phenomenon to flocculation, as addition rate has been 
shown to affect the particle size and its reproducibility, structure and 
composition of precipitates (Fisher et al., 1986; Franke and Mersmann, 1995; 
Hofland et al., 2003) and crystals (Torbacke and Rasmuson, 2001).  
These results meant that tf was a key variable affecting flocculation performance 
and therefore needed to be considered during the scale-up process between the 
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two geometrically-different flocculation vessels used. The small difference 
between the largest and smallest particles obtained in the two vessels illustrates 
that similar physicochemical conditions were obtained at both scales at the 
fastest and shortest flocculant addition rates studied, and therefore that 
flocculation could be successfully scaled-up between the two systems. However, 
the different gradual decrease in floc size observed in   Figure 4.4 confirmed the 
effect of tf upon particle size was not proportional to its value but was determined 
by another variable that was at the same time modulated by tf.                       
4.3.4. Mixing Time Characterisation of the Flocculation Systems 
The effect of reagent addition rate upon PSD in precipitation and crystallisation 
processes has been described by the influence the predominant mixing time scale 
(i.e. macromixing, mesomixing or micromixing) has upon the resulting local 
concentration gradients of the reagent (see Section 1.5.3) (Franke and 
Mersmann, 1995; Marcant and David, 1991; Pohorecki and Bałdyga, 1988; 
Torbacke and Rasmuson, 2001; Zauner and Jones, 2002). Before a chemical 
reaction can occur between two or more reactants, the reactants have to be mixed 
on a molecular scale. When a reaction is slow in comparison to the mixing 
process, the reaction will only depend on its chemical kinetics as the solution will 
be homogeneously distributed before any reaction takes place. However, when 
the reaction times are of the same order of magnitude as the characteristic mixing 
times, the mixing process will determine the local reagent concentration 
gradients thus affecting the yield and selectivity of the reaction (Verschuren et 
al., 2001). 
The rapid polymer adsorption rates of PEI (Birkner and Morgan, 1968) suggested 
the mixing conditions could also have been responsible for the effect of flocculant 
addition time upon the PSD of the flocs (see Section 4.3.3). The predominant 
mixing time scale under each of the addition times studied were theoretically 
calculated as well as experimentally determined in order to explain the different 
gradual decrease in floc size observed at both flocculation scales (see Figure 4.4).   
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4.3.4.1. Theoretical Characterisation  
The characteristic mixing time scales were theoretically calculated for the 
pilot-scale system at nine different feed addition times according to Section 2.4.1. 
The results obtained are summarised in Table 4.4. The USD-scale mixing system 
was not characterised due to differences in the vessel and impeller geometries 
for which the equations applied were developed. Refer to Section 1.5.3 and  
Figure 1.9 for a description of the different mixing regimes (i.e. macromixing, 
mesomixing and micromixing time scales).  
Macromixing time (tm) remained constant since it was independent of the feed 
time (tf) values and therefore of the experimental flocculant addition times. The 
results in Table 4.4 show tm was two orders of magnitude larger than turbulent 
dispersion mesomixing time (td), large eddy disintegration mesomixing time (ts) 
and micromixing time (te). Additionally, feed addition time was between one to 
two orders of magnitude larger than circulation time (tc) and macromixing time. 
Consequently, at the range of tf studied the reactor should be assumed to be 
completely macromixed (Bałdyga and Bourne, 1999; Bałdyga et al., 1993, 1997).  
Because macromixing was not the mixing time scale affecting pilot-scale 
flocculation performance, micromixing and mesomixing time scales were 
evaluated. The values of te, td and ts varied with tf. At the longest feed addition 
times (tf ≥ 143 s), micromixing time was between four to six times larger than 
large eddy disintegration mesomixing time and turbulent dispersion mesomixing 
time (see Table 4.4). Consequently, micromixing time was the limiting mixing 
time scale at tf ≥ 143 s; therefore, it is thought that micromixing governed at long 
flocculant addition times (tf > 140 s). In contrast, at the shortest feed addition 
times (tf ≤ 24 s) the limiting mixing time scale was turbulent dispersion 
mesomixing (see Table 4.4); therefore, mesomixing was the predominant mixing 
time scale at short flocculant addition times (tf < 20 s). For tf values between 
20 and 140 s, it is thought that both micromixing and mesomixing were the 
controlling mechanisms.  
Theoretical characteristic time values cannot be taken as absolute values due to 
the assumptions used during the calculations regarding vessel geometry and 
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turbulent mixing conditions. Nonetheless, these theoretical mixing time values 
can be used as an indication of when the transition between micromixing regimes 
(i.e. micromixing to mesomixing) occurred in the pilot-scale system.  
Table 4.4. Theoretical values of the characteristic mixing time scales for the 
pilot-scale flocculation system.  
Table adapted from Espuny Garcia del Real et al. (2014).   
Circulation time (tc), macromixing time (tm), turbulent dispersion mesomixing time 
(td), large eddy disintegration mesomixing time (ts) and micromixing time (te) were 
calculated as described in Section 2.4.1. Calculations were performed for an 
impeller speed of 4.8 rps and for the nine different feed addition times (tf) specified 
in the table. Reagent (i.e. flocculant) volume was equal to 75 mL. The kinematic 
viscosity of the feed material (i.e. clarified yeast homogenate) was 1.92x10-6 m2.s-1.  
 
 tf (s) tc (s) tm (s) td (s) ts (s) te (s) 
Micromixing 
254 
1.6 6.4 
0.012 0.014 
0.081 200 0.015 0.015 
143 0.021 0.017 
Micromixing 
& 
Mesomixing 
102 
1.6 6.4 
0.030 0.019 
0.081 71 0.042 0.022 
45 0.067 0.025 
Mesomixing 
24 
1.6 6.4 
0.127 0.031 
0.081 18 0.170 0.034 
12 0.259 0.040 
 
4.3.4.2. Experimental Characterisation 
The iodide-iodate system of parallel competing reactions developed by Fournier 
et al. (1996b) was used to study micromixing time in the pilot and USD mixing 
systems. This experimental method consists in determining the segregation state 
of the fluid, which is quantified by the segregation index (XS); the values of XS lie 
between 0 and 1, where 0 refers to a perfectly micromixed system and 1 to a 
completely segregated system. The segregation state of the fluid (i.e. XS) was 
studied with increasing addition times to experimentally determine the value of 
tf at which the systems transitioned from a micromixing-mesomixing regime to a 
fully micromixing regime. This transition, which is specific to the vessel and 
hydrodynamic conditions, is identified as the critical addition time (tcrit).  
The pilot-scale system was characterised at three different impeller speeds (1.8, 
4.8 and 7.9 rps). Figure 4.5.A describes how the value of XS gradually decreased 
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at pilot scale with increasing values of acid addition time for the three impeller 
speeds studied. This trend indicated improved micromixing with longer values of 
tf. The transition from a micromixing-mesomixing controlled regime to a fully 
micromixing regime (Bałdyga and Bourne, 1992) was indicated by the plateauing 
in the value of XS at tf equal to 150 s, approximately. This transition, or tcrit, 
occurred at the three impeller speeds studied. Another trend observed at pilot 
scale was a decrease in the overall value of XS, thus improved micromixing, with 
increasing impeller speeds; the same observation was made by Fournier et al. 
(1996a). The value of tcrit confirmed the theoretical approximation of the time 
constants shown in Table 4.4. 
The results obtained for the USD mixing device (Figure 4.5.B) describe the same 
trend of decreasing values of XS with longer addition times and faster impeller 
speeds observed at pilot scale.  Critical addition time was identified to occur at tf 
values between 2 and 3 seconds, hence indicating that the system was only 
micromixing controlled for values of tf > 3s. However, the influence of 
macromixing could not be determined in the USD mixing system. Therefore, if the 
predominance of the micromixing time scale wanted to be guaranteed, a larger 
value of addition time than the tcrit experimentally obtained should be used; 
Assirelli et al. (2002) and Bałdyga and Bourne (1999) stated the effects of 
macromixing and mesomixing can be neglected if sufficiently long addition times 
are used.  
Different values of XS were obtained in each flocculation mixing device (see 
Figure 4.5) since they are associated with (i) the location of the feed point, (ii) the 
reaction zone, and (iii) the vessel geometry (Bałdyga and Bourne, 1999). These 
results confirmed the need to characterise how the segregation state of the fluid 
changed with increasing feed addition times in each mixing system studied.  
No increase in the value of XS was observed with longer acid addition times (see 
Figure 4.5), which suggested the absence of backmixing effects at the range of 
feed addition times used (Bałdyga et al., 1993). The data then confirmed that the 
feed points were appropriately located and oriented relative to the fluid flow 
pattern in the USD and pilot-scale mixing vessels.  
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Figure 4.5. Experimental micromixing time studies for the pilot-scale (A) 
and USD (B) flocculation systems.   
Figure adapted from Espuny Garcia del Real et al. (2014). 
Micromixing time was experimentally determined as described in Section 2.4.2. At 
pilot scale (A), micromixing time was studied at three impeller speeds (1.8, 4.8 and 
7.9 rps) using eight different acid addition times (340, 250, 170, 120, 70.0, 40.0, 20.0 
and 3.80 s). At USD scale (B), micromixing time was studied at two impeller speeds 
(17 and 27 rps) using eight different acid addition times (6.4, 5.5, 4.3, 3.2, 2.0, 
9.1x10-1, 3.2x10-1 and 7.0x10-3 s). Error bars indicate one standard deviation where 
n = 8.  
 
The viscosity of the two different feed streams employed in the flocculation 
studies was higher than that of the water-based solutions used in the mixing time 
A 
B 
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scale experiments, for which a viscosity similar to that of water at 22°C was 
assumed (i.e. 0.97 mPa.s – (Perry and Green, 2008)). For a given tank and impeller 
geometry in a fully turbulent flow, viscosity has no effect on the macromixing or 
mesomixing parameters. However, it does influence the micromixing parameters 
by increasing molecular segregation and micromixing time, as it can be observed 
by the larger values of XS obtained when higher values of viscosity are used when 
other independent variables are kept constant (Bourne et al., 1989, 1995; Gholap 
et al., 1994). These effects on the micromixing parameters were observed with a 
fourfold (Bourne et al., 1989), a seven fold (Gholap et al., 1994) and a six fold 
(Bourne et al., 1995) increase in viscosity with respect to the control solution. 
However, the viscosity values of the clarified yeast homogenate and PEI stock 
solutions used in the flocculation studies were less than double the viscosity of 
the water-based solutions employed during the micromixing time scale 
experiments. Therefore, the micromixing parameters obtained during the mixing 
time studies were assumed to remain unchanged during the flocculation studies.  
4.3.5. Effect of Mixing Time Scales on Particle Size Distribution 
To understand the effect that mixing time scales had upon the flocculation 
process in the pilot-scale and USD mixing systems, Figure 4.4 was re-plotted 
considering the predominant mixing time scale in the vessel at each one of the 
flocculant addition times studied (see Section 4.3.4 for the results). Figure 4.6 
shows the effect of micromixing and mesomixing time scales upon the 
flocculation performance; flocculation performance was described by the d10, d50, 
and d90 particle size characteristic descriptors, and by the PSD curves with the 
aim to reveal bimodal or tri-modal distributions.  
As described in Section 4.3.3, wider floc distributions were gradually obtained at 
both scales with decreasing flocculant addition times. However, Figure 4.6.A 
shows the PSD range differed depending on the predominant mixing regime and 
the flocculation vessel used. Constant values of d10 and d50 were found at pilot 
scale and across the micromixing regime, while the values of d90 increased by 8 %. 
A step increase in the values of d50 and d90 occurred at pilot scale with flocculant 
addition times between 102 and 45 s; the step increase was of 4 μm (d50) and of 
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9 μm (d90). The increase in PSD observed might be explained by both micromixing 
and mesomixing regimes influencing flocculation despite the theoretical mixing 
time predictions continued describing the predominance of micromixing within 
the 102-45 s range (i.e. te > td and ts) (see Table 4.4). Faster flocculant addition 
rates led to wider PSDs at pilot scale (see Figure 4.6.A). When mesomixing was 
the only mixing mechanism (tf < 24 s) (see Table 4.4), the pilot-scale values of d50 
and d90 increased by 70 % and 90 % in size, respectively; the change in the d10 
data set was more moderate with a 13 % increase in size. In the USD mixing 
system, the PSD of the flocs generated decreased in a more gradual manner with 
longer tf (see Figure 4.6.A). The largest decrease at USD scale was observed 
during the transition between a mesomixing to a micromixing-mesomixing 
controlled regime, where the reductions in size ranged between 35 % and 75 %. 
The transition to a micromixing controlled regime saw a smaller change in 
particle size at USD scale, with a 25 % reduction in the size of d90 and 20 % for 
the d50 data set. It was also observed that in both flocculation systems the mixing 
time scales influenced the least upon the size of the smallest particles and the 
most upon the largest ones, thus significantly impacting upon the width of the 
PSD.  
Figure 4.6.B shows the PSD curves obtained at both scales across the three mixing 
regimes. Under fully mesomixing conditions, comparable PSD curves 
(variation < 10 % between 3 and 70 μm) were obtained at USD and pilot scale 
despite impeller speed and tf being different at both scales. The fast flocculant 
addition rates used could have flooded the impeller region with an excess 
concentration of flocculant. At fast addition rates the flocculant might not 
uniformly adsorb onto the particles thus resulting in the re-stabilisation of the 
colloidal suspension; therefore, it is important to ensure the added flocculant is 
evenly distributed throughout the flocculation vessel (Bolto and Gregory, 2007). 
While monomodal PSDs were obtained at pilot scale in the 
micromixing-mesomixing regime, bimodal and wider PSDs were observed at USD 
scale in the same mixing regime. Finally, the micromixing regime led to narrower 
monomodal distributions with a maximum difference of 14 % in the values of d10, 
d50, and d90 at both pilot and USD scale.  
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Figure 4.6. Effect of flocculant addition time on the size distribution of the 
flocs generated in the flocculation systems. 
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Narrow monomodal floc populations are always of interest, particularly if they 
are clarified by centrifugation (Berrill et al., 2008) or depth filtration (Singh et al., 
2013). In addition to the particle size, the complexity of the PSDs obtained at USD 
and pilot scale was also modulated by the governing mixing regime. Figure 4.7, 
left, describes that the bimodal and dispersed populations obtained at USD scale 
with fast flocculant addition rates, shifted to monomodal and narrower 
distributions with slower flocculant addition rates. This trend, also observed at 
pilot scale (Figure 4.7, right), might be due to slower flocculant addition rates 
allowing a more homogeneous distribution of the flocculant inside the mixing 
vessel. Similar results have been reported by Berrill et al. (2008) on Escherichia 
coli feeds.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Effect of flocculant addition time on the complexity of the 
population of flocs obtained at USD and pilot scale.   
Figure adapted from Espuny Garcia del Real et al. (2014).  
Arrows show the shift in PSD with longer flocculant addition times. Flocculation was 
performed at room temperature with a final 0.2 % v/v PEI concentration and fixed 
impeller speed (17 rps – USD scale and 4.8 rps – pilot scale). The following flocculant 
addition rates were used: 1.00, 5.00, 20.0, 50.0, 250, 550, 700 μL.s-1 at USD scale and 
8.57, 10.7, 15.0, 21.4, 30.0, 47.6, 90.0, 120, 184 mL.min-1 at pilot scale. These values 
represent the different mixing time scales encountered in the flocculation mixing 
systems. Refer to Section 2.7.2 for the detailed flocculation methodology.  
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The results described in this subsection have demonstrated that mesomixing 
regimes resulted in the creation of wide PSDs challenging for the subsequent 
solid-liquid separation step. In addition to this, they required rapid flocculant 
addition rates inappropriate for scale-up. Therefore, long flocculant addition 
times that would guarantee a fully micromixing regime (152 s at pilot scale and 
40 s at USD scale) were chosen to study the effect of impeller speed upon 
flocculation performance (see Section 4.3.6).  
4.3.6. Effect of Mixing Intensity on the Particle Size Distribution 
Flocculation experiments using the pilot and USD-scale mixing systems at 
different impeller speeds were performed and their PSDs studied. As observed 
by Shamlou et al. (1996), the hydrodynamic conditions inside the vessel affected 
particle growth and particle break-up; nonetheless, these two variables were 
independent of the source providing the liquid motion. Faster impeller speeds 
resulted in narrower PSDs both in the USD (Figure 4.8, left) and the pilot-scale 
(Figure 4.8, right) mixing systems. Particle break-up occurred with faster 
impeller speeds, as confirmed by the shift of the monomodal PSDs to 
progressively smaller sizes with increasing impeller speed values. The values of 
percentage volume frequency also increased with faster impeller speeds as a 
consequence of particle fragmentation. The rapid decrease in particle size 
observed between 5.3 and 20 rps at USD scale (Figure 4.8, left) and between 1.8 
and 4.8 rps at pilot scale (Figure 4.8, right) suggested that particles formed under 
low shear environments were more susceptible to break-up than those exposed 
to fast impeller speeds. These results confirmed that impeller speed is another 
key process variable affecting flocculation performance and therefore needs to 
be considered when changes in scale are made.    
Particle breakage with increasing impeller speed values was also observed 
microscopically (Figure 4.9). The images also confirmed that similar particles 
were obtained at USD and pilot scale under similar values of εavg or values of vtip 
that differed two fold. 
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Figure 4.8. Effect of impeller speed on the particle size distribution of the 
flocs obtained at USD and pilot scale.  
Figure adapted from Espuny Garcia del Real et al. (2014).  
Arrows show the shift in PSD with faster impeller speeds. Flocculation was 
performed at room temperature with a final 0.2 % v/v PEI concentration and fixed 
flocculant addition rate (1.0 μL.s-1 – USD scale and 15 mL.min-1 – pilot scale). 
Different impeller speeds were used: 5.3, 8.4, 12, 15, 17, 20, 23, 27 rps at USD scale 
and 1.8, 3.4, 4.8, 6.0, 6.8, 7.5, 7.9 rps at pilot scale. These values were grouped in low, 
medium and high impeller speeds as shown in the figure. Refer to Section 2.7.2 for 
the detailed flocculation methodology.  
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Figure 4.9. Representative images of flocs obtained at increasing values of 
impeller speed in the USD and pilot-scale flocculation systems.  
Figure adapted from Espuny Garcia del Real et al. (2014). 
The pictures are arranged in three groups according to the values of εavg and vtip 
used to generate the flocs. Flocculation was performed at room temperature with a 
final 0.2 % v/v PEI concentration, fixed flocculant addition rate (1.0 μL.s-1 – USD 
scale and 15 mL.min-1 – pilot scale) and different impeller speeds (8.4, 15, 27 rps – 
USD scale and 1.8, 3.4, 6.8 rps – pilot scale). Refer to Section 2.7.2 for the flocculation 
methodology. 20 μL of flocculated sample were carefully pipetted onto a glass slide 
within 5 minutes of the end of the flocculation experiment and studied under a 
phase contrast microscope. Refer to Section 2.12 for the microscope details and 
methodology used to process the images. Bar size on the images indicates 200 μm. 
 
4.3.7. Flocculation Scale-Up Correlations 
The effect of increasing values of impeller speed upon floc size was evaluated by 
two established scale-up correlations found in the literature for impeller-based 
mixing systems. Impeller tip speed and average turbulent energy dissipation 
were selected to test if they could predict, under a micromixing-controlled 
regime, the flocculation performance obtained between non-geometrically 
similar mixing systems.  
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The d10, d50 and d90 data sets obtained in the USD and pilot-scale mixing systems 
were plotted against the corresponding values of εavg (Figure 4.10) and vtip 
(Figure 4.11) at which the flocs were generated. The negative correlation 
between floc particle size and impeller speed, and therefore εavg and vtip, was best 
described by a negative power curve where R2 ≥ 0.95 in all cases. Figure 4.10 
shows the d10, d50 and d90 data sets obtained at both scales tightly superimposed 
each other, thus εavg was an adequate scale-up correlation to predict the 
flocculation performance of the pilot-scale vessel from the USD scale data, or vice 
versa. Impeller tip speed, as shown in Figure 4.11, did not achieve the same 
results. However, the best fit equations for vtip described that a better correlation 
could be obtained if the pilot scale-vessel was operated at twice the USD-scale 
impeller tip speed.  
To analyse which scale-up “rule of thumb” best predicted the flocculation 
performance between the two mixing systems, the εavg and vtip best fit equations 
and the different impeller speed values for the two mixing systems were used to 
generate three parity plots, one for each characteristic particle size descriptor. 
Figure 4.12 shows the parity plots generated when εavg was the scale-up 
correlation applied and Figure 4.13 shows the parity plots obtained when using 
vtip. The data followed a one to one correlation when using εavg, but when scaling 
up based on constant vtip a global best fit was achieved with a two to one 
correlation for the pilot and USD-scale mixing systems, respectively. The d10 data 
set was predicted within a ± 10 % error margin by εavg (see Figure 4.12). When 
scaling based on constant vtip, the error margin increased to ± 25 %; the highest 
difference was observed under a transitional flow regime (3x103 < Reynolds 
number (Re) < 104; (Doran, 1995)) (see Figure 4.13). In the d50 data sets, the 
particles formed under a transitional flow regime lay within the ± 10 % error 
margin line irrespective of the scale-up criteria used; under a turbulent regime 
(Re > 104; (Bates et al., 1966)) they lay between the ± 10 % and ± 25 % error lines. 
Finally, the d90 values were predicted by εavg with an error margin of ± 25 %, while 
the vtip error exceeded ± 25 %. Both correlations proved to be successful scale-up 
bases but εavg was chosen for further flocculation studies for its ability to more 
accurately predict the PSD of small flocs. In a polydisperse population the 
smallest particles determine the filter pore size in depth filtration (Singh et al., 
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2013) and microfiltration (Kim et al., 2001) unit operations as well as the 
supernatant clarification in centrifugation processes (Berrill et al., 2008; 
Iammarino et al., 2007). 
Average turbulent energy dissipation averages the widely different values of local 
turbulent energy dissipation rate (ε) encountered in the vessel, which can 
underestimate the impact that the high values of ε existing in the impeller region 
have upon the flocs (Zhou and Kresta, 1996). However, when micromixing is the 
limiting mixing time scale and in isotropic turbulent conditions, constant power 
input per unit volume (P/Vl) is the relevant scale-up criteria (Bourne and Yu, 
1994; Zlokarnik, 2002). Micromixing was guaranteed at both flocculation scales 
using sufficiently long flocculant addition times, yet isotropic turbulence was 
achieved differently at each scale. In the microwells of the USD-scale mixing 
system, the oversized impeller guaranteed isotropic turbulence; increasing 
values of the ratio Di/DT decrease the values of maximum energy dissipation rate 
per unit mass of fluid (εmax) present in the reactor (Henzler, 2000; Hortsch and 
Weuster-Botz, 2010). At pilot scale, the flocculation experiments were performed 
at Reynolds values below a fully developed turbulent regime (i.e. Re ≤ 1.3x104); 
consequently, the ε differences between the impeller area and the bulk of the 
vessel were reduced. Although this explanation invalidates the assumption of 
turbulent isotropic regimes required to apply εavg, it is reinforced by the 
pilot-scale d50 and d90 data set deviations observed during turbulent conditions 
(see Figure 4.12 and Figure 4.13). The tight fit between the d10 data sets obtained 
at pilot and USD scale (Figure 4.13) might be due to the fact that vtip determines 
maximum fluid shear rate or shear stress (Uhl and Von Essen, 1986). The global 
best fit between the d10, d50 and d90 data sets of the pilot and USD flocculation 
systems needs to be investigated beforehand, thus requires an additional 
characterisation step during early process development. Consequently, εavg was 
the preferred scale-up criteria because (i) it tightly predicted the d10 data set, and 
(ii) it does not require to previously characterise the flocculation systems used.  
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Figure 4.10. Effect of increasing average turbulent energy dissipation 
values upon floc size for the USD and pilot-scale flocculation systems.  
  
4. Development af an Automated Ultra Scale-Down Flocculation Technique 
 
 183 
 
Figure 4.11. Effect of increasing impeller tip speed values upon floc size for 
the USD and pilot-scale flocculation systems.  
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Figure 4.12. Parity plots of the predicted pilot and USD-scale d10, d50 and d90 
data sets when using average turbulent energy dissipation as the scale-up 
basis. 
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Figure 4.13. Parity plots of the predicted pilot and USD-scale d10, d50 and d90 
data sets when using impeller tip speed as the scale-up basis.  
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4.3.8. Validation of the Flocculation Scale-Down Methodology 
The use of constant εavg as the scale-up criteria was validated by performing 
flocculation studies at both scales using the same εavg value at the USD and 
pilot-scale mixing systems and over a wide range of flocculant addition times to 
represent the three mixing time scales.  
The USD mixing system predicted the pilot-scale d10, d50 and d90 particle size 
characteristic descriptors within a ± 5 % error margin when micromixing was the 
controlling mixing time scale (see Figure 4.14.A). Furthermore, the PSD curves 
obtained by the USD and pilot-scale mixing sytems in the micromixing regime 
overlapped each other with their peak volume frequencies between 9 and 10 μm 
(see Figure 4.14.B). In the micromixing-mesomixing regime, the USD-scale 
mixing system predicted the pilot-scale d10, d50 and d90 data sets within a ± 11 % 
error margin (see Figure 4.14.A). Additionally, the PSD curves obtained at both 
scales in the micromixing-mesomixing regime no longer overlapped each other 
(see Figure 4.14.B). In a fully mesomixing regime the USD-mixing system 
predicted the pilot-scale d10 data set within a ± 5 % error margin, while the d50 
and d90 data sets were underpredicted by up to 50 % in size. The presence of the 
mesomixing time scale in the vessel resulted in broader PSDs at both scales. The 
largest particle size increases were observed in the d90 data set, with increments 
between 30 and 170 % at pilot scale and between 5 and 60 % at USD scale (see 
Figure 4.14.A). The greater sensitivity to mesomixing observed at pilot scale 
might be due to longer lasting effects of the flocculant flooding the STR impeller 
region when using fast addition rates when compared to the USD mixing system 
(see Section 4.3.5).  
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Figure 4.14. Validation of average turbulent energy dissipation as the scale-
up basis between the USD and pilot-scale flocculation systems.  
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4.4. Conclusions 
This chapter has described the development and validation of an automated ultra 
scale-down flocculation technique that is used for the characterisation and 
optimisation of the flocculation of clarified cell broths. A summary of the chapter 
conclusions, with reference to their aims and objectives, are below.  
1. Investigate the critical parameters controlling the scale-up/scale-down of 
flocculation unit operations between two geometrically different vessels. 
Two key parameters to consider during the flocculation scale-up process 
between two vessels of different geometry and scale were found. These were: 
mixing time scales and impeller speed. The governing mixing time scale in the 
vessel was a critical variable affecting the size and the complexity of the particle 
size distributions. Impeller speed affected particle growth and breakage hence 
the final size distribution of the flocs.  
2. Develop an USD flocculation platform based upon the process understanding 
acquired. 
The understanding of the mixing fundamentals gained from the study of the 
flocculation performance of a 1.5 L scale vessel of standard configuration and a 
800 μL mixing device resulted in the development of an ultra scale-down 
methodology to control and mimic the flocculation process between these two 
mixing systems. This method proposes: (i) maintainance of a micromixing 
controlled regime by using flocculant addition times larger than the critical 
addition time; and (ii) the use of constant average turbulent energy dissipation 
rate to scale up impeller speed between the two mixing systems in order to tightly 
correlate the distribution of the small particles, which is typically critical for 
solid-liquid separations. Therefore, this method requires the experimental 
characterisation of micromixing time in the vessels used with the aim to 
investigate the values of critical addition time at the conditions used during 
flocculation.  
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3. Successfully scale-up the flocculation process of pre-clarified cell broths 
between two non-geometrically similar vessels.  
Using the USD method developed, the particle size distribution of clarified 
Saccharomyces cerevisiae homogenate flocculated in the 1.5 L STR described was 
mimicked within a ± 5 % error margin by the USD mixing system presented in 
this chapter. Failing to guarantee micromixing as the predominant mixing regime 
during scale-up led to particle size distribution predictions that differed by up to 
50 % in size.  
5. Ultra Scale-Down Flocculation of Clarified Mammalian Cell Culture Broths 
 
 190 
 
5. Ultra Scale-Down Flocculation of Clarified 
Mammalian Cell Culture Broths  
5.1. Introduction and Aims 
Chapter 4 described an ultra scale-down (USD) flocculation methodology to scale 
up flocculation processes between two mixing systems of different scale and 
geometry. The methodology was validated with clarified Baker’s yeast 
homogenate as described in Chapter 4. This method was then used to study 
flocculation with clarified high cell density (HCD) mammalian cell broths. It was 
expected that clarified Baker’s yeast homogenate and HCD mammalian cell 
centrate would yield very different feed properties. The impact that these would 
have upon the USD flocculation methodology was unknown and therefore 
required its re-validation with clarified mammalian cell broths.  
The USD flocculation methodology was developed based on the description of 
particle size distributions (PSDs) measured by laser light diffraction. Although 
this approach was suitable for development and validation purposes, analysis by 
laser light diffraction did not offer the high-throughput (HTP) capabilities that 
flocculation required during early process development. A HTP methodology that 
allowed facile identification of the least favourable flocculation conditions in an 
automated manner was required.  
Summary of the chapter’s aims and objectives:  
1. To validate the USD flocculation methodology described in Chapter 4 with 
clarified HCD mammalian cell broths.  
2. To develop a HTP methodology using the USD mixing device described in 
Chapter 4 to evaluate flocculation conditions.  
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5.2. Experimental Set-Up 
5.2.1. Mammalian Cell Culture Preparation 
High cell density mammalian cell culture was prepared and stored as described 
in Section 2.1.2. Centrate was defrosted at room temperature prior to use. 
5.2.2. Characterisation of the Flocculation Streams 
The dynamic viscosity and density values of the thawed HCD mammalian cell 
centrate were investigated for their effect upon the mixing time scales in the 
flocculation systems. Measurements were performed according to Section 2.11.5 
and Section 2.11.6, respectively. Total protein and monoclonal antibody (mAb) 
concentration were quantified as described in Section 2.10.1 and Section 2.10.2, 
respectively.  
The dynamic viscosity and density of 4 % w/v polyethylenimine (PEI) were 
measured as described in Section 2.11.5 and Section 2.11.6, respectively. 
5.2.3. Flocculation Experiments 
Different PEI stock solutions were used to flocculate HCD mammalian cell 
centrate. A 4 % w/v PEI stock solution was used during the validation 
experiments of the USD flocculation methodology, while 4, 6 and 12 % w/v PEI 
stock solutions were used during the HTP evaluation experiments. Fresh PEI 
stock solutions were prepared before each flocculation experiment by overnight 
mixing of the required amount of PEI in phosphate buffered saline (PBS tablets). 
Refer to Section 2.7.1 for the detailed flocculation methodology. The impeller 
speed and flocculant addition time were varied depending upon the flocculation 
study conducted.  
5.2.3.1. Validation of the USD Flocculation Methodology 
Mammalian cell centrate was flocculated with 0.20 % w/v PEI, constant impeller 
speed and different flocculant addition rates. At pilot scale, impeller speed was 
set to 4.6 rps and flocculant addition rate to 8.57, 15.0, 21.4, 47.6, 90.0 and 
184 mL.min-1. At USD scale, impeller speed was set to 19 rps and flocculant 
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addition rate to 1.00, 1.67, 5.00, 20.0, 50.0, 100, 250, 400 and 900 μL.s-1. The 
pilot-scale impeller speed corresponded to the intermediate impeller speed value 
of the motor used at this scale. Ultra scale-down impeller speed was calculated 
following the USD flocculation methodology (see Chapter 4), where the values of 
average turbulent energy dissipation rate per unit mass of fluid (εavg) are the 
same at both flocculation scales. The value of εavg was calculated as described in 
Section 2.5. Polyethylenimine concentration was chosen based on the results 
described in Section 3.3.2 for HCD mammalian cell centrate. The ranges of 
flocculant addition rate used were limited by the liquid handling robot (USD 
scale) and the syringe pump (pilot scale) employed. The PSD of the flocs was 
measured by laser light diffraction according to Section 2.11.4.  
5.2.3.2. High-Throughput  Evaluation 
These experiments were performed at USD scale using the microplate-based 
mixing system described in Chapter 4; refer to Section 2.3.3 for a detailed 
description of the system’s configuration. Impeller speed and flocculant addition 
rate were kept constant and equal to 17.4 rps and 900 µL.s-1, respectively. Four 
different PEI concentrations were studied based on Lonza Biologics’ in-house 
knowledge of flocculation processes when using their commercial CHO cell line; 
these were: 0.05, 0.15, 0.30 and 0.60 % w/v. Flocculation performance was 
evaluated in two ways: (i) resultant PSD measured by laser light diffraction (see 
Section 2.11.4), and (ii) supernatant absorbance at 600 nm wavelength at 
different time points.  
Absorbance measurements were performed as follows: after flocculation (see 
Section 2.7.1 for the detailed methodology), the lid of the microwell mixing 
system (see Figure 2.3.A) was lifted and the flocs allowed to settle in the 
microplate for 15, 30, 60, 180 or 360 minutes; then, the liquid handling robot 
aspirated 200 µL of liquid phase from the liquid surface and dispensed it into a 
96-well, flat bottom, transparent microplate (Corning® 96 well plates, 
UV-transparent; Sigma-Aldrich, Gillingham, UK) suitable for absorbance 
measurements at 600 nm. A microplate reader was used for the absorbance 
measurements as described in Section 2.11.1.  
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5.3. Results and Discussion 
5.3.1. Characterisation of the Flocculation Streams 
Defrosted HCD mammalian cell centrate was used in the flocculation studies. The 
effect that freeze-thawing had upon the PSD of clarified HCD mammalian cell 
culture was studied in Chapter 3. The reader is referred to Section 11.1.2 for a 
detailed description of the freeze-thawing effect on the PSD of HCD mammalian 
cell centrate.  
The physical properties of the thawed HCD mammalian cell centrate were 
measured for their effect upon the micromixing parameters of the flocculation 
vessels under a turbulent flow regime (Bourne et al., 1989, 1995; Gholap et al., 
1994). The thawed HCD mammalian cell centrate used was a Newtonian fluid 
with a dynamic viscosity value at 22°C equal to 1.06 mPa.s and a density value 
equal to 1010 kg.m-3. Total protein concentration was equal to 15.2 ± 0.6 g.L-1, 
while mAb concentration was equal to 4.7 ± 0.2 g.L-1 thus representing 31 % of 
the total protein concentration. The host cell protein (HCP) content in the cell 
culture centrate is impacted by the cell line, the recombinant protein product, the 
cell culture media, the feeding strategy, the bioreactor control, the cell culture 
duration (Jin et al., 2010; Tait et al., 2012) and the harvesting strategy (Hogwood 
et al., 2013b). Therefore, both total protein concentration and the relative mAb 
to HCP concentration observed were specific to the HCD mammalian cell centrate 
used in this chapter.  
Finally, with regards to the flocculant, the 4 % w/v PEI stock solution used in the 
validation experiments was a Newtonian fluid with a density of 1030 kg.m-3 and 
a dynamic viscosity of 1.98 mPa.s at 22°C.  
5.3.2. Validation of the Ultra Scale-Down Flocculation 
Methodology with Mammalian Cell Centrate 
The USD flocculation methodology, which is described in Chapter 4, states that 
flocculation performance can be successfully scaled up between two different 
mixing systems if (i) slow flocculant addition rates that guarantee a predominant 
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micromixing regime in the flocculation vessels are used, and (ii) constant εavg is 
used to scale up impeller speed. This method was successfully validated with 
clarified Baker’s yeast homogenate (see Section 4.3.8). The differences in the 
physical and biological properties between the clarified Baker’s yeast 
homogenate and the HCD mammalian cell centrate suggested possible changes in 
the mixing time scales and hence in the USD flocculation methodology. The 
validation protocol (see Section 4.3.8) used with HCD mammalian cell centrate 
was identical to that of Baker’s yeast homogenate in order to investigate the 
possible differences.  
The dynamic viscosity values of the flocculation feed streams (i.e. thawed HCD 
mammalian cell centrate and a 4 % w/v PEI solution) were less than double (see 
Section 5.3.1) the viscosity of the water-based solutions used to characterise 
micromixing time in the flocculation vessels (see Section 4.3.4).  Changes in the 
micromixing parameters have been reported with fourfold (Bourne et al., 1989), 
six fold (Bourne et al., 1995) and seven fold (Gholap et al., 1994) increases in 
viscosity with respect to the control solution. Therefore, with less than a twofold 
increase in viscosity, the micromixing values described in Chapter 4 were 
assumed to remain unchanged during the flocculation studies with HCD 
mammalian cell centrate. However, the re-validation experiments were still 
carried out to confirm this hypothesis.  
To re-validate the USD flocculation methodology with HCD mammalian cell 
centrate, εavg was kept constant at both flocculation scales while a wide range of 
flocculant addition rates were used. The feed conditions and flocculant 
concentration were also constant at both scales. The aim was to represent the 
different mixing time scales in the vessel (i.e. mesomixing and micromixing) and 
evaluate whether the USD flocculation methodology was successful, 
independently of the predominant mixing time scale when using HCD 
mammalian cell centrate. Figure 5.1 describes the particle size characteristic 
descriptors d10, d50 and d90, and the PSD curves resulting from the flocculation 
studies at USD and pilot scale. Figure 5.1.A shows that wider and larger PSDs were 
obtained at USD scale with slower flocculant addition rates. The USD d10 
characteristic descriptor increased, on average, from 13 to 39 µm; the d50 from 
5. Ultra Scale-Down Flocculation of Clarified Mammalian Cell Culture Broths 
 
 195 
 
29 to 78 µm; and the d90 from 58 to 152 µm. As observed in Figure 5.1.A, the 
largest increase in floc size at USD scale occurred when shifting from a 
micromixing-mesomixing regime to a system where micromixing was the 
predominant mixing time scale in the vessel; this change represented an increase 
in particle size between 75 and 110 %. However, the shift from a mesomixing to 
a micromixing-mesomixing regime resulted in a smaller particle size increase 
(between 25 and 31 %). With regards to the pilot-scale data set, PSDs became 
narrower but larger with slower flocculant addition rates (see Figure 5.1.A). The 
pilot d10 characteristic descriptor increased from 31 to 45 µm; the d50 from 67 to 
82 µm; and the d90 remained constant at 148 µm. At pilot scale, particle size only 
increased when shifting from a mesomixing to a micromixing-mesomixing 
controlled regime; the pilot d10, d50 and d90 data sets remained constant, on 
average, during the shift from a micromixing-mesomixing regime to a 
micromixing regime (see Figure 5.1.A).  
Flocculation, described by the d10, d50 and d90 data sets, was successfully 
scaled-up with a ± 7 % error margin in the micromixing regime (see Figure 5.1.A). 
The PSD curves obtained in this mixing regime overlapped each other with their 
peak volume frequencies at 55 μm (USD scale) and 62 μm (pilot scale) (see   
Figure 5.1.B). However, the influence of mesomixing led to the formation of 
bimodal PSD curves that differed at both scales (see Figure 5.1.B) as well as to 
d10, d50 and d90 data sets with particle size differences of up to ± 60 % between 
the two scales (see Figure 5.1.A). This data confirmed the USD flocculation 
methodology could be successfully implemented in clarified HCD mammalian cell 
flocculation processes, but only when a micromixing regime was guaranteed in 
both flocculation mixing systems.  
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Figure 5.1. Validation of the ultra scale-down flocculation methodology 
using high cell density mammalian cell centrate.  
  
  
5. Ultra Scale-Down Flocculation of Clarified Mammalian Cell Culture Broths 
 
 197 
 
The effect of flocculant addition time upon the morphology of the flocculated 
particles was studied at pilot scale since no significant differences were observed 
upon particle size as described by the pilot d10, d50 and d90 data sets (see          
Figure 5.1.A). Figure 5.2 shows that more consistently shaped and sized particles 
were obtained with longer flocculant addition times. This observation was 
validated by Berrill et al. (2008), who visually observed higher variability in floc 
size when using short flocculant addition times. These results were also 
corroborated with the pilot-scale PSD curves plotted in Figure 5.1.B. While 
monomodal PSDs were obtained at long flocculant addition times 
(i.e. micromixing regime), bimodal PSDs resulted from the influence of 
mesomixing at shorter flocculant addition times. The formation of complex PSDs 
might have been due to fast flocculant addition rates not allowing the 
homogeneous distribution of the flocculant inside the vessel.  
 
 
 
 
 
Figure 5.2. Representative images of flocs obtained at pilot scale with high 
cell density mammalian cell centrate.  
High cell density mammalian cell (peak cell count = 28.0x106 cells.mL-1) centrate 
was flocculated with 0.2 % w/v PEI, 4.57 rps impeller speed and 184, 47.6 and 
15.0 mL.min-1 flocculant addition rates. Refer to Section 2.7.1 for the detailed 
flocculation methodology. A volume of flocculated sample equal to 20 μL was 
carefully pipetted onto a glass slide within 5 minutes of finishing the flocculation 
experiment, and studied under a phase contrast microscope. Refer to Section 2.12 
for the microscope details and methodology used to process the images. Bar size 
indicates 200 μm. 
 
The effect of flocculant addition time upon the size distribution of the resultant 
flocs differed depending upon the feed material used despite performing 
flocculation under very similar conditions. Wider and larger PSDs were obtained 
at both pilot and USD scale with faster addition rates when flocculating clarified 
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Baker’s yeast homogenate (see Figure 4.14 in Section 4.3.8). However, the effect 
of faster addition rates upon PSD was different depending on the scale when 
flocculating HCD mammalian cell centrate; while narrower and smaller PSDs 
were obtained at USD scale, slightly wider floc distributions were observed at 
pilot scale (see Figure 5.1.A). These data confirm that, although the USD 
flocculation methodology was successful when using clarified feeds of different 
characteristics, it might be of interest to study the effect that impeller speed and 
flocculant addition rate have upon flocculation performance before scaling up. 
Understanding the effect that process variables have upon process performance 
allows easier and more accurate troubleshooting, if required.   
5.3.3. Automated, High-Throughput Evaluation of Flocculation 
Conditions  
The 96-well microplate-based USD mixing device described in Chapter 4 was 
developed to obtain a platform that allowed screening flocculation conditions in 
an automated and HTP manner suitable for early process development studies. 
Flocculation performance was assessed by means of the resultant PSD measured 
by laser light diffraction. However, this technique did not offer the automation 
and HTP capabilities required. Absorbance measurements at 600 nm wavelength 
(Abs600), also referred to as optical density at 600 nm (OD600), were proposed as 
an alternative method for the evaluation of optimal flocculation conditions.  
Optical density measurements at 600 nm wavelength have been commonly used 
in bioprocesses to analyse the solid content in samples (Berrill et al., 2008; Chatel 
et al., 2014; Hogwood et al., 2013b; Kim et al., 2001; Lau et al., 2013; Tait et al., 
2009; Tustian et al., 2007). However, the presence of large, non-colloidal particles 
like flocs would result in highly variable OD600 measurements. To avoid this, the 
flocculated material was allowed to settle under gravity and the OD of the 
resulting supernatant measured at 600 nm wavelength. After gravitational 
settling, the flocculated material would be constituted of small colloidal particles 
that flocculation did not remove. Small particulates determine the performance 
of the subsequent centrifugation (Berrill et al., 2008; Iammarino et al., 2007) or 
filtration (Iammarino et al., 2007; Kim et al., 2001; Singh et al., 2013) unit 
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operations. Therefore, this approach was of interest when scouting for optimal 
flocculation conditions. In addition to this, this approach offered the opportunity 
to automate the flocculation experiments and absorbance measurements within 
the same robotic platform where experiments could be run without supervision. 
But since the PSD of flocculated particles determines the performance of 
subsequent solid-liquid separations (Berrill et al., 2008; Singh et al., 2013), it was 
necessary to study the correlation between the size distribution of the flocs and 
the OD600 values of the settled flocculated material. Furthermore, various settling 
times were studied to test whether different time points could more accurately 
identify differences in the PSD.  
Four different flocculant concentrations were used to generate an array of PSDs. 
Figure 5.3 plots the resulting PSDs measured by laser light diffraction. The size 
and complexity (i.e. monomodal or bimodal distribution) of the population of 
flocs tightly depended upon the flocculant concentration. An inflection point in 
the correlation between higher flocculant concentration and larger particle size 
occurred at PEI concentrations larger than 0.30 % w/v. A concentration of 
0.60 % w/v PEI resulted in a narrower and smaller PSD than that achieved with 
0.15 and 0.30 % w/v PEI. The smallest PEI concentration studied (0.05 % w/v) 
was not able to flocculate the submicron particles present in the thawed HCD 
mammalian cell centrate (see Figure 11.2), possibly due to the fact that flocculant 
concentration was too low to form any flocs.  
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Figure 5.3. Particle size distribution of flocs generated at USD scale with 
different flocculant concentrations.  
High cell density mammalian cell (peak cell count = 28.0x106 cells.mL-1) centrate 
was flocculated at USD scale with 17.3 rps impeller speed, 900 µL.s-1 flocculant 
addition rate and 0.05, 0.15, 0.30 or 0.60 % w/v PEI concentration. Refer to 
Section 2.7.1 for the detailed flocculation methodology. Particle size was measured 
by laser light diffraction according to Section 2.11.4. The PSD curves plotted are the 
average of 10 independent measurements.  
 
The four flocculant concentrations studied also resulted in different gravity 
settling profiles (see Figure 5.4). Flocculation with 0.05 % w/v PEI led to OD600 
values around 0.500 A.U. that did not change over the settling period studied. The 
final OD600 value represented an 8 fold increase from the HCD mammalian cell 
centrate OD. These data suggested flocculation took place at 0.05 % w/v PEI, but 
the flocs created were so small (see Figure 5.3) that they remained in suspension. 
As it has been mentioned in this section, small particulates determine the 
performance of the subsequent centrifugation and filtration unit operations 
(Berrill et al., 2008; Iammarino et al., 2007; Kim et al., 2001; Singh et al., 2013). 
Therefore, high OD600 values over long settling time periods are indicative of 
non-optimal flocculation conditions. Flocculant concentrations higher than 
0.05 % w/v PEI resulted in particles big enough to settle over time as observed 
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in Figure 5.4. When flocculating with 0.15 and 0.60 % w/v PEI, OD600 increased 
to 0.110 and 0.650 A.U., respectively, thus representing a 1.6 and 10 fold 
increment with respect to the HCD mammalian cell centrate OD. After this OD 
peak at 15 minutes, OD600 decreased in the course of a six-hour period to 
0.007 A.U. (0.15 % w/v PEI) and 0.014 A.U. (0.60 % w/v PEI). With regards to 
0.30 % w/v PEI, the supernatant OD600 was never greater than the initial HCD 
mammalian cell centrate OD and after six hours settling time it was equal to 
0.010 A.U. When comparing these OD settling profiles to their corresponding 
PSDs (Figure 5.3), it was observed that large and wide PSDs like the one obtained 
with 0.30 % w/v PEI did not result in an initial OD600 peak; instead, it gradually 
decreased from the initial OD600 value. In addition to this, the narrower and 
smaller the PSD of the flocs, the slower particle settling was.  
 
Figure 5.4. OD600 of flocculated high cell density mammalian cell centrate 
after gravity settling.   
High cell density mammalian cell (peak cell count = 28.0x106 cells.mL-1) centrate 
was flocculated at USD scale with 17.3 rps impeller speed, 900 µL.s-1 flocculant 
addition rate and 0.05, 0.15, 0.30 or 0.60 % w/v PEI concentration. Refer to 
Section 2.7.1 for the detailed flocculation methodology. Optical density 
measurements were taken with a plate reader according to Section 2.11.1. Error 
bars describe standard deviation of one where n = 96. 
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The difference in PSD could be most accurately depicted after 30 minutes of 
gravity settling (see Figure 5.4). While short experimental times are of interest to 
speed up process development, longer gravity settling times such as 3 hours 
allowed the confirmation of non-optimal flocculation conditions 
(e.g. 0.05 % w/v PEI). Polyethylenimine concentrations equal to 0.15, 0.30 and 
0.60 % w/v resulted in distributions with flocculated particles larger than 2.5 µm 
and changing OD600 gravity settling profiles over time. Therefore, the results 
showed that non-optimal flocculation conditions, defined as those resulting in the 
formation of submicron particles, could be scouted in an automated and HTP 
manner by measuring the settled supernatant OD600 over a period of 3 hours. The 
flocculation conditions resulting in rapid settling profiles, hence in flocs bigger 
than 1 µm, should be considered for the subsequent centrifugation or filtration 
process development studies where they should be assessed based upon process 
performance.  
5.4. Conclusions 
This chapter presented the validation of the USD flocculation methodology with 
HCD mammalian cell centrate and the implementation of the microplate-based 
USD mixing device as part of a HTP, automated platform for the analysis of 
flocculation conditions during early process development studies. A summary of 
the key findings, based upon the chapter aims and objectives is as follows:   
1. To validate the USD flocculation methodology described in Chapter 4 with 
clarified HCD mammalian cell broths.  
The USD flocculation methodology described in Chapter 4 allowed to successfully 
scale up the flocculation of HCD mammalian cell centrate between two vessels of 
different scale and geometrical configuration. Scale-up was only successfully 
achieved when micromixing was the predominant mixing time scale in the 
flocculation vessels. The influence of mesomixing increased the particle size 
differences between flocculation scales from ± 7 % to ± 60 %. Mesomixing had a 
similar effect when flocculating clarified Baker’s yeast homogenate since particle 
size differences increased from ± 5 % to ± 50 % (see Section 4.3.8). Therefore, 
flocculant addition time was confirmed to be a key flocculation process variable 
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for the scale-up success between mixing systems of different scale and geometry 
independently of the biological material being flocculated.  
2. To develop a HTP methodology using the USD mixing device described in 
Chapter 4 to evaluate flocculation conditions.  
By letting the flocs settle under gravitational forces and by measuring the 
absorbance of the resultant supernatant at 600 nm wavelength over a period of 
3 hours, (i) non-optimal flocculation conditions, defined as those resulting in 
submicron flocculated particles, were successfully identified; and, (ii) differences 
in the size distribution of particles larger than 2 µm were accurately exhibited. 
This methodology, in combination with the microplate-based USD mixing system, 
allows automating high-throughput flocculation experiments within the same 
liquid handling platform making it suitable for early process development 
activities.  
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6. Depth Filtration of Flocculated 
Mammalian Cell Culture Centrate  
6.1. Introduction and Aims 
The particles generated after flocculation required a subsequent solid-liquid 
separation step. Charged normal flow depth filtration was chosen for its ability to 
additionally reduce the impurity content in the feed material (Yigzaw et al., 
2006). Examples of its successful implementation with flocculated fluids are 
reported in the literature (Buyel and Fischer, 2014; Kang et al., 2013, 2013; Singh 
et al., 2013; Tomic et al., 2015). The introduction of any new unit operation 
requires a study of how the new process variables will affect the subsequent 
stages. By investigating unit operations employing ultra scale-down (USD) 
technologies, a greater understanding of the unit operation and its interaction 
with other steps can be achieved using only millilitre volumes of process material. 
Ultra scale-down methodologies allow the evaluation of different operating 
parameters in an automated and parallel fashion, and can result in relevant 
process-scale data too. The decision of whether laboratory-scale validation 
studies are needed before the pilot-plant process development activities can start 
depends upon a number of factors. One is the experience of past similar USD scale 
studies (Titchener-Hooker et al., 2008).        
The process interaction between flocculation and depth filtration was studied in 
this chapter. Different flocculation conditions, depth filter media (multi-layer and 
single-layer filters) and normal flow filtration (NFF) modes were evaluated. 
Firstly, USD flocculation and USD constant pressure depth filtration 
(i.e. single-layer filters) were employed to provide an automated, 
high-throughput technique that integrated both unit operations at USD scale. This 
allowed the study of several process variables with small volumes of process 
material. Then, constant flux depth filtration of flocculated feeds was studied at 
laboratory scale to evaluate the effect of multi-layer depth filtration in the 
clarification of polydisperse flocculated fluids. These results were used to choose 
the flocculation and filtration process conditions used in Chapter 7.  
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Summary of the chapter’s aims and objectives:  
1. Assess the use of USD flocculation and USD constant pressure depth filtration 
to investigate how flocculation performance affects depth filtration 
performance.  
2. Assess the suitability of multi-layer depth filters to clarify polydisperse 
flocculated streams.  
6.2. Experimental Set-Up 
Figure 6.1 summarises the experimental set-up of this chapter. The experimental 
details are described below.  
6.2.1. Mammalian Cell Culture Preparation  
High cell density mammalian cell centrate was prepared and stored as described 
in Section 2.1.2. Centrate was defrosted at room temperature prior to use.  
6.2.2. Ultra Scale-Down Process Integration 
Ultra scale-down flocculation and USD constant pressure depth filtration were 
employed as described in Section 2.7.1 and Section 2.8.1, respectively. A set 
volume of 800 µL of HCD mammalian cell centrate was flocculated at USD scale 
with 0.15 % and 0.30 % w/v polyethylenimine (PEI) and fixed impeller speed 
(17.3 rps). Flocculant was added at 1 and 900 μL.s-1 to study the effect of mixing 
time scales (see Chapter 4). The flocs were left to mature for 10 minutes before 
assessing flocculation performance via particle size distribution (PSD) 
measurements according to Section 2.11.4.  
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Figure 6.1. Diagram summarising the experimental work performed in 
Chapter 6.  
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Less than 3 minutes passed between the completion of USD flocculation and the 
start of USD filtration; the flocs were kept suspended by gentle inversion during 
this time. Non-treated centrate was depth filtered using the same conditions as 
the flocculated material to provide a benchmark comparison for filtration 
performance. Two different single-layer depth filter media were tested: DE45 
grade (Millistak+® DE media series; EMD Millipore Billerica, MA, USA) with a 
retention rating of 1 – 0.5 μm and 05SP grade (Zeta Plus™ SP series; 
3M Purification Inc., St Paul, USA) with a retention rating of 10 – 1.5 μm. Filtration 
was performed at a constant negative pressure drop (ΔP) of 100, 400 and 
700 mbar. A set volume of 4 mL of process material was manually loaded into the 
filter reservoir per filtration run (equivalent filter loading = 143 L.m-2). Four 
repeats were carried out per filtration condition. Filter specifications and 
detailed USD methodology are described in Section 2.8.1. At USD scale, filtration 
performance was assessed based upon filter capacity and filtrate clarification 
(see Figure 6.1). At USD constant pressure filtration, filter capacity was calculated 
as the filtration throughput obtained when filter flux equals to 10 % of the value 
of initial filter flux. Filtrate clarification was expressed in terms of optical density 
measurements at 600 nm wavelength (OD600). The filtrate samples were stored 
at -80°C after the OD600 measurements.  
6.2.3. Laboratory-Scale Process Integration 
Flocculation was performed in a 1.5 L vessel (see Section 2.3.1 for the 
configuration details) following the methodology described in Section 2.7.1. 
Polyethylenimine was added at 184 and 8.47 mL.min-1 to a final concentration of 
0.15 % w/v while impeller speed was fixed at 4.8 rps. Flocculation performance 
was assessed and measured as in Section 6.2.2.  
Depth filtration was performed at a constant flux of 100 L.m-2.h-1 using a 
commercially available 23 cm2 multi-layer depth filter capsule 
(Clarisolve® 40MS μPod®; EMD Millipore Billerica). Filter specifications and 
detailed methodology are described in Section 2.8.2. Filtrate was collected in 
10 mL fractions. At laboratory scale, filtration performance was assessed based 
upon filter capacity, filtrate clarification, product recovery and impurity removal 
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(see Figure 6.1). At constant flux filtration, filter capacity was calculated as the 
filtration throughput achieved at a pressure differential of 1.4 bar (Kang et al., 
2013; Riske et al., 2007; Yavorsky et al., 2003). Filtrate clarification was 
expressed in terms of OD600 measurements. After the OD measurements, the 
filtrate fractions were pooled together and stored at -80°C for future product 
recovery and impurity removal analyses. Product recovery was evaluated by 
measuring the concentration of monoclonal antibody (mAb) before and after 
depth filtration. Antibody concentration was quantified as described in 
Section 2.10.2. Impurity removal was evaluated by measuring total protein and 
DNA concentration before and after depth filtration. Total protein and DNA 
concentration were quantified as described in Section 2.10.1 and Section 2.10.3, 
respectively.  
6.3. Results and Discussion 
Flocculation and depth filtration performance were studied to understand how 
the PSD of flocculated streams impacts upon depth filtration, and how this can be 
modulated by the use of different filter media and filtration operating conditions 
such as pressure drop. The PSD of flocculated streams has been shown to impact 
upon the performance of subsequent unit operations, such as charged normal 
flow depth filtration (Singh et al., 2013) and centrifugation (Berrill et al., 2008). 
Flocculation and depth filtration were studied at USD scale first because 
(i) flocculation and depth filtration performance depend on many process 
variables; and (ii) a limited volume of HCD mammalian cell centrate was 
available. Both USD flocculation (Chapter 4 and Chapter 5) and USD depth 
filtration (Lau et al., 2013) have been proved to successfully predict the 
performance of their pilot-scale counterparts. Therefore, the methodology 
described in this chapter presents the opportunity to be implemented during the 
early bioprocess development studies when process-relevant materials are often 
limited, or later in development when process changes might need to be tested 
(Tait et al., 2009; Titchener-Hooker et al., 2008).  
Laboratory-scale experiments were necessary to evaluate how the PSD of 
flocculated populations impacts upon depth filtration performance when using 
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multi-layer depth filters; the current USD depth filtration design only allows the 
fitting of single-layer depth filters. The aim was to investigate if a robust depth 
filtration process that is not affected by shifts in the size distribution of 
flocculated particles could be obtained with multi-layer depth filters. The 
filtration conditions and filter media used at laboratory scale were selected based 
upon the literature results described for the depth filtration of flocculated HCD 
mammalian cell feeds (Kang et al., 2013; Singh et al., 2013; Tomic et al., 2015).  
6.3.1. Ultra Scale-Down Flocculation 
Before any detailed analysis, the aim was to first study whether flocculation 
affected depth filtration performance in any way. As a result, the USD flocculation 
parameters and conditions studied were chosen for their ability to generate 
different PSDs. The two flocculation parameters selected were: flocculant 
concentration and flocculant addition rate; these two parameters have shown to 
generate very different PSDs when flocculating HCD mammalian cell feeds (see 
Figure 3.8 in Section 3.3.4.1 and Figure 5.1 in Section 5.3.2, respectively). 
Flocculation performance was measured in terms of its ability to generate 
monomodal and tight PSDs by flocculating the small particles present in the HCD 
mammalian cell centrate (see Section 3.3.4.1). Flocculated feeds with narrow 
monomodal PSDs are always of interest, particularly if they are to be processed 
by depth filtration (Singh et al., 2013) or centrifugation (Berrill et al., 2008).  
The different flocculation conditions studied generated a range of PSDs, from 
wide bimodal distributions to narrow monomodal distributions (see Figure 6.2). 
Both flocculant concentration and flocculant addition rate determined the 
complexity of the population of flocculated particles. Flocculant concentrations 
of 0.30 % w/v led to the formation of small particles with diameters between 2 
and 10 μm regardless of the flocculant addition rate used. However, fast addition 
rates (900 μL.s-1) formed narrower PSDs. At 0.15 % w/v PEI, small particles were 
only generated at slow addition rates (1 μL.s-1) (see Figure 6.2). Nonetheless, it is 
possible that this small population of particles was produced at any of the 
flocculation conditions tested, but that at fast addition rates particles of similar 
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size were also created. These small particles could have been camouflaged under 
a bigger PSD curve. 
 
Figure 6.2. Particle size distribution of the flocs generated during the 
flocculation – depth filtration integration studies at USD scale.  
A volume of 800 μL of HCD mammalian cell culture (peak cell 
count = 29.0x106 cells.mL-1) centrate (Q/Σ = 2.85x10-8 m.s-1) was flocculated with 
PEI (concentration: 0.30 and 0.15 % w/v; addition rate: 1 and 900 μL.s-1). After 
10 minutes of floc maturation, the PSD of the flocculated material was measured as 
described in Section 2.11.4. Error bars represent one standard deviation where 
n = 12. 
 
6.3.2. Ultra Scale-Down Depth Filtration 
Normal flow filtration performance is judged according to filter capacity and 
retention (Yavorsky et al., 2003). At USD scale, where filtration was performed at 
constant vacuum pressure, capacity was calculated as the volume of fluid that 
could be processed at a minimum flow limit. In this chapter all the data was 
normalised by filter area. Therefore, capacity is redefined as the filtration 
throughput achieved at a minimum flux limit. Minimum flux was the flux value 
that was equal to 10 % of the initial flux obtained at the filtration conditions 
studied. Retention is defined as the filter capacity of the trailing sterile filter 
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(i.e. 0.22 µm) (Yavorsky et al., 2003). Retention was not studied in this chapter 
but it is calculated in Chapter 7. Filtrate clarification, measured as the end-point 
OD600, was also studied to assess filter performance. 
Industrially relevant filters with different pore sizes were used. DE45 (1 – 0.5 μm) 
was chosen for a tighter filter media. 05SP (10 – 1.5 μm) was a looser depth filter. 
Tight filters (e.g. 0.45 μm) have been successfully used to filter flocculated feeds 
(Chandler and Zydney, 2004). 05SP media has been repeatedly used to filter 
crude mammalian cell stocks (Hogwood et al., 2013b; Lau et al., 2013; Singhvi et 
al., 1996), where large solid volumes similar to those encountered with 
flocculated feeds were processed. All the filter media used were positively 
charged. Different pressure drops, which included the maximum and minimum 
operational pressures with the vacuum system used, were also examined.  
To understand the fouling mechanisms that occurred during the filtration runs, 
the experimental data were fitted to four different linearised constant pressure 
filtration models (standard pore blockage, intermediate pore blockage, pore 
constriction and cake filtration) (see Figure 1.6 in Section 1.4.2 for their detailed 
description). Maximum projected filtration throughput values were calculated 
where possible to assess filtration performance and not for filter sizing purposes.  
6.3.2.1. Filter Resistance Measurements 
Filter resistance (Rf) was calculated at the three different pressure drops used 
during USD filtration. The results are summarised in Table 6.1. The DE45 filter 
resistance values were higher than those of the 05SP media due to its tighter pore 
size. Filter resistance increased with ΔP independently of the filter media used. 
However, the increment was not proportional. While Rf remained constant at 400 
and 700 mbar, Rf at 100 mbar was smaller by 39 % and 43 % in the DE45 and 
05SP media, respectively. The increment in Rf with ΔP can be attributed to a more 
compact nature of the sponge-like depth filter material. The physical strength of 
the filter could have possibly been maintaned at 100 mbar, but not at 400 and 
700 mbar. At higher ΔP values, the filter would have compacted thus increasing 
Rf as a consequence. The effect of ΔP on Rf might be more evident when using 
filter sheets than with depth filter capsules. In the latter the filter medium is 
6. Depth Filtration of Flocculated Mammalian Cell Culture Centrate 
 
 212 
 
sealed hence conferring the filter stronger resistance to ΔP (3M Purification Inc, 
2011). The Rf values were consistent, as described by the percentage standard 
deviation calculations (see Table 6.1). However, differences in the Rf of ± 30 % 
(Yavorsky et al., 2003) or even up to ± 57 % (Chandler and Zydney, 2004) can be 
expected due to the inherent variability of filter sheets.   
Table 6.1. Change in filter resistance with pressure drop during the USD 
constant pressure filtration studies. 
Filter resistance was measured with deionised water, and calculated as described 
in Section 2.8.1. The dV/dt variable in Equation 2.24 was the first derivative of the 
linear best fit obtained for the water flux data (R2 ≥ 0.999). Viscosity was that of 
water at 22°C (9.544x10-4 Pa.s) and area was the USD effective filter area 
(0.28 cm2). Percentage standard deviation was calculated as the ratio between the 
values of one standard deviation (n = 4) and the average Rf.  
 
 DE45 media 05SP media 
ΔP 
Average  
Rf (m-1) 
% Standard 
deviation 
Average  
Rf (m-1) 
% Standard 
deviation 
100 1.0x1010 8.0 % 0.5x1010 11 % 
400 2.4x1010 7.6 % 1.3x1010 6.1 % 
700 2.3 x1010 9.9 % 1.4x1010 11 % 
 
 
6.3.2.2. DE45 Filter Performance: Non-Treated Centrate 
The filtration curves obtained from filtering HCD mammalian cell centrate at 
constant vacuum pressures equal to 100, 400 and 700 mbar are plotted in     
Figure 6.3. Flux decayed with increasing filtration throughput as the depth filter 
gradually got clogged with particulates present in the centrate. Flux decreased 
more rapidly at 100 and 400 mbar than it did at 700 mbar. Consequently, larger 
filter capacity values were achieved at high pressure drops (40 L.m-2 at 100 and 
400 mbar vs. 55 L.m-2 at 700 mbar) (see Figure 6.3). Higher initial fluxes were 
also obtained with larger ΔP, although the high variability observed at 400 and 
700 mbar could only certify differences between 100 mbar and the other two 
pressure drops (see Figure 6.3).  
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Figure 6.3. Flux decay of the non-treated centrate during USD constant 
pressure filtration when using DE45 depth filter media. 
A set volume of 4 mL of non-treated HCD mammalian cell culture (peak cell 
count = 28.9x106 cells.mL-1) centrate (Q/Σ = 2.85x10-8 m.s-1) was filtered at three 
different constant vacuum pressures (100, 400 and 700 mbar) employing the USD 
filtration methodology (see Section 2.8.1). The last data point in the filtration curves 
is equal to the filter capacity value; filtration stopped when flux decayed by 90 % 
(see Section 2.8.1). Error bars represent one standard deviation where n = 4. 
 
 
The raw filtration data obtained experimentally (i.e. cumulative filtrate volume 
vs. time) was transformed and fitted according to the linearised constant 
pressure filtration fouling models (see Table 2.5 in Section 2.8.1). The linearised 
forms are convenient for data analysis and model identification (van Reis and 
Zydney, 2007). The model that best fitted the data was pore constriction 
(R2 ≥ 0.981; P < 0.01), meaning that fouling occurred within the depth filter by 
small particles gradually reducing its effective pore size (van Reis and Zydney, 
2007). This is in line with the pore size range of the DE45 filter (1 - 0.5 μm) and 
the sub-micron particles present in centrifuge supernatants (Iammarino et al., 
2007). Nonetheless, none of the other three filtration fouling models could be 
ruled out since there was no clear difference in the R2 values obtained 
(0.974 ≤ R2 ≤ 0.898). The linearised modified pore constriction model (see 
Section 2.8.1) was used to calculate the projected maximum volume of fluid per 
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unit filter area that can be filtered before the filter is completely plugged by 
fouling, which is referred to as 𝑉𝑚𝑎𝑥
∗  (L.m-2); this model was developed by Lau et 
al. (2013) to account for the significant filtration changes occurring in timescales 
of the order of 1 to 60 seconds when employing the USD constant pressure 
filtration methodology. The 𝑉𝑚𝑎𝑥
∗  results are summarised in Table 6.2. As 
observed in the table, the 𝑉𝑚𝑎𝑥
∗  values obtained at 100 and 400 mbar were the 
same (considering the standard deviation of one). However, 𝑉𝑚𝑎𝑥
∗  increased 
between 1.5 and 2 fold at 700 mbar.  
Higher pressure drops led to higher initial flow rates (see Figure 6.3). Higher 
initial flow rates are expected to prematurely foul the depth filter resulting in low 
throughputs (Singhvi et al., 1996; Yavorsky et al., 2003). However, the 
experimental data showed otherwise. Flux decayed faster at lower initial flow 
rates (i.e. ΔP = 100 and 400 mbar) resulting in lower filtration throughputs (see 
Figure 6.3). The more opened filter structure obtained at 100 mbar (i.e. smaller 
Rf – see Table 6.1) could have drawn big particles into the depth filter that 
prematurely clogged the filter. Big particles could have been formed upon freeze-
thawing the centrate (see Figure 11.2 in Section11.1.2). At 400 mbar the flux 
declined at a lower rate, probably due to the tighter filter structure (i.e. larger Rf 
– see Table 6.1), although no difference in filtration throughput was achieved 
with respect to 100 mbar. The flux decline observed at 700 mbar was almost 
linear (see Figure 6.3), suggesting that a different filtration fouling mechanism to 
pore constriction could have occurred. The use of simple fouling models to 
analyse flux decline data has been shown to be ineffective in describing filtration 
in some cases. There is experimental evidence showing that a transition in the 
fouling behaviour from a pore constriction and/or pore blockage fouling 
behaviour to cake filtration can commonly occur during filtration (van Reis and 
Zydney, 2007). This could have occurred during filtration at 700 mbar. The 
formation of a cake layer where large particulates gradually deposited would 
have prevented the premature clogging of the filter. The cake layer, combined 
with a larger driving pressure force, led to higher filtration throughput values.    
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Table 6.2. Vmax* values predicted with USD constant pressure filtration 
when using DE45 and 05SP depth filter media.   
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Finally, Figure 6.4 describes the clarification achieved by depth filtration at any 
of the flocculation and filtration conditions studied when using the DE45 filter 
media. The centrate OD600 value was reduced by 8 fold after a single depth 
filtration step with the DE45 filter media. Higher OD600 values were achieved at 
100 mbar because of the more open filter structure obtained at this ΔP (i.e. lower 
Rf - see Table 6.1). Nonetheless, the large error bars obtained at 400 and 
700 mbar fell within the 100 mbar range of OD600 values. Therefore, the 
dependence between ΔP and filtrate clarification could not be confirmed 
experimentally at the conditions studied for non-treated HCD mammalian cell 
culture streams.   
 
Figure 6.4. Effect of USD-scale flocculation and USD constant pressure depth 
filtration operations on filtrate clarification when using DE45 filter media.  
Filtrate clarification was quantified by optical density measurements at 600 nm 
wavelength. Centrate was HCD mammalian cell culture (peak cell 
count = 29.0x106 cells.mL-1) centrifuged at pilot scale (Q/Σ = 2.85x10-8 m.s-1). This 
material was then filtered at USD scale (see Section 2.8.1) at three different 
constant ΔP (100, 400 and 700 mbar). Prior to filtration, process material was 
either non-treated (i.e. non-flocculated) or flocculated with PEI at USD scale (see 
Section 2.7.1) (0.30 % w/v and 0.15 % w/v) using two different flocculant addition 
rates (1 and 900 μL.s-1). Error bars represent one standard deviation where n = 4. 
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6.3.2.3. DE45 Filter Performance: Flocculated Centrate 
The filtration curves obtained from filtering centrate flocculated with 0.30 % w/v 
PEI are plotted in Figure 6.5. Filtration was performed at USD scale using three 
different constant vacuum pressure drops (100, 400 and 700 mbar). Flocculation 
was also performed at USD scale using slow (Figure 6.5, top) and fast (Figure 6.5, 
bottom) flocculant addition rates. Flux rapidly decayed with increasing filtration 
throughputs for all the ΔP and flocculant addition rates studied. As with the 
non-treated centrate (Figure 6.3), flux decline was slower at 700 mbar than at 
100 and 400 mbar. Consequently, larger filter capacity values were obtained at 
higher ΔP, possibly due to the tighter filter structure and higher driving force. 
Flocculant addition rate did not seem to affect filtration at the conditions tested 
(see Figure 6.5). The same filter capacity values were obtained at the same ΔP 
independent of flocculant addition rate. The only exception was at 100 mbar, 
where filter capacity was 2 L.m-2 larger when flocculated at 1 µL.s-1. Figure 6.2 
shows similarly sized particles were generated at both flocculant addition rates 
when flocculating at 0.30 % w/v PEI. Significantly different PSDs might be needed 
to see any impact upon filter capacity. 
The experimental data obtained at USD scale from filtering centrate flocculated 
at 0.30 % w/v PEI was transformed and fitted into the linearised forms of the 
constant pressure filtration fouling models (see Table 2.5 in Section 2.8.1). Pore 
constriction was the best fit (R2 ≥ 0.983; P < 0.01). Nonetheless, a cake layer build-
up could be observed on the filter surface at the end of every filtration run (see 
Figure 6.6.A). This visual observation contradicted the mathematical predictions 
from the filtration models. It is possible there was a transition in the fouling 
behaviour from pore constriction to cake filtration during the filtration run as 
described in the article published by van Reis and Zydney (2007). Ultra 
scale-down filtration data was gathered for less than 100 seconds since data 
acquisition was automatically stopped when flux dropped by 90 %. It is 
hypothesised that the filtration data points obtained did not include the 
transition in the fouling behaviour. Assuming the experimental data only 
contained the initial pore constriction fouling behaviour, the linearised modified 
pore constriction model (see Section 2.8.1) was used to calculate 𝑉𝑚𝑎𝑥
∗ . The values 
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summarised in Table 6.2 show 𝑉𝑚𝑎𝑥
∗  increased with ΔP. The increment was not 
proportional, with the biggest increase in 𝑉𝑚𝑎𝑥
∗  happening between 400 and 
700 mbar. The 𝑉𝑚𝑎𝑥
∗  results confirmed flocculant addition rate did not affect USD 
depth filtration at the conditions tested.  
As with the non-treated centrate, filtrate clarification of the centrate flocculated 
at 0.30 % w/v PEI improved with ΔP (see Figure 6.4) due to the higher Rf values 
(see Table 6.1). Flocculant addition rate impacted upon filtrate clarification 
unlike with filter capacity. However, the effect of flocculant addition rate upon 
clarification performance was subjected to filter resistance. When ΔP was equal 
to 100 mbar, fast flocculant addition rates (900 µL.s-1) resulted in a 2 fold increase 
in filtrate OD600 when compared to slow addition rates (1 µL.s-1) (see Figure 6.4). 
In contrast, filtrate OD600 was constant at 400 and 700 mbar independently of the 
flocculation conditions. It is possible that the larger amounts of small particles 
obtained at 900 µL.s-1 (see Figure 6.2), in combination with the lower Rf values of 
100 mbar (see Table 6.1), led to more particles passing through the filter thus 
lowering filtrate clarification.  
Figure 6.7 describes the depth filtration curves obtained at USD scale from 
filtering HCD mammalian cell centrate flocculated at slow (Figure 6.7, top) and 
fast (Figure 6.7, bottom) flocculant addition rates with PEI concentrations of 
0.15 % w/v. Flux rapidly declined with increasing filtration throughputs at 
pressure drops of 100, 400 and 700 mbar. As observed with the non-flocculated 
(see Figure 6.3) and 0.30 % w/v PEI-flocculated centrate (see Figure 6.5), flux 
decayed more slowly at larger ΔP leading to higher filter capacity values. 
Flocculant addition rate did not impact upon filter capacity despite the different 
PSDs generated (see Figure 6.2); the exception occurred at 400 mbar, where the 
fast flocculant addition rate obtained a filter capacity value 5 L.m-2 larger than the 
slow flocculant addition rate (Figure 6.7).  
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Figure 6.5. Flux decay of 0.30 % w/v PEI-flocculated centrate during USD 
constant pressure filtration when using DE45 depth filter media.   
A set volume of 4 mL of flocculated HCD mammalian cell (peak cell 
count = 28.9x106 cells.mL-1) centrate (Q/Σ =2.85x10-8 m.s-1) was filtered at USD 
scale (see Section 2.8.1). Depth filtration was performed at three different constant 
vacuum pressures (100, 400 and 700 mbar). Process material was flocculated at 
room temperature (0.30 % w/v PEI; flocculant addition rate: 1 μL.s-1  and 900 μL.s-1 
) using the USD flocculation methodology (see Section 2.7.1). The last data point in 
the filtration curves is equal to the filter capacity value since filtration stopped when 
flux decayed by 90 % (see Section 2.8.1). Error bars represent one standard 
deviation where n = 4. 
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Figure 6.6. Cake layer formation on the filter surface after USD constant 
pressure filtration with flocculated high cell density mammalian cell 
centrate.  
Cake layer build-up was observed when filtering flocculated samples using DE45 (A) 
and 05SP (B) depth filter media at any of the USD flocculation and USD filtration 
conditions studied.  
At 0.15 % w/v PEI, the linearised pore constriction model was also the filtration 
fouling model that best fitted the experimental data (R2 ≥ 0.989; P < 0.01) despite 
a cake layer built up on the filter surface (see Figure 6.6.A). As with 
0.30 % w/v PEI, a transition in the fouling mechanism from pore constriction to 
cake filtration could have occurred (van Reis and Zydney, 2007). The linearised 
modified pore constriction model (see Section 2.8.1) showed 𝑉𝑚𝑎𝑥
∗  increased with 
ΔP (see Table 6.2). But while at slow flocculant addition rates the biggest increase 
in 𝑉𝑚𝑎𝑥
∗  was observed between 400 and 700 mbar, at fast addition rates the 
difference was largest between 100 and 400 mbar. Flocculant addition rate did 
not impact the calculated 𝑉𝑚𝑎𝑥
∗  value when operating at 100 and 700 mbar; 
however, a 5.8 L.m-2 difference was obtained at 400 mbar between the fast and 
slow flocculant addition rates (Table 6.2).   
A 
B 
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Figure 6.7. Flux decay of 0.15 % w/v PEI-flocculated centrate during USD 
constant pressure filtration when using DE45 depth filter media.   
A set volume of 4 mL of flocculated HCD mammalian cell (peak cell 
count = 29.0x106 cells.mL-1) centrate (Q/Σ = 2.85x10-8 m.s-1) was filtered at USD 
scale (see Section 2.8.1). Three different constant vacuum pressures were studied 
(100, 400 and 700 mbar). Process material was flocculated at room temperature 
(0.15 % w/v PEI; flocculant addition rate: 1 μL.s-1  and 900 μL.s-1) using the USD 
flocculation methodology (see Section 2.7.1). The last data point in the filtration 
curves is equal to the filter capacity value since filtration stopped when flux decayed 
by 90 % (see Section 2.8.1). Error bars represent one standard deviation where 
n = 4.  
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Finally, flocculant addition rate impacted upon filtrate clarification when 
flocculating the HCD mammalian cell centrate at 0.15 % w/v PEI, but only at 
100 mbar (see Figure 6.4). The same combination of factors as the encountered 
with the 0.30 % w/v PEI data was assumed. That is, the larger amount of small 
particles generated at 900 µL.s-1 (see Figure 6.2) and the low Rf values when 
operating at 100 mbar (see Table 6.1) allowed small particles passing through 
the depth filter thus reducing clarification performance.  
6.3.2.4. 05SP Filter Performance: Non-Treated and Flocculated 
Centrate 
A wider pore size range depth filter with 10 - 1.5 μm retention rating was used to 
evaluate if the rapid flux decay results obtained with the DE45 media were filter 
specific. Two feed conditions were studied at first to evaluate the 05SP media; 
these were: non-treated centrate and flocculated centrate (flocculant 
concentration: 0.30 % w/v PEI; flocculant addition rate: 900 µL.s-1). Filtration 
was performed at the same three pressure drops used with the DE45 media (100, 
400 and 700 mbar). Both flocculation and depth filtration were performed at USD 
scale. The resultant filtration curves are plotted in Figure 6.8.  
When filtering the non-treated centrate (Figure 6.8, top), filter capacity increased 
by 40 % at 400 and 700 mbar with respect to that obtained at 100 mbar. The 
trend of larger filter capacity values achieved with larger ΔP was also observed 
when using the DE45 media. The same hypothesis is given: the tighter filter 
structure at 400 and 700 mbar (see Table 6.1) prevented large particles present 
in the centrate from penetrating the filter and prematurely clogging it; big 
particles could have been generated when freeze-thawing the centrate 
(see Figure 11.2 in Section 11.1.2). Pore constriction was the filtration fouling 
model that best fitted the experimental data (R2 ≥ 0.986; P < 0.01). The value of 
𝑉𝑚𝑎𝑥
∗  was then calculated applying the linearised modified pore constriction 
model (see Section 2.8.1). The results summarised in Table 6.2 show 𝑉𝑚𝑎𝑥
∗  
increased between 25 and 31 % when operating at 400 and 700 mbar, 
respectively, with respect to 100 mbar. These values are smaller than the 40 % 
difference observed with the filter capacity values (i.e. raw experimental data) 
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(see Figure 6.8, top). Filtration with the 05SP media reduced the centrate OD600 
by 6 fold, independently of the operating ΔP (see Figure 6.9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8. Flux decay of non-treated and flocculated centrate during USD 
constant pressure filtration when using 05SP depth filter media.  
A set volume of 4 mL of non-treated and flocculated (0.30 % w/v PEI, flocculant 
addition rate: 900 μL.s-1) HCD mammalian cell (peak cell 
count = 29.0x106 cells.mL-1) centrate (Q/Σ = 2.85x10-8 m.s-1) was filtered at three 
different constant vacuum pressures (100, 400 and 700 mbar) employing the USD 
filtration methodology (see Section 2.8.1). Flocculation was also performed at USD 
scale (see Section 2.7.1). The last data point in the filtration curves is equal to the 
filter capacity value since filtration stopped when flux decayed by 90 % (see 
Section 2.8.1). Error bars represent one standard deviation where n = 4. 
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The filtration curves resulting from the USD depth filtration of flocculated 
centrate (0.30 % w/v PEI and 900 µL.s-1 flocculant addition rate) are plotted in 
Figure 6.8, bottom. Flux rapidly decayed at all of the ΔP studied when compared 
to the non-flocculated curves (Figure 6.8, top). Filter capacity increased by 16 % 
at 400 and 700 mbar, with respect to that of 100 mbar. The filtration fouling 
model with the best fit was pore constriction (R2 ≥ 0.989; P < 0.01) despite the 
formation of a cake layer on the filter surface in every flocculated run (see     
Figure 6.6.B). It is thought a transition in the filtration fouling mechanism from 
pore constriction to cake filtration occurred during the run, as described by van 
Reis and Zydney (2007). Assuming the filtration run was governed by the pore 
constriction fouling mechanism, the linearised modified pore constriction model 
(see Section 2.8.1) was used to calculate 𝑉𝑚𝑎𝑥
∗ . The value of 𝑉𝑚𝑎𝑥
∗  did not change 
with ΔP (see Table 6.2); only a difference of 0.17 L.m-2 was calculated between 
100 and 400 mbar. Finally, the centrate OD600 was reduced by 9 to 14 fold by 
combining PEI flocculation and the 05SP depth filter media (see Figure 6.9). The 
best clarification performance was achieved at 400 and 700 mbar due to the 
tighter filter structure at these ΔP values (i.e. higher Rf – see Table 6.1).  
In comparison to the DE45 media results (Figure 6.3 and Figure 6.5), flux decayed 
more slowly with the 05SP media at all of the ΔP studied. The larger filter capacity 
values obtained overall were due to the lower filter resistance encountered with 
the 05SP media (see Table 6.1). However, the lower Rf values were detrimental 
to filtrate clarification. With the exception of one process condition 
(0.30 % w/v PEI, 900 µL.s-1 addition rate, 100 mbar pressure drop), filtrate OD600 
increased between 25 and 92 % when compared to the DE45 clarification results 
(see Figure 6.4 and Figure 6.9). 
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Figure 6.9. Effect of USD flocculation and USD constant pressure depth 
filtration operations on filtrate clarification when using 05SP filter media. 
Filtrate clarification was quantified by optical density measurements at 600 nm 
wavelength. Centrate was HCD mammalian cell culture (peak cell 
count = 29.0x106 cells.mL-1) centrifuged at pilot scale (Q/Σ = 2.85x10-8 m.s-1). This 
material was then filtered at USD scale (see Section 2.8.1) at three different ΔP (100, 
400 and 700 mbar). Prior to filtration, process material was either non-treated 
(i.e. non-flocculated) or flocculated at USD scale (see Section 2.7.1) with PEI at 
900 μL.s-1 to a final concentration of 0.30 % w/v. Error bars represent one standard 
deviation where n = 4. 
 
6.3.2.5. Evaluation of the Ultra Scale-Down Method  
Flocs rapidly clogged the depth filters studied at USD scale. The filter capacity 
values achieved when filtering the flocculated centrate ranged between 14 and 
32 L.m-2 (DE45 media) (see Figure 6.5 and Figure 6.7) and between 30 and 
34 L.m-2 (05SP media) (see Figure 6.8, bottom) depending upon the flocculation 
conditions and ΔP. These values represented a throughput reduction between 1.7 
and 2.9 fold when compared to the filter capacity values achieved at the same ΔP 
with the non-treated centrate (see Figure 6.3 – DE45 media and   Figure 6.8, top 
– 05SP media). Furthermore, the filter capacity values obtained with the 
6. Depth Filtration of Flocculated Mammalian Cell Culture Centrate 
 
 226 
 
flocculated centrate were up to 28 fold smaller than those reported in the 
literature (110 and 400 L.m-2) when depth filtering HCD mammalian cell broths 
(Singh et al., 2013). Nonetheless, the filter capacity values taken from the 
literature are considered a reference since the process material, the flocculation 
conditions and the NFF mode used were different. The filtration fouling models 
predicted both the DE45 and the 05SP filter media were clogged by a pore 
constriction mechanism when processing the flocculated centrate. However, 
there was visual evidence of cake layer formation in all flocculated runs (see 
Figure 6.6). This indicated that, at the experimental conditions tested, the USD 
contant pressure filtration methodology was unable to obtain enough data points 
to appreciate any transition in the fouling mechanism (van Reis and Zydney, 
2007). Nonetheless, it is also possible that a very permeable cake layer built up 
on the filter surface letting small particles through and into the depth filter, which 
ultimately clogged the filter via the pore constriction fouling mechanism.   
When filtering the non-treated centrate at USD scale, the filter capacity values 
ranged between 40 and 55 L.m-2 (DE45 media) (see Figure 6.3) and between 60 
and 82 L.m-2 (05SP media) (see Figure 6.8, top). The literature reports filter 
capacity values of ~194 L.m-2 when depth filtering non-treated mammalian cell 
centrate stocks (Riske et al., 2007). However, this is taken as a reference value 
since the experiments were carried out at a larger scale in the literature, in 
addition to the fact that the cell culture and centrifugation processes were 
different, which significantly impacts upon the centrate properties (Liu et al., 
2010).  
The disparity between the experimental and the reported filter capacity values 
could be due to the filtration mode employed at USD scale and/or the use of 
single-layer filters. The implementation of constant flux filtration is advised to 
obtain an accurate filtration profile and retention performance of a given depth 
filter media (Liu et al., 2010; Yavorsky et al., 2003). The initial high feed flow rates 
obtained with constant pressure filtration have been described to inefficiently 
load the filter and cause premature clogging. However, the experimental data at 
USD scale showed greater throughputs were achieved with high initial flow rates. 
Multiple-layer, and not single-layer, depth filters are typically used 
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post-centrifugation (Liu et al., 2010). Multi-layer depth filters have been 
developed to improve the particle removal capabilities of the filter, with each 
layer having a unique pore size, electrical charge, and surface chemistry (van Reis 
and Zydney, 2007). The stratified retention of different sized particles reduces 
premature filter fouling and increases filtration capacity. Additionally, 
multi-layer depth filters have been demonstrated to achieve large filtration 
capacities when processing flocculated mammalian cell broths (Kang et al., 2013; 
Singh et al., 2013).  
To evaluate the use of multi-layer depth filters, filtration had to be performed at 
laboratory scale since the USD contant pressure filtration design could only 
accommodate single-layer filters (see Section 2.8.1). The larger volumes of 
process-relevant material required limited the number of flocculation and 
filtration variables that could be studied. Section 6.3.3 explores the use of a 
selected multi-layer depth filter and studies how flocculant addition rate affects 
filtration performance.  
6.3.3. Laboratory-Scale Depth Filtration 
High cell density mammalian cell centrate was flocculated at pilot scale to a final 
0.15 % w/v PEI concentration. Flocculant concentration was chosen based upon 
the flocculation results obtained in Section 3.3.4 and Lonza Biologics’ in-house 
knowledge for flocculation processes when using their high cell density CHO cell 
line. A slow flocculant addition rate (8.47 mL.min-1) that guaranteed the 
predominance of the micromixing time scale in the pilot-scale vessel (see 
Chapter 4) was used. The macromixing and mesomixing time scales were studied 
using a fast flocculant addition rate (184 mL.min-1) (see Chapter 4). The 
flocculant addition rates chosen for the pilot-scale experiments replicated the 
mixing time scale conditions encountered in the USD flocculation experiments; 
the aim was to replicate the same flocculation conditions at both scales to isolate 
the effect that multi-layer depth filters have on filtration performance. Based on 
the USD flocculation methodology successfully validated at pilot scale with 
flocculated HCD mammalian cell centrate (see Chapter 5): (i) the PSDs obtained 
with 8.47 mL.min-1 (pilot) and 1 µL.s-1 (USD) (see Figure 6.2) were assumed to be 
6. Depth Filtration of Flocculated Mammalian Cell Culture Centrate 
 
 228 
 
identical at both scales at the same PEI concentration; (ii) the PSDs obtained with 
184 mL.min-1 (pilot) and 900 µL.s-1 (USD) (see Figure 6.2) were assumed to be 
different at both scales at the same PEI concentration; (iii) the PSDs generated at 
pilot scale with 8.47 mL.min-1 and 184 mL.min-1 were assumed to be different.  
Normal flow depth filtration was performed using a 23 cm2 positively charged, 
multi-layer depth filter (refer to Section 6.2.3 for the details) operated at a 
constant flux of 100 L.m-2.h-1, as recommended by the manufacturer. Filter 
performance was assessed based on filter capacity, filtrate clarification 
(measured as filtrate OD600), impurity removal and product recovery (see     
Figure 6.1). Filter retention, also important to assess depth filtration 
performance (Yavorsky et al., 2003), was studied in Chapter 7 with flocculation 
and filtration conditions selected from this section.  
6.3.3.1. Multi-Layer Depth Filter Performance  
Figure 6.10 shows the evolution of pressure drop, filtrate OD600 and absorbance 
at 280 nm wavelength (Abs280) obtained with filtration throughput. These 
filtration curves were obtained with centrate flocculated at pilot scale using slow 
(Figure 6.10, top) and fast (Figure 6.10, bottom) flocculant addition rates. Filter 
capacity could not be calculated at any of the two flocculant addition rates studied 
since the pressure drop limit of 1.4 bar was never reached with the volume of 
flocculated material available. Instead, a constant ΔP around 0.10 bar was 
maintained during both filtration runs. A throughput value of 490 L.m-2 was 
obtained at the end of both filtration runs. Therefore, flocculant addition rate did 
not impact upon filtration performance at the conditions tested, although these 
experiments need to be repeated with larger process volumes to calculate filter 
capacity.  
The filtrate OD600 profile changed with flocculant addition rate (see Figure 6.10). 
Depth filters behave like adsorbent beds where filtrate quality initially is high 
until the media is saturated with adsorbed material (Yavorsky et al., 2003). After 
this point, known as breakthrough, the amount of particles in the filtrate 
increases. At fast flocculant addition rates (Figure 6.10, bottom), filtrate OD600 
gradually increased to 0.015 A.U. and remained constant around this value until 
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the end of the filtration run. No breakthrough was observed. The gradual initial 
increase in OD600 was due to filtrate dilution as a consequence of residual 
phosphate buffer present in the filter capsule (after wetting, flushing and blowing 
the filter) and the filtration system’s dead volume. At slow flocculant addition 
rates (Figure 6.10, top), filtrate OD600 quickly increased up to 0.030 A.U., after 
which OD600 gradually decreased and stabilised around 0.016 A.U.. A similar 
filtrate OD600 profile was obtained in Chapter 7 at identical flocculation and 
filtration conditions but with a different batch of HCD mammalian cell centrate 
(see Figure 7.6). It is possible the filter’s removal efficiency improved with 
filtration throughput due to previously retained particles acting as additional 
collectors for other particles (Zhu et al., 1996). This is known as filter ripening. 
Clarification improvement with filtration throughput was only encountered at 
slow flocculant addition rates, where a bimodal PSD with small flocculated 
particles was expected from the USD flocculation mimic (see Figure 6.2). It is 
possible the population of small particles initially flowed through the filter before 
acting as collectors for equally sized or bigger particles. Despite the initial 
increase in filtrate OD600 at slow flocculant addition rates, the pooled filtrate 
resulted in the same OD600 value at both flocculant addition rates when 
accounting for the standard deviation of one (see Table 6.3). Finally, the 
combination of flocculation and multi-layer depth filtration reduced the centrate 
OD600 between 40 and 60 times (see Table 6.3). 
The filtrate Abs280 values obtained at fast flocculant addition rates were 70 % 
larger than those achieved at slow addition rates (see Figure 6.10). Since Abs280 
was monitored in-line with un-diluted samples, the large difference observed was 
not considered to be proportional to the protein content in the filtrate. Analytical 
measurements confirmed the total protein content was very similar in both 
filtration runs (see Table 6.3). The table also shows flocculation reduced the total 
protein content in the centrate between 16 and 23 %, with slightly larger 
decrements obtained at slow flocculant addition rates. Such decrease in protein 
content could be attributed to HCP reduction as product concentration remained 
constant during flocculation (see Table 6.3). Depth filtration further reduced the 
total protein content by 17 to 25 % thanks to its adsorptive properties. This 
additional decrease could also be attributed to HCP removal, although some 
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product loss occurred (see Table 6.3). Finally, flocculation reduced the DNA 
content present in the centrate by more than 99.9 % (see Table 6.3). Flocculant 
addition rate did not impact upon DNA removal. The positively charged depth 
filter also assisted in DNA removal by lowering the DNA content by 4.5 fold (see 
Table 6.3).  
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 6.10. Laboratory scale, multi-layer constant flux depth filtration of 
flocculated mammalian cell centrate.   
A set volume of 1.5 L of HCD mammalian cell (peak cell count = 29.0x106 cells.mL-1) 
centrate (Q/Σ = 2.85x10-8 m.s-1) were flocculated at pilot scale to a final 
0.15 % w/v PEI concentration using slow and fast flocculant addition rates 
(8.47 mL.min-1 and 184 mL.min-1, respectively) (refer to Section 2.3.1 for the vessel 
configuration and Section 2.7.1 for the detailed flocculation methodology). After 10 
minutes of floc maturation, the flocculated feed was depth filtered at a constant flux 
of 100 L.m-2.h-1 using a 23 cm2 Clarisolve® 40MS (Millipore) filter capsule. Filtration 
was performed and monitored with an ÄKTAcrossflow system (GE Healthcare) (see 
Section 2.8.2 for the detailed filtration methodology). Filtrate was manually 
collected in 10 mL fractions. Filtrate OD600 values were measured every 20 mL of 
filtrate with a spectrophotometer as described in Section 2.11.1.   
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Table 6.3. Clarification, impurity removal and product recovery achieved 
with multi-layer, constant flux depth filtration of flocculated feed at 
laboratory scale.  
Clarification was measured in terms of filtrate OD600. Optical density measurements 
were taken using a spectrophotometer (see Section 2.11.1) and within 10 minutes 
of completing the filtration step; centrate values correspond to defrosted 
supernatant. Impurity removal and product recovery were expressed as percentage 
yield relative to the HCD mammalian cell centrate. Concentrations for yield 
calculations were determined as follows: total protein (Pierce™ BCA protein assay, 
Thermo Scientific) (see Section 2.10.1), DNA (Quant-iT™ PicoGreen®, Thermo 
Scientific) (see Section 2.10.3) and mAb (protein G HPLC) (see Section 2.10.2). 
Standard deviations correspond to 3x (OD600) and 6x (total protein, DNA and mAb) 
measurements where n = 1. 
 
 
Sample OD600 (A.U.) 
Total 
protein (%) 
DNA (%) mAb (%) 
Centrate 0.804 ± 0.001 100 100 100 
8
.4
7
 m
L
.m
in
-1
 
Flocculated N/A 77.1 ± 2.63 0.079 ± 0.004 96.0 ± 6.51 
Filtered  0.019 ± 0.005 59.7 ± 2.15 0.018 ± 0.002 90.0 ± 3.90 
1
8
4
 m
L
.m
in
-1
 
Flocculated N/A 84.0 ± 1.02 0.082 ± 0.001 95.2 ± 7.19 
Filtered  0.014 ± 0.004 59.5 ± 2.39 0.018 ± 0.001 87.4 ± 4.83 
 
6.3.3.2. Evaluation of Multi-Layer Depth Filters 
Depth filtration of HCD mammalian flocculated feeds achieved larger throughput 
values when performed at laboratory scale using multi-layer depth filters than 
when carried out at USD scale with single-layer depth filters (as predicted by the 
𝑉𝑚𝑎𝑥
∗  method). The laboratory-scale filtration throughput values were between 
4.3 and 33 times larger than those observed at USD scale. Moreover, larger 
throughput values could be expected at laboratory scale since the maximum filter 
pressure drop was not achieved during the filtration runs (see Figure 6.10). The 
superior performance of multi-layer depth filters (laboratory scale), when 
compared to single-layer depth filters (USD scale), could be attributed to a full 
utilisation of the depth filter. That is, entrapment and/or adsorption of particles 
of a wide size range inside the filter thanks to the multiple layers of gradually 
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tighter media. Furthermore, the filtrate clarification achieved at laboratory scale 
with multi-layer depth filters was up to 6.3 times higher than those obtained with 
single-layer USD constant pressure depth filtration; nonetheless, the extent of the 
clarification improvement depended upon the flocculant addition rate and 
filtration pressure drop used at USD scale. Notwithstanding, the superior 
filtration performance observed at laboratory scale could also be attributed to 
the use of constant flux filtration mode; constant flux filtration has been 
described to gradually load the filter thus avoiding the high initial feed flow rates 
characteristic of constant pressure filtration that cause premature clogging (Liu 
et al., 2010; Yavorsky et al., 2003).  
Total protein, DNA and mAb content were not quantified at USD scale, so no 
comparison was provided for the laboratory-scale experiments. Total protein 
and DNA measurements showed the filtration conditions chosen at laboratory 
scale exploited the adsorptive properties of the multi-layer depth filter to assist 
in the removal of impurities. However, product recovery at laboratory scale was, 
on average, equal to 89 % due to volumetric losses. The optimisation of the 
flocculation and filtration conditions could offer greater impurity removal and 
higher product recovery yields.  
6.4. Conclusions 
This chapter presented the process interaction between flocculation and depth 
filtration studied at USD and laboratory scale. A summary of the key findings, 
based upon the chapter aims and objectives is as follows:   
1. Assess the use of USD flocculation and USD constant pressure depth filtration 
to investigate how flocculation performance affects depth filtration 
performance.  
Ultra scale-down flocculation and ultra scale-down contant pressure depth 
filtration offered the potential to be integrated in the same robotic liquid handling 
platform for complete process automation and high-throughput analysis. Process 
interaction between flocculation and depth filtration unit operations was studied 
with small volumes of process-relevant material, which was available in limited 
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quantities. Flocculant concentration, flocculant addition rate and filtration 
pressure drop impacted upon depth filtration performance, which was assessed 
via filter capacity and filtrate clarification measurements; the effect on step yield 
and impurity removal was not assessed at USD scale. Single-layer depth filters 
showed to be insufficient to cope with the large solid volumes present in the 
flocculated feeds and the HCD mammalian cell centrate tested. Rapid filter fouling 
rates were obtained when processing the flocculated HCD mammalian cell 
centrate, thus limiting data acquisition to few points and consequently hindering 
the identification of the filter’s fouling behaviour. The design of the USD constant 
pressure filtration device only allowed the use of single-layer filters. Therefore, 
to investigate if depth filtration performance could be improved with multi-layer 
depth filters, experiments had to be performed at laboratory scale.  
2. Assess the suitability of multi-layer depth filters to clarify polydisperse 
flocculated streams.  
The structure of multi-layer depth filters when operated in constant flux mode 
offered high filtration throughputs and clarification performance during the 
flocculation of HCD mammalian cell centrate at laboratory scale. Multi-layer 
depth filters also provided a robust filtration performance against changes in the 
flocculant addition rate. However, more studies with larger volumes of 
flocculated material are necessary before concluding so. Laboratory-scale 
experiments offered a larger data, set but at the expense of high-throughput 
capability and sample volume consumption. To characterise process interaction 
between two or more unit operations many variables need to be evaluated hence 
demanding high-throughput and low volume requirements. Therefore, the 
development of a USD filtration methodology to accommodate multi-layer filters 
is of interest.   
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7. Laboratory-Scale Comparison of 
Non-Treated vs. Flocculated Mammalian 
Cell Culture Processes 
7.1. Introduction and Aims 
Flocculation was introduced as part of the primary recovery step in the 
production of a monoclonal antibody (mAb) by a high cell density (HCD) 
mammalian cell line. This unit operation was included after centrifugation to 
reduce the high impurity levels and particulate content of the centrate. The aim 
was to enhance the performance of the subsequent depth filtration step and 
minimise the precipitation of process-related impurities during the low pH 
elution step of protein A chromatography. The fit of flocculation within the mAb 
production process had to be assessed before its implementation. In order to 
investigate this, the newly suggested primary recovery strategy (centrifugation – 
flocculation – depth filtration) was compared to a platform primary recovery 
strategy for mAbs (centrifugation – depth filtration – depth filtration). The 
comparison study extended into the protein A affinity chromatography step. The 
assessment was made at laboratory scale by comparing filter capacity and filter 
retention, product recovery and impurity removal achieved after each unit 
operation. Furthermore, the impact of flocculation upon the purification process 
was also included in the feasibility assessment.   
Summary of the chapter’s aims and objectives:  
1. Assess at laboratory scale the effect of introducing a flocculation step after 
centrifugation upon the performance of the primary recovery and capture 
chromatography processes.  
2. Evaluate at laboratory scale the possibility of replacing the mAb platform 
primary recovery strategy (i.e. centrifugation followed by two depth 
filtration stages) by the flocculated primary recovery strategy 
(i.e. centrifugation followed by flocculation and depth filtration).  
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7.2. Experimental Set-Up 
A schematic diagram of the experimental set-up is shown in Figure 7.1. The 
details of the studies performed are described below.  
7.2.1. Mammalian Cell Culture Preparation  
High cell density mammalian cell centrate was prepared and stored as described 
in Section 2.1.2. Centrate was defrosted at room temperature prior to use.  
7.2.2. Non-Treated Process Stream 
A volume of 1.50 L of HCD mammalian cell culture centrate was filtered at a 
constant flux of 130 L.m-2.h-1. Depth filtration was performed in two stages using 
a dual-layer ZetaPlus™ BC25 capsule of 25 cm2 filter area in each stage. In the first 
depth filtration stage a 60ZA05A (3 - 0.30 μm) filter grade was used. The second 
filtration stage used a 90ZA05A (3 - 0.20 μm) depth filter grade (see Figure 7.1). 
After the second filtration stage, the filtrate was stored at +4°C for less than 10 
hours. Once room temperature was reached, the material was filtered through a 
17.3 cm2 sterilising grade filter (SartoScale Disposable Sartopore® 2 
0.45/0.2 μm) operated at a constant flux of 130 L.m-2.h-1 (see Figure 7.1). The 
filtrate was then stored at -80°C for further affinity chromatography processing. 
Samples of 10 mL volume from each unit operation were stored at -20°C prior to 
analysis. The filter grades were chosen based upon Lonza Biologics’ 
manufacturing experience. The flux values were taken from the literature (Riske 
et al., 2007). Filter specifications and detailed methodology can be found in 
Section 2.8.2. Filter capacity was calculated as the filtration throughput obtained 
at a pressure drop (ΔP) of 1.4 bar (Kang et al., 2013; Riske et al., 2007; Yavorsky 
et al., 2003). Depth filter retention corresponded to the filter capacity of the 
sterilising grade filter.  
7.2.3. Flocculated Process Stream 
A volume of 1.50 L of HCD mammalian cell culture centrate was flocculated at 
pilot scale to a final 0.15 % w/v polyethylenimine (PEI) concentration and 
neutral pH by adding 75 mL of a 3 % w/v PEI stock solution at a constant addition 
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rate of 8.47 mL.min-1. See Section 2.3.1 for the detailed configuration of the 
flocculation system, and Section 2.7.1 for the flocculation methodology. The flocs 
were left to mature for 10 minutes before filtering 1.38 L through a 23 cm2, multi-
layer depth filter capsule (Clarisolve® 40MS μPod®) at a constant flux of 
100 L.m-2.h-1. The resultant filtrate was then stored at +4°C for less than 10 hours 
to be filtered at room temperature through a 17.3 cm2 sterilising grade filter 
(SartoScale Disposable Sartopore® 2 0.45/0.2 μm) at a constant flux of 
100 L.m-2.h-1 (see Figure 7.1). The resultant filtrate was stored at -80°C for further 
affinity chromatography studies. Samples of 10 mL volume from each unit 
operation were stored at -20°C prior to analysis. Depth filter grade was selected 
based on depth filtration results for flocculated mammalian cell broths published 
in the literature (Kang et al., 2013; Singh et al., 2013); flux value was chosen based 
upon the manufacturer’s recommendations. Filter specifications and detailed 
methodology are described in Section 2.8.2. Filter capacity and filter retention 
were calculated as described in Section 7.2.2.  
7.2.4. Affinity Chromatography Using Protein A 
The filtrates obtained from sterile filtration in the non-treated and flocculated 
process streams were defrosted at room temperature prior to use. A volume of 
20 mL from the non-treated and flocculated samples was loaded onto an 
equilibrated 4.7 mL MabSelect SuRe column (10 cm bed height) with a loading 
capacity of 30 mg.mL-1 (see Figure 7.1). At the end of each run, the 2 mL eluate 
fractions were adjusted to pH 7.0 using 2.0 M Tris base. In the non-treated stream, 
2 column volumes (CVs) of pH 2.1 buffer were used to strip the column; six CVs 
were used in the flocculated stream with the aim to strip any remaining PEI off 
the column. Flow-through, elution and strip fractions were stored at -20°C for 
subsequent analysis. Refer to Section 2.9 for details of the column, protocol and 
equipment used. 
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Figure 7.1. Schematic diagram of the flocculated and non-treated mAb 
production primary recovery strategies.  
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7.3. Results and Discussion 
7.3.1. Filtration of Non-Treated Mammalian Cell Centrate 
Centrifugation coupled with depth filtration is the industry’s standard for 
primary recovery, particularly with increasingly high cell density cultures (Roush 
and Lu, 2008; Shukla et al., 2007). The non-treated primary recovery strategy 
studied in this chapter consisted of a disc-stack centrifuge (primary clarification) 
followed by a two-stage depth filtration step (secondary clarification) and a 
sterilising grade filter; this primary recovery strategy was used as a benchmark 
for the flocculated process stream (Section 7.3.2). The HCD mammalian cell 
centrate was provided by Lonza Biologics to obtain a representative 
production-scale centrate feedstock. Two depth filtration stages were used to 
remove the significant amounts of debris present in the post-centrifuge centrate 
(Low et al., 2007; Shukla et al., 2007). One or more depth filters can be used 
during secondary clarification (Dave et al., 2009; Yavorsky et al., 2003). Multiple 
depth filtration optimises solid removal with each successive filter progressively 
removing smaller particles. In the non-treated primary recovery strategy, a 
loose-grade depth filter was used followed by a tighter-grade media to prevent 
the premature blockage of the relatively expensive final sterilising grade filter 
(van Reis and Zydney, 2007; Yavorsky et al., 2003). In turn, the sterilising grade 
filter was used after depth filtration to remove any residual particulates that may 
clog the subsequent affinity capture chromatography step, although it is also used 
to reduce adventitious microbes during production (Shukla and Kandula, 2008).  
The study of centrifugation performance was out of the scope of this chapter and 
was not analysed. Each filtration step was studied individually with the aim to 
find the limiting step and offer some insight into the filtration fouling mechanisms 
involved.  
7.3.1.1. First Depth Filtration Stage 
Figure 7.2 shows the evolution of ΔP, filtrate optical density measured at 600 nm 
wavelength (OD600) and absorbance at 280 nm (Abs280) with filtration 
throughput when using the 60ZA05A dual-layer depth filter media. Pressure drop 
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gradually rose with increasing filtration throughput values. A maximum ΔP of 
2.3 bar was reached at filtration throughputs of 540 L.m-2. But filter capacity, 
which was calculated as the filtration throughput obtained at a maximum ΔP of 
1.4 bar, was equal to 461 L.m-2. A change in the slope of the ΔP curve between 180 
and 200 L.m-2 was observed, possibly indicating a transition in the fouling 
mechanism. The experimental data was transformed and fitted with the four 
different constant flux filtration models (i.e. pore blockage, intermediate 
blockage, pore constriction and cake filtration) (see Table 2.7 in Section 2.8.2). 
The entire data set fitted poorly with any of the filtration models studied 
(R2 ≤ 0.878). However, more success was obtained when splitting the data in two 
sets. Filtration throughputs < 180 L.m-2 best fitted the cake filtration model 
(R2 = 0.985; P < 0.01), while pore constriction was the best fit for filtration 
throughputs > 200 L.m-2 (R2 = 0.973; P < 0.01). This observation was supported 
by previous reports in the literature that indicate a single filtration mechanism is 
unlikely during a filtration run (van Reis and Zydney, 2007). A combination 
between cake filtration and pore constriction fouling mechanisms might have 
happened. Freeze-thawing the centrate used in the filtration experiments could 
have resulted in the formation of large particles formed by the submicron 
particles present in it, as observed with another batch of HCD mammalian cell 
centrate (see Figure 11.2 in Section 11.1.2). It is possible that during the 
freeze-thawing process, particles with diameters bigger than the 3 - 0.30 µm filter 
retention range were formed. These solids, unable to penetrate deep into the 
depth filter, would have gradually generated a cake layer on the filter surface. 
After the formation of this layer, the smaller particles could have clogged the 
porous cake thus translating into a pore constriction fouling mechanism. Another 
possibility is that the structure of the cake was very porous and allowed small 
particulates to flow through the cake and into the depth filter, which was 
ultimately clogged via pore constriction.  
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Figure 7.2. Performance of the first constant flux depth filtration stage from 
the non-treated primary recovery strategy.   
A volume of 1.50 L of HCD mammalian cell culture centrate was further clarified 
using a 25 cm2 ZetaPlus™ BC25 capsule with 60ZA05A (3 - 0.30 μm) filter grade (3M 
Purification Inc.). Filtration was performed at a constant flux of 130 L.m-2.h-1 and 
at room temperature. Filtrate was manually collected in 10 mL fractions but the 
first five fractions were later discarded to avoid filtrate dilution in the subsequent 
processing steps. Filtration was performed with an ÄKTAcrossflow system (GE 
Healthcare), which also monitored pressure drop (refer to Section 2.8.2 for the 
detailed filtration methodology). Filtrate OD600 and Abs280 were manually 
measured every 20 mL of filtrate with a spectrophotometer (see Section 2.11.1).   
 
The evolution of clarification performance during the filtration run was 
monitored off-line with OD600 measurements. No solids breakthrough occurred 
during filtration despite reaching feed pressures close to the maximum specified 
by the manufacturer (see Figure 7.2). Therefore, either the filter media was not 
saturated with particulates, or a cake layer formed on the filter surface acted as a 
pre-filter. After an initial increment in OD600 from 0.000 to 0.017 A.U., the OD600 
gradually decreased to 0.015 A.U. with increasing filtration throughputs. The 
inherent filtrate dilution caused by the residual phosphate buffer present in the 
filter capsule (after wetting, flushing and blowing the filter) and the filtration 
system’s dead volume, explained the initial OD600 increase. The following 
reduction in OD600 suggested the existence of a cake layer or the occurrence of 
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filter ripening. If a cake layer was formed, small particles initially penetrated 
through the filter. As filtration advanced and the cake layer became thicker, the 
small particles became trapped in it thus acting as a pre-filter. Similar 
observations are reported in the literature (Sorensen et al., 1995). If filter 
ripening occurred instead, the particles adsorbed and/or trapped in the filter 
became additional collectors for other particles hence improving solids retention 
(Zhu et al., 1996). Finally, Abs280 remained constant throughout the filtration run 
at 3.7 A.U. (see Figure 7.2). 
7.3.1.2. Second Depth Filtration Stage 
The filtration conditions employed in the second depth filtration stage (90ZA05A 
dual-layer depth filter media) were the same as those used in the first depth 
filtration stage (60ZA05A dual-layer depth filter media) (see Figure 7.1).        
Figure 7.3 shows the ΔP, filtrate OD600 and Abs280 profiles obtained with 
increasing filtration throughput values with the 90ZA05A dual-layer depth filter 
media. Pressure drop had only increased by 0.08 bar when the feed material was 
totally exhausted at a filtration throughput of 445 L.m-2 (see Figure 7.3). 
Therefore, filter capacity, which was calculated as the filtration throughput 
obtained at a maximum ΔP of 1.4 bar, could not be determined. In addition to this, 
the small increase in ΔP indicated that only a reduced amount of solids was 
retained in the filter media. Also, the filter fouling mechanism could not be 
identified. Filtrate OD600 gradually increased but did not reach a constant value 
until filtration throughputs of 230 L.m-2 were achieved (see Figure 7.3). The filter 
achieved a reduction in OD600 of 0.001 A.U. with respect to the feed material 
(i.e. filtrate from the first depth filtration stage), hence corroborating the 
hypothesis of low solids retention drawn from the ΔP results. Filtrate Abs280 
remained constant across the two depth filtration stages thus implying no protein 
retention (see Figure 7.2 and Figure 7.3). The data suggested an inefficient 
utilisation of the filter media chosen. A tighter filter grade should be employed in 
future studies. 
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Figure 7.3. Performance of the second constant flux depth filtration stage 
from the non-treated primary recovery strategy.  
The pooled fractions obtained from the first depth filtration stage (Figure 7.2) were 
immediately filtered at room temperature using a 25 cm2 ZetaPlus™ BC25 capsule 
with 90ZA05A (3 - 0.20 μm) filter grade (3M Purification Inc.). Filtration was 
performed at a constant flux of 130 L.m-2.h-1. Fractions of 10 mL volume were 
manually collected to monitor the filtrate OD600 and Abs280. The first five filtrate 
fractions were discarded to avoid feed dilution in the subsequent process steps. The 
resultant filtrate volume was pooled and stored at +4°C for < 10 hours before the 
subsequent sterile filtration step. Filtration was performed and monitored as 
described in Figure 7.2.   
 
7.3.1.3. Sterile Filtration 
Sterile filtration was stopped when ΔP reached 3 bar (see Figure 7.4). The 
resultant filter capacity, which was measured at a maximum ΔP of 1.4 bar, was 
equal to 527 L.m-2. Pressure drop data was transformed and fitted with the four 
constant flux filtration models (i.e. pore blockage, intermediate blockage, pore 
constriction and cake filtration) (see Table 2.7 in Section 2.8.2). The results 
suggested sterile filtration was governed by a pore constriction fouling 
mechanism (R2 = 0.985; P < 0.01). That is, fouling occurred within the membrane 
by small particles gradually reducing its effective pore size (van Reis and Zydney, 
2007).  
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Filtrate clarification was maintained constant throughout the filtration run with 
a filtrate OD600 value of 0.013 A.U. (see Figure 7.4). Sterile filtration only achieved 
a reduction in filtrate OD600 of 0.001 A.U.. Therefore, clarification did not improve 
despite the ΔP data suggesting that there was particle retention. These results 
confirmed, as it is reported in the literature (Arnold, 2005), that it is very 
important to measure the evolution of ΔP during the filtration run as well as the 
difference in turbidity or OD600 between the feed material and the filtrate to 
assess filtration performance. Finally, Abs280 was constant (see Figure 7.4) and 
equal to the two previous depth filtration stages (see Figure 7.2 and Figure 7.3), 
hence suggesting similar protein content.  
 
Figure 7.4. Performance of the sterile filtration step from the non-treated 
primary recovery strategy.  
After the two depth filtration stages (Figure 7.2 and Figure 7.3), the resultant 
material was filtered at room temperature using a sterilising grade filter (17.3 cm2 
SartoScale Disposable Sartopore® 2 0.45/0.2 μm, Sartorius). Filtration was 
performed at a constant flux of 130 L.m-2.h-1. Fractions of 10 mL volume were 
manually collected to monitor the filtrate OD600 and Abs280. The first five filtrate 
fractions were discarded to avoid feed dilution due to the presence of phosphate 
buffer in the dead volume of the filtration system used. The resultant filtrate volume 
was pooled and stored at -80°C for subsequent affinity chromatography processing. 
Filtration was performed and monitored as described in Figure 7.2.   
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7.3.2. Filtration of Flocculated Mammalian Cell Centrate 
The flocculation of HCD mammalian cell centrate generated a population of 
particles with a wide range of diameters (see Figure 7.5). The depth filter of 
choice had to be able to cope with the wide range of particle sizes and the solid 
content generated during flocculation. Flocculated feeds have traditionally been 
clarified via centrifugation (Chatel et al., 2014; Habib et al., 1997; Low et al., 2007; 
Riske et al., 2007) and microfiltration (Aspelund et al., 2008; Karim et al., 2008; 
Kim et al., 2001; Wickramasinghe et al., 2002, 2004). Nonetheless, the use of 
normal flow depth filtration has also been reported (Buyel and Fischer, 2014; 
Kang et al., 2013; Singh et al., 2013).  
Centrifugation followed by flocculation and a single depth filtration step was the 
strategy chosen (see Figure 7.1) because the approach was to develop a 
clarification process that would fit in the non-treated centrifugation-depth 
filtration strategy without the addition of any further centrifugation or filtration 
unit operations. Clarification of the flocculated feed was also chosen to be 
performed via depth filtration because of the lower investment and more flexible 
nature of this unit operation when compared to centrifugation (Peram et al., 
2010). Furthermore, flocculated solids have been reported to stick to the walls of 
the centrifuge thus requiring the optimisation of the centrifuge cleaning process 
(Peram et al., 2010). The selection of filter media, flocculation and filtration 
operating conditions were explored in Chapter 6. Chapter 7 studies the process 
performance achieved and its impact upon the subsequent sterile filtration and 
capture affinity chromatography steps.   
7.3.2.1. Flocculation 
Flocculation was performed at a slow flocculant addition rate (8.47 mL.min-1) to 
guarantee the predominance of the micromixing time scale in the flocculation 
vessel, which would allow the successful scale-up and scale-down of the process 
(see Chapter 4 and Chapter 5). The particle size distribution (PSD) of the flocs 
generated is shown in Figure 7.5. A monomodal distribution with particle 
diameters between 26 and 268 μm was obtained; the peak in percentage volume 
frequency occurred between 40 and 100 μm.  
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Figure 7.5. Particle size distribution of the flocculated mammalian cell 
centrate.   
A volume of 1.50 L of HCD mammalian cell culture (peak cell 
count = 46.6x106 cells.mL-1) centrate (Q/Σ = 2.85x10-8 m.s-1) was flocculated with 
PEI added at 8.47 mL.min-1 to a final concentration of 0.15 % w/v. Refer to 
Section 2.3.1 for the vessel configuration and Section 2.7.1 for the detailed 
flocculation methodology. After 10 minutes of floc maturation, the PSD of the 
flocculated material was measured as described in Section 2.11.4. Error bars 
represent standard deviation of six repeated measurements of the same experiment 
(n = 1). 
 
7.3.2.2. Depth Filtration 
A multi-layer depth filter devised for the filtration of flocculated particles with a 
mean size of 40 μm was used (see Section 7.2.3 for the depth filter details). The 
resultant ΔP, filtrate OD600 and Abs280 profiles are plotted in Figure 7.6. Pressure 
drop gradually increased with filtration throughput, although many fluctuations 
occurred during the run. Under constant flux conditions, fluctuations in ΔP have 
been reported to originate from the re-deposit of particle clusters created in the 
filter media (Burganos et al., 2001; Dave et al., 2009). These particle formations 
breach after a critical fouling point and re-deposit themselves within the filter. 
These events cause changes in the filter permeability and measurable flow 
re-distributions during the filtration run (Burganos et al., 2001).  
The ΔP data obtained from the depth filtration run with flocculated material was 
transformed and fitted with the four different constant flux filtration models 
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(i.e. pore blockage, intermediate blockage, pore constriction and cake filtration) 
(see Table 2.7 in Section 2.8.2). The results suggested filtration was governed by 
a pore constriction fouling mechanism (R2 = 0.963; P < 0.01), where particles 
gradually clogged the different media layers by reducing their effective pore size 
(van Reis and Zydney, 2007). Filter capacity could not be determined since the 
maximum ΔP of 1.4 bar was not reached during experimentation; the flocculated 
material was exhausted at a filtration throughput of 596 L.m-2 when ΔP was equal 
to 0.73 bar. Based upon the pore constriction fouling mechanism, filter capacity 
was projected to be 710 L.m-2. Nonetheless, this value can only be considered as 
an estimation of filter capacity at the conditions tested.  
 
Figure 7.6. Performance of the constant flux depth filtration step from the 
flocculated primary recovery strategy.  
A volume of 1.38 L of flocculated HCD mammalian cell centrate (see Figure 7.5) was 
filtered via normal flow depth filtration at a constant flux of 100 L.m-2.h-1 and at 
room temperature using a 23 cm2 Clarisolve® 40MS (Millipore) filter capsule. 
Filtrate was manually collected in 10 mL fractions but the first five fractions were 
discarded to avoid feed dilution. The resultant filtrate volume was pooled and 
stored at +4°C for < 10 hours for subsequent sterile filtration. Filtration was 
performed and monitored as described in Figure 7.2.   
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The filtrate clarification achieved with the multi-layer depth filter improved with 
higher filtration throughputs (see Figure 7.6). Filtrate OD600 rapidly increased to 
0.046 A.U. at the beginning of the filtration run, but decreased to 0.012 A.U. with 
higher filtration throughputs (see Figure 7.6). This clarification profile was also 
observed in Section 6.3.3 when using the same operating conditions with a 
different batch of flocculated HCD mammalian cell centrate. Filter ripening, 
where particulates trapped in the filter retain additional particles hence 
improving clarification (Zhu et al., 1996), could have occurred. Finally, Abs280 was 
maintained constant and equal to 3.6 A.U. throughout the filtration run (see 
Figure 7.6).  
7.3.2.3. Sterile Filtration 
The ΔP, filtrate OD600 and Abs280 profiles obtained with the sterile filtration step 
from the flocculated primary recovery strategy are plotted in Figure 7.7. Pressure 
drop rapidly increased to 3 bar during sterile filtration (see Figure 7.7). Filter 
capacity, which was calculated at a maximum ΔP of 1.4 bar, was determined to be 
75.4 L.m-2. Pressure drop fluctuations were observed at filtration throughputs 
exceeding 70 L.m-2 (see Figure 7.7). The ΔP data was transformed and fitted with 
the four different constant flux filtration models (i.e. pore blockage, intermediate 
blockage, pore constriction and cake filtration) (see Table 2.7 in Section 2.8.2) to 
elucidate the fouling mechanism governing the filtration run. The best fit was 
obtained with the cake filtration model (R2 = 0.902; P < 0.01). The transformed 
data showed a change in the slope of the regression line at filtration throughputs 
around 36 L.m-2. This observation suggested the formation of a cake layer on the 
filter surface with a noticeable change in the permeability of the cake around 
36 L.m-2. These results indicated the presence of large particles in the feed 
material.  
The OD600 measurements showed an initial sudden increase in OD600 to 0.058 A.U. 
followed by a gradual decline and stabilisation around 0.014 A.U. (see Figure 7.7). 
The gradual clarification improvement with larger filtration throughput values 
suggested the formation of a cake layer on the filter surface; while some large 
particles passed initially through the filter, those retained gradually built up a 
cake layer that acted as a pre-filter. Filtrate Abs280 remained constant throughout 
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the run around values of 3.6 A.U. (see Figure 7.7), hence indicating no change in 
the protein content with respect to the previous depth filtration step.  
 
Figure 7.7. Performance of the sterile filtration step from the flocculated 
primary recovery strategy.  
The pooled filtrate obtained from the normal flow depth filtration step (Figure 7.6) 
was further clarified at room temperature with a sterilising grade filter (17.3 cm2 
Sartopore® 2 0.45/0.2 μm, Sartorius) operated at a constant flux of 100 L.m-2.h-1. 
Filtrate was manually collected in 10 mL fractions. The first five fractions were 
discarded to avoid filtrate dilution due to the presence of phosphate buffer in the 
dead volume of the filtration system used. The remaining filtrate was then pooled 
and stored at -80°C for subsequent chromatography processing. Filtration was 
performed and monitored as described in Figure 7.2.   
 
Sterile filtration was repeated three times with the same feed material (i.e. filtrate 
from the previous multi-layer depth filtration step). The ΔP profiles obtained 
from each run are plotted in Figure 7.8. Filter capacity, which was calculated at a 
maximum ΔP of 1.4 bar, decreased from 75.4 L.m-2 (first run) to 47.7 L.m-2 
(second run) and 31.7 L.m-2 (third run) (see Figure 7.8); therefore, filter capacity 
was reduced 2.4 fold between the first and the third sterile filtration run. The feed 
material was filtered at room temperature within a period of < 3 hours, and no 
more than 90 minutes passed between the completion of two consecutive runs. 
During this time flocculation could have continued due to the presence of residual 
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PEI in the feed material. The results shown in Figure 7.8 manifested the need to 
further optimise flocculant concentration and mixing time during floc maturation 
if flocculation is to be performed in similar HCD mammalian cell cultures. The 
development of an analytical assay to quantify the presence of residual PEI in 
clarified flocculated feeds is also of interest to optimise PEI concentration during 
flocculation.  
 
Figure 7.8. Change in the performance of the sterile filtration step from the 
flocculated primary recovery strategy.  
Three different sterile filtration runs (— 1st run, ···· 2nd run, -- -- 3rd run) were 
performed with the filtrate obtained from the previous depth filtration step 
(see Figure 7.6). The feed material was filtered at the same conditions described in 
Figure 7.7 and within a period of < 3 hours. Each run was completed within 
90 minutes of completing the previous sterile filtration run. Filtration was 
performed and monitored as described in Figure 7.2.   
 
7.3.3. Depth and Sterile Filtration Comparison between the Non-
Treated and Flocculated Strategies 
The depth filters used to process the non-treated centrate were 2 cm2 larger than 
the ones used to filter the flocculated centrate. To account for this difference, the 
ratio of volume loaded to filter area was kept constant. Nonetheless, this was only 
achieved during the first depth filtration stage of the non-treated stream; filtrate 
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volume was lost for priming and sampling during the subsequent second depth 
filtration and sterile filtration stages. The number of layers in the depth filters 
used during the non-treated strategy (dual-layer filters) were also different to 
those used in the flocculated strategy (8-layer filters). Since the thickness of each 
filter layer was not provided by the manufacturers, the volume of feed material 
loaded onto the filter could not be normalised by the volume of depth filter. 
Normalising by filter volume instead of by filter area allows the evaluation of 
filter media utilisation. Examples of this approach can be found in the literature 
(Singh et al., 2013).  
The flocculated stream achieved a depth filter capacity 30 % higher than the 
non-treated stream (see Table 7.1); the second depth filtration stage of the 
non-treated stream was not considered in this calculation since pressure drop 
only increased by 0.08 bar thus suggesting a tighter filter media was necessary 
for the process studied. Larger differences in depth filter capacity can be expected 
between both primary clarification strategies since a filter capacity of 710 L.m-2 
was projected for the flocculated stream by the pore constriction fouling model 
(see Section 7.3.2). Nonetheless, this projected value must be considered an 
estimate as filtration throughput should not be predicted from mechanical 
fouling only; the exhaustion of the filter’s adsorptive capacity (i.e. breakthrough), 
which must be tested explicitly, should be accounted for as well (Dave et al., 
2009). Furthermore, more optimisation experiments are needed before a 
quantitative comparison between both primary recovery strategies can be made.  
Sterile filtration indirectly described the capacity of the previous depth filtration 
steps to retain small particulates and other impurities. That is, filter retention. 
However, filter retention could not be accurately determined for the flocculated 
stream; flocculation continued taking place after floc removal by depth filtration 
possibly due to residual PEI still present in the filtrate (see Section 7.3.2). The 
flocculation conditions chosen led to a sterile filtration capacity seven times 
smaller in the flocculated strategy than in the non-treated strategy (see             
Table 7.1).  
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Table 7.1. Depth and sterile filter capacities experimentally calculated with 
the non-treated and flocculated primary recovery strategies.  
 
 Non-treated Flocculated 
Throughput‡ (L.m-2) ΔP (bar) Throughput‡ (L.m-2) ΔP (bar) 
Depth 
filtration† 
461 1.4 596 0.73 
Sterile 
filtration 
527 1.4 75.4 1.4 
† First depth filtration step. 
‡ Filtration throughput at the specified ΔP. 
 
7.3.4. Affinity Capture Chromatography  
Protein A chromatography was chosen as the first affinity capture step for  its 
high selectivity for mAbs and capacity to extensively remove process-related 
impurities (e.g. host cell proteins (HCPs), DNA and cell culture media 
components) (Liu et al., 2010; Shukla and Thömmes, 2010). After the loading 
step, a neutral pH washing step (50 mM sodium phosphate, 250 mM sodium 
chloride, pH 7.0), referred to as Wash 1, was used to wash unbound HCPs and 
other impurities off the column (Shukla et al., 2007). Two more washes were 
added to improve HCP clearance (Liu et al., 2010; Shukla and Hinckley, 2008). 
The first one (Wash 2) was a high salt wash (50 mM sodium phosphate, 2.0 
M sodium chloride, pH 7.0). The second one (Wash 3) used the same Wash 1 
buffer to re-establish the neutral pH and ionic strength conditions before the 
elution step. Elution was performed at low pH conditions (10 mM sodium 
formate, pH 3.5). Finally, the column was stripped with an acidic buffer (100 mM 
citric acid, pH 2.1) and regenerated with 0.1 M sodium hydroxide. Figure 7.9 
describes the evolution of Abs280 during the different chromatographic steps. 
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Figure 7.9. Chromatograms obtained with the non-treated and flocculated 
primary recovery strategies. 
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During the loading step most of the impurities flowed through the column, 
signalled by the elevated absorbance reading at 280 nm wavelength obtained in 
both the non-treated and flocculated runs (see Figure 7.9). Wash 1 reduced the 
absorbance practically to baseline in both chromatography runs. The 
flow-through signal of the flocculated run during the loading and Wash 1 steps 
was less intense and shorter than that of the non-treated run. Since Abs280 is used 
to continuously monitor the protein content eluted during chromatography 
(Noble and Bailey, 2009), the data suggested that a smaller amount of protein 
impurities were loaded onto the column during the flocculated run; it is also 
possible that the protein impurities present in the flocculated material eluted 
faster off the column as well. These results indicated that the flocculation and 
depth filtration steps from the flocculated strategy were able to remove 
impurities which may have a higher non-specific affinity for the product and/or 
the chromatographic resin (Shukla and Hinckley, 2008). This hypothesis was 
supported by the lower concentration of total protein, HCPs and DNA measured 
after flocculation (see Table 7.2), as well as the  findings reported by Hogwood 
and co-authors (2013b). In this article, the authors described that the primary 
recovery strategy significantly impacted upon the HCP profile and the abundance 
of particular proteins in the material fed into the chromatographic stages. A small 
increase in Abs280 was observed during Wash 2 but only in the non-treated run 
(see Figure 7.9), possibly due to the lower content in process-related impurities 
of the flocculated feed. Wash 3 did not result in any noticeable Abs280 peak in any 
of the chromatography runs (see Figure 7.9) as it was only included to remove 
the high salt content from Wash 2.  
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Table 7.2. Clarification and purification process performance comparison 
of the flocculated and non-treated primary recovery strategies.  
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The elution peaks of the non-treated and flocculated runs (Figure 7.9) differed in 
width but not in height. It is possible that the maximum signal detectable by the 
chromatographic system was reached and no differences in signal intensity were 
measurable. The larger peak width in the non-treated run (see Figure 7.9) 
described that the product took more CVs to elute than in the flocculated run. 
Also, the flocculated elution peak was sharper and more symmetrical than that of 
the non-treated peak (see Figure 7.9). The mAb results summarised in Table 7.2 
confirmed there was no difference in product yield between the non-treated and 
flocculated eluates. However, the HCP content in the non-treated eluate was 
larger than in the flocculated eluate (see Table 7.2). The greater protein content 
of the non-treated eluate would have led to differences in peak intensity, which 
could not be observed (see Figure 7.9) possibly due to the fact that the maximum 
signal intensity of the chromatographic system was reached.  
The low pH conditions used during the elution step often result in the 
precipitation of the product species and/or process-related impurities 
(e.g. HCPs) that have persisted protein A purification when followed by pH 
neutralisation (Gagnon et al., 2014; Kandula et al., 2009; Shpritzer et al., 2006; 
Shukla and Hinckley, 2008; Shukla and Thömmes, 2010; Shukla et al., 2005, 2007; 
Yigzaw et al., 2006). The solid particulates formed in consequence result in 
eluates with elevated turbidity that reduce the lifetime of the chromatographic 
column and pose filtration challenges post-protein A chromatography (Kandula 
et al., 2009; Shpritzer et al., 2006; Shukla et al., 2005; Yigzaw et al., 2006). Turbid 
elution fractions were obtained in the non-treated run (see Figure 7.10.). The 
mAb step yield values for chromatography were the same for both streams (see 
Table 7.2), hence suggesting the solid particulates observed in the non-treated 
eluate could have been HCP impurities; this hypothesis was later confirmed via 
the mass spectrometry studies discussed in Section 8.3.2. These results proved 
the use of feed pre-treatment methodologies such as flocculation during primary 
recovery can have a positive effect on the control of impurities as well as on 
process economics (e.g. longevity of the protein A chromatography column 
(Kandula et al., 2009; Shukla et al., 2005) and no need for a depth filtration step 
after protein A chromatography).  
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Figure 7.10. Turbidity differences in the chromatographic elution pool of 
the non-treated and flocculated primary recovery strategies.  
 
 
7.3.5. Clarification and Purification Performance Comparison 
between the Non-Treated and Flocculated Strategies 
The clarification performance of each unit operation was analysed via turbidity 
measurements. Purification was assessed in terms of total protein, mAb, HCP and 
DNA content. Mass balances were calculated to account for differences in the 
processed volume and were used to determine process yield; a starting yield of 
100 % was assumed for the HCD mammalian cell centrate. Results are 
summarised in Table 7.2.  
7.3.5.1. Turbidity 
The turbidity of the centrate was 320 ± 2.00 Nephelometric Turbidity Units 
(NTU) (see Table 7.2). As mentioned in Section 7.3.1, freeze-thawing the centrate 
could have generated larger solid particles formed by smaller ones coming 
together that resulted in increased turbidity values. Nonetheless, such high 
turbidity readings for centrifuged mammalian cell broths have been reported 
(McNerney et al., 2012). Flocculation reduced the turbidity of the centrate by 
41 fold (see Table 7.2). As discussed in Section 7.3.2, flocculation conditions were 
not optimal hence greater turbidity reductions might be achievable. After 
multi-layer depth filtration, turbidity had been decreased 62 times from the 
starting centrate turbidity (see Table 7.2). However, sterile filtration did not have 
NON-TREATED 
ELUTION POOL 
FLOCCULATED 
ELUTION POOL 
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any effect upon filtrate clarification. With regards to the non-treated process, the 
first dual-layer depth filter reduced the centrate turbidity by 22 fold (see          
Table 7.2). After a second dual-layer depth filtration stage and sterile filtration, 
turbidity was 40 times lower than the centrate turbidity (see Table 7.2). 
Nonetheless, a greater clarification performance could have been achieved had a 
tighter filter media being chosen for the second depth filtration stage (see 
Section 7.3.1).  
Both primary recovery strategies greatly improved centrate clarification. But 
turbidity reduction was mainly achieved by the first step of the primary recovery 
strategies studied. That is, by flocculation (flocculated strategy) and by the first 
dual-layer depth filtration stage (non-treated strategy). Depth and sterile 
filtration contributed to further remove the particulate content. At the end of 
primary recovery, the clarification performance achieved by both strategies were 
very similar since turbidity only differed by 2.88 NTU (see  Table 7.2). Although 
this result could change with the optimisation of flocculation and depth filtration 
unit operations.  
7.3.5.2. Total Protein, HCP and mAb Content 
The total protein concentration in the centrate was 16 g.L-1. Flocculation achieved 
a reduction in total protein content of 12 % (see Table 7.2). The mAb 
quantification data suggested there was no product loss during the flocculation 
step, but the HCP data showed a reduction in the HCP content of 42 % after 
flocculation (see Table 7.2). These results corroborated the reported ability of PEI 
to flocculate the HCPs present in centrifuged mammalian cell feedstocks at 
neutral pH conditions (Peram et al., 2010). With regards to the non-treated 
stream, the first depth filtration stage reduced the total protein content by 6.6 %, 
but according to the mAb data no product loss occurred (see Table 7.2). 
Therefore, protein reduction was attributed to HCP removal by the depth filter 
adsorptive properties (Yigzaw et al., 2006). Total protein content continued to 
gradually decrease with depth and sterile filtration in both primary recovery 
strategies (see Table 7.2). Yet it was affinity chromatography the unit operation 
that led to the highest reduction in total protein content, with 41 % decrease in 
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the flocculated process and 54 % in the non-treated process with respect to the 
previous unit operation (see Table 7.2).   
Capture protein A chromatography was the purification workhorse of the 
non-treated process for reducing the centrate HCP content by 99.9 % (see       
Table 7.2). The HCP concentration of the non-treated eluate was 
2.55x106 pg.mL-1. This value was in accordance with the HCP concentration in the 
protein A chromatography eluate reported by Hogwood and co-authors (2013b), 
where the primary recovery strategy chosen for a mAb process was disc-stack 
centrifugation followed by depth filtration. However, it is possible that the HCP 
content was higher than the reported by the immunoassay considering there was 
a large fraction of precipitated proteins (see Figure 7.10. and Section 8.3.2), which 
might have not been recognised, thus quantified, by the immunoassay antibodies. 
With regards to the mAb content, HCP concentration in the protein A eluate was 
171 ± 21 parts per million (ppm) (i.e. nanograms of HCP per milligrams of mAb). 
The concentration of HCPs in the protein A eluate of a generic industrial mAb 
process have been reported to range between 50 and 500 ppm (Müller-Späth and 
Morbidelli, 2014). Nonetheless, HCP levels between 2,000 and 50,000 ppm have 
also been encountered (Wang et al., 2009). The HCP data showed that the first 
and second depth filtration stages of the non-treated process achieved a 
maximum HCP reduction of 6 % (see Table 7.2). It is possible that HCP removal 
could be enhanced by optimising the depth filter adsorptive properties (Yigzaw 
et al., 2006). With regards to the flocculated primary recovery strategy, 
flocculation decreased the centrate HCP content by 42 %, which continued 
decreasing during the depth and sterile filtration steps (see Table 7.2). The 
flocculation primary recovery strategy led to a process where (i) the impurity 
load passed onto the chromatography column had been significantly reduced; 
and (ii) the purification performance achieved post-protein A chromatography 
was higher than that of the non-treated stream since HCP concentration was 
1.34x106 pg.mL-1 and HCP to mAb content 106 ± 17 ppm (see Table 7.2). Reduced 
impurity loads have an important positive effect upon the longevity of the 
protein A column (Hogwood et al., 2013b; Yigzaw et al., 2006) as well as on the 
post-protein A sterile filtration step by preventing the aggregation and co-elution 
of HCPs with the product (see Figure 7.10. and Section 8.3.2). Therefore, 
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flocculation can improve process performance as well as process economics by 
reducing production costs.  
The mAb quantification data showed there was no product loss during the 
primary clarification steps of the flocculated and non-treated strategies (see 
Table 7.2). However, mAb yield decreased between 5 and 25 % during affinity 
chromatography. The column was loaded to the dynamic binding capacity 
specified by the manufacturer, and the washing steps had been optimised for the 
capture of the IgG4 used. Product loss could be explained by excessive mAb being 
loaded onto the column and, to some extent, due to product aggregation 
occurring during low pH elution (see Section 7.3.4).  
7.3.5.3. DNA Content 
In the flocculated primary recovery strategy, flocculation reduced the DNA 
content in the centrate by 99.88 % (see Table 7.2). The efficacy of PEI to remove 
DNA from complex biological samples has been reported in the literature (Cordes 
et al., 1990; Milburn et al., 1990; Salt et al., 1995). The multi-layer depth filter 
used did not further decrease the DNA content, but sterile filtration did (see  
Table 7.2). It is thought that flocculation continued taking place after depth 
filtration thus further flocculating DNA molecules before sterile filtration (see 
Section 7.3.2). Finally, protein A chromatography achieved an additional 25 % 
reduction with respect to the pre-column’s DNA content, making it a total 
decrease in the centrate DNA content of 99.92 % (see Table 7.2). 
With regards to the non-treated process, the first depth filtration stage decreased 
the centrate DNA content by 63 % (see Table 7.2). The second depth filter 
contributed to a further 5 % reduction. A greater decrease in the DNA content 
was expected since the filter media used was positively charged, thus it was able 
to trap DNA molecules via electrostatic and hydrophobic interactions (Liu et al., 
2010). Sterile filtration did not reduce the DNA content, but protein A affinity 
chromatography achieved the same DNA purification level as the flocculated 
stream (see Table 7.2).  
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7.4. Conclusions 
The flocculated primary recovery strategy proposed in Chapter 6, which 
consisted of a centrifugation step followed by flocculation and depth filtration, 
was compared in Chapter 7 to a platform primary recovery design constituted of 
a centrifugation step followed by two depth filtration stages. A summary of the 
key findings based on the aims and objectives for Chapter 7 is as follows: 
1. Assess at laboratory scale the effect of introducing a flocculation step after 
centrifugation upon the performance of the primary recovery and capture 
chromatography processes.   
The data presented in this chapter provides an insight as to how the choice of 
primary recovery unit operations can significantly impact upon the purification 
steps and process economics. The proposed process conditions showed 
flocculation had great capacity for cell debris, HCP and DNA removal. Multi-layer 
depth filtration offered larger filter capacities than the ones achieved by the 
dual-layer depth filters used in the non-treated primary recovery strategy. 
However, flocculation was the step shown to achieve the greatest clarification 
and purification improvement pre-protein A chromatography. In conclusion, the 
results showed that introducing a flocculation step in the primary recovery 
process can extend the chromatography column lifetime and reduce the 
post-protein A sterilising grade filter area. 
2. Evaluate at laboratory scale the possibility of replacing the mAb platform 
primary recovery strategy (i.e. centrifugation followed by two depth 
filtration stages) by the flocculated primary recovery strategy 
(i.e. centrifugation followed by flocculation and depth filtration).  
Further process optimisation studies are necessary both in the flocculated and 
non-treated primary recovery streams before a decision over one of the two 
strategies can be made. However, considerations that go beyond process 
performance need to be included to decide which clarification technologies to 
use. Cost of goods to manufacture, capital expenditure (e.g. piping 
reconfiguration, new equipment purchase), scale-up know-how, new equipment 
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validation and other implementation requirements contribute to the decision of 
whether to implement a clarification technique besides its clarification 
performance (Felo et al., 2013).  
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8. Proteomic Analysis of Protein A 
Chromatography Eluates  
8.1. Introduction and Aims 
Host cell proteins (HCPs) are critical process-related impurities encountered in 
the production of biopharmaceuticals as they pose an immunogenicity risk to 
patients (Wang et al., 2009). Before the administration of therapeutic monoclonal 
antibodies (mAbs) to patients, HCPs need to be removed to acceptable levels, 
typically < 100 parts per million (ppm) (i.e. nanograms of HCP per milligrams of 
mAb) (Chollangi et al., 2015; Hogwood et al., 2014; Thompson et al., 2014). The 
quantitative assessment of HCPs investigates the impact that unit operations and 
process conditions have on the HCP content, but does not allow the identification 
of specific HCPs (Hogwood et al., 2014; Thompson et al., 2014). Host cell protein 
identification improves the downstream processing (DSP) knowledge (Hogwood 
et al., 2013a, 2014), and therefore supports knowledge-based process decisions 
that can result in reduced DSP costs, which account for ~80 % of the total mAb 
production costs (Hogwood et al., 2013a).  
The choice of depth filter media during secondary clarification has been shown 
to impact upon the abundance and profile of HCPs post-protein A 
chromatography (Hogwood et al., 2013b). Chapter 7 showed that the 
introduction of a flocculation unit operation as part of the primary recovery 
strategy of a mAb process reduced the abundance of HCPs post-protein A 
chromatography. The aim of this chapter was to investigate whether the choices 
of primary recovery studied in Chapter 7 had also changed the HCP profile 
post-protein A chromatography; this was achieved by comparing the HCP profiles 
of the protein A eluates from the non-treated and flocculated streams (see    
Figure 7.1). The mAb content in the protein A eluate samples was first depleted 
to increase the sensitivity and resolution for HCPs (Thompson et al., 2014), which 
were in lower abundance. The HCP profiles of the protein A eluate samples were 
then analysed via sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE), and by combining the liquid chromatography-mass 
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spectrometry/mass spectrometry (LC-MS/MS) technique with bioinformatic 
tools.   
Summary of the chapter’s aims and objectives:  
1. Investigate whether flocculation during primary recovery can modify the 
HCP profile post-protein A chromatography.   
8.2. Experimental Set-up 
8.2.1. SDS-PAGE 
The protein A chromatography eluates from the non-treated (i.e. non-flocculated) 
and flocculated streams in Chapter 7 (see Figure 7.1) were studied via 
polyacrylamide gel electrophoresis under reducing conditions as described in 
Section 2.10.5. The gel was stained using a Coomassie based staining solution.  
8.2.2. LC-MS/MS 
8.2.2.1. Depletion of mAb Content in Protein A Chromatography 
Eluate Samples 
A schematic diagram of the sample preparation procedure performed before LC-
MS/MS analysis is shown in Figure 8.1. The protein A eluates, which were stored 
at -20°C, were thawed at room temperature. The non-treated protein A eluate 
was centrifuged (Eppendorf 5180R, Eppendorf, Hamburg, Germany) for 
5 minutes at 200 rps using the FA-45-6-30 rotor (45° angle) to separate the 
soluble fraction from the solid particulates present in the eluate (see Figure 8.1). 
While the particulates, which constituted the ‘solids fraction’, were directly 
analysed via LC-MS/MS, the ‘soluble fraction’ was further processed to depleat 
the mAb content in the sample. A 3 mL volume of ‘soluble fraction’ was pipetted 
into a Vivaspin®6 centrifugal concentrator (Sartorius Stedim, Göttingen, 
Germany) with a molecular weight cut-off (MWCO) filter of 100 kDa. The ‘soluble 
fraction’ was then centrifuged (Eppendorf 5180R, Eppendorf, Hamburg, 
Germany) for 10 minutes at 6000 g using a fixed 45° angle rotor (FA-45-6-30 
rotor); any molecules with a molecular weight (MW) larger than 100 kDa 
(i.e. mAb molecules) were retained by the filter, while smaller molecules were 
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filtered out. The clear protein A chromatography eluate obtained with the 
flocculated primary recovery strategy (see Figure 8.1) was indicative of no solid 
particulates present in the sample. Consequently, 3 mL of flocculated protein A 
eluate were directly pipetted into a Vivaspin®6, 100 kDa MWCO centrifugal 
concentrator to deplete the sample from the high amounts of mAb present; the 
centrifugation conditions were these used for the non-treated ‘soluble fraction’.  
8.2.2.2. Sample Preparation and LC-MS/MS Analysis 
The mAb-depleted flow-through fractions obtained from concentrating the 
non-treated ‘solube fraction’ and the flocculated protein A eluate (see Figure 8.1 
and Section 8.2.2.1) were precipitated with acetone as described in Section 2.10.6 
before LC-MS/MS analysis. The ‘solids fraction’ from the non-treated protein A 
eluate (see Figure 8.1) did not require acetone precipitation before LC-MS/MS 
analysis. The three samples were analysed via LC-MS/MS as detailed in 
Section 2.10.6.  
8.2.2.3. Protein Sequence Search 
Protein sequence searches were performed against the SwissProt/UniProt data 
base on the 19th of February 2016 as described in Section 2.10.6; the protein 
sequence data base contained a total of 60,971,489 entries that date. The results 
were split in two groups according to the Mascot score obtained. Whilst those 
above the identity threshold indicated identity or extensive homology (ANOVA 
P < 0.05), those below the threshold denoted tentative identifications. The 
protein’s sequence coverage, MW and calculated pI were obtained from the 
Mascot search results. The protein’s biological and molecular functions were 
investigated with peer-reviewed publications and by searching in the UniProt 
website (www.uniprot.org) using the accession number obtained during the 
protein sequence searches.  
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Figure 8.1. Schematic diagram of monoclonal antibody depletion from 
protein A chromatography eluate samples before LC-MS/MS analysis. 
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8.3. Results and Discussion 
8.3.1. SDS-PAGE Analysis 
The protein profiles of the protein A chromatography eluates obtained from the 
flocculated and non-treated primary recovery strategies studied in Chapter 7 (see 
Figure 7.1) were first evaluated via polyacrylamide gel electrophoresis. The gel 
was stained with InstantBlue™ protein stain, a Coomassie based dye of high 
sensitivity (5 – 25 ng of protein per band), to detect differences in the protein 
content between the two samples. However, protein quantification of the 
electrophoretic bands was not intended thus no calibration curves were included.  
Figure 8.2 shows the protein bands obtained during gel electrophoresis under 
reducing conditions. Two overloaded protein bands (number 5 and 9) in both the 
flocculated and the non-treated protein A eluate samples were observed (see 
Figure 8.2). These corresponded to the heavy chain (MW = 50 kDa; band 
number 5) and light chain (MW = 25 kDa; band number 9) of the recombinant 
mAb, which was present in large amounts (see the initial/centrate mAb 
concentration in Table 7.2). Other protein bands with higher and lower MWs 
were observed on the gel (see Figure 8.2), which confirmed the co-elution of 
protein impurities with the mAb. Protein A chromatography has been reported 
to remove > 99 % of the impurities present in the feed stream (Follman and 
Fahrner, 2004). However, HCPs co-elute with the mAb at the low pH elution 
conditions used due to non-covalent interactions (i.e. electrostatic, hydrophobic 
and hydrogen bonds) with the mAb (Chollangi et al., 2015; Gagnon et al., 2014; 
Levy et al., 2014; Nogal et al., 2012; Shukla and Hinckley, 2008; Sisodiya et al., 
2012; Tarrant et al., 2012), as well as with the chromatographic resin (Gagnon et 
al., 2014; Hogwood et al., 2013b; Shukla and Hinckley, 2008; Tarrant et al., 2012). 
These interactions, which depend upon the chromatographic resin (Sisodiya et 
al., 2012; Tarrant et al., 2012) and the protein sequence of the mAb (Levy et al., 
2014; Nogal et al., 2012; Sisodiya et al., 2012), can be disrupted by the presence 
of additives in the post-load washing steps (Chollangi et al., 2015; Shukla and 
Hinckley, 2008; Sisodiya et al., 2012). However, further chromatographic steps 
are necessary to achieve the purity levels required for the administration of 
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therapeutic mAbs to patients (Chollangi et al., 2015; Liu et al., 2010; Shukla et al., 
2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2. SDS-PAGE of the flocculated and non-treated protein A 
chromatography eluates.  
Gel electrophoresis was performed under reducing conditions as described in 
Section 2.10.5. The gel was stained with InstantBlue™ protein staining solution (see 
Section 2.10.5). The same total protein concentration of sample (12.9 g.L-1) was 
loaded in the wells. Sample loading was performed in the same gel but not in 
consecutive lanes to avoid cross-contamination. A commercial protein standard 
(see Section 2.10.5), referred to as ‘Std’ in the figure, was loaded in the first lane; the 
molecular weight values, expressed in kDa, are detailed in the figure. The samples 
studied were the protein A chromatography eluates obtained with the flocculated 
(F) and non-treated (NT) primary recovery strategies described in Figure 7.1. Gel 
images were obtained as detailed in Section 2.10.5.  
 
Feed conditioning strategies used on mammalian cell culture fluids pre-protein A 
chromatography have been shown to reduce (i) the impurity load passed onto 
the chromatographic step; and (ii) the co-elution of process-related impurities 
with the mAb (Chollangi et al., 2015; Gagnon et al., 2014). In order to evaluate 
whether the flocculated primary recovery strategy minimised the co-elution of 
HCPs with the mAb, the intensity of the defined protein bands observed on the 
gel for the flocculated and non-treated protein A eluates (see Figure 8.2) were 
compared. Table 8.1 shows the areas (expressed in absolute terms) obtained for 
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each defined protein band, and the increase or decrease in band intensity 
achieved with the flocculated strategy. The protein bands 1 to 4 in Figure 8.2 
showed the flocculated primary recovery strategy reduced the content of high 
MW proteins (MW > 70 kDa) by half or completely (i.e. no visual protein band) 
(see Table 8.1). The protein bands with MWs between 40 and 25 kDa were not 
always less intense in the flocculated eluate; band number 8 was 34 % more 
intense in the flocculated than in the non-treated eluate (see Table 8.1). With 
regards to the mAb, the intensity of the mAb heavy and light chain protein bands 
(band number 5 and 9, respectively) were higher in the flocculated than in the 
non-treated eluate; the increase in protein band intensity for the flocculated mAb 
heavy and light chains were 17 and 5 %, respectively (see Table 8.1). Gel 
electrophoresis was performed loading the same total protein concentration per 
sample. Because the initial total protein concentration was larger in the 
non-treated than in the flocculated protein A eluates (16.21 g.L-1 versus 
12.91 g.L-1, respectively), the non-treated eluate had to be diluted before loading 
the gel thus explaining the lower mAb content in this sample.  
 
Table 8.1. Protein band intensity comparison between the flocculated and 
the non-treated protein A chromatography eluates analysed via SDS-PAGE. 
Protein band intensity analysis was performed in ImageJ v. 1.47 with the gel image 
shown in Figure 8.2. First, the intensity profile along the gel lane was obtained for 
the flocculated and non-treated protein A chromatography eluates. Then, the area 
of the well-defined intensity peaks, thus well-defined protein bands, was measured 
using the software; the area under the peak given by the software is an absolute 
value. Band number is as detailed in Figure 8.2.  
 
Band 
number 
Flocculated area 
(absolute value) 
Non-treated area 
(absolute value) 
Flocculation 
effect 
1 No band 289.87 - 
2 No band 474.60 - 
3 1841.3 4704.7 -60.9 % 
4 2616.6 4914.8 -46.8 % 
5 53742 45769 +17.4 % 
6 2049.5 2471.8 -17.1 % 
7 1006.4 985.48 +2.12 % 
8 945.26 704.36 +34.2 % 
9 23224 22133 +4.93 % 
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Finally, the solid particulates present in the non-treated protein A 
chromatography eluate (see Figure 8.1) were re-dissolved and migrated through 
the gel in the reducing conditions used during SDS-PAGE analysis; no band was 
observed at the top of the gel hence indicating the absence of large insoluble 
proteins (see Figure 8.2).  
8.3.2. LC-MS/MS Analysis 
The non-treated and flocculated protein A chromatography eluates were 
analysed via LC-MS/MS to (i) investigate the nature of the solid particulates 
contributing to the turbidity of the non-treated protein A eluate (see Figure 8.1); 
and (ii) compare if the two primary recovery strategies studied in Chapter 7 
(i.e. centrifugation-depth filtration versus centrifugation-flocculation-depth 
filtration; see Figure 7.1) resulted in a different HCP profile post-protein A 
chromatography. To increase the sensitivity of the LC-MS/MS technique for HCPs 
that might be in low concentration, the mAb content in the protein A 
chromatography eluates was depleted as shown in Figure 8.1. 
The protein searches performed with the mass spectrometry results obtained 
after LC-MS/MS analysis were not exclusively limited to the Chinese hamster 
(Cricetulus griseus) proteome. Rather, the search was extended to the mouse (Mus 
musculus), rat (Rattus novergicus) and human (Homo sapiens) proteomes to 
include homologous proteins in the search. The protein search results (Table 8.2 
to Table 8.4) showed the protein sequence coverage values obtained ranged 
from 1 to 64 %; however, the maximum protein sequence coverage value for an 
HCP was 11 %. The short protein sequence coverage values obtained for HCPs 
might have been due to (i) their low concentration in the protein A eluate samples 
analysed; (ii) protein degradation occurring during sample storage at -20°C as a 
result of enzymatic and/or non-enzymatic cleavage (Cordoba et al., 2005); 
and/or (iii) a non-optimal trypsin digestion step used as part of the LC-MS/MS 
protocol to prepare the samples for analysis. The protein search results were not 
analysed based on the protein sequence coverage values since the MW and 
concentration of the protein must be also considered. Instead, the protein search 
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results were evaluated based upon the proteins’ homology to one of the four 
proteomes searched against.  
The protein search results for the ‘solids fraction’ of the non-treated protein A 
chromatography eluate (see Figure 8.1) showed the solid particulates were 
constituted of HCPs and IgG (i.e. mAb) fragments (see Table 8.2). A total of 
14 HCPs were identified in the ‘solids fraction’, although only 7 of these were 
protein identities or proteins identified with extensive homology. Their 
theoretical MW values ranged from 177 to 13.9 kDa, with the majority being 
< 80 kDa (see Table 8.2). With regards to their pI, more than half of the HCPs 
identified were acidic (i.e. pI < 7.0) (see Table 8.2). The HCPs obtained from 
harvested Chinese hamster ovary (CHO) cell culture fluids have been reported to 
tend towards acidic and low to mid-molecular weight proteins (i.e. MW < 75 kDa) 
(Jin et al., 2010). Published two-dimensional gel electrophoresis images of 
intracellular proteins obtained from cultured CHO cells also showed some degree 
of bias towards acidic pI values (Champion et al., 1999). The presence of IgG 
fragments in the ‘solids fraction’ could have been triggered by their co-elution 
with the mAb due to non-specific interactions with HCPs and/or with the resin 
(Gagnon et al., 2014; Hogwood et al., 2013b; Shukla and Hinckley, 2008; Tarrant 
et al., 2012). Then, these IgG fragments could have precipitated during the 
subsequent pH neutralisation step (Kandula et al., 2009; Shukla et al., 2005) or 
during the low pH elution conditions in protein A chromatography (Shukla et al., 
2005).  
The numerous HCPs identified in the ‘solids fraction’ of the non-treated protein A 
chromatography eluate (Table 8.2) differed from the results obtained in the 
mAb-depleted non-treated and flocculated protein A eluates (see Table 8.3 and 
Table 8.4, respectively). The main proteins identified in the mAb-depleted 
samples were mAb fragments. The mAb fragments could have co-eluted with the 
product due to non-covalent interactions with the mAb (Chollangi et al., 2015; 
Gagnon et al., 2014; Levy et al., 2014; Nogal et al., 2012; Shukla and Hinckley, 
2008; Sisodiya et al., 2012; Tarrant et al., 2012) and/or with the resin (Gagnon et 
al., 2014; Hogwood et al., 2013b; Shukla and Hinckley, 2008; Tarrant et al., 2012). 
Antibody fragments could have also resulted from mAb fragmentation in the IgG’s 
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hinge region during sample storage at -20°C (Cordoba et al., 2005). Only one HCP 
was identified with extensive homology in the mAb-depleted non-treated and 
flocculated protein A eluates; this HCP was in both cases ubiquitin 
carboxyl-terminal hydrolase 30, or USP30 (see Table 8.3 and Table 8.4). This HCP 
of 59 kDa had a calculated pI value of 8.8 (see Table 8.3 and Table 8.4), and 
therefore was positively charged at the neutral pH conditions at which 
flocculation was conducted when using the cationic flocculant polyethylenimine 
(see Section 7.2.3). USP30 co-eluted with the product possibly as a result of 
non-covalent interactions with either the protein A resin or the mAb. Finally, one 
tentative HCP was identified in the mAb-depleted non-treated eluate (see       
Table 8.3) and none in the mAb-depleted flocculated eluate (see Table 8.4). 
The greater number of HCPs identified via LC-MS/MS in the non-treated protein A 
chromatography eluate when compared to the flocculated eluate was in line with 
the HCP quantification results reported in Section 7.3.5 and in Table 7.2. The 
immunoassay results showed the HCP content in the non-treated protein A 
pooled eluate was higher than in the flocculated protein A pooled eluate; the HCP 
content was 2.02x107 pg and 1.34x107 pg, respectively. Nonetheless, it is possible 
that the HCP content in the non-treated sample was higher than that reported by 
the immunoassay considering there was a large fraction of precipitated proteins 
(see Table 8.2); these precipitates might have not been recognised, thus 
quantified, by the immunoassay antibodies due to the fact that the protein’s 
three-dimensional conformation is lost when precipitation occurs (Mathews et 
al., 2000). Furthermore, it has been reported that histones, one of the tentative 
HCPs identified in the solids fraction of the non-treated protein A eluate (see 
Table 8.2), are not easily detected by the common immunoassay procedures used 
for HCP quantification (Gagnon et al., 2014). If this was the case for the 
immunoassay used in this thesis (see Section 2.10.4), the actual HCP content in 
the non-treated protein A eluate might have been higher than the quantitative 
value experimentally reported.  
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Table 8.2. Host cell protein identification in the solids fraction of the non-
treated protein A chromatography eluate via LC-MS/MS analysis.   
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Table 8.3. Host cell protein identification in the mAb-depleted soluble 
fraction of the non-treated protein A chromatography eluate via LC-MS/MS 
analysis.  
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Table 8.4. Host cell protein identification in the mAb-depleted fraction of 
the flocculated protein A chromatography eluate via LC-MS/MS analysis.  
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The LC-MS/MS results for the mAb-depleted flocculated fraction (Table 8.4) were 
not in line with the SDS-PAGE results (Figure 8.2); while only one HCP was 
identified (i.e. USP30) via LC-MS/MS analysis (see Table 8.4), multiple protein 
bands that did not correspond to the mAb heavy or light chains were observed 
on the SDS-PAGE gel (see Figure 8.2). The same observation was made for the 
mAb-depleted non-treated soluble fraction (see Table 8.3), although the HCP 
results obtained for the non-treated solids fraction (Table 8.2) could have 
accounted for the small amount of HCPs identified in the mAb-depleted soluble 
fraction. Large amounts of IgG fragments in the pooled protein A eluates could 
have hindered the identification of HCPs present in low quantities during 
LC-MS/MS analysis (Thompson et al., 2014). The sample preparation protocol 
(see Section 8.2.2 and Figure 8.1) where the eluates were filtered through a 
100 kDa MWCO membrane was not expected to be the reason for the limited 
number of HCPs identified via LC-MS/MS analysis in the mAb-depleted 
non-treated and flocculated samples. The MW of the bulk of HCPs present in 
harvested recombinant CHO cell cultures has been reported to range between 25 
and 100 kDa (Jin et al., 2010). Furthermore, most of the protein bands observed 
on the SDS-PAGE gel attributed to impurities (Figure 8.2) had a MW smaller than 
70 kDa. Therefore, the majority of HCPs in the protein A eluate samples were 
expected to flow through the 100 kDa MWCO filter. The disparity between the 
LC-MS/MS and SDS-PAGE results showed that (i) the methodology chosen for 
HCP identification needs to be optimised; and (ii) the effect of the flocculation 
strategy on the HCP profile post-protein A chromatography could not be 
concluded with certainty.  
All the HCPs identified in the solids fraction of the non-treated protein A 
chromatography eluate were intracellular proteins with the exception of 
Semaphorin-3E (see Table 8.5). The abundance of intracellular HCPs in harvested 
CHO cell culture fluids has been reported by different authors (Hogwood et al., 
2013a). Intracellular HCPs are released into the cell culture fluid due to cell lysis 
or cell breakage after cell death during cell culture, and during primary recovery 
due to shear stress (Hogwood et al., 2013b; Tait et al., 2012). Table 8.5 also shows 
the HCPs identified in the solids fraction of the non-treated protein A eluate were 
involved in, amongst other cellular mechanisms, replication, transcription, 
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cellular metabolism, protein folding, cell signalling and organisation of the 
cytoskeleton. One of these HCPs was GRP78 (78 kDa glucose-regulated protein) 
(see Table 8.2 and Table 8.5), which is also known as chaperone BiP. This HCP 
has been described as one of the most abundant proteins in the proteome of 
mAb-producing CHO cells (Champion et al., 1999; Meleady et al., 2011) and 
murine myeloma NS0 cells (Alete et al., 2005; Smales et al., 2004). GRP78 is a key 
chaperone involved in the correct assembly of mAbs, as it associates via 
non-covalent interactions with unfolded antibody chains in the endoplasmic 
reticulum (Lee et al., 1999; Meunier et al., 2002). Furthermore, GRP78 has been 
linked to increase mAb productivity in murine myeloma NS0 cells (Alete et al., 
2005; Smales et al., 2004). Therefore, the abundance of GRP78 in the high cell 
density CHO cell culture fluid used in this chapter (see Section 2.1.2) was 
expected to be high. Glycolytic enzymes, such as the glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) encountered in the solids fraction of the non-treated 
protein A chromatography eluate (see Table 8.2 and Table 8.5), have also  been 
reported to be amongst the most abundant HCPs in high mAb productivity 
murine myeloma NS0 cells (Smales et al., 2004). Tubulin and actin-related 
proteins, also identified in the solids fraction of the non-treated protein A eluate 
(see Table 8.2 and Table 8.5), have been reported to co-elute with the mAb during 
protein A chromatography in different CHO cell lines (Doneanu et al., 2012). The 
presence of actin-related protein 3 in the protein A eluate (see Table 8.2) could 
have been due to attractive interactions between this HCP and the constant 
region of the mAb (Levy et al., 2014). Moreover, increased levels of cytoskeletal 
proteins, such as tubulin and actin, are found in high mAb producing mammalian 
cell lines due to (i) their role in  carrying the secretory vesicles containing the 
mAb to the plasma membrane (Smales et al., 2004); and (ii) to their potential 
contribution to the cell’s translational machinery (Stapulionis et al., 1997).  
The tentative HCPs identified in the solids fraction of the non-treated protein A 
chromatography eluate (see Table 8.2) were integral parts of the cell or proteins 
involved in various cellular mechanisms such as replication, transcription, 
cellular metabolism, protein post-translational modifications and cell survival 
(see Table 8.5). Histone H2, a core component of the nucleosome, was one of the 
tentative HCPs identified in the solids fraction (see Table 8.2). Histones have been 
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reported to co-elute with the mAb during protein A chromatography in CHO cell 
processes, and contribute to the turbidity in neutralised protein A 
chromatography elution pools (Gagnon et al., 2014). The GTP-binding nuclear 
protein Ran was another of the tentative HCPs identified in the solids fraction of 
the non-treated protein A eluate (see Table 8.2). This protein was also identified 
in proteome studies for different recombinant murine myeloma NS0 cell lines, 
although it was not present amongst their most abundant HCPs (Smales et al., 
2004); nonetheless, these results cannot be directly translated to the CHO cell line 
or the mAb product used in this chapter since differences in the proteome and 
interactions HCP-mAb can arise (Sisodiya et al., 2012). Finally, the other two 
tentative HCPs identified in the solids fraction of the non-treated eluate were 
glutamine fructose-6-phosphate aminotransferase and CMP-N-
acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (see     
Table 8.2). These proteins, which are involved in protein glycosylation 
mechanisms (see Table 8.5), might be more abundant in highly productive 
recombinant CHO cell lines due their role in the synthesis of functional mAbs.  
Ubiquitin carboxyl-terminal hydrolase 30, the HCP identified in both the 
non-treated and flocculated mAb-depleted protein A eluates (see Table 8.3 and 
Table 8.4), is involved in the control of mitochondria fusion (Yue et al., 2014). 
Therefore, this deubiquitinating enzyme is involved in cellular activities related 
to functional regulation, and not to protein degradation via the 
ubiquitin-dependent pathway. However, further research is needed to confirm 
this hypothesis and to elucidate whether USP30 has any role in supporting and 
maintaining the high mAb productivity of recombinant mammalian cell lines. 
Finally, E-selectin, the tentative HCP identified in the non-treated mAb-depleted 
soluble fraction (see Table 8.3), is not directly involved in the synthesis of 
recombinant mAbs since this is a cell-surface glycoprotein involved in cellular 
immunoadhesion (Hession et al., 1990). No tentative HCPs were identified in the 
flocculated mAb-depleted fraction (see Table 8.4).  
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Table 8.5. Biological function and cellular location of host cell proteins 
present in the protein A chromatography eluates for the flocculated and 
non-treated primary recovery strategies.  
Host cell proteins were identified via LC-MS/MS analysis and are listed in Table 8.2 
to Table 8.4. The samples studied were the non-treated and flocculated protein A 
chromatography eluates, which were prepared as shown in Figure 8.1. 
Peer-reviewed publications (refer to the text) and the online UniProt protein 
database were used to establish the biological function and cellular location of the 
HCPs identified.  
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Continuation from table above. 
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Continuation from table above. 
 
8.4. Conclusions 
The non-treated and flocculated protein A chromatography eluates obtained 
from the experiments performed in Chapter 7 (see Table 7.1) were analysed via 
SDS-PAGE and LC-MS/MS to compare their protein profiles. A summary of the 
key findings based on the chapter aims and objectives is as follows: 
1. Investigate whether flocculation during primary recovery can modify the 
HCP profile post-protein A chromatography.   
The three pre-elution washes performed during protein A chromatography in 
Chapter 7 were not effective in disrupting the non-covalent interactions between 
the HCPs and the mAb and/or the chromatographic resin. Consequently, these 
bound HCPs co-eluted with the mAb during the low pH elution step in both the 
non-treated and flocculated primary recovery strategies.  
The analysis of the protein A eluates via SDS-PAGE concluded the flocculated 
primary recovery strategy (i.e. centrifugation – flocculation - multilayer depth 
filtration) was effective at removing high MW protein impurities (MW > 70 kDa) 
when compared to the non-treated strategy (i.e. centrifugation – two-stage depth 
filtration). The LC-MS/MS analysis confirmed the HCP nature of the solid 
particulates observed in the non-treated protein A chromatography eluate, which 
were absent in the flocculated eluate. However, SDS-PAGE verified the HCPs 
identified via LC-MS/MS analysis were an under-representation of the samples’ 
HCP populations. Therefore, the effect of the flocculated primary recovery 
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strategy on the HCP profile post-protein A chromatography could not be 
determined with certainty.  
The sample preparation protocol used to decrease the mAb content from the 
protein A eluate samples before LC-MS/MS analysis was not effective at removing 
the mAb fragments present in the samples. The presence of large quantities of 
mAb fragments might have hindered the identification of HCPs via LC-MS/MS 
analysis in both the non-treated and flocculated eluates, particularly those HCPs 
present in low concentrations. Protein separation via polyacrylamide gel 
electrophoresis before LC-MS/MS analysis could have enhanced HCP 
identification by minimising the presence of high quantities of mAb. This and 
other HCP identification approaches need to be explored.  
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9. Conclusions and Recommendations for 
Future Work 
The work presented within this thesis has focussed on the implementation of 
flocculation as a post-centrifugation feed conditioning strategy in a mAb 
production process using a high cell density (HCD) glutamine synthetase-Chinese 
hamster ovary (GS-CHO) cell line. This work has been performed using both new 
and proven ultra scale-down (USD) techniques to explore the impact that 
flocculation had on subsequent downstream unit operations. The results 
obtained at USD scale were then validated at laboratory scale and complemented 
with analytical techniques to evaluate process performance.  
The conclusions reached from this thesis research have been summarised in 
Section 9.1, with reference to the research objectives defined in Section 1.7. 
Section 9.2 follows with the possible directions for future work. The suggestions 
made for future work have taken into account the findings obtained in this thesis 
as well as the results from recent peer-reviewed publications in the field.  
9.1. Review of Overall Research Objectives 
Objective 1: Assess the possibility to use flocculation as a 
post-centrifugation feed conditioning strategy, identify a successful 
flocculant and establish the analytical methods and protocols to 
characterise flocculation performance. 
Chapter 3 described the implementation of cationic polyelectrolyte flocculation 
as a post-centrifugation unit operation using two different GS-CHO cell lines. This 
chapter also characterised different analytical methods to evaluate flocculation 
performance; these methodologies were then used in subsequent chapters.  
Polyelectrolyte flocculation in mammalian cell processes had only been reported 
on cell culture broths (Aunins and Wang, 1989; Kang et al., 2013; Riske et al., 
2007; Singh et al., 2013). Therefore, the validation of polyelectrolyte flocculation 
on centrifuged mammalian cell cultures was required. Maximum cell density was 
shown to be a critical parameter to successfully flocculate centrifuged GS-CHO 
9. Conclusions and Recommendations for Future Work 
 
 287 
 
cell cultures with linear polyethylenimine (PEI). Maximum cell densities larger 
than 20x106 cells.mL-1 resulted in a positive flocculation outcome (i.e. PEI 
successfully flocculated the submicron particles present in that GS-CHO 
centrate); contrary, values of maximum cell density equal or lower than 
10x106 cells.mL-1 were insufficient for PEI to successfully flocculate the GS-CHO 
centrate obtained. These results limited all the flocculation studies included in 
this thesis to high cell density GS-CHO cell cultures (i.e. maximum cell 
densities > 20x106 cells.mL-1).  
Linear PEI was a successful agent to flocculate the submicron particles present in 
the centrifuged HCD GS-CHO cell cultures used. The low concentrations of PEI 
required for flocculation to occur (≥ 0.10 % w/v), in addition to its high affinity 
for DNA and low binding to the mAb product, made this cationic polyelectrolyte 
a good candidate. Therefore, linear PEI was used in all the flocculation 
experiments included in this thesis.  
Certain polyelectrolytes have been found to interfere with some analytical assays 
used to assess flocculation performance (Peram et al., 2010), which in this thesis 
was characterised according to the size distribution of the flocs, impurity removal 
and product yield. Polyethylenimine and the flocculation conditions used 
(i.e. flocculant concentration and pH) determined the analytical methods and 
protocols chosen to assess impurity removal and product yield. These results 
showed the need to evaluate, on a case-by-case basis, the interference of the 
flocculating agent with the analytical assays used and its impact upon the assay 
results depending upon the flocculation settings chosen.  
Objective 2: Develop and validate an ultra scale-down flocculation 
methodology for the rapid evaluation of flocculation conditions during 
early process development. 
The primary focus of Chapter 4 was to develop a methodology for the 
scaled-down, automated and high-throughput study of flocculation that 
mimicked the conditions encountered at production scale. Due to the limited 
availability of centrifuged HCD GS-CHO cell broth, the methodology was 
developed and validated using clarified Baker’s yeast homogenate. However, the 
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USD flocculation methodology developed was then validated with centrifuged 
HCD GS-CHO cell broth in Chapter 5.  
Chapter 4 described the development of an automated, high-throughput 
flocculation methodology based on a 96-well plate with 800 µL working volume 
in each well. This microplate was equipped with 96 individual magnetic stirrers 
and could be automated with a robotic liquid handling platform. Clarified Baker’s 
yeast homogenate was then used to develop a methodology to scale-up 
flocculation between vessels of different geometry and volume capacity. The 
96-well plate described (800 µL) and a stirred tank reactor of standard 
geometrical configuration (1.5 L) were used for this purpose. The fast reaction 
kinetics of flocculation, when compared to the mixing process after flocculant 
addition in the vessels used, converted flocculant addition time into a critical 
variable for the success of the flocculation scale-up process. Impeller speed was 
another critical flocculation scale-up variable since it determined the growth and 
breakage of the flocs. The effect of flocculant addition time was described by the 
influence that the predominant mixing time scale in the vessel (i.e. micromixing, 
mesomixing or macromixing) had upon the size and the distribution 
(i.e. monomodal or bimodal) of the flocs. The effect of impeller speed was 
described by two common scale-up “rules of thumb”: average turbulent energy 
dissipation and impeller tip speed. While only micromixing time scale guaranteed 
a similar floc size distribution in both flocculation vessels, constant average 
turbulent energy dissipation offered better particle size predictions than 
constant impeller tip speed by tightly mimicking the size of the smaller flocs; the 
tight prediction of small particles is critical for the performance of the subsequent 
solid-liquid separation step. These results provided the basis for the design of the 
USD flocculation methodology, which stated the use of (i) flocculant addition 
times that guarantee the predominance of micromixing (according to the 
experimental characterisation of micromixing time for the mixing vessel used); 
and (ii) constant average turbulent energy dissipation to scale up impeller speed. 
Failing to guarantee a predominant micromixing time scale in both flocculation 
vessels resulted in yeast flocs that differed up to 50 % in size.  
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The findings obtained with the clarified Baker’s yeast homogenate (Chapter 4) 
were applied to clarified HCD GS-CHO cell broths (Chapter 5). However, slight 
differences in the scale-up error margins were observed depending on the 
characteristics of the fluid being flocculated; while clarified Baker’s yeast 
homogenate was scaled up within a ± 5 % error margin, clarified GS-CHO cell fluid 
was scaled up within a ± 7 % error margin. Failing to guarantee the established 
USD flocculation methodology also led to higher floc size deviations when using 
clarified GS-CHO cell fluid (Chapter 5).  
The automated, 96-well mixing system described in Chapter 4 required an 
equally automated, high-throughput platform to achieve a first evaluation of 
different flocculation conditions when using GS-CHO HCD mammalian cell 
centrate. Chapter 5 describes that absorbance measurements at 600 nm 
wavelength over a period of 3 hours were a good approach to assess different 
flocculation conditions since they allowed (i) the identification of non-optimal 
flocculation conditions (i.e. these resulting in submicron flocculated particles); 
and (ii) the differentiation of floc populations of different sizes. Automated 
absorbance measurements can be combined with automated analytical assays for 
the study of protein and DNA removal, as well as for product yield studies if a high 
performance liquid chromatography instrument is integrated in the robotic 
platform. All together, these methods offer the capability to fully automate the 
evaluation of flocculation conditions early in process development.  
Objective 3: Evaluate the capacity of post-centrifuge flocculation to assist 
depth filtration in the removal of solids and process-related impurities 
during mAb production with GS-CHO cell lines.  
The downstream impact of a post-centrifuge flocculation step was studied in 
Chapter 6 to Chapter 8 to assess the fit of this new unit operation in the current 
Lonza Biologics monoclonal antibody (mAb) production process. To 
accommodate flocculation in the current primary recovery strategy of 
centrifugation followed by two depth filtration steps, a single depth filtration step 
was chosen for floc removal. This strategy reduces the capital investment 
necessary (in comparison to a centrifugation step) and offers the ability to reduce 
the impurity content of the post-flocculated fluid (Yigzaw et al., 2006).  
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Chapter 6 described the integrated study of flocculation and constant pressure 
depth filtration using USD methodologies, which were chosen to gain process 
understanding of larger scale operations using millilitre volumes of process 
material (4 mL). Flocculant concentration, flocculant addition rate, depth filter 
media and filtration pressure drop impacted differently upon filtration 
throughput and clarification performance. However, the USD depth filtration 
study was limited by the need to use single layer filters when employing the USD 
constant pressure filtration methodology due to the design limitations of the 
filter housings used. Single layer filters (0.28 cm2) were shown to be insufficient 
to cope with the large solid volumes present in both the non-treated 
(i.e. centrifuged) and flocculated feeds since they resulted in rapid filter clogging 
and low filtration throughput values thereof (< 85 and < 35 L.m-2, respectively). 
As a consequence, only small data sets were acquired, which hindered the 
identification of the filter’s fouling behaviour.  
Multi-layer depth filters have been shown to be capable of obtaining favourable 
throughput values for pilot and manufacturing scale production when filtering 
flocculated CHO cell feeds (Kang et al., 2013; Singh et al., 2013). Multi-layer depth 
filters were then used at laboratory scale to process the flocculated clarified HCD 
GS-CHO cell material (Chapter 6). The multi-layer depth filter capsules chosen 
(23 cm2) offered high filtration throughput values (> 490 L.m-2) and high 
clarification performance independently of the size distribution of the flocs 
filtered. Nonetheless, the large volumes of feed material consumed limited the 
number of flocculation and depth filtration variables studied to two and one, 
respectively. The constraints of the USD constant pressure filtration methodology 
with flocculated feeds shown in Chapter 6 provides scope for future work into the 
modification of this technology to use multi-layer depth filters. Such 
improvement would allow to integrate USD flocculation and depth filtration 
studies in the same automated platform.  
Chapter 7 extended the downstream evaluation of post-centrifuge flocculation to 
protein A chromatography and compared the process performance achieved by 
this new strategy to that of the current mAb production process 
(i.e. centrifugation – two-step depth filtration – protein A chromatography). All 
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the settings for the process variables were determined by the flocculation and 
filtration results obtained in Chapter 6 or by the recommendations from the 
manufacturer and Lonza Biologics. At these conditions, the flocculated strategy 
achieved larger depth filter capacities and greater clarification performance 
pre-protein A chromatography. No differences were observed in the DNA and 
mAb content post-protein A chromatography between the flocculated and 
non-treated processes. However, a smaller host cell protein (HCP) content 
post-protein A chromatography was obtained with the flocculated strategy. 
Furthermore, the impurity load (i.e. HCP and DNA content) pre-protein A 
chromatography was considerably lower in the flocculated stream, mainly due to 
the polyelectrolyte flocculation step. Different examples describing the positive 
impacts upon the purification process of reduced impurity loads pre-protein A 
chromatography can be found in the literature (Kandula et al., 2009; Thömmes 
and Etzel, 2007; Yigzaw et al., 2006). Nonetheless, studying such effects upon the 
chromatographic purification train, both from the process performance and 
process economics points of view, constitutes future work. Notwithstanding, 
further flocculation and depth filtration optimisation studies are also required in 
both the flocculated and non-treated process streams before a final decision over 
the suitability of a post-centrifuge flocculation step can be made.  
Precipitated particles were observed in the neutralised non-treated protein A 
chromatography elution pool, but not in that of the flocculated stream 
(Chapter 7). Studies employing the liquid chromatography – mass 
spectrometry/mass spectrometry (LC-MS/MS) technique combined with 
bioinformatic tools showed these precipitates were mainly constituted of HCPs 
negatively charged at neutral pH (Chapter 8). This technique, however, 
under-represented the population of HCPs in the soluble fractions of the 
non-treated and flocculated protein A chromatography eluates, as corroborated 
by the multiple non-mAb protein bands observed on a polyacrylamide gel 
(Chapter 8). Gel electrophoresis also confirmed that PEI removed high molecular 
weight (MW) proteins (MW > 70 kDa), albeit the identity of these HCPs could not 
be determined by LC-MS/MS analysis (Chapter 8). The poor sensitivity for HCPs 
in the protein A elutes showed by the LC-MS/MS technique could have been 
related to faults in the sample preparation protocol. The mAb content in the 
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eluate samples was depleted by filtering out the intact mAb molecules taking 
advantage of the differences in MW between the mAb and the HCPs. Contrary, the 
fragments of mAb, probably also present in large amounts, could not be removed 
by this strategy. Future work will therefore need to include the depletion of mAb 
molecules and mAb fragments from the protein A elutes for increased sensitivity 
to characterise their HCP profiles.   
9.2. Future Work 
This thesis has demonstrated the challenges posed and opportunities offered by 
the implementation of a polyelectrolyte flocculation step in the primary recovery 
of a mAb production process when using a GS-CHO cell line. Although the work 
presented in this thesis has addressed the objectives defined for this project, 
questions that were out of the scope of the investigation presented have arisen. 
This section discusses the opportunity for future investigations, either directly 
related to the research described in this thesis or in other areas of potential 
interest. 
9.2.1. Validation of the USD Flocculation Methodology with 
Whole Cell Broths 
The flocculation of whole cell broths has been commonly reported in the 
literature for its ability to improve the removal of cells and cell debris (Aunins 
and Wang, 1989; Coffman et al., 2006; Kang et al., 2013; Riske et al., 2007; 
Shpritzer et al., 2006; Singh et al., 2013). Flocculating whole cell broths also offers 
the advantage of adding the flocculating agent into the fermenter thus not 
requiring the modification of the process flow with an additional flocculation 
vessel (or in-line flocculant addition) and a solid-liquid separation step. 
Predicting the flocculation performance that will be obtained at pilot and 
manufacturing scale when flocculating whole cell broths during early process 
development is important. For example, the size distribution of the flocs will 
determine the performance of the subsequent centrifugation (Berrill et al., 2008; 
Milburn et al., 1990) or filtration (Aspelund et al., 2008; Kang et al., 2013; Singh 
et al., 2013) steps. Consequently, the size distribution of the flocs will establish 
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which the subsequent downstream unit operations and their operating 
conditions will be. It is therefore of interest for the biopharmaceutical industry to 
investigate how the presence of solids and the change to non-Newtonian fluids of 
higher viscosity and density values will affect the USD flocculation methodology 
described in Chapter 4 and Chapter 5. Viscosity-raising polymers have been used 
in the literature to study how mixing time scales, and product distribution in fast 
chemical reactions thereof, are affected by the values of fluid viscosity (Bourne et 
al., 1989, 1995; Gholap et al., 1994). Model fluids and latex particles of different 
diameters, for instance, could be used to evaluate how the rheological behaviour 
and the presence of solid particles in the fluid being flocculated affect the mixing 
time scales and, ultimately, the USD filtration methodology.  
9.2.2. Ultra Scale-Down Filtration with Multi-Layer Depth Filters  
Multi-layer depth filters are being commonly used either as a primary 
clarification step (Roush and Lu, 2008; Singh et al., 2013) or as a secondary 
clarification step (i.e. following centrifugation or tangential flow microfiltration) 
(Roush and Lu, 2008). In order to improve depth filtration capacity, different 
depth filter media need to be screened to identify the optimal filter for the 
intended feed stream (Roush and Lu, 2008). These studies are performed before 
the pilot scale trials due to their cost and high process volume requirements. Ultra 
scale-down techniques offer the possibility to obtain process design information 
during early process development (Titchener-Hooker et al., 2008). As 
demonstrated in Chapter 6 by the USD constant pressure filtration data obtained, 
it is of interest for the biopharmaceutical industry to modify the current USD 
filtration technique (see Section 1.4.2) to accommodate multi-layer filters. Noyes 
and co-workers (2015) developed a proprietary technology that scaled down a 
double-layer filter from 23 cm2 to 0.22 cm2 cross-sectional area. However, further 
work is needed in this field since the authors could not explain the basis for the 
hydrodynamic scaling differences they observed between the single and 
double-layer filters tested. Furthermore, a USD filtration methodology that is not 
limited to dual-layer filters is necessary considering that commercially available 
depth filters used for pre-treated feeds are constituted by up to eight filter layers. 
The development of USD multi-layer depth filters might require the input of filter 
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manufacturers, not only to acquire the individual depth filter media a multi-layer 
depth filter is constituted of, but to also cut the different filters in small discs with 
ultimate precision and seal them together without damaging the structure of the 
filter.  
9.2.3. Protein A Resin Lifetime Studies 
Protein A chromatography has become the workhorse of mAb and Fc fusion 
protein purification processes despite the high cost of the protein A resin, 
reusability and concerns over the clearance of leached ligand (Kelley, 2007; Liu 
et al., 2010; Low et al., 2007; Shukla et al., 2007). Protein A chromatography 
performance has been reported to decrease with chromatographic cycles thus 
resin usage (Jiang et al., 2009; Kelley et al., 2008). The consequences of a decrease 
in protein A chromatography performance are such that health authority 
guidance for mAb production requires to specify the number of times a 
chromatography resin can be used in manufacturing based upon validation 
studies specific to the process under review (U.S. Department of Health and 
Human Services, Food and Drug Administration, 1997). Process impurities can 
remain on the resin and either block pores and/or block the access to surface 
ligands thus reducing the useful lifetime of the chromatography resin over 
repeated uses (Jiang et al., 2009). Chapter 7 and Chapter 8 showed that the 
impurity load passed onto the protein A chromatography step was lower for the 
flocculated feed stream than for the non-treated stream. Consequently, it is of 
interest to study the effect that a flocculation feed conditioning step during 
primary recovery would have upon the protein A resin lifetime. The same studies 
should be performed with the non-treated stream for direct comparison 
purposes. Evaluating the effect of residual amounts of flocculant present in the 
feed stream upon the protein A resin lifetime is also necessary. Finally, these 
studies should be complemented with an assessment of the impact that extended 
or reduced protein A resin lifetime has upon the overall process costs.  
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9.2.4. Identification of HCPs in the Presence of High Amounts of 
mAb 
The identification of HCPs and the study of how the HCP profile changes over the 
clarification and purification steps will improve the process knowledge of its 
downstream unit operations (Hogwood et al., 2013a, 2014). The characterisation 
of individual HCPs is a critical step forward in (i) process development for its 
potential to reduce the downstream processing costs through knowledge-based 
process decisions (Hogwood et al., 2013a); (ii) ensuring patient safety since 
certain HCPs have been referred to as of particular concern for the risk they pose 
to patient safety (Tscheliessnig et al., 2013); and (iii) formulation design studies 
since certain HCPs have been shown to compromise the integrity of highly 
purified mAb products (Gao et al., 2011). 
The LC-MS/MS results for protein A chromatography eluates described in 
Chapter 8 suggested large amounts of fragmented mAb might have interfered 
with the detection of HCPs present in small amounts. The depletion of intact mAb 
molecules by pre-filtering the samples was not efficient at removing the smaller 
mAb fragments. Filtering out the mAb fragments is not a possibility due to the 
similar molecular weight between mAb fragments and HCPs. Future work 
developing a technique where mAb fragments can be isolated from the HCPs 
present in the sample could resolve this issue. Such problem could be approached 
by separating the protein via gel electrophoresis first, and then analysing the 
protein bands obtained on the electrophoretic gel via LC-MS/MS. These changes 
would increase the content of HCPs available for LC-MS/MS analysis and improve 
the technique’s sensitivity to identify them even when their content in the sample 
is low.  
9.2.5. Microscale Whole Bioprocessing 
The work presented in this thesis and the review article published by 
Titchener-Hooker et al. (2008) have described the opportunities offered by the 
USD approach in the race for biopharmaceutical drug launch to market. The 
ultimate goal would be to scale-down and integrate all the process unit 
operations to gain in-depth knowledge of the key process interactions between 
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each step. With regards to upstream operations, systems for the automated study 
of different cell lines and cell culture conditions are commercially available 
(e.g. ambr® cell culture systems from Sartorius Stedim). With regards to 
downstream operations, USD centrifugation (Tait et al., 2009) and USD normal 
flow filtration (Jackson et al., 2006; Kong et al., 2010; Lau et al., 2013), which have 
been demonstrated to mimic the conditions of their laboratory and pilot-scale 
counterparts, can be partially integrated in automated platforms. Commercial 
systems for the automated study of chromatography are also available (e.g. 
MediaScout® MiniColumns from Atoll GmbH and PhyTip® from PhyNexus). The 
integration of all these unit operations in a single automated platform would 
require to adapt current liquid handling platforms to incorporate, amongst 
others, bench-top centrifuges and vacuum pressure manifolds. Such approach 
would allow the optimisation of the overall process with limited feed volume. 
This, in combination with high-throughput analytical techniques, would generate 
a deeper understanding of the production process. Consequently, process 
development would be accelerated and the overall production costs would be 
reduced by minimising risk of failure during the pilot plant trials and subsequent 
GMP production for clinical trials and in-market supply. Furthermore, the data 
generated could be used to create models for process development and process 
control and, ultimately, increase process robustness by applying the quality by 
design (QbD) approach (Rathore and Winkle, 2009).  
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10. Process Validation Concerns during 
Early Phase Product Development 
This chapter has been included in this thesis to satisfy the requirements of the 
Validation module of the Engineering Doctorate programme. 
10.1. Introduction 
Monoclonal antibodies (mAbs) are complex high molecular weigth molecules 
difficult to manufacture because deviations from their final product quality 
attributes can detrimentally impact upon patient safety. Consequently, regulation 
of biologics includes final product characterisation, characterisation and control 
of raw materials and manufacturing process validation (Lutz, 2005). Process 
validation needs to meet the regulations set by the Food and Drug Administration 
(FDA), European Medicines Agency (EMA) and any other regulatory agencies 
required in the country where the drug is intended to be commerciliased.  
This chapter provides an overview of specific process validation issues arising for 
this project. That is, from the introduction of a post-centrifuge flocculation step 
in the mAb production process of a contract manufacturing organisation (CMO) 
such as Lonza Biologics.  
10.2. Validation Concerns for a Contract 
Manufacturing Organisation   
10.2.1. Technology Transfer between Manufacturing Sites  
Lonza Biologics is a CMO with production and research and development centres 
worldwide. While in some cases these two departments will be based at the same 
location, in others the facilities will be exclusively dedicated to one of them. 
Therefore, technology transfer, one of the major challenges in process validation, 
will have to take place at some point during the process development phase.   
The output of this research project has been obtained at small (process 
volumes < 1 mL) and laboratory (process volumes < 2 L) scale. The ultimate goal 
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was to translate these findings to production scale (process volumes of 20,000 L). 
As a consequence, the CMO will face difficulties when translating the flocculation 
and depth filtration unit operations investigated in this thesis to a different scale 
and location while ensuring that an equivalent flocculation performance is 
achieved.    
10.2.2. Flocculation: an Alternative, Non-Established 
Primary Recovery Strategy 
This project relies on the use of a novel downstream technology for the 
biopharmaceutical industry. Although some research in the area has been 
published and previous studies have been performed within the CMO, no 
historical data and manufacturing knowledge has been built for this specific unit 
operation. Consequently, validation using historical data is not possible. This 
means process data has to be generated to achieve in-depth knowledge of the 
variables affecting flocculation performance and how this step affects subsequent 
unit operations.  
10.2.3. Process Monitor and Control  
Flocculation is a technology that depends on a myriad number of variables that 
affect the output of the process. Therefore, a strategy for process control and 
monitoring needs to be in place at manufacturing scale to maintain the critical 
process parameters within their acceptable range, as identified during process 
development. Such critical variables include the different flocculation parameters 
(e.g. stirrer speed, flocculant concentration, flocculant addition rate) and the 
characteristics of the fluid being flocculated. In that regard, all the cell culture 
variables and the levels of solid content and process-related impurities will need 
to be monitored as they determine the properties of the cell culture broth.  
A control or action plan is required in addition to a monitoring strategy. In the 
case physico-chemical variables such as pH and ionic strength are beyond the 
pre-determined thresholds, strategies like feed dilution, salt addition or pH 
adjustment must be in place and take place before flocculation is carried out. 
These action points may be performed in the same flocculation vessel or in-line 
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between the centrifuge and the flocculation vessel. Nonetheless, planning before 
the implementation of flocculation at manufacturing scale is necessary in order 
to perform any required minor changes in the process design, which will have to 
be re-validated. With regards to cell debris and other process-related impurities, 
these will vary depending upon (i) cell culture performance (e.g. peak cell density 
and/or viability at harvest); (ii) the effect of centrifugation shear forces on the 
cells; and (iii) centrifugation performance. The quantification and control of these 
process-related impurites is not as straight forward as with pH, for instance, and 
might not be performed within the specified time frame (i.e. from harvesting to 
centrifugation). As a consequence, other strategies such as empirical correlations 
between cell density or viability at harvest and process-related impurity content 
in the centrifuge supernatant might be useful in planning how to maintain the 
critical flocculation variables within their thresholds.   
Finally, the flocculation output and its effect upon the performance of the 
subsequent depth filtration step must be taken into account as well. Process 
control in this case might be carried out by empirical correlations between 
flocculation conditions and filter capacity, filtration throughput, impurity 
removal or/and process yield; quality control of the flocs such as particle size 
distribution or floc density may not be possible in the time frame required since 
these are off-line and time-consuming measurements.   
To sum up, process control and monitoring relies on the knowledge the 
manufacturer has of its process. In the case of new technologies, such as 
flocculation, this knowledge needs to be generated since no historical data is 
currently available for the CMO at production scale.   
10.2.4. Project-Specific Validation Concerns   
10.2.4.1. Flocculation  
One of the main validation concerns of adding a flocculation step in the primary 
recovery or purification steps of a bioprocess is the ability of the subsequent 
downstream unit operations to remove any residual flocculant present in the 
feed. First of all, it is necessary to determine whether the flocculation agent has 
any toxicity effects upon the patients, which can be humans or animals, if for 
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veterinary purposes. Toxicity may be defined differently depending upon the 
flocculant used. For example, the nature of the substance, the polymeric form 
(i.e. monomer versus polymer), final concentration, or the origin of the raw 
materials in the case of natural flocculants. Validated clinical studies must be 
carried out before the final Validation Master Plan so that patient safety is 
ensured and the toxicity thresholds of the flocculating agent used are defined.  
Following the toxicity concern, efforts must be concentrated in validating an 
assay to quantify the flocculating agent. This assay might vary depending on the 
flocculant used. However, this assay must be straightforward and robust so that 
flocculant removal (either total or below critical levels) can be proved during the 
validation and production runs.   
 In addition to the above, the effect that the residual flocculating agent has upon 
the lifetime, stability and performance of the depth filter and chromatography 
resins used has to be considered within the validation scenario. Potential 
detrimental effects are: (i) filtration media and chromatography resin blockage 
by the flocculant, particularly by high molecular weight polymeric flocculants; 
and (ii) charge interaction between the flocculant and the charged depth filter 
and/or chromatographic resin.   
10.2.4.2. Depth Filtration  
The most relevant filtration concerns for this unit operation are: (i) the nature of 
the interaction between the flocculant and the depth filter; and (ii) how 
flocculant-filter media interaction translates into filtration robustness.  
The removal of flocs and process-related impurities such as cell debris, host cell 
proteins and DNA by the depth filter chosen needs to be characterised and 
validated. However, enough historical data must be generated before process 
validation since similar processes might not be available for comparison 
purposes.   
Next, data for filter media extractables should be obtained from water and model 
solvent extraction studies performed by the filter supplier. If applicable, testing 
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for leachables will need to be carried out on-site by the CMO, although it could be 
performed by the filter supplier it they have a service in place.  
It is to be noted that, in the case the ultra scale-down (USD) depth filtration 
technology was validated, filtration studies could be performed at USD scale 
using process-relevant flocculated feed for the final Validation Master Plan.   
10.2.4.3. Assays for Process Performance Analysis 
The content of mAb, process-related impurities and residual flocculant need to 
be quantified after the flocculation and depth filtration steps. The presence of 
residual flocculant in the samples has been proved to interfere with assays used 
for process performance analysis such as enzyme-linked immunosorbent assays 
used during host cell protein quantification (Peram et al., 2010). Therefore, in the 
event of flocculant interference these assays will have to be modified or 
substituted by others depending on the flocculant used. This implies that the 
quantification methods for product and/or process-related impurities might 
have to be validated on a case-by-case basis in addition to the flocculant 
quantification assay developed.  
Furthermore, the reproducibility of the above assays must be ensured since the 
output of this research project was initially planned to be implemented into a 
different manufacturing location, hence they will eventually be performed by 
different operators.  
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11. Appendix 
11.1. Effect of Storage Conditions on the 
Characteristics of Mammalian Cell Centrate 
The effect of storage conditions (5°C vs. -80°C) on high cell density (HCD) 
mammalian cell centrate was evaluated measuring the centrate’s particle size 
distribution (PSD) and the optical density at 600 nm wavelength (OD600); 
measurements were performed according to Section 2.11.4 and Section 2.11.1, 
respectively. Protein degradation during storage at 5°C was also studied for a 
period of 95 days; protein degradation was studied via polyacrylamide gel 
electrophoresis in non-reducing conditions and with silver staining as described 
in Section 2.10.5.  
11.1.1. Storage at 5°C 
High cell density centrate was stored at 5°C in the presence of 0.05 % w/v sodium 
azide to prevent bacterial growth (Lichstein and Soule, 1944) for a period of up 
to 95 days. However, the HCD centrate used in the flocculation studies was stored 
at 5°C for a period of up to 15 days. In order to evaluate the effect that storage at 
5°C had upon the centrate’s protein profile, HCD centrate samples were taken 
over a period of 3 months and analysed via SDS-PAGE. The electrophoresis gel 
was stained with silver ions to achieve higher protein sensitivity (i.e. in the 
nanogram range) than with the Coomassie blue dye (Merril et al., 1981a, 1981b). 
A visual inspection of the gel (see Figure 11.1) concluded that the number of 
bands per sample did not change over the time period studied. Protein 
quantification of the bands could not be performed due to the limitations of silver 
staining with regards to quantification purposes (Grove et al., 2009). 
Nonetheless, protein degradation reactions such as peptide bond hydrolysis 
and/or aspartic acid isomerisation are expected to have taken place (Rathore and 
Rajan, 2008). 
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Figure 11.1. Effect of storage at 5°C on the protein profile of high cell density 
mammalian cell centrate.  
Gel electrophoresis was performed in non-reducing conditions and stained with a 
commercial silver staining kit as described in Section 2.10.5. Samples were diluted 
1 in 200 before gel loading. A commercial protein standard (see Section 2.10.5), 
referred to as Std in the figure, was loaded in the first and last lanes; the molecular 
weight values, expressed in kDa, are detailed in the figure. From left to right, HCD 
mammalian cell centrate samples were: H (centrate sampled on harvest day) and 
9, 19, 29, 36, 48, 62, 74, 84 and 95 (days in storage at 5°C from cell culture harvest). 
All samples contained 0.05 % w/v sodium azide.  
 
The OD600 of the HCD centrate was also measured over a period of 3 months to 
evaluate any change in the solids content (Berrill et al., 2008; Chatel et al., 2014; 
Hogwood et al., 2013b; Kim et al., 2001; Lau et al., 2013; Tait et al., 2009; Tustian 
et al., 2007). Table 11.1 shows OD600 increased 1.7 fold after a three-month 
storage period at 5°C. This data suggested the formation of larger solid particles 
(Roush and Lu, 2008) as a result of particle aggregation and/or protein 
degradation during long-term storage (Rathore and Rajan, 2008). The values of 
OD600 were maintained around 0.090 A.U. during the first 11 days of storage, 
when the HCD centrate was used in the flocculation studies.  
Due to the limited availability of HCD cell culture material, which was supplied by 
Lonza Biologics (Slough, UK), HCD centrate was required to be stored for long 
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periods of time. The results obtained when storing the HCD centrate at 5°C 
suggested that other storage methods were needed.   
Table 11.1. Change in optical density at 600 nm wavelength of the high cell 
density mammalian cell centrate stored at 5°C.  
Optical density measurements at 600 nm were taken with a spectrophotometer as 
described in Section 2.11.1. Cell culture (Xceed™ cell line; peak cell 
count = 29.0x106 cells.mL-1) was obtained from Lonza Biologics (Slough, UK), and 
clarified at UCL using a pilot scale disc-stack centrifuge (Q/∑ = 2.85x10-8 m.s-1). 
Centrate was stored at 5°C in the presence of 0.05 % w/v sodium azide. One 
standard deviation of triplicate measurements where n = 1 is indicated.  
 
Days stored at 5°C OD600 (A.U.) 
0 0.087 ± 0.003 
6 0.092 ± 0.002 
8 0.096 ± 0.003 
11 0.093 ± 0.009 
90 0.152 ± 0.012 
91 0.130 ± 0.015 
92 0.148 ± 0.011 
 
11.1.2. Storage at -80°C 
A 200 mL aliquot of HCD mammalian cell centrate was stored at -80°C to study 
the effect of freeze-thawing on the particle content of the centrate, and by doing 
so, assess whether freezing was a viable storage option for the HCD centrate. The 
PSD and the OD600 of the HCD centrate were measured before and after freezing 
at -80°C; the measurements were performed in less than 1 hour after 
centrifugation (i.e. fresh centrate) and after thawing at room temperature the 
HCD centrate stored at -80°C (i.e. thawed centrate). Figure 11.2 shows the HCD 
centrate was always constituted of a bimodal population of particles. In the fresh 
centrate the particles ranged from 0.041 to 0.974 µm and from 1.24 to 128 µm 
(see Figure 11.2). In the thawed material the solid particulates ranged from 0.041 
to 0.862 µm and from 1.24 to 100 µm (see Figure 11.2). Therefore, freeze-thawing 
did not significantly change the size of the solid particulates since particle size 
decreased by 0.112 µm (submicron particles) and by 28.0 µm (larger sized 
particles). Nonetheless, the percentage volume frequency values changed during 
the freeze-thawing process (see Figure 11.2). The maximum percentage volume 
frequency value for the submicron particles decreased from 372 to 152 % after 
freeze-thawing (see Figure 11.2), thus representing a 2.5 fold reduction. 
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Contrary, the percentage volume frequency of the larger sized particles increased 
from 4.4 to 6.6 % after freeze-thawing (see Figure 11.2), which was equal to a 
1.5 fold increase. These data suggested the submicron particles (allegedly cell 
debris) formed larger particles sized between 1.24 and 100 µm during the 
freeze-thawing process.  
When comparing the values of OD600 before and after freezing, freeze-thawing led 
to a 2.3 fold increase (0.094 ± 0.002 A.U. – fresh centrate and 0.220 ± 0.005 A.U. 
– thawed centrate). The increase in the percentage volume frequency of particles 
sized between 1.24 and 100 µm (see Figure 11.2) could have led to the rise in 
OD600 observed. However, proteins in solution and other impurities could have 
also precipitated upon freeze-thawing (Rathore and Rajan, 2008) and resulted in 
particles out of the detection size range of the laser light diffraction technique 
used (0.02 to 2000 μm).  
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Figure 11.2. Effect of freeze-thawing on the particle size distribution of high 
cell density mammalian cell centrate.  
The PSDs of fresh and thawed HCD mammalian cell (Xceed™ cell line; peak cell 
count = 29.0x106 cells.mL-1) centrate (Q/Σ = 2.85x10-8 m.s-1) were measured via laser 
light diffraction (see Section 2.11.4). The fresh PSD curves were obtained within an 
hour of centrifuging the HCD mammalian cell culture fluid. The thawed PSD curves 
were obtained after a 200 mL aliquot of HCD centrate stored at -80°C was defrosted 
at room temperature. The PSD results are divided in 3 graphs with the x and y-axis 
adjusted accordingly. Error bars indicate one standard deviation where n = 6 
(fresh) and n = 12 (thawed).  
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